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Abstract 
 
A physiological culture system that supports the in vitro growth (IVG) and development of 
oocytes would be an invaluable tool for the development and optimisation of fertility 
preservation techniques.  Markers of oocyte, follicle and ovarian stromal tissue normality need 
to be established to ensure in vitro-derived oocytes are healthy and developmentally 
competent. 
 
A 2-step, physiological IVG system was developed that supported (1) activation, growth and 
development of ovine primordial follicles in situ over 16-23 days; yielding 37 secondary follicles 
over 31 repeat cultures and (2) development of in vivo- (n=85) and in vitro-derived secondary 
follicles to the early antral stage, 25% and 19%, respectively.  Step (1) was compared to an 
accelerated system (n=24), which, unlike the physiological system, resulted in a significant 
increase (p<0.05) in the proportion of degenerating follicles and decrease (p<0.05) in stromal 
tissue integrity following 6 days culture compared to day 0 control tissue.  In addition a 
significantly higher yield of transitional (p<0.01) and secondary (p<0.05) follicles resulted from 
the physiological vs. the accelerated system.  The expression patterns of 20 genes key to 
oogenesis and folliculogenesis were established in vivo and compared to stage-matched 
samples derived using the physiological IVG system, revealing significant changes (p<0.05) in 
the expression of AMH, IGF1, INHα, INHβA, FST, ZP2, GTSF1, BMP6, BMP15 and MEST.  Step (1) 
was used to evaluate damage to oocyte and ovarian tissue health following the perfusion of 48 
ovaries, with either 1.5M dimethyl sulphoxide (DMSO) or L-15 control medium, in combination 
with the use of NMR spectroscopy to determine the level of DMSO permeation.  Perfusion 
times of 10 and 60 minutes were required permeate the pedicle and cortex tissue, 
respectively, however, 60 minutes perfusion resulted in a significant decrease in follicle 
number (p<0.01) and stromal tissue integrity (p<0.05).  
 
The overall results indicate that the IVG of oocytes is a suitable tool to both assess the patency 
of fertility preservation systems and as a means to restore female fertility. 
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1 General Introduction 
 
Improvements in cancer treatments have resulted in increasing survival rates of patients.   
However, treatments used are often aggressive and can cause infertility.  In addition patients 
suffering from premature ovarian failure (POF), abdominal trauma, Turner syndrome, or other 
autoimmune diseases that require chemotherapeutic treatment would benefit from the 
development of fertility preservation techniques.  Current methods of fertility preservation, 
such as oocyte or embryo cryopreservation are not suitable for prepubertal girls or 
adolescents nor are they ideal for women of reproductive age who have not yet found their 
life partner.  Recent advances in cryobiology have meant that it is now possible to freeze-store 
intact ovarian tissue for girls and young women requiring fertility preservation.  At present 
fertility restoration may be achieved after ovarian freezing by autograft.  However, there is a 
risk that malignant cells may be reintroduced.  The ovary is not immunologically privileged so 
allografting of the tissue is not possible.  The development of methods to enable the complete 
in vitro growth of follicles from the primordial to pre-ovulatory stages would overcome many 
of the problems posed by current fertility restoration methods.  Although the complete in vitro 
growth and maturation and subsequent fertilisation of oocytes has resulted in the birth of live 
young in mice this has been much more difficult to replicate in larger species and humans.  
This is partly due to both the greater timescales of oogenesis and folliculogenesis and the size 
of oocytes and follicles in larger species, as well as decreased accessibility of tissue.  However, 
progress has been made towards the optimisation of these systems.   
 
Oogenesis and folliculogenesis are complex and protracted processes.  Growth and 
development of follicles and oocytes in vivo are regulated by numerous peptides and growth 
factors as well as hormones such as the pituitary gonadotrophins: follicle stimulating hormone 
(FSH) and luteinizing hormone (LH) and ovarian steroid hormones including progesterone (P4), 
testosterone and oestrogen (E2).  The development of oocytes within follicles from the 
primordial to the pre-ovulatory stage takes around 6-9 months in humans and is only 
completed once puberty has been reached. 
 
A clear understanding of the processes of oogenesis and folliculogenesis, as well as the 
optimisation of in vitro growth and maturation systems are of great importance to fertility 
preservation strategies.  Before these techniques are used as fertility restoration methods in 
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humans it is essential that the in vitro-derived oocytes are developmentally competent and 
that following fertilisation the health of the resultant offspring can be guaranteed.  In order to 
ensure this goal is achieved a greater understanding of the expression patterns of genes during 
oocyte development in vivo is required, as well as the establishment of imprints that occurs 
during oogenesis.  This review will therefore outline the current understanding of the 
processes of oogenesis and folliculogenesis in vivo, the current methods of fertility 
preservation, progress that has been made with respect to developing culture systems that 
support the in vitro growth and maturation of oocytes and the methods used to establish the 
developmental competence of these in vitro-derived oocytes. 
 
1.1 Formation and colonization of the early human ovary 
The human ovary is composed of germ and somatic cells.  The somatic cell components are 
derived from primarily mesonephric cells, as well as coelomic epithelium and mesenchymal 
cells.  The proliferation of these somatic cell components starts 4 weeks post fertilisation (p.f.) 
resulting in the formation of the fetal ovary (Byskov, 1986).  Germ cells, however, are derived 
from an extragonadal region and must migrate to the genital ridge.  The formation and 
migration of primordial germ cells (PGCs) and subsequent differentiation into oogonia and 
oocytes has been extensively reviewed by various authors (Motta et al., 1997a, Motta et al., 
1997b, Pereda et al., 2006).  PGCs can first be detected in the human embryo 3 weeks p.f., via 
staining for the enzyme, alkaline phosphatase.  Bone morphogenetic proteins (BMPs) – 2 
(endoderm-derived), 4 and 8b (ectoderm-derived) are required for PGC generation in mice 
(Ying et al., 2001, Ying and Zhao, 2001, Lawson et al., 1999).  Early evidence suggests that 
these factors may also be required in human PGC specification (Hiller et al., 2011).  Primordial 
germ cells are located in the endoderm of the dorsal wall of the yolk sac, close to the 
neighbouring allantois.  To reach the genital ridge the PGCs first passively migrate to the 
connective tissue of the hindgut, this occurs around week 4 p.f.  This movement is brought 
about by the rearrangement of the embryo into a tubular shape as it develops.  Further 
migration of the PGCs from the hindgut, through the dorsal mesentery, to the genital ridge is 
an active process occurring in week 5-6 p.f. 
 
The active migration of PGCs is enabled by a change in the morphology and cytoplasmic 
contents of the cells.  Initially PGCs are rounded cells, with few organelles but rich in glycogen 
particles and lipid droplets, which may be sources of energy substrate once active migration 
has commenced (Funkuda, 1976).  On leaving the hindgut PGCs become spindle-shaped.  The 
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development of pseudopodia and the concentration of microtubules and microfilaments in the 
cytoplasm enable the PGCs to actively migrate via amoeboid-like movements to the genital 
ridge (Fujimoto et al., 1977).  Migration is also aided by the interaction between the PGCs and 
somatic cells as the 2 cell components interact via cell contacts and chemotaxic signalling.  Kit 
ligand (KL) exists in 2 forms, a soluble and a membrane-bound form, KL-1 and KL-2, 
respectively (see Section 1.5) (Huang et al., 1992). The interaction between the 2 forms of KL 
and their receptor, c-kit, stimulates PGC survival (KL-2) and migration (KL-1) to - and 
colonisation (KL-2) of - the genital ridge (Driancourt et al., 2000, Hoyer et al., 2005, Wehrle-
Haller and Weston, 1995).  Leukaemia inhibitory factor (LIF) and fibroblast growth factor (FGF) 
have been identified as cytokines which stimulate PGC survival and proliferation, respectively 
(Anderson et al., 2001).  Members of the Transforming growth factor (TGF)-β superfamily have 
also been shown to contribute to the regulation of the migration process, for example TGF-β1 
has been shown to negatively regulate PGC proliferation (Godin and Wylie, 1991).  Active 
migration is further aided by the interaction between components on the surface of the PGCs 
and the extracellular matrix surrounding the somatic cells.  During this migratory period the 
PGCs undergo division by mitosis (Garcia-Castro et al., 1997).  Activin A has been implicated as 
a stimulatory factor with respect to PGC proliferation and survival (Martins da Silva et al., 
2004). 
 
1.2 Development of PGCs to primordial follicles 
Upon reaching the genital ridge the PGCs lose their motility and become incorporated into 
germ cell nests.  They are now termed oogonia.  Within these nests, synchronous and rapid 
mitotic division of the oogonia, in which the cytoplasm is incompletely divided, results in the 
formation of intracellular bridges (Pepling and Spradling, 1998).  In the human ovary mitotic 
division of oogonia continues until around 12 weeks p.f. when a transition to meiotic cell 
division begins (Gondos et al., 1986).  Oogonia located in the inner cortex are the first to 
undergo this transition and are now termed primary oocytes. The commencement of meiosis 
is accompanied by both changes in the oocyte nucleus and cytoplasmic rearrangements, which 
are important for oocyte metabolism (Makabe et al., 1992).  Meiosis progresses up to 
diplotene of prophase I (4 months p.f.) where it then arrests until oocyte maturity is complete.  
Mitotic divisions continue up to 7 months p.f. in the human ovary and the high rates observed 
in months 3-4 generate a maximum number of germ cells.  Around 6.8 million have been 
observed at month 5 p.f. in humans.  However, this number greatly declines to 2 million at 
birth as activation of oocyte growth occurs but is not sustained past the early antral (EA) stages 
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due to the absence of gonadotrophic stimulation.  The stores are not re-established as mitosis 
ceases and germ cells degenerate within the ovary, and are lost via exfoliation from the 
ovarian surface (Baker, 1963, Motta and Makabe, 1986, Pepling and Spradling, 2001). 
   
Oocyte survival is dependent upon germ cell incorporation into primordial follicles.  Primordial 
follicles each consist of a diplotene oocyte encompassed by a single layer of squamous 
follicular somatic cells, termed pre-granulosa cells, which are derived from the ovarian surface 
epithelium (Eppig, 2001, Sawyer et al., 2002).  Primordial follicle formation requires the 
breakdown of germ cell nests.  This is achieved via the majority of oocytes undergoing 
apoptosis thus ensuring the surviving oocytes have increased access to pre-granulosa cells and 
intracellular organelles, which are actively transported via the aforementioned intracellular 
bridges (Gondos, 1973, Pepling and Spradling, 1998).  Cytoplasmic processes originating from 
the surrounding somatic cells aid the breakdown of connections between germ cells in oocyte 
nests and once the pre-granulosa cells have secreted an outer membrane, the basal lamina, 
the primordial follicles become isolated from the surrounding stroma and exist as individual 
entities (Francavilla et al., 1990). The basal lamina is primarily composed of collagen IV, laminin 
and entactin/ nidogen, the exact composition, however, varies throughout follicular 
development (Rodgers et al., 2003).   
 
Oocyte survival is dependent upon the maintenance of interactions with granulosa cell (GC) 
layers, and vice versa.  The somatic cell compartment provides each oocyte with the necessary 
nutrients, amino acids, growth factors and oxygen to support growth and maturation.  
Bidirectional communication of regulatory factors between the germ cell and somatic 
compartments is required to regulate oocyte and follicular growth and development is 
achieved via the presence of heterologous and homologous gap junctions between the oocyte 
and somatic cells and between the GCs themselves (Anderson and Albertini, 1976, Eppig, 
2001).  As oocyte-derived factors play a key role in the regulation of paracrine factors 
produced by the GCs, the oocyte is effectively regulating its own microenvironment (Gilchrist 
et al., 2004).  Furthermore, the production of factors by oocytes and the establishment of 
morphogen gradients results in a heterologous pattern of gene expression in GC populations in 
the later stages of development.  The oocyte is held in meiotic arrest by the maintenance of 
gap junctional contacts which facilitate the provision of somatic cell-derived cyclic adenosine 
3′,5′-monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) to the oocyte 
(Anderson and Albertini, 1976, Gilchrist, 2010).  Note that second messenger molecule cAMP is 
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also produced by the oocyte.  Maintenance of meiotic arrest by high cAMP levels is achieved 
via the promotion of cAMP-dependent protein kinase A, an enzyme that inhibits maturation 
promoting factor (Gilchrist, 2010).  The supply of cGMP to the oocyte is also key as this inhibits 
phosphodiesterase 3, an enzyme that degrades cAMP, thus maintaining high levels of cAMP 
(Törnell et al., 1991, Tsafriri et al., 1996).  Closure of gap junctions in response to the LH surge 
prevents the transfer of cAMP and cGMP from the somatic cells to the oocyte and thus results 
in the resumption of meiosis (see Section 1.5.4). 
 
The transcription factor, Factor in the germline-α (Fig-α) has been implicated in the assembly 
of primordial follicles via its role in the regulation of the expression of oocyte-specific genes 
involved in folliculogenesis and the formation of the zona pellucida (ZP).  Initially shown in 
mice prior to the identification of human homologues, Fig-α forms a heterodimer with 
ubiquitously expressed transcription factor, E12 and then binds an E-box in the promoter 
region of the zona genes (Huntriss et al., 2002, Bayne et al., 2004).  Targeted mutagenesis of 
Fig-α in mice results in abnormal follicular development (Soyal et al., 2000). 
 
1.3 Morphological aspects of preantral follicle development 
Preantral follicle growth and development is characterised by the oocyte increasing in volume 
as it acquires the proteins needed for maturation, fertilisation and early development of the 
post-implantation embryo prior to embryonic genome activation.  The activation of primordial 
follicle growth is accompanied by the pre-GCs becoming cuboidal and proliferating to form 
several avascular layers.  The morphological changes occurring throughout follicle 
development and the approximate size of oocytes and follicles are summarised in Figure 1.1.  
At the primordial stage spheroidal/ elliptical follicles consist of a centrally located germinal 
vesicle (GV) oocyte surrounded by a continuous or discontinuous layer of squamous GCs all of 
which is enclosed by a thin basal lamina.  These follicles are mainly located in the outer layer of 
ovarian cortex (Zamboni, 1974).  Initiation of follicle growth can be divided into 2 stages.  
During the first stage GC proliferation results in the transition to a thicker single GC layer 
consisting of cuboidal/ columnar cells.  During the second stage the follicle and oocyte 
diameter as well as GC number increase dramatically.  The point at which the oocyte starts to 
grow at a higher rate can be linked to the number of GCs in the largest cross-section of the 
follicle.  For example, this number is 14-15 in sheep and humans and 40 in the cow (Cahill and 
Mauleon, 1981, Gougeon and Chainy, 1987, Braw-Tal and Yossefi, 1997).   
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Figure 1.1 A diagrammatic representation of the morphological aspects of follicular development from the primordial to the Graafian stage.  Oocyte and follicle 
diameters are shown for mouse, sheep and human, information taken from 1 Griffin et al. (2006), 2 Pedersen (1970), 3 Lundy et al. (1999), 4 Gonzalez-Bulnes et al. 
(2001), 5 Himelstein-Braw et al. (1976). 
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During the oocyte growth phase the deposition of a glycoprotein coat within the perivitelline 
space initiates, resulting in the formation of the ZP.  In humans ZP deposition begins in the 
primary follicle and by the transitional stage these areas of deposition have coalesced to form 
a continuous layer around the oocyte.  Cytoplasmic processes traverse the ZP allowing the 
maintenance of intercellular contact (Zamboni, 1974).  The composition of the ZP is species-
specific, ensuring that only sperm from the correct species can fertilise the oocyte.  The mouse 
ZP is composed of 3 sulphated glycoproteins (ZP1, ZP2 and ZP3) and is permeable to relatively 
large macromolecules.  A fourth ZP gene, ZP4, has been identified and shown to be expressed 
in the oocytes of humans, rats and hamsters (Lefievre et al., 2004, Gupta and Bhandari, 2010).  
Glycoproteins; ZP2 and ZP3 form heterodimers which are cross-linked by ZP1 (Wassarman et 
al., 1996).  In the mouse, the sperm binds the ZP primarily via ZP3 resulting in the induction of 
the acrosome reaction.  Whereas in the human 3 ZP proteins, ZP1, ZP3 and ZP4, facilitate the 
binding of sperm and induction of the acrosome reaction (Gupta and Bhandari, 2010).  In both 
humans and mice the ZP2 protein acts as a secondary sperm receptor and is not involved in 
the acrosome reaction.  Once the oocyte is fertilised hardening of the ZP provides a block to 
polyspermy (Wassarman, 1988).  At the transitional stage of follicle development a theca layer 
begins to form.  Theca cells are derived from fibroblast-like precursor cells present in the 
ovarian stroma.  Once the follicle has developed to the secondary stage it will be enclosed by a 
full theca layer that will start to differentiate into 2 distinct populations.  Surrounding the basal 
lamina, the theca interna is composed of highly vascularised steroidogenic cells, 1 or 2 
arterioles provide vascularisation (Gougeon, 1996).  Whereas the theca externa is composed of 
a loosely associated layer of connective tissue of non-steroidogenic cells (Magoffin, 2005).  
 
Figure 1.1 contains information regarding oocyte and follicle diameter, respectively, during 
preantral development in the sheep, human and mouse.  Development from the primordial 
follicle to the secondary stage takes around 18, 78 and 270 days in the mouse, sheep and 
human, respectively (Cahill and Mauleon, 1980, Himelstein-Braw et al., 1976, Gougeon, 1986, 
Picton, 2001, Pedersen, 1970).  Throughout the process of follicle development, up to antral 
cavity formation, the oocyte increases dramatically in size (Cotterill et al., 2013) and acquires 
the components required to attain competence with respect to resumption of meiosis, 
germinal vesicle breakdown, chromatin decondensation and to block polyspermy (Picton et al., 
1998).  Oocyte growth is achieved via the accumulation of ions, water and lipids and due to the 
fact that the oocyte does not divide the volume of cytoplasm is maintained.  During 
development the oocyte undergoes large-scale cytoplasmic rearrangement as organelles are 
redistributed and new organelles and vesicles containing substrates required for synthesis and 
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energy are acquired.  The process of oocyte development has been reviewed in detail in 
numerous reviews (Picton et al., 1998, Li and Albertini, 2013, van den Hurk and Zhao, 2005). 
 
1.4 Morphological aspects of antral follicle development  
The major morphological changes that occur as follicles develop from the preantral stages 
onwards are related to growth. The manifestations of growth are marked by continued GC 
proliferation, followed by the formation of a follicular antrum (Lussier et al., 1987), and the 
differentiation of GCs into cumulus and mural populations.  The process of follicle 
development is long and protracted, for example the development of follicles from the 
transitional stage up to the pre-ovulatory stage takes around 6 months in sheep (Cahill and 
Mauleon, 1980). 
 
Antrum formation begins when the follicle reaches a species-specific size; 0.2-0.4mm in human 
(Gougeon, 1986, Gosden and Telfer, 1987a).  Antral cavity formation is promoted by 
gonadotrophins (see Section 1.5.3).  Figure 1.1 illustrates the process of antral cavity formation 
in which follicular fluid (FF) begins to accumulate in multiple lacunae, possibly in areas of 
reduced GC contact (Baca and Zamboni, 1967).  As the accumulation of fluid continues these 
areas expand and coalesce forming 1 large antrum, which continues to grow (Baca and 
Zamboni, 1967).  Fluid accumulation occurs as a result of glycoprotein production by the GCs.  
Glycoproteins, such as GC-derived hyaluranon, inter-α trypsin inhibitor and versican, are 
secreted into the FF then bind/ cross-link each other so are therefore retained (Clarke et al., 
2006).  The presence of these glycoproteins forms an osmotic gradient which causes fluid to 
enter the developing antral cavity from the thecal vasculature (Rodgers and Irving-Rodgers, 
2010).  This process requires the remodelling of cell-cell junctions, as well as the theca layer 
and ovarian stroma.  The FF may be an important source of various blood and follicular cell-
derived substances including gonadotrophins, steroids, growth factors, enzymes, 
proteoglycans and lipoproteins which are required for the regulation of folliculogenesis and 
oogenesis (van den Hurk and Zhao, 2005). 
 
The division of the GCs into 2 morphologically distinct populations occurs as a consequence of 
the formation of the follicular antrum.  The cumulus and mural GCs have a common origin but 
differentiate to become functionally distinct with respect to the production of secretory 
products and receptor expression (Telfer et al., 1988).  For example, expression of LH receptors 
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is present to a much greater extent in the mural rather than cumulus GCs (Amsterdam et al., 
1975).  Follicular antrum expansion and GC proliferation continue until the pre-ovulatory 
follicle reaches a size of around 20mm (Gougeon, 1986).  Progression from the secondary to 
pre-ovulatory follicle takes around 85 days in humans.  
 
1.5 Factors controlling oogenesis and folliculogenesis 
1.5.1 Primordial follicle activation 
Until recently it was widely accepted that the total population of oocytes in the ovary – the 
ovarian reserve - was finite and that by birth there were no oogonial stem cells remaining, 
therefore explaining why when the ovarian reserve became depleted this resulted in ovarian 
failure and menopause in women (Gosden and Telfer, 1987a, Zuckerman, 1951).  Based on this 
theory the Faddy-Gosden model, in which the rate of follicle activation increases with 
decreasing size of the remaining follicle reserve, was presented as a means of illustrating the 
rate of depletion of the follicle store (Faddy and Gosden, 1996).  However, increasing evidence 
is emerging that a limited population of oogonial germ cells may exist in adult ovaries in both 
mice (Johnson et al., 2004, Johnson et al., 2005) and human (White et al., 2012) and that these 
cells are mitotically active and capable of forming oocytes and thus may contribute to the 
replenishment of the primordial follicle store.  It remains unclear what contribution, if any, the 
small number of putative ovarian stem cells make to the reproductive longevity of an 
individual.  
 
Locally produced growth factors are essential for the activation and development of follicles.  
From the EA stage onwards gonadotrophins are also essential (see Section 1.5.4).  Both the 
oocyte and somatic cells of the follicle produce growth factors that have autocrine and 
paracrine actions.  Gap junctional contacts which extend from the somatic cells, through the 
ZP to the oolemma enable the transfer of growth factors between the different cell types 
(Anderson and Albertini, 1976).  The nature of these contacts alters throughout follicular 
development, with respect to their number and form, to meet the requirements of the follicle.  
The process of gap junction (GJ) alteration is mediated to an extent by external factors, such as 
FSH (Anderson et al., 2001).   
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Both oocyte and follicular somatic cell development depend upon the maintenance of 
signalling between the 2 compartments.  Granulosa cell contact is essential to the oocyte to 
hold it in meiotic arrest until it has become competent to progress to metaphase II (MII) 
(Pincus and Enzmann, 1935, Eppig, 2001, Gilchrist et al., 2008).  Although oocytes are usually 
able to resume meiosis once antrum formation has occurred they will not yet have acquired 
the molecular and cytoplasmic machinery needed to complete nuclear maturation and to 
progress to MII (Handel and Eppig, 1998).  The oocyte will not acquire the machinery to enable 
vital processes such as ‘sperm head penetration, decondensation of chromatin and 
polyspermy block until the final days of maturation prior to ovulation’ (Picton et al., 1998).  
Furthermore, exposure to certain oocyte-secreted factors is essential to prevent the 
premature luteinisation of somatic cells (el-Fouly et al., 1970, Nekola and Nalbandov, 1971).  In 
this section the roles of growth factors that are key to folliculogenesis and oogenesis will be 
summarised and the importance of oocyte-granulosa cell interactions discussed.  Key species- 
specific differences and conflicting information will be highlighted.  These are complex 
processes and conflicting evidence concerning the roles of various factors also exists, this may 
be partly due to differences in techniques used in different studies.   
 
1.5.2 Oocyte-derived factors 
The oocyte and somatic cell compartment of the follicle are mutually dependent upon each 
other with respect to the production of growth factors that promote development and 
differentiation and the provision and utilisation of nutrients.  The oocyte was originally 
thought to be passive, however, evidence now shows that the oocyte is key in regulating its 
own microenvironment.  The oocyte achieves this via the secretion of paracrine factors that 
promote the surrounding GCs to differentiate and develop in such a way as to provide the 
oocyte with the substrates required for normal continued growth and development.    
 
Numerous oocyte-derived transcription factors that are key to PGC migration, oocyte survival, 
follicle assembly and oogenesis have been identified in mice, with some homologues also 
identified in humans, see Table 1.1.   
 
 
 
 
1
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Table 1.1 Oocyte-derived transcription factors; their expression pattern and experimental evidence to support their roles.  References: 1 Kehler et al. (2004), 
2 Yamaguchi et al. (2009), 3 Liu et al. (2007), 4 Castrillon et al. (2003), 5 Li et al. (2010), 6 John et al. (2008) 7 Biggs et al. (2001), 8 Pangas et al. (2006), 9 Choi 
et al. (2008b), 10 Huntriss et al. (2002), 11 Bayne et al. (2004), 12 Soyal et al. (2000), 13 Rajkovic et al. (2004), 14 Choi et al. (2008a). 
 Transcription Factor Expression Role Evidence/ Extra Information 
Octamer-binding protein 4 (OCT-4) 
PGCs 
Required for PGC 
survival 
Decrease in PGC population in Nanog and Oct4 knockdown mice 1, 2 
NANOG 
PGCs 
Required for PGC 
survival 
FOXO3a - mouse, FOXO2 - human Primordial 
and 
Primary 
Inhibition of primordial 
follicle activation 
Inactivation of FOXO in mouse ovarian cortex in vitro results in the large scale 
activation of primordial follicles. Activation regulated by (PI3K)-Akt pathway; 
which, when active hyperphosphorylates FOXO3a/2 leading to deactivation and 
nuclear export 3, 4, 5, 6, 7 
Spermatogenesis and oogenesis 
specific basic helix-loop-helix 1 
(SOHLH1) 
Primordial 
and 
Primary 
Required for oogenesis Knockout of Sohlh1 in mice results in down regulation of Fig-α and Nobox 8 
Spermatogenesis and oogenesis 
specific basic helix-loop-helix 2 
(SOHLH2) 
Primordial 
and 
Primary 
Critical for regulation of 
early oogenesis 
Misexpression of oocyte-specific genes in Sohlh2 knockout mice. GCs are unable 
to differentiate past primordial phenotype in knockout mice 9 
FIG-α PGC 
onwards 
Primordial follicle 
assembly and zona 
formation via regulation 
of the expression of 
oocyte-specific genes 
Targeted mutagenesis of Fig-α in mouse oocytes resulted in abnormal follicular 
development. Fig- α forms a heterodimer with ubiquitously expressed 
transcription factor, E12 and then binds an E-box in the promoter region of the 
zona genes 10,11,12 
Newborn ovary homeobox 
(NOBOX) 
Primordial 
onwards 
Regulates expression of 
oocyte-specific genes 
Oocyte-specific genes are down-regulated in NOBOX deficient mice. Critical for 
primordial to primary follicle transition 13 
LIM homeobox protein 8 (LHX8) Primordial 
onwards 
Critical for regulation of 
early oogenesis 
Misexpression of oocyte-specific genes in Lhx8 knockout mice. Down regulates 
Nobox pathway 14 
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One way in which the activation of primordial follicles is promoted is via the 
phosphatidylinositol-3′-kinase (PI3K)-Akt pathway, as shown in Figure 1.2 (Reddy et al., 2008).  
As mentioned in Table 1.1 the action of Forkhead transcription factor (FOXO) 3a/2 is regulated 
via PI3K-Akt (Castrillon et al., 2003).  FOXO inhibits primordial follicle activation.  Interaction of 
KL and its receptor, c-kit, results in the phosphorylation of PI3K, which then binds and 
phosphorylates phosphatidylinositol 4,5-bisphosphate (PIP2) to form phosphatidylinositol 
(3,4,5)-trisphosphate (PIP3) (Reddy et al., 2005).  Once phosphorylated PIP3 then 
phosphorylates and activates the protein kinase B, Akt, which can then phosphorylate FOXO.  
Hyperphosphorylation of FOXO by PI3K-Akt results in its exportation from the nucleus thus 
preventing its inhibitory action on follicle activation (Adhikari and Liu, 2009). In addition, the 
PI3K-Akt pathway promotes activation of follicles via the indirect activation of mammalian 
target of rapamycin complex 1 (mTORC1).  The promotion of human primordial follicle 
activation by mTORC1 has been demonstrated in a study in which rapamycin, an inhibitor of 
mTORC1, reduced follicle activation rates (McLaughlin et al., 2011).  The PI3K-Akt pathway and 
therefore primordial follicle activation is negatively regulated, in part, by phosphatase and 
tensin homologue deleted on chromosome ten (PTEN) (Reddy et al., 2008).  The actions of 
PI3K are antagonised by PTEN as it dephosphorylates PIP3 to PIP2, thus inhibiting Akt.  In a 
study in which PTEN was inhibited, large-scale activation of primordial follicles was observed 
resulting from the exportation of FOXO from the nucleus (Li et al., 2010).  The follicle reserve is 
therefore partly maintained via the actions of PTEN.  Maintenance of the follicle reserve is also 
achieved via the PI3K-pathway mediated activation of 3-phosphoinositide-dependent protein 
kinase-1 (PDK1), although rather than suppressing primordial follicle activation this is achieved 
by promoting the survival of dormant follicles (Reddy et al., 2009).   
 
A number of important oocyte-specific growth factors that play key roles in the regulation of 
the development of the follicles have been identified, these include: growth differentiation 
factor 9 (GDF9) and bone morphogenetic protein (BMP)15 and BMP6.  These factors are 
members of the TGF-β superfamily, which will be discussed in greater detail in the following 
section.  There is also some evidence of TGF-β expression in the oocytes of rats, humans and 
cows, but not sheep (Juengel and McNatty, 2005). To this end, GDF9 is expressed by oocytes 
from the primary stage in mice and humans, and the primordial stage to the Graafian stage in 
sheep (Bodensteiner et al., 1999, McGrath et al., 1995, Bodensteiner et al., 2000, Teixeira Filho 
et al., 2002, Aaltonen et al., 1999).  This expression patterns is unlike that of BMP15, which is 
expressed from the primary stage up to ovulation, in sheep, humans and mice (Aaltonen et al., 
1999, Galloway et al., 2000, Dube et al., 1998).  GDF9 and BMP15 may form 
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homo/heterodimers, however, unlike all other members of the TGF-β superfamily they lack 
the conserved 4th cysteine residue needed for dimerisation (Dube et al., 1998).  BMP6 is 
expressed from the primordial to the antral stage in sheep (Juengel et al., 2006).  Unlike GDF9 
and BMP15, BMP6 expression has been detected in the GCs in mice, from the primary to antral 
stages (Elvin et al., 2000).  The exact expression patterns of BMP6 with respect to follicular 
stage are ill-defined, in the mouse and human.  Expression of BMP6 has been detected in 
primordial- and primary human follicles (Shi et al., 2009).   
 
Figure 1.2 Schematic representation of process of primordial follicle activation via the PI3K-Akt 
pathway in the (a) absence and (b) presence of activated PTEN.  Green and red boxes 
represent activation and deactivation, respectively.  Yellow circles indicate phosphorylation. 
 
The roles of GDF9, BMP15 and BMP6 are summarised in Table 1.2.  As previously described the 
expression patterns of these oocyte-derived factors are species-specific.  Similarly the actions 
of these factors vary between species.  For example, in rodents GDF9 is sufficient to promote 
GC proliferation, whereas in sheep both GDF9 and BMP15 are required (Lin et al., 2012).  In all 
species detailed in Table 1.2, however, the role of GDF9, BMP15 and BMP6 can be broadly 
summarised as regulation of the proliferation and differentiation of CCs in order to regulate 
and optimise the microenvironment experienced by the oocyte. 
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Table 1.2  Oocytes regulate the development and differentiation of granulosa cells to ensure that an optimised microenvironment is provided.  This is achieved via 
secretion of oocyte-secreted factors (OSFs).  The table below summarises key roles of the OSFs, the species in which there is evidence of this, the mechanism by 
which it is achieved and the evidence for this.  Abbreviations: gonadotrophin (GN), mouse (M), rodent (R), porcine (P), bovine (B), ovine (O) and human (H). 
References: 1 Joyce et al. (2000), 2 Thomas and Vanderhyden (2006), 3 Vanderhyden et al. (1992), 4 Otsuka et al. (2001), 5 Gilchrist et al. (2004), 6 Vitt et al. (2000) 
7 Gilchrist et al. (2008) 8 Otsuka et al. (2000), 9 (McNatty et al., 2005), 10 Su et al. (2009), 11 Sugiura et al. (2005), 12 Colonna and Mangia (1983), 13 Su et al. 
(2008), 14 Hussein et al. (2005), 15 Dragovic et al. (2005).  
 OSF-regulated process (species) Mechanism Evidence 
Regulation GC differentiation 
e.g. KL expression (M)
1,2
 
KL expression is suppressed by GDF9 (antral follicle) and 
stimulated by BMP15 (EA follicle).  BMP15 is also 
regulated by FSH via KL signalling 
In vitro studies revealed that GDF9 and fully grown, but not partially grown, oocytes 
inhibited GC KL expression  
Promotion of GC proliferation 
via production of mitogens 
(R,O)
3,4,5,6
 
GDF9 identified as OSF responsible but is not the sole 
contributor.  BMP6 is has a weak or no mitogenic effect 
on GCs in the sheep and mouse, respectively 
Culture of GCs with denuded rodent oocytes or GDF-9 increased GC number and 
thymidine incorporation 
Inhibition of CC luteinisation 
(M, P, B, O)
6,7,8,9
 
Via regulation of GC steroidogenesis - GDF9 and BMP15 
inhibit FSH-induced GC differentiation and P4 
production.  GDF9 inhibits FSH-induced E2 production.  
BMP6 inhibits P4 production (O) 
Removal of oocyte from COCs led to increased CC markers of luteinisation. This effect 
was reversed by oocyte co-culture. Effects of GDF9 and BMP15 on FSH-induced E2 
and P4 assessed using GC culture 
Regulation of metabolic 
cooperativity between CCs and 
oocyte (M, B, H)
10,11,12,13
 
Production of oocyte-derived factors GDF9 and BMP15 
stimulate CC production of metabolites (amino acids, 
cholesterol and oxidative phosphorylation substrates), 
which are then transferred to the oocyte via GJs 
Glycolysis - oocytes unable to use glucose as an energy source as they lack the 
glycolytic machinery, which CCs possess allowing them to supply oocytes with 
substrates required for oxidative phosphorylation.  Illustrated by removal of oocyte 
from COCs (M) 
Amino Acid and Cholesterol Biosynthesis - used radioactively labelled amino acids (eg. 
L-alanine) and acetate (cholesterol precursor) and tested levels of radioactivity in 
denuded oocytes vs. CC enclosed oocytes.  Levels in the cumulus-enclosed group were 
higher than in denuded oocytes (M). Illustrated by oocyte removal from COCs  
Promotion of CC survival (B)
14
 BMP15 and 6 implicated, whereas GDF9 is not. Effect via 
promotion and suppression of Bcl-2 (anti-apoptotic) and 
Bax (apoptotic) gene expression, respectively, in CCs 
Removal of oocyte from COCs resulted in increased levels of apoptosis in CCs, this 
effect was reversed by co-culturing with oocytes 
Promotion of CC mucification 
and expansion (M)
7,10,15
 
GDF9 and BMP15 production enables CCs to respond to 
GN and EGF-like peptide stimulation to undergo 
expansion and mucification, via EGF receptor induction 
Oocytectomy prevents cumulus expansion and mucification.  This can be reversed by 
co-culture with oocytes and/or factors GDF9.  Other OSFs also involved - shown using 
neutralising antibodies against GDF9 
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1.5.3 The transforming growth factor- β (TGF-β) subfamily and superfamily 
Many of the factors involved in folliculogenesis and oogenesis are members of the TGF-β 
subfamily and superfamily.  The cellular localisation and expression patterns in the mouse, 
sheep and human and roles of the members of the TGF-β subfamily and superfamily members 
are summarised in Table 1.3 and Table 1.4.  The TGF-β superfamily members share common 
structural motifs and form homo-or heterodimers via covalent disulphide bonds between 
conserved cysteine residues (Massague, 2000).  However, GDF9 and BMP15 are exceptions 
and form non-covalent bonds.  With the exception of inhibins A and B (see below), the 
majority of TGF-β superfamily members bind to and signal via serine/ threonine kinase 
receptors via a common pathway, summarised in Figure 1.3 (Chang et al., 2002, Miyazawa et 
al., 2002, Massague, 2000).  Oocyte-derived factors, GDF-9 and BMP-15, however, also signal 
via an alternative Mitogen-activated protein Kinase (MAPK) pathway.  Once activated MAPK 
isoforms ERK1/2 interact with Smads, which is essential for the promotion of GC proliferation 
(Moore et al., 2003, Su et al., 2002).   
 
 Figure 1.3 The TGF-β/SMAD pathway.   A member of the TGF- β superfamily (1) binds a type II 
receptor (2) and a type I receptor (3) resulting in the formation of a receptor complex (4).  This 
induces the phosphorylation and activation (5) of the type I receptor, which can then 
phosphorylate a receptor-regulated SMAD (R-Smad).  Smad4 (a co-smad) (6) then forms a 
heteromeric complex with the active R-Smad (7) and translocates to the nucleus, where it 
binds a DNA-binding partner (8) and modulates target gene expression (9).  These actions are 
differentially inhibited by Smads 6 and 7.  Diagram adapted from (Massague, 1998).  
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Information regarding expression patterns shown in Table 1.3 suggests that the theca cells are 
the main site of action of members of the TGF-β subfamily.  However, particularly as there is 
some disagreement regarding TGF-β receptor-II expression in GCs, the role of the TGF-β 
subfamily in this cell type requires further investigation (Qu et al., 2000, Roy and Kole, 1998).  
Note that the beta-glycan referred to in Table 1.3 facilitates the binding of TGF-β 2 to its 
receptor (Jaatinen et al., 2002).   
 
Figure 1.4 Subunit composition of known inhibin and activin forms. 
 
As described in Table 1.4 the actions of inhibin and activin oppose each other.  Inhibins exert 
their effect by blocking the actions of activins.  As mentioned above the mechanism of inhibin 
A and B signalling is different to that of the other members of the TGF-β superfamily as binding 
of an inhibin β subunit to the activin type II receptor and binding of an inhibin α subunit to the 
receptor, ALK4, antagonises activin signalling thus bringing about the effects of inhibin (Zhu et 
al., 2012).  TGF-β superfamily member activin A has been shown to accelerate the 
development of secondary follicles in vitro (Thomas et al., 2003, Telfer et al., 2008).  Activin is a 
dimeric protein which exists in 3 forms; see Figure 1.4 (Pangas et al., 2002).  When co-
expressed with a distantly related α subunit the dimeric protein inhibin (see Figure 1.4) is 
formed.  The effects of activin A on secondary follicle development are species-specific, for 
example this growth factor promotes antrum formation in human but not ovine follicles (Zhao 
et al., 2001).  A summary of the key factors involved in folliculogenesis and oogenesis that are 
not part of the TGF-β subfamily and superfamily is provided in Table 1.5.  Insulin and Insulin-
like Growth Factors (IGF1 and IGF2) are considered separately in Section 1.5.4. 
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Table 1.3  The role, localisation and stage of follicular development during which TGF-β subfamily members, their receptors and binding proteins are expressed in 
sheep and humans.  The + symbol indicates the factor’s presence throughout follicular development/ a – symbol indicates its absence.  Abbreviations: 
androstenedione (A4), steriodogenic acute regulatory protein (StAR). 
 Species 
TGF-β subfamily 
member/ receptor/ 
binding protein 
Site of Expression   
Effect 
Oocytes Granulosa Cells Theca Cells   
Ovine   
 
(Juengel, 2004) 
TGF-β1 and 2 - - Small preantral ->antral 
 Anti-differentiative role, 
inhibited P4 synthesis by 
granulosa cells.  Possible 
role in regulation of 
follicular cell proliferation 
and apoptosis. 
TGF-β RI Primordial -> antral Small preantral -> antral Small preantral -> antral 
 
TGF-β RII - - Small preantral -> antral 
 
Beta-glycan + + +   
Human 
                          
(Chegini and 
Flanders, 1992, Qu 
et al., 2000, Pangas 
et al., 2002, Liu et 
al., 2003, Attia et al., 
2000, Carr et al., 
1996) 
 
TGF-β1 + + +   
TGF-β1 inhibits 
steroidogenesis in human 
theca cells.  Production of 
A4 by theca cells is 
suppressed via the 
inhibitory effects of TGF-β1 
on StAR.  
TGF-β2 - All stages Larger follicles only 
 
TGF-β RI Primordial -> antral Primordial -> antral Preantral -> antral 
 
TGF-β RII Primordial -> primary - All stages 
 
Smad 2 Primordial -> primary Preantral -> antral Preantral -> antral 
 
Beta-glycan - Antral -> pre-ovulatory Antral -> pre-ovulatory   
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Table 1.4 The origin, site of action and role of somatic-cell derived TGF-β superfamily members and the stage of follicle development at which they are expressed 
in the mouse (M), rat (R), sheep (S), cow (C) and human (H).  Note the BMP4 and BMP7 expression was detected at very low levels in the sheep therefore these 
factors are unlikely to play a significant role in regulating ovine follicular development (Juengel et al., 2006). 
 TGF-β superfamily 
member 
Origin Site of 
action 
Effect Expression pattern Extra information References 
BMP4 TC GC/ 
oocyte 
Promote primordial to primary 
transitionR.  Suppression of GC 
apoptosis via non-Smad 
pathways; BMP4 via the 
PI3K/PDK-1/PKC and BMP7 via 
the PI3K/PDK-1/Akt. 
Primordial follicleM - 
may also have an 
effect later in 
development 
Promotes primordial 
follicle survival  
(Shimasaki et al., 1999, 
Lee et al., 2001, Nilsson 
and Skinner, 2003)  
BMP7 TC GC/ 
oocyte 
Increases GC 
proliferation via the 
promotion of BMP15 
expression 
(Lee et al., 2004b, 
Shimizu et al., 2012) 
Anti-mullerian 
hormone (AMH) 
GC GC Inhibits follicle development Primary -> antralH,M,S Alters gene expression of 
stimulatory factors and, 
in the antral follicle, 
attenuates actions of 
FSH 
(Durlinger et al., 1999, 
Weenen et al., 2004) 
Activin A  GC GC Stimulates GC proliferation and 
differentiation - specifically 
steroidogenesis and FSH 
receptor expression.  Inhibited 
by follistatin  
Primordial stage 
onwards.  However, 
activin SUs, receptors, 
and Smads not 
coexpressed until 
small antral stage S,H 
Studies have shown that 
activin a accelerates 
secondary follicle growth 
in vitro - exact effects are 
species-specific  
(Rabinovici et al., 1991, 
Findlay, 1993, Liu et al., 
1999, McNatty et al., 
2000, Zhao et al., 2001, 
Pangas et al., 2002, 
Thomas et al., 2003, 
Telfer et al., 2008)  
Inhibin A and B GC GC/TC Opposes effects of activin in 
order to promote the latter 
stages of follicle development 
Detected in the antral 
follicle - increases 
during dominant 
follicle selectionC  
  (Wrathall and Knight, 
1995) 
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Table 1.5  The target, localisation and action of key somatic growth factors involved in folliculogenesis, in the mouse (M), rat (R), sheep (O) and human (H).  
Abbreviations: Oocyte (Ooc), primary (1°), Tyrosine Kinase (TyrK).  References 1 Manova and Bachvarova (1991), 2 Huang et al. (1992), 3 Manova et al. (1993),4 
Clark et al. (1996), 5 Tisdall et al. (1997), 6 Joyce et al. (1999), 7 Parrott and Skinner (1999), 8 (Driancourt et al., 2000), 9 Hoyer et al. (2005), 10 Anderson and Lee 
(1993), 11 Lavranos et al. (1994), 12 van Wezel et al. (1995), 13 Rodgers et al. (1996), 14 Yamamoto et al. (1997), 15 Quennell et al. (2004), 16 Arici et al. (1997), 17 
Abir et al. (2004), 18 Nilsson et al. (2002), 19 Parrott et al. (1994), 20 Kezele et al. (2005), 21 Nilsson et al. (2006), 22 Yoon et al. (2006), 23 Pinkas et al. (2008).  
 Factor (species) Target Localisation Action Extra information 
KL (M,O,H) 
1,2,3,4,5,6,7,8,9,10
 
c-kit (Ooc) 
PGG c-kit expression until 
meiosis initiation. KL (GC) 
and c-kit expression 
primordial to antral 
Promotes PGC migration, primordial 
follicle activation, development and 
survival 
Exists in 2 trans membrane forms KL-1 and KL-2.  Both of which 
can be cleaved to soluble forms, however, KL-2 lacks the 
cleavage site thus mainly exists in the membrane bound form 
and KL-1 in the soluble form 
Basic Fibroblast 
Growth Factor 
(bFGF) (M,O,H) 
11,121,3,14,15,16
 
Receptor 
on GCs 
Ooc - all stages, GC - 1°  
onwards, TC - preantral 
onwards (human) 
Induces primordial follicle development 
via stimulation of basement membrane 
formation and GC proliferation and 
differentiation (mice) 
Species-specific differences in terms of the role of bFGF in 
follicular development. Conflicting evidence regarding the role 
of bFGF in humans - inhibitory vs stimulatory 
LIF (R,H) 
17,18,19
 GC and TC GC 
Promotes primordial follicle development 
via promotion of KL expression 
Potential role in ovulation  as the concentration of LIF in FF 
increases in response to LH 
Keratinocyte 
Growth Factor 
(KGF) (R) 
20,21
 
TC and GC Pre-TCs 
Stimulates development from the 
primordial to 1°  stage via recruitment of 
theca cells and promotion of GC 
proliferation 
Exists in a positive feedback loop with KL 
Platelet-derived 
growth factor 
(PDGF) (R, H) 
21,22,23
 
TyrK 
receptor 
(GCs) 
Ooc - all stages of 
development.  GCs and TCs 
- growing follicles 
Promotion of primordial to 1° follicle 
transition possibly via the stimulation of 
KL expression 
Treatment of rat ovaries with PDGF led to a significant 
decrease in the number of primordial follicles and a 
concomitant increase in the number of growing follicles as well 
as an increase in KL expression 
20 
 
 
 
1.5.4 The role of Insulin, IGF1 and IGF2 
Insulin and insulin-like growth factors, IGF1 and IGF2 are of particular interest as they are 
common constituents of IVG culture media (see Table 1.10).  Insulin is an oocyte-derived 
growth factor that acts upon the GC and TC via its receptor.  The actions of insulin, IGF1 and 
IGF2 in rodent, cow, sheep and human are similar in that they all stimulate mitosis, DNA 
synthesis, steroidogenesis in somatic cells as well as the nuclear maturation of the oocyte 
(Duleba et al., 1997, Duleba et al., 1998, Thomas et al., 2007, Walters et al., 2006).  
Additionally in vitro insulin increases both basal and LH-stimulated steroid hormone 
production by GCs (Willis et al., 1996).  The actions of IGF1 are mediated predominantly via the 
IGF1R although it also binds IGF2R with very low affinity (Silva et al., 2009).  The actions of IGF2 
are mediated predominantly via the IGF2R although it binds IGF1R with relatively high affinity 
(Silva et al., 2009).  Insulin also binds IGF1R, although with very low affinity, but does not bind 
IGF2R (Silva et al., 2009).  The bioavailability of IGFs is regulated by 6 IGF binding proteins 
(IGFBPs), resulting in either the augmentation or inhibition of the actions of IGFs (Baxter, 2000, 
Silva et al., 2009).  Levels of IGFBPs are themselves regulated by IGFBP proteases; for example, 
during dominant bovine follicle selection IGFBP4 protease is responsible for the proteolysis of 
IGFBP4 resulting in an increase in IGF bioavailability and subsequent establishment of follicular 
dominance (Rivera et al., 2001).  In addition, the level of IGFBP expression is linked to the level 
of exposure to IGFs as well as the stage of follicular development (Walters et al., 2006).  The 
importance of the regulation of IGF bioavailability was demonstrated in a study conducted by 
(Thomas et al., 2007) in which bovine preantral follicles were treated with the IGF1 analog- 
long-R3 IGF1, for which IGFBPs have a lower binding affinity for than for IGF1.  Treatment 
resulted in follicles displaying greater increases in diameter but smaller oocyte: follicle ratios 
and higher levels of follicular degeneration than that observed in controls.  Oocyte health in 
larger antral follicles, however, improved in response to incubation with high levels of IGF1, 
thus illustrating the fact that the effects of IGFs are stage dependent (Walters et al., 2006). 
 
The thecal cell-derived factor IGF1 is not expressed until the EA follicular stage, whereas its 
receptor (IGF1R) is expressed from the primordial stage by oocytes and GCs, in the cow and 
human (el-Roeiy et al., 1993, Qu et al., 2000, Armstrong et al., 2002).  Thecal-cell expression of 
IGF1R has been detected in large antral bovine follicles.  The expression of IGF1R early in 
follicular development can be exploited in vitro to promote follicle development (el-Roeiy et 
al., 1993).  In mice IGF1 has also been shown to stimulate FSHR expression (Zhou et al., 1997).  
In human follicles expression of IGF2 by GC and TC is detected during preantral follicle 
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development and increases with increasing follicle size (el-Roeiy et al., 1993).  In addition IGF2 
mediates the effects of FSH on E2 production in preantral follicles, thus promoting growth and 
steroidogenesis (Erickson et al., 1979, Voutilainen et al., 1996).  In vitro IGF2 increases E2 
production by GCs – this is augmented by insulin pre-incubation, possibly via increased 
expression of the IGF1R (Mason et al., 1994). 
 
Research regarding the expression patterns of IGFs and their receptors in the ovine model has 
focused on mainly on the latter stages of development with all follicles <2-4mm diameter 
grouped together.  Therefore the exact patterns of expression during ovine preantral follicle 
development remain to be elucidated (Perks et al., 1995, Monget and Bondy, 2000).  Although 
IGF1 was not initially detected in ovine follicles (Perks et al., 1995) subsequent studies have 
detected low levels of IGF1 expression in GC and TC (Hastie and Haresign, 2006).  Expression of 
IGF2 was detected in the GC, but not the TC layer.  Expression of IGF1R and IGF2R was 
detected in both the GC and TC layer, but to a lesser extent in the latter, with levels increasing 
with follicle size (Hastie and Haresign, 2006). 
 
1.5.5 The role of gonadotrophins 
Gonadotrophins (GNs); FSH and LH are produced by the anterior pituitary gland in response to 
gonadotrophin releasing hormone (GnRH) stimulation, which is released by the hypothalamus 
in a pulsatile manner every 1-3 hours in humans (Johnson, 2000).  Both FSH and LH are 
heterodimers, composed of a common α subunit and distinct β subunits (Pierce and Parsons, 
1981).  Oestrogen levels indirectly regulate FSH and LH release by the pituitary gland, via 
regulation of the frequency of GnRH pulsatile release by the hypothalamus (McNatty et al., 
1975, Bouchard et al., 1988, Aerts and Bols).  Oestrogen levels in the bloodstream determine 
the frequency of GnRH release which itself controls FSH and LH release by the pituitary.  Low 
oestrogen levels promote a lower frequency of GnRH release, which promotes the production 
of FSH by the pituitary.  Whereas high oestrogen levels result in a relatively faster frequency of 
GnRH release, which promotes LH release and suppresses FSH release by the pituitary gland 
(Wildt et al., 1981, Molter-Gerard et al., 1999).  Progesterone also regulates LH release via 
regulation of GnRH frequency, in the presence of oestrogen (Bergfeld et al., 1996, McCartney 
et al., 2007).  FSH production and release is also moderated by numerous members of the TGF-
β superfamily.  The rate-limiting step with respect to the overall production of FSH is the 
production of the FSH β subunit.  The members of the TGF-β superfamily implicated in the 
regulation of FSH production are: inhibin A and B - which inhibit production and release; 
22 
 
 
 
activin A, AB and B - which promote production and release, BMP4 - which inhibits production 
as well as the effects of activin (Faure et al., 2005); and BMP6, BMP7 and BMP15 - which 
promote production (Rivier and Vale, 1981, Rivier and Vale, 1989, de Kretser et al., 2000, 
Huang et al., 2001, Otsuka and Shimasaki, 2002). 
 
The pituitary-derived GNs FSH and LH are both required for follicular growth and development 
from the EA up to the pre-ovulatory stage.  Furthermore, FSH and LH promote GC proliferation 
and steroidogenesis and are required for the selection of the dominant follicle (Gougeon, 
1986, Gougeon, 1996, Webb et al., 2007).  In the absence of these hormones, for example 
prior to puberty, later-staged antral follicles will become atretic and degenerate.  FSH has been 
identified as the key survival factor as investigations carried out by (Chun et al., 1996) revealed 
that at the EA stage FSH reduced the levels of apoptosis to a greater extent than other 
previously identified anti-apoptotic factors.  In these experiments IGF1 was identified as a 
possible mediator of the anti-apoptotic actions of FSH.  Further experiments with pre-
ovulatory follicles have shown that the level of suppression of apoptosis is stage and dose-
dependent, with respect to various GNs and GFs (Chun et al., 1994).  Prior to this stage GNs are 
not essential, however, FSH receptors are expressed from the primary stage in sheep and 
humans, thus FSH is able to play a permissive role in supporting follicle health as well as 
growth and development (Tisdall et al., 1995, Oktay et al., 1997a). FSH has been shown to 
promote the growth and differentiation of rat preantral follicles (McGee et al., 1997).  In the 
sheep FSH has been shown to promote GC proliferation in small (2-3.5mm) and large follicles 
in vitro (Campbell et al., 1996), furthermore FSH has been shown to promote antral cavity 
formation in cultured secondary follicles (Newton et al., 1999b) and  FSH has been shown to 
stimulate the growth of large antral follicles in vivo (Picton et al., 1990).   
 
The hormones FSH and LH exert their effects on follicular development through binding to 
their cognate FSH and LH receptors, respectively.  The GN receptors are members of the 7 
transmembrane G-protein superfamily (Richards and Midgley, 1976, McFarland et al., 1989, 
Sprengel et al., 1990, Hillier, 2001).  Post-receptor signalling then results in the activation of 
genes involved in proliferation, differentiation, steroidogenesis and the production of peptides 
regulating GN release, via adenylyl cyclase-mediated signalling and the stimulation of cAMP 
production, which acts as a secondary messenger (Richards, 1994, Hillier, 2001, Segaloff et al., 
1990).  FSH receptors are expressed only by GCs, whereas LH receptors are initially only 
expressed by theca cells, however, following FSH stimulation, at the mature, antral stage GCs 
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also express LH receptors (Zeleznik et al., 1974, Camp et al., 1991, Piquette et al., 1991).  Prior 
to the expression of FSH and LH receptors on GCs and TCs, respectively, GNs are unable to 
directly stimulate follicle growth and development.  As mentioned previously, it is initially FSH 
that stimulates follicle growth and development via the promotion of GC maturation and 
proliferation, FSHR production by GCs – thus increasing their sensitivity to FSH and augmenting 
its action, production of peptides involved in the regulation of GN production (inhibin and 
activin) and proteoglycan production resulting in FF formation (Yanagishita and Hascall, 1979, 
Yanagishita et al., 1981).  Following LHR induction in the theca layer, FSH and LH become 
involved in a loop termed the 2-cell, 2-GN theory which promotes the production of 
oestrogens, as shown in Figure 1.5 (Armstrong and Dorrington, 1977).  The production of 
oestrogens in GCs is achieved via the aromatization of thecal-derived androgens, which have 
been produced in response to LH stimulation.  The aromatisation of androgens requires the 
induction of cytochrome aromatase (P450arom) expression via FSH binding to the GCs (Hillier, 
1994). 
 
 
Figure 1.5 The 2 cell, 2 gonadotrophin theory.  Androgens, produced in the theca layer as a 
result of LH stimulation, are used as substrates for oestrogen production in the GC layer.  
Oestrogens then bind receptors in the GC layer and promote GC proliferation thus resulting in 
increased production of oestrogen.  Both FSH and oestrogen promote the expression of LHRs 
in the GC layer allowing LH to promote growth and development in a similar manner to FSH, 
once FSH levels start to fall (Zeleznik and Hillier, 1984, Taylor and Al-Azzawi, 2000).  It should 
also be noted that in some species a small amount of oestrogen synthesis by the thecal cells is 
exhibited (Armstrong, 1981, Tsang et al., 1985).  
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As previously described E2 has a central effect on GnRH secretion but it also has a local, intra-
ovarian effect.  Oestrogen promotes GC proliferation and enhances aromatase activity; thus 
increasing its own production and amplifing the ability of GNs to stimulate the expression of 
FSHR and LHR (Richards and Midgley, 1976).  Locally produced growth factors also promote GC 
differentiation and proliferation, enhance the actions of FSH with respect to: E2 production, 
LHR expression by GCs, stimulation of the conversion of cholesterol to androgens.  For 
example, IGF1 amplifies the effect of FSH in GCs (Adashi, 1995).  The effects of E2 are 
important in terms of the establishment of dominance. 
 
Thus the development of follicles from the EA stage onwards involves a complex interaction of 
steroids, gonadotrophins and locally produced GFs.  Development from the EA to preovulatory 
follicle stage can be described in 3 phases: recruitment, selection and dominance.  
Recruitment requires a transient increase in FSH levels to rescue a cohort of EA follicles from 
atresia.  Such a rise in FSH levels requires a drop in E2 and inhibin levels, which occurs at the 
transition between the luteal and follicular phases when a corpus luteum (CL) is degenerating.  
Studies have shown that the decrease in E2 rather than in inhibin is the main cause of the FSH 
rise (le Nestour et al., 1993).  At this stage the P4 to E2 production ratio has increased.  In 
humans around 11 follicles per ovary are recruited to grow in each new reproductive cycle 
(Schipper et al., 1998).  Follicles continue to develop to the Graafian stage and reach a 
diameter of 2-5mm, at which point selection occurs during the follicular phase of the cycle 
(McGee and Hsueh, 2000).  As the follicles are developing E2 production increases, resulting in 
the negative feedback and hence suppression of FSH production and increasing LH release by 
the pituitary gonadotrophs.  During the follicular phase E2 levels rise further resulting in a 
decrease in FSH levels, at this point the dominant follicle appears (van Santbrink et al., 1995).  
In monovular species one follicle becomes dominant and continues to grow, while the 
remaining follicles regress.  The selected follicle has an early developmental advantage and is 
larger early in the cycle and is either the largest at the time of selection or the most 
oestrogenic, or both (Ginther et al., 1997).  Studies in humans have shown that the dominant 
follicle can be identified around day 7 of the menstrual cycle.  The dominant follicle continues 
to increase in size to reach a median diameter of 20mm in humans and 5-7 mm in sheep, at 
the pre-ovulatory stage (Fauser and Van Heusden, 1997, Hunter et al., 2004).  This follicle has 
the highest levels of E2 and growth factors thus increasing its sensitivity to FSH and allowing its 
continued development in a low FSH level environment.  Furthermore, this follicle will be the 
first to express LHRs on GCs thus allowing LH to take over the role of FSH in driving E2 
production in the presence of declining peripheral FSH levels.  This follicle will continue to 
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produce high levels of E2 thus further decreasing FSH levels to an extent to which the 
remaining recruited follicles are unable to continue their development and so then undergo 
atresia.  The production of E2 in the late follicular phase of the cycle promotes LH production 
and so ultimately causes the LH surge.  The LH surge ultimately results in the ovulation of the 
cumulus oocyte complex (COC) (Aerts and Bols, 2010).  In order for ovulation to occur the CC 
mass must undergo a process known as expansion, in which GC-derived hyaluronic acid, 
secreted in response to the GN-surge, binds cumulus cells (CCs) and increases the space 
between them (Eppig, 2001, Schoenfelder and Einspanier, 2003). At this point activity of P450 
aromatase is suppressed and the steroid production by the follicle switches from mainly E2 to 
P4 causing the resumption of meiosis, cellular and nuclear maturation, follicle wall rupture and 
COC release (Hillier, 2001).  The reduction in the level of cAMP being transferred to the oocyte, 
as a result of the LH surge disrupting the CC-oocyte interactions also contributes to the 
resumption of meiosis (Dekel, 1988).  A summary of the mechanism by which the LH surge 
occurs is provided below, adapted from Conti et al. (2012).  Prior to the GN-surge high levels of 
cAMP maintain the phosphosphorylation and therefore the inhibition of maturation promoting 
factor, via the promotion of cAMP-dependent PKA, which promotes Wee1 kinases and inhibits 
Cdc25 phosphatase.  Although high enough levels of cAMP are produced by the oocyte, 
connections between the oocyte and GCs are still essential for the maintenance of meiotic 
arrest, due to the provision of cGMP to the oocyte by the GCs.  In response to the LH surge, 
the permeability of GJs between GCs is reduced resulting in cGMP levels in the GCs and 
subsequently the oocyte dropping.  Reduced levels of cGMP in the oocyte cause the activation 
of phosphodiesterase 3A, an enzyme which hydrolyses cAMP, thus resulting in a decrease in 
cAMP levels.  The exact mechanism of this is unknown, however, the EGF network has been 
implicated, as the levels of EGF-like GFs including: amphiregulin, epiregulin and betacellulin, in 
murine (Shimada et al., 2006), human (Zamah et al., 2010), ovine (Cotterill et al., 2012) and 
porcine (Procházka et al., 2011) follicular somatic cells rapidly and transiently increase in 
response to LH.  This increase is proposed to be mediated via the phosphorylation and 
activation of serine/threonine kinase, ERK1/2 and p28 map kinase induction (Conti et al., 
2012).  The TGF-β superfamily have also been implicated in the regulation of ovulation and 
luteinisation as knock out of Smad4 in mice revealed that it was required for LH-induced 
cumulus expansion and expression of ovulation related-genes (Yu et al., 2013).  The 
resumption of meiosis progresses as follows: the nuclear membrane degenerates and meiotic 
arrest ends; chromosomes complete their first meiotic division; the polar body is extruded and 
an MII oocyte is formed; nuclear progression is accompanied by cytoplasmic maturation and 
gap junctional breakdown with the cumulus cells.  Following ovulation the somatic cells of the 
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follicle enter a phase of terminal differentiation in which the cells stop proliferating, they 
undergo cellular remodelling and they produce large amounts of P4 before eventually 
regressing. At this stage the follicle is referred to as a corpus luteum (Stocco et al., 2007).  Note 
that in sheep, in contrast to humans, the large antral follicles continue to develop throughout 
the luteal phase, as sufficient levels of FSH and LH are present (Baird, 1983). 
 
The responsiveness of the different follicular components to GNs are regulated by autocrine 
and paracrine actions, via IGFs and their binding proteins, activin and inhibin and various 
steroids including; androgens, E2, P4 and glycocortoids – the latter possibly being involved in 
injury repair post-ovulation.  The oocyte will remain at the MII stage until fertilisation triggers 
the resumption and subsequent completion of meiosis and extrusion of the second polar body, 
this has been reviewed in (van den Hurk and Zhao, 2005, Li and Albertini, 2013).  
 
The process of oogenesis and folliculogenesis is therefore highly complex and still not fully 
understood.  A summary of the key factors involved and their role (if known) in sheep and 
human is provided in Table 1.6. 
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Table 1.6 The role of growth factors in human and ovine oogenesis and folliculogenesis.  Abbreviations; human (H), ovine (O).  References; (1) see Table 1.2; (2) 
see Table 1.5; (3) see Section 1.5.4; (4) Zeleznik et al. (1974); (5) Pangas et al. (2002) and Thomas et al. (2003); (6) see table 1.3; (7) Weenen et al. (2004); (8) 
Wrathall and Knight (1995); (9) McNatty et al. (2000). 
 Follicle 
stage 
Stimulatory Inhibitory 
Factor (Origin) Species Effect Factor (Origin) Species Effect 
Primordial 
GDF9 (Ooc) O
1 
Mitogenic TGF-β2 (GC) H
6 
Anti-differentiative, inhibits steroidogenesis 
BMP6 (Ooc) H, O
1 
Possibly mitogenic 
  
KL
2 
Promotes primordial follicle activation, growth and 
development 
  bFGF (Ooc) H,O
2 
Unknown 
  LIF (GC) H
2 
Promotes KL expression and thus follicle development 
  PDGF (Ooc) H
2 
Promotes KL expression and thus follicle development 
  IGF1R (Ooc, GC) H
3 
Mediates actions of insulin, IGF1 and IGF2 
  
Preantral 
GDF9 (Ooc) H,O
1 
Mitogenic TGF-β2 (GC) H, (TC) H, O
6 
Anti-differentiative, inhibits steroidogenesis 
PDGF (Ooc, GC, TC) H
2 
Promotes KL expression and thus follicle development AMH (GC) H,O
7 
Inhibits primordial follicle activation and 
desensitises GC and TC to FSH and LH 
BMP15 (Ooc ) H, O
1 
Mitogenic Follistatin (GC) O,H
9 
Inhibits actions of activins 
BMP6 (Ooc) H, O
1 
Possibly mitogenic 
  FSHR (GC) H,O
4 
Mediates the actions of FSH 
  KL
2 
Promotes growth and development 
  bFGF (Ooc, GC, TC) H
2 
Unknown 
  IGF1R (Ooc, GC) H, O
3 
Mediates actions of insulin, IGF1 and IGF2 
  IGF1 (GC, TC) O?
3 
Promote GC and TC proliferation 
  IGF2 (GC, TC) H, O?
3 
Promotes growth and steroidogenesis 
  IGF2R (GC, TC) H, O
3 
Mediates actions of insulin, IGF1 and IGF2 
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Table 1.6 (continued) 
Follicle 
Stage 
Stimulatory Inhibitory 
Factor (Origin) Species Effect Factor (Origin) Species Effect 
EA 
GDF9 (Ooc) H, O
1 
Mitogenic TGF-β2 (GC) H, (TC) H, O
6 
Anti-differentiative, inhibits steroidogenesis 
BMP15 (Ooc ) H, O
1 
Stimulate KL expression Follistatin (GC) O,H
9 
Inhibits actions of activins 
BMP6 (Ooc) H, O
1 
Mitogenic (O) Activin A  and B(GC) H,O
5 
Inhibit FSH-stimulated E2 and inhibin A production 
and LH-stimulated A4 production FSHR (GC) H,O
4 
Mediates the actions of FSH 
IGF2R (GC, TC) H, O
3 
Expression patterns unclear - mediates actions of 
insulin, IGF1 and IGF2 
AMH (GC) H,O
7 
Inhibits primordial follicle activation and 
desensitises GC and TC to FSH and LH 
PDGF (Ooc, GC, TC) H
2 
Promotes KL expression and thus follicle development Inhibin A (GC) O
8 
Inhibits FSH release by pituitary and inhibit actions 
of activins 
Activin A and B (GC) H,O
5 
Promote GC proliferation, FSHR and LHR expression 
  KL
2 
Promotes growth and development 
  IGF1R (Ooc, GC) O, H
3 
Mediates actions of insulin, IGF1 and IGF2 
  IGF2 (GC, TC) H, O?
3 
Promotes growth and steroidogenesis 
  IGF1 (TC)
3 
Promotes GC and TC proliferation, FSHR expression      
Graafian 
GDF9 (Ooc) H, O
1 
Mitogenic, promote CC mucification, inhibit 
luteinisation 
GDF9 (Ooc) H, O
1 
Suppress KL expression and FSH-stimulated P4 and 
inhibin production by GCs 
BMP15 (Ooc ) H, O
1 
Mitogenic, promote CC mucification and survival, 
inhibit luteinisation 
BMP6 (Ooc) H, O
1 
Inhibits A4, E2 and inhibin A production by GCs and 
TCs 
BMP6 (Ooc) H, O
1 
Mitogenic (O), promote CC survival, inhibit 
luteinisation 
AMH (GC) H,O
7 
Inhibits primordial follicle activation and 
desensitises GC and TC to FSH and LH 
FSHR (GC) H,O
4 
Mediates the actions of FSH TGFβ2 (GC) H, (TC) H, O
6 
Anti-differentiative, inhibits steroidogenesis 
Activin A and B (GC) H,O
5 
Promote GC proliferation, FSHR and LHR expression 
Activin A and B (GC) H,O
5 
Inhibit FSH-stimulated E2 and inhibin A production 
and LH-stimulated A4 production 
IGF1 and IGF1R
3 
Promote GC and TC proliferation and GC expression of 
FSHR 
Inhibin A (GC) O
8 
Inhibits FSH release by pituitary and inhibit actions 
of activins 
KL
2 
Promotes growth and development Follistatin (GC) O,H
9 
Inhibits actions of activins 
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1.6 Current methods of female fertility preservation 
1.6.1 Introduction 
A detailed understanding of the mechanisms regulating oogenesis and folliculogenesis is 
essential to support the development of strategies aimed at preserving the fertility of girls, 
adolescents and young women who are at risk of premature ovarian failure (POF). For 
example, improvements in cancer treatments have resulted in increasing survival rates of 
patients.  The treatments used, however, are often aggressive and can cause infertility.  In fact, 
cancer treatments are the most common cause of POF in girls (Jadoul et al., 2010).  Other 
causes of POF include treatments used for autoimmune diseases as well as the diseases 
themselves, genetic abnormalities such as chromosome X defects: Turner syndrome and 
Fragile X syndrome, infections such as herpes zoster or isolated defects: for example those 
affecting GN receptors (Beck-Peccoz and Persani, 2006, Grynberg et al., 2012).  Therefore, 
effective methods of fertility preservation are required.  In the following sections fertility 
preservation techniques that are currently in use, or are under development, are summarised 
and discussed.  All these techniques require the use of cryopreservation, therefore firstly the 
basic principles and methods of optimising cryopreservation techniques will be considered. 
 
1.6.2 Basic principles of cryopreservation 
The development of cryopreservation techniques has enabled the long-term storage of cells.  
In order to optimise cryopreservation techniques an understanding of the mechanisms of 
cellular freezing and the damage that this can cause is required.  The level and nature of 
damage to cells when cryopreserved are dependent on a number of factors including cell type 
and size, external cooling and warming rates, and the presence/ absence of cryoprotective 
agents.   
 
The major factors likely to cause damage during the cryopreservation process are intracellular 
ice formation and exposure of the cells to solute effects.  The formation of ice in the 
extracellular environment can also cause cell damage.  When ice forms extracellularly a series 
of channels are formed within which cells are held, the width of which decrease with 
decreasing temperature thus increasing the mechanical pressure on the cells (Rapatz, 1966).  
Ashwood-Smith et al. (1988) showed that the initial contact of the cell caused a change in cell 
shape and formed a weak spot where blebbing of the cytoplasm was seen during thawing.  Gas 
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bubbles were also observed which were probably formed as dissolved gases come out of 
solution upon freezing (Carte, 1961).  The mechanical stress from the formation of both 
intracellular and extracellular ice can damage the plasma membrane to an extent which is 
lethal to the cell.  Furthermore, the formation of intracellular ice can lethally damage the 
membranes of intracellular organelles (Fujikawa, 1986, Karlsson and Toner, 1996).  Fujikawa 
(1980) used freeze-fracture experiments and etching studies to assess the effect intracellular 
ice coming into direct contact with membranes, thus revealing the structural alterations and 
molecular disorganisation.       
 
As ice forms in the extracellular environment this causes the concentration of electrolytes 
present to increase, thus raising the ionic strength of the medium and altering the osmolality 
of the system.  This change in osmolality leads to water leaving the cell along the osmotic 
gradient resulting in an increase in electrolyte concentration in the cell.  These changes can 
lethally damage cells (Lovelock, 1954).  Ice formation alters the pH within and without the cells 
and causes substances, such as urea or dissolved gases that at normal physiological levels 
would not be damaging, to reach toxic levels (Lovelock, 1957).  These ‘solution effects’ can 
lead to the denaturation of lipid-protein complexes of which membranes are composed, thus 
acting as another mechanism by which freezing can cause damage.  Other mechanisms of 
intracellular ice formation (IIF) damage include cytoskeleton rearrangement, chromosome 
loss/gain, polyspermy, polygyny and tetraploidy, DNA fusion and rearrangements, dissolution 
and rearrangements and denaturation of proteins/enzymes (Shaw et al., 2000, Lane et al., 
2000, Eroglu et al., 1998). 
 
Cooling and warming rates used in cryopreservation procedures have long been recognised as 
important factors with respect to cell survival.  This is mainly due to the relationship between 
cooling/ warming rates and IIF.  When cells are cooled to a sufficiently low temperature, of 
between -5°C and –15°C, ice initially forms in the extracellular medium.  As there are no 
intracellular nucleation centres present the protoplasm can theoretically become super-cooled 
down to -40°C - the temperature at which spontaneous ice formation occurs (Richard, 1995).  
Optimisation of cooling rates is of great importance.  Slow, rather than rapid cooling rates have 
been shown to result in the highest cell survival rates.  However, if the cooling rate used is too 
slow this can also result in cell damage.  When a cell is cooled sufficiently slowly ice will firstly 
form in the extracellular environment and thus the vapour pressure of the extracellular 
medium will decrease rapidly to a level that is a lot lower than that of the protoplasm.  
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Furthermore the formation of ice will change the osmolality of the system.  These changes will 
result in water leaving the cell along the vapour pressure differential and osmotic gradients. 
The rate at which water leaves a cell is dependent upon a number of factors: the surface area 
to volume ratio of the cell; the permeability of the membrane to water; and the temperature 
co-efficient of the permeability constant (Mazur, 1963).  If the cooling rate is sufficiently slow 
this will allow water to leave the cell at a rate that keeps the protoplasm at its freezing point 
thus preventing ice from forming intracellularly.  However, if the rate of cooling is more rapid 
then water will be unable to leave the cell quickly enough to maintain this equilibrium and ice 
will form intracellularly.  Due to the absence of any nucleation centres in the intracellular 
compartment IIF should theoretically not be possible at temperatures above -40°C (Richard, 
1995).  Furthermore, the plasma membrane has been shown to act as an effective barrier 
against ice in the extracellular environment (Chambers and Hale, 1932).  A number of possible 
mechanisms by which IIF could be induced at temperatures higher than –40°C have been 
suggested.  Mazur (1960) hypothesised that the presence of aqueous pores in the plasma 
membrane provides a route through which ice crystals can grow and seed ice formation 
intracellularly.  However, temperatures must be sufficiently low for ice crystals that are small 
enough to grow through these pores to exist before this is possible.  A second mechanism by 
which IIF can occur has been proposed in which the frictional drag of water moving out of the 
cell is sufficient to rupture the extracellular membrane and allow extracellular ice crystals to 
enter the cell (Muldrew and McGann, 1994).   
 
Therefore a slow cooling rate to facilitate cellular dehydration is preferable to a rapid cooling 
rate.  However, if the cooling rate used is too slow this too can have detrimental effects.  An 
excessively slow cooling rate can result in the cells being exposed to the high solute 
concentrations for an extended period thus causing cell damage (Schneider and Mazur, 1984).  
Conversely, rapid warming rates increase the survival rates of cells that have been 
cryopreserved.  This is due to a process called recrystallisation, in which small crystals that 
have formed during the cooling process aggregate upon the increase in temperature to form 
larger crystals.  Before the recrystallisation process these ice crystals are too small to cause any 
damage to the cell, whereas, after they are large enough to cause damage, which can cause 
cell death.  If warming rates are sufficiently rapid the small crystals melt before 
recrystallisation is able to occur (Schneider and Mazur, 1984). 
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1.6.3 Cryoprotective agents (CPAs) 
Some of the adverse effects of cryopreservation can be reduced with the use of cryoprotective 
agents (Lovelock, 1954).  Agents used for cryoprotection can be divided into two categories: 
penetrating and non-penetrating CPAs.  Penetrating CPAs are able to pass through the plasma 
membrane and therefore must be gradually added to the medium in which the cells are 
suspended to prevent excessive cell shrinkage prior to the establishment of an osmotic 
equilibrium (Meryman, 1971).  Examples of penetrating CPAs include glycerol, dimethyl 
sulphoxide (DMSO), ethylene glycol and propene glycol (Newton et al., 1998).  Non-
penetrating CPAs are unable to pass through the cell’s plasma membrane. Sucrose is a very 
effective and commonly used example of a non-penetrating CPA (Koshimoto and Mazur, 
2002).  
 
The use of CPAs protect against cryodamage partly via depression of the freezing point of 
water (Wolfe and Bryant 1999).  Due to their relatively large molar volume the addition of 
CPAs reduces cell shrinkage when water leaves the cell by osmosis during the freezing 
procedure (Meryman, 2007).  In addition, CPAs protect against cryodamage by stabilising 
proteins and membranes at low temperatures (Crowe, 1990).  The penetrating CPA, DMSO is 
also a scavenger of free radicals (Yu and Quinn, 1994).  The mode of protection against 
cryodamage by non-penetrating CPA is probably via the reduction of the extracellular medium 
freezing point.  Non-penetrating CPAs are most valuable when used in combination with 
penetrating cryoprotectants by protecting against detrimentally large volume changes by 
acting as osmotic buffers (Fuller, 2004). 
 
The use of CPAs can, however, be detrimental to cell viability as many commonly used CPAs 
have cytotoxic effects.  For example, the use of CPAs in the cryopreservation of mature 
oocytes has been shown to result in damage to the internal structure of the cell.  For example, 
the use of DMSO as a cryoprotectant when cryopreserving murine oocytes resulted in zona 
hardening and disorganisation of the cytoskeleton and plasma membrane (Trounson and 
Kirby, 1989).  Furthermore, if CPAs are not used at the optimal concentration and/or applied/ 
removed at the correct rate their use can cause cell shrinkage prior to cryopreservation and 
the swelling of cells once they are thawed and returned to hypotonic solution possibly leading 
to cell lysis (Picton et al., 2000).  A delicate balance must be struck between ensuring the CPA 
has fully penetrated the cell/ tissue and overexposure to cytotoxic effects (Meryman, 1971).  
Note that the degree of cytotoxicity varies between CPAs, for example glycerol is relatively 
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non-toxic, however its low penetration rate makes it less efficient than other more toxic CPAs 
with respect to cell survival following cryopreservation of larger cells and tissue.   
 
Newton et al. (1998) found that adding the CPA at a lower temperature reduced the 
penetration rate and the level of cytotoxic damage.  Reducing the rate of cooling also 
decreases the level of damage caused by CPAs however, there must be a compromise as too 
slow a rate increases the risk of intracellular freezing (Newton et al., 1999a).  Although glycerol 
is a useful CPA when cryopreserving sperm, when used during the cryopreservation of ovarian 
tissue it produced a much lower survival rate (10%) than other CPAs; DMSO, propylene glycol 
and ethylene glycol (50-80%) (Newton et al., 1996).   Therefore it is important to establish the 
optimal cryoprotectant for the type of cell/ tissue that is to be cryopreserved with respect to 
permeation rate, toxicity and ice crystal formation.  
   
1.6.4 Cryopreservation techniques 
Standard cryopreservation protocols utilise either slow freezing or vitrification techniques.  
‘Slow-cool’ protocols are commonly used for the cryopreservation of embryos, oocytes, sperm 
and ovarian tissue (Karlsson and Toner, 1996, Newton et al., 1996, Royere et al., 1996, Edgar et 
al., 2005).  The specifics of the freeze-thaw techniques, such as the type of CPAs used, 
warming and cooling rates and seeding temperatures vary with tissue type however the basic 
principles remain the same.  It should be noted that every cell type has an optimal cooling rate 
that is determined by the cell’s permeability and surface area to volume ratio (Schneider and 
Mazur, 1984).  The cells/ tissue are first incubated in CPA for a sufficient period of time for 
equilibration to occur.  Following this the samples are then cooled to a specific temperature at 
which manual seeding is carried out.  Manual seeding is the process by which some form of 
instrument, such as forceps, is cooled in liquid nitrogen then applied to the straw containing 
the sample thus inducing ice formation.  If the samples were left to become highly super-
cooled ice formation would occur spontaneously which is more damaging to the cells and 
results in less predictable survival rates than manually inducing ice formation.  This is because 
when ice forms the solution will briefly increase in temperature then cool again.  The lower the 
temperature at which ice formation occurs the more rapid the subsequent cooling leading to 
rapid crystallisation thus increasing the risk of cell damage and IIF as cellular dehydration will 
not be able to occur at this rate (Isachenko et al., 2008).  Research has shown that using a 
seeding temperature close to the melting point of the solution resulted in higher survival rates 
of the frozen cell samples (Trad et al., 1999).  Once the crystallisation has spread throughout 
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the solution the cooling process can continue, at a slow rate to reduce IIF.  Once a temperature 
of –40°C has been reached it is no longer necessary to cool the cells at this slow rate as the 
plasma membrane is no longer permeable to water.  Thus the sample is rapidly cooled to a 
temperature of –196°C, at which it will be stored to prevent any chemical reactions due to the 
lack of thermal energy (Karlsson and Toner, 1996).  
 
Unlike the freeze-thaw protocols, in which ice is allowed to form extracellularly, vitrification 
techniques avoid the formation of ice altogether.  Vitrification is the process by which a liquid 
enters a glass-like solid state upon super-cooling (Rall and Fahy, 1985).  The probability of 
vitrification can be roughly defined by the formula shown in Equation 1.1. 
 
Equation 1.1  
Probability of vitrification = (cooling rate x medium viscosity) / volume of media 
 
Thus vitrification protocols require: a small sample volume; incubation with high CPA 
concentrations, which will raise the viscosity of the solution and therefore raise the glass 
transition temperature, thus lowering the probability of ice nucleation, and rapid cooling- 
achieved by plunging samples into liquid nitrogen or liquid nitrogen slush (Saragusty and Arav, 
2011).  The use of vitrification methods carry a number of advantages over the use of slow-
freeze methods as there is no risk of ice formation or dehydration damage, the procedures are 
quicker, simpler and require less expensive equipment and the osmotic stress, solute effects 
and chilling sensitivity are all reduced in comparison.  However, although using high 
concentrations of CPAs does allow exposure time to be reduced this means that the cells will 
be exposed to CPAs at more toxic levels.  In both techniques rapid warming rates are used for 
reasons explained in Section 1.6.2.  Although more research is needed to determine which 
method of cryopreservation is preferable there is increasing evidence that vitrification may be 
equally effective as slow-freezing for embryo cryopreservation (Loutradi et al., 2008, 
Wennerholm et al., 2009). 
 
1.6.5 The use of cryopreservation for fertility preservation 
Table 1.7 summarises the current techniques that are used to preserve fertility and highlights 
the advantages and disadvantages of each.  The information in provided Table 1.7 shows that 
the use of ovarian tissue cryopreservation holds numerous advantages over the other methods 
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of fertility preservation.  Earlier studies investigating cryopreservation of MII and GV oocytes 
utilised slow-freezing protocols, see Table 1.7.  More recently vitrification is increasingly being 
investigated.  Survival rates of cryopreserved human GV oocytes have been shown to be 
improved by the use of vitrification rather than slow-freeze protocols (Zhang et al., 2011).  
Investigations using ovine (Mo et al., 2014), human (Khalili et al., 2012), porcine (Rojas et al., 
2004) and bovine (Men et al., 2002) oocytes have shown that MII oocytes are more tolerant to 
the vitrification procedure than GV oocytes, with respect to cleavage, blastocyst formation and 
survival rates.  In addition the use of a cytoskeleton stabilisers such as Taxol, can also improve 
these rates (Mo et al., 2014).   
  
Although cryopreservation of ovarian tissue was believed to be the only method suitable for 
fertility preservation in prepubertal girls there have been several investigations in which 
oocytes/ COCs from small antral follicles were retrieved from the ovaries of prepubertal girls 
and the oocytes matured in vitro (Revel et al., 2009, Fasano et al., 2011).  While embryo and 
mature oocyte cryopreservation are viable means of preserving the fertility of young women, 
see Table 1.7 for details, the main focus of this review is on ovarian tissue cryopreservation. 
 
1.6.6 Ovarian tissue cryopreservation 
The use of ovarian tissue cryopreservation for fertility preservation in females of all age groups 
is preferable over the previously discussed methods for a number of reasons as detailed in 
Table 1.7.  There are no major ethical issues associated with the collection and frozen-storage 
of ovarian tissues for either young girls or young women. The vast majority of follicles in 
ovarian tissue are at the primordial stage.  Primordial follicles have a higher tolerance to both 
cryopreservation and autografting as a means of fertility restoration than follicles at later 
stages.  This may be due to their small size, lack of zona pellucida and cortical granules, 
metabolic quiescence and undifferentiated state (Newton et al., 1996).  In addition their low 
capillary density shows that they are more tolerant to hypoxic conditions than more developed 
follicles (Gosden et al., 2002). It has also been suggested that the meiotic stage at which 
primordial follicles are arrested (prophase) should result in fewer cytogenetic errors, and their 
prolonged growth phase allow more time to repair sublethal damage (Oktay et al., 1998, Kim 
et al., 2001). 
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Table 1.7 Utilisation of cryopreservation as a method of fertility preservation.  This table considers the advantages and disadvantages of the various ways in which 
cryopreservation can be used to preserve fertility.  Abbreviations: ovarian hyperstimulation syndrome (OHSS). 
 Cell type Advantages Disadvantages/ Problems References 
Embryo  • Most established and routinely used 
technique in assisted conception 
• Not suitable for prepubertal girls or adolescents  (Testart et al., 1986, Gook 
and Edgar, 2007, Lahav-
Baratz et al., 2003, Tiitinen 
et al., 1995) 
• Women without life partners require the use of donor sperm 
• High success rates (80-90%) • Ovulation induction can delay cancer treatment and cause OHSS 
• Risk associated with ovarian stimulation and breast cancer 
  • Not allowed in certain countries 
• Ethical issues and risk of creating orphan embryos 
MII 
oocytes 
• Overcomes ethical issues associated with 
embryo cryopreservation by reducing the 
number of unused embryos 
• Suitable for use with egg donation 
programmes 
• Low success rates with respect to survival, fertilisation and development can be 
attributed to the following factors; 
(Pickering and Johnson, 
1987, Sathananthan et al., 
1992, Gook et al., 1995, 
Kazem et al., 1995, Carroll et 
al., 1990, Paynter, 2000, 
Jones et al., 2004, Mullen et 
al., 2004, Koutlaki et al., 
2006) 
• Damage to oocyte cytoskeleton can result in disruption of syngamy and 
cytokinesis 
• Cryopreservation can induce parthenogenetic activation 
  • Both the subzero temperatures and use of CPAs can irreversibly disrupt the MII 
spindle in humans; disrupts final meiotic division/ results in an anueuploid embryo 
  • Disruption of the plasma membrane 
  • Hardening of the ZP thus preventing sperm penetration (overcome by use of ICSI) 
Germinal 
vesicle 
(GV) 
oocytes 
• Less temperature-sensitive than MII oocytes 
as the microtubular spindle has not yet formed 
- chromosomes are packaged within the GV 
• Although higher survival rates have been reported in more recent studies than 
earlier studies maturation and fertilization rates remain variable 
• Necessary to cryopreserve cumulus enclosed oocytes 
(Mandelbaum et al., 1988, 
Park et al., 1997, Son et al., 
1996, Paynter, 2000, 
Koutlaki et al., 2006, 
Versieren et al., 2011) 
• GV oocyte collection would require patients 
to undergo less (or no) hormonal stimulation in 
comparison MII oocyte collection 
• Post-thaw GV oocytes must be matured in vitro - complex and made more difficult 
by the fact that cryopreservation results in CC loss 
• High incidence of chromosomal and spindle abnormalities 
Ovarian 
tissue 
• Tissue collection by laparoscopy at any stage 
of menstrual cycle 
• No delay in cancer treatment 
• Autotransplantation of tissue may carry the risk of reintroducing the cancer, in 
blood borne leukaemia and cancers with a high risk of ovarian metastasis, e.g. 
breast or ovarian cancer 
(Newton et al., 1996, Oktay 
et al., 1997b, Oktay et al., 
1998, Hovatta et al., 1996, 
Onions et al., 2008, Onions 
et al., 2009, Onions et al., 
2013)  
 • High primordial follicle survival rates  • Primordial follicle IVG and IVM techniques have not been optimised 
 • Fertility drugs not required  
 • Ovarian tissue rich in primordial follicles  
  • Suitable for prepubertal girls, adolescents    
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Early investigations have shown that primordial follicles are able to survive the freeze-thaw 
and autografting process.  Histological comparisons of fresh and frozen-thawed tissue, and 
individual follicles before and after freeze-thaw have revealed relatively high survival rates 
(Newton et al., 1996, Hovatta et al., 1996, Gook et al., 1999).  It should be noted that the 
survival rates of primordial follicles are highly dependent upon the CPA used in the 
cryopreservation process.  Furthermore, studies in sheep and humans have shown primordial 
follicles within slices of cortical tissue are able to survive the grafting process (Newton et al., 
1996, Gosden et al., 1994). More recently, the capacity of primordial follicles to survive the 
process of whole ovary cryopreservation (WOCP) and grafting has been demonstrated in ewes 
(Arav et al., 2010, Onions et al., 2008, Onions et al., 2009, Onions et al., 2013).  Studies of the 
in vitro growth capacity of ovine secondary follicles post freeze-thaw have indicated that these 
follicles have the potential to develop to antral stages over 30 days in vitro (Newton et al 
1999b).  Secondary follicles recovered following WOCP were also observed to survive and 
exhibit signs of GC proliferation for 48 hours in culture following WOCP (Onions et al., 2008).  
The authors, however, draw attention to the fact that in studies in which the follicle 
population dynamics are monitored within the graft for an extended period of time growing 
preantral follicles show signs of irrevocable damage (Gosden et al., 1994, Baird et al., 1999).  
However, there is some evidence to suggest that although primordial follicles are 
morphologically normal following the freeze-thaw process there may be some alterations at 
the cellular level, with respect to metabolomics and developmental rate (Qu et al., 2000, Choi 
et al., 2007, Collado-Fernandez, 2013).  Conventionally, slow-freeze methods are used to 
cryopreserve ovarian tissue, with penetrating CPAs: DMSO, ethylene gycol (EG) or propanediol 
(PROH), in combination with the non-penetrating CPA- sucrose (Hovatta, 2005).  Human 
ovarian tissue cryopreservation protocols have been optimised via experimentation initially 
with in vitro culture of frozen-thawed tissue, then xenotransplantation in severe combined 
immunodeficiency (SCID) mice, and then heterotopic and orthotopic autotransplantation, to 
assess follicle, oocyte and stromal tissue health and survival rates (Picton et al., 2000).  
Optimisation of orthotopic autotransplantation techniques have resulted in numerous live 
births, which will be discussed in more detail below.   
 
More recently research into the optimisation of vitrification methods for the cryopreservation 
of ovarian tissue has been conducted (Isachenko et al., 2009).  Although relatively high follicle 
cell and oocyte survival rates have been reported, using slow-freeze protocols, the survival 
rate of the stromal cells may be improved using vitrification.  Histological analysis of vitrified 
ovarian tissue using electron microscopy revealed improved preservation of ovarian tissue 
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morphology compared to tissue that had been frozen using slow-freeze protocols (Keros et al., 
2009, Hreinsson et al., 2003).  In a subsequent study the effects of the use of vitrification on 
follicle and oocyte ultrastructural morphology were assessed histologically using both light and 
electron microscopy revealing no differences when compared to non-vitrified control tissue 
(Sheikhi et al., 2011). Detailed investigation of the integrity and long-term developmental 
competence of vitrified ovarian tissue has yet to be rigorously assessed and proven using 
either xenografting or autotransplantation. 
 
Another advantage of the use of ovarian tissue cryopreservation to restore fertility over other 
methods is the fact that tissue is relatively easy and safe to obtain.  Tissue can be obtained 
laparascopically under anaesthetic; procedures that are of relatively low risk even in infants, 
over the age of 3 years old (Davidoff et al., 1996, Weintraub et al., 2007). 
 
The main cause of follicle loss following freeze-thaw and autotransplantation is ischaemic 
damage during the grafting process, rather than the cryopreservation procedure itself (Liu et 
al., 2002).  During the period of ischaemia the tissue is susceptible to damage by reactive 
oxygen species (Nugent et al., 1998).  It should also be noted that the stromal tissue is more 
susceptible to cryo-injury than primordial follicles, although this can be reduced by the use of 
vitrification rather than slow-freeze protocols (Keros et al., 2009). 
 
Xenografting, in which the recipient of the graft is of a different species to that of the donor, 
was first used to investigate the grafting of ovarian tissue.  Xenografting, of both animal and 
human ovarian tissue into immunodeficient animal strains, such as SCID mice, has proved 
successful (Gosden et al., 1994, Candy et al., 1995, Van den Broecke et al., 2001, Gook et al., 
2003, Kim et al., 2005).  Although in the case of human tissue MII oocytes were able to develop 
but with microtubule and chromatin abnormalities.  This technique cannot be used to restore 
fertility due to the risk of viral transfer across species.  However, it has proved a useful 
experimental tool with respect to the use of different cryoprotectants, exogenous 
gonadotrophic stimulation and reducing ischaemic damage (Newton et al., 1996, Israely et al., 
2006, Israely et al., 2004, Maltaris et al., 2007).      
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Figure 1.6 Diagrammatic summary of the uses of frozen-thawed ovarian tissue and whole 
ovaries.  Adapted from (Oktay et al., 1998).  
 
Figure 1.6 summarises the potential uses of ovarian tissue with respect to fertility 
preservation.  There are 2 methods of autografting, in which the donor and recipient of the 
graft are the same individual - orthotopic and heterotopic grafting, which can be used either 
alone or in combination.  Orthotopic transplantation is a procedure in which the ovarian tissue 
is transplanted to either the remaining ovary or the pelvic region of a patient.  Whereas 
heterotopic transplantation is a procedure in which ovarian tissue is grafted to various other 
sites such as the abdominal wall or even subcutaneous regions, such as the forearm.  In 
rodents it has been possible to orthotopically transplant frozen-thawed whole ovaries, 
however due to the larger size of the ovaries and lower follicular density this is more difficult in 
larger animals and humans, therefore small pieces of ovarian cortex are usually transplanted 
instead of the intact organ (von Wolff et al., 2009, Grynberg et al., 2012).  Most of the cases 
reported have used slow-freezing cryopreservation techniques, however, more recently 
vitrification techniques have been utilised to preserve tissue.  The success of ovarian tissue 
transplantation is not only dependent upon grafting site, freezing protocol and level of 
ischaemic damage, but also on the density and distribution of follicles within the frozen-
thawed transplanted tissue, between patients, the age of the patient at the time of tissue 
cryopreservation and the size of the grafts transplanted (Newton, 1998). 
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Orthotopic autotransplantation has been more often favoured than heterotopic 
transplantation in the restoration of human fertility as it has the potential to enable natural 
conception to occur, although assisted reproduction is more commonly used as an adjunct 
therapy post grafting to restore fertility.  Furthermore, the transplanted tissue will be exposed 
to optimal conditions in terms of locally produced factors and levels of mechanical stress and 
temperature.  The first birth resulting from orthotopic transplantation of frozen-thawed 
ovarian tissue was reported by Donnez et al. (2004).  Since then there have been numerous 
reports of births resulting from orthotopic transplantation of tissue (Meirow et al., 2005, 
Andersen et al., 2008, Revelli et al., 2013).  The potential of this technique to restore fertility 
long-term was first demonstrated when a patient underwent orthoptopic transplantation in 
May 2006 and gave birth to two healthy children in June 2007 and November 2009 
(Demeestere et al., 2007, Demeestere et al., 2010).  In these cases patients have had sterilising 
treatment however it is still possible that the pregnancies could have resulted from surviving 
oocytes in the native ovary, rather than the graft.  However, in these cases the patients have 
undergone ovarian failure and the timing of restoration of ovarian function following grafting 
corresponds with the time it takes for primordial follicles to initiate growth and reach 
maturation stage.  Furthermore, a live birth has been reported following the transplantation of 
ovarian tissue to a patient who had undergone a bilateral oophorectomy, thus in this case the 
resumption of ovarian function had to be due to the grafted tissue (Donnez et al., 2012).  
However, Detti et al. (2012) argued that the many cases in which orthotopic transplantation is 
not successful go unreported, therefore the overall efficiency of the technology is unknown. 
 
The nature of the heterotopic site used for autografting can affect oocyte quality, possibly due 
to suboptimal temperatures and increased exposure of the tissue to mechanical stress 
(Wolner-Hanssen et al., 2005, Yang et al., 2006).  Autografting of fresh tissue to a 
subcutaneous site in primates resulted in the development of mature oocytes that were then 
aspirated and fertilised using ICSI, resulting in a live birth (Lee et al., 2004a).  Furthermore, in 
humans, autografting frozen-thawed tissue to a heterotopic site resulted in the development 
of oocytes that were aspirated, matured in vitro and fertilised, resulting in development to the 
4-cell embryo stage (Oktay et al., 2004).  Recently a 26 week twin pregnancy has been 
reported following the transfer of 2 embryos resulting from the IVF of 2 oocytes derived from a 
heterotopic graft in the anterior abdominal wall of a patient who had undergone bilateral 
oophorectomy in response to ovarian stimulation (Stern et al., 2013).  For the great majority of 
heterotopic transplants there is, however, evidence to suggest that grafting to a heterotopic 
site may affect oocyte development as shown by the fact that oocytes reach maturity at a 
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smaller size than when orthotopically grafted (Oktay et al., 1997a).  Heterotopic 
transplantation has also been used to induce fertility in a young girl who received sterilising 
treatment for sickle-cell disease (Poirot et al., 2012).  Heterotopic ovarian cortex 
transplantation may be useful in patients in which there is excessive scarring or radiation 
damage in the pelvic region. 
 
Heterotopic and orthotopic transplantation are often used in combination and this has 
resulted in spontaneous pregnancies.  The presence of a heterotopic graft may aid oocyte 
development in the orthotopic graft via the increased number of follicles transferred and the 
subsequent improvement in cycles (Demeestere et al., 2006).  Similarly, heterotopic grafting in 
humans has also promoted oocyte development in a native, atrophic ovary following sterilising 
treatment, thus resulting in 4 spontaneous pregnancies (Oktay et al., 2011).  There are a 
number of theories regarding the mechanism by which this occurred.  Controversially, Oktay et 
al. (2011) proposed that the production of endocrine-paracrine factors by the grafted tissue 
promoted oogonial stem cells from either the bone marrow or native ovary to develop into 
functioning oocytes, or alternatively that the grafted tissue itself provided the oogonial stem 
cells.  Although the theory that oogonial stem cells exist and are able to repopulate the ovary 
has been contested (Telfer et al., 2005, Byskov et al., 2011) the idea has been supported by 
more evidence from a study carried out by Lee et al. (2007) in which bone marrow-derived 
stem cells are taken up by native ovaries resulting in the restoration of fertility in mice.  Indeed 
the presence of oocyte stem cells in the mouse and human ovary has been demonstrated via 
the use of green fluorescent protein (GFP) (Woods et al., 2013).  Human oogonial stem cells 
engineered to express GFP were competent to develop into oocytes when injected into human 
cortical tissue and xenotransplanted into SCID mice (White et al., 2012). 
 
Finally, ovarian tissue cryopreservation has proven successful in monozygotic twins discordant 
for POF.  Transplantation of an ovary from the fertile twin to the twin with POF resulted in a 
number of live births or on-going pregnancies (Silber et al., 2008). 
 
Concerns have been raised about the potential increased risks of cancer treatments to the 
offspring of cancer survivors.  It was hypothesised that there would be an increased risk of 
offspring inheriting genetic abnormalities following the gonadotoxic treatment of their 
parents.  However, the results of a large study conducted comparing the incidence of genetic 
abnormalities in offspring of cancer survivors and sibling controls suggested there was no 
increased risk (Boice et al., 2003).  Another concern is that the offspring of cancer survivors will 
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be of increased risk of developing cancer themselves.  However, a large epidemiological study 
failed to find a significant link, with the exception of diseases where there is a recognised 
familial link (Hawkins et al., 1989). 
 
Autotransplantation of tissue back into a patient may in some circumstances carry the risk of 
re-establishing disease, therefore the technique would not be suitable for all patients (Shaw et 
al., 1996).  This risk is particularly relevant to blood borne diseases such as leukaemia and also 
to cancers where there is a high risk of secondary metastasis in the ovary- such as breast 
cancer. In order to minimise the risk of reintroduction of malignant cells with the graft, 
techniques including histological and immunohistochemical analysis of the ovarian tissue have 
been developed to detect malignant cells prior to grafting (Meirow et al., 2008).  In addition 
real time (RT) polymerase chain reaction (PCR) techniques were developed in the 
aforementioned study to enable testing for minimal residual disease.  Grafting of isolated 
cryopreserved follicles is an alternative technique that may enable the restoration of fertility 
whilst avoiding re-introduction of malignant tissue.  The successful freeze-thawing of isolated 
primordial follicles followed by aggregation into ovarian tissue and transplantation has 
resulted in the birth of live offspring in mice (Carroll and Gosden, 1993).  The use of this 
technique in humans is currently under investigation, with isolated follicles being transferred 
to SCID mice (Dolmans et al., 2007, Dolmans et al., 2008).  Finally, where there is a high risk of 
reintroducing malignant cells the only safe option for fertility restoration is to grow follicles to 
maturity in vitro to facilitate fertility restoration following IVF and embryo transfer (see Section 
1.7).  
 
1.6.7 Whole ovary cryopreservation 
Due to the difficulties associated with whole ovary cryopreservation, in terms of optimizing 
cryoprotectant type and exposure time, ovarian tissue is usually stored as slices.  Optimization 
of the type of CPA to use for whole ovary cryopreservation (WOCP) is challenging because it 
must be suitable for the stroma, follicular cells, oocyte and vasculature (Hovatta, 2005).  
However, when grafting, the slices of ovarian tissue are exposed to relatively long periods of 
ischaemia, as it takes 5-7 days in humans for the formation of new vasculature (Israely et al., 
2004, Israely et al., 2006).  This period of ischaemia is a greater factor in determining the 
number of surviving follicles than the cryopreservation or perfusion processes (Newton et al., 
1996).  In contrast when grafting whole ovaries the existing vasculature is used and 
microsurgical anastomosis carried out (Onions et al., 2009).  There have been a number of 
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successful attempts at transferring whole fresh ovaries in sheep and humans, in terms of 
restoration of ovarian function (Jeremias et al., 2002, Courbiere et al., 2009, Mhatre et al., 
2005, Imhof et al., 2006, Laufer et al., 2010, Onions et al., 2013).  Furthermore, 
autotransplantation of frozen-thawed ovaries into ewes resulted in limited restoration of 
ovarian function and in one case a spontaneous live birth 545 days after transplantation 
(Bedaiwy et al., 2003, Imhof et al., 2006).  However, these procedures have lead to a large loss 
of follicles, which can be attributed to the perfusion and cannulation techniques, as opposed 
to the cryopreservation techniques, as shown by the use of fresh ovary controls (Onions et al., 
2009).  The use of WOCP as a fertility restoration technique will be discussed in more detail in 
Chapter 6. 
 
1.7 In vitro growth of oocytes as a method of fertility preservation  
Cryopreservation of ovarian tissue and the subsequent in vitro growth and maturation of 
oocytes could potentially be used as a method of fertility preservation.  This method would be 
suitable for both prepubertal girls, adolescents and young women (Picton et al., 2008).  
Development of culture systems able to support the complete in vitro growth (IVG) and in vitro 
maturation (IVM) of oocytes would also aid the understanding of the role of growth factors in 
vivo and the determination of acceptable candidates for this treatment, with respect to, for 
example, age (Smitz et al., 2010). 
 
Eppig and O'Brien (1996) were the first to develop a culture system that was able to support 
the IVG and IVM of oocytes from the primordial stage in mice.  Note that IVG refers to the 
development of the immature MI oocyte in vitro, whereas IVM refers to the process by which 
fully grown/competent oocytes undergo germinal vesicle breakdown (GVBD) and progression 
to the MII stage in response to GN stimulation in vitro.  Fertilisation of the resultant mature 
oocytes resulted in the live birth of one pup, named Eggbert.  Eggbert, however, exhibited a 
range of health problems, which were likely to result from epigenetic disruption induced by 
suboptimal culture conditions (Dennis, 2003).  Furthermore, less than 2% of the 2-cell embryos 
so derived developed to the blastocyst stage and only 0.5% of embryos transferred resulted in 
a live birth.  Subsequent alterations to the culture medium and protocol improvements 
resulted in improved success rates and a further 59 live births (O'Brien et al., 2003).  Due to 
the larger size and longer growth period of oocytes in larger mammals and humans it has 
proved difficult to adapt these rodent culture systems to suit these species and work is still 
ongoing (Picton et al., 2008).  Since the advances made by Epigg and O’Brien there has been a 
44 
 
 
 
lot of research into the optimisation of IVG and IVM systems.  Details of investigations, which 
have provided the evidence and knowledge needed to continue this process of optimisation 
are shown in Table 1.8 and Table 1.9.  It is important to note that the culture systems 
developed must be optimised for both fresh and frozen-thawed tissue, as the latter is more 
therapeutically-relevant for treatment of iatrogenic infertility (Smitz et al., 2010). 
 
1.7.1 Optimisation of IVG culture systems 
The optimisation of follicle culture systems is of high importance, not only to improve success 
rates but also to ensure the health of the resultant offspring.  When developing a culture 
system the culture media composition, pH, temperature, oxygen tension as well as the method 
of follicle culture must be considered.  There is conflicting evidence regarding the optimal 
oxygen tension for follicle culture.  Some authors have advocated the use of low (5%) oxygen 
tension, presenting evidence that low oxygen tension improved growth and differentiation 
rates of sheep follicles in vitro (Cecconi et al., 1999).  In contrast, studies performed by Jin et 
al. (2007) showed that low oxygen tension usage led to reduced rates of antral cavity 
formation compared to follicles grown in 20% oxygen.  Similarly, the use of 5% oxygen in 
mouse preantral follicle culture prevented antral cavity formation (Smitz et al., 1996).  
Furthermore, culturing follicles in hypoxic environments increased the rates of chromosomal 
misalignment and precocious oocyte release and germinal vesicle breakdown in mice (Smitz et 
al., 1996, Hu et al., 2001). 
 
Regulation of the temperatures to which ovarian follicles and oocytes are exposed, during 
transport to the laboratory, tissue processing, tissue culture and media changes, is important.  
Regulation of tissue temperature following collection and transport to the laboratory is often 
challenging.  The temperature at which tissue is processed is often species-specific, with 
respect to body temperature (Telfer et al., 2008, McLaughlin and Telfer, 2010, Newton et al., 
1999b).  This applies to the temperature during follicle culture and media changes also.  
However, in some culture systems tissue is processed at lower temperatures (4°C).  Processing 
the tissue at a lower temperature increases the efficiency of differential staining using the 
viability stain- neutral red dye (Chambers et al., 2010).  Culture of ovine follicles following 
processing at 4°C did not have a detrimental effect on follicle growth and development.  
Furthermore, Lucci et al. (2004) showed that storing bovine preantral follicles at 4°C for 18 
hours did not result in morphological damage, as assessed by histological analysis. 
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Table 1.8  Culture Systems for the in vitro growth of early preantral follicles.  Details concerning the nature of the culture system, species and results are 
shown.  Abbreviations; mouse (M), human (H), sheep (S), cow (C), non-human primate (P), primordial (prd), primary (1°), secondary (2°), preantral (PA), transitional 
(trans), insulin, transferrin, selenium (ITS+), proliferating cell nuclear antigen (PCNA).  
Details of follicle culture 
system (species) 
Follicle stage at start 
and end of culture 
Culture length Results/ extra information References 
Isolated follicle culture within 
alginate beads, serum-based 
(H) 
Prd/EP->1° 7 days Isolated using enzymes (Liberase and collagenase) -> large 
numbers of viable follicles Large numbers of follicles were 
able to survive and grow using this culture system 
(Amorim et al., 
2009, Vanacker et 
al., 2011) 
Isolated follicles cultured on 
matrices composed of 
collagen, ECM or poly-L-
lysine, serum-based (H) 
Prd 24 hours Follicles cultured within collagen gels grew over the 24 hour 
period 
(Abir et al., 2001) 
Cultured lectin-aggregated 
follicles, serum-free (S) 
Prd 28 days Follicles grew and exhibited a 50% survival rate (Muruvi et al., 
2005) 
Cortical slices cultured on 
ECM coated inserts, serum-
based (H) 
Prd-2°-> late PA ≤21 days Follicles cultured on inserts pre-coated with ECM showed 
increased rates of viability compared to uncoated inserts 
(Hovatta et al., 
1997) 
Whole ovary, serum-based 
(M) 
Prd->mature 
oocytes – fertilised    
->birth of a live pup 
8 days (organ culture), 
then 14 days (isolated 
COCs), IVM 
One resultant live birth, Eggbert, however, <2% of 2-cell 
embryos developed to blastocyst stage and only 0.5% of 
embryos transferred resulted in a live birth.  Eggbert 
exhibited health problems, including 'obesity and 
neurological abnormalities'. 
(Eppig and O'Brien, 
1996, Eppig and 
O'Brien, 1998)  
Whole ovary, serum-free (M)  Prd->mature 
oocytes-> fertilised  
->birth of a 59 live 
pups->adulthood 
8 days (organ culture), 
further 6+8 days (change 
in media composition) 
(isolated COCs), IVM 
Modifications to the culture medium used resulted in 
increased rates GVBD in oocytes, cleavage to 2-cell stage and 
live births 
(O'Brien et al., 
2003) 
Cortical slice culture, serum-
free (H) 
Prd->transitional 6 days Cortical pieces were cut into pyramid shapes and 
mechanically loosened.  Follicles isolated after cortical culture 
were competent to develop up to the antral stage 
(Telfer et al., 2008) 
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Table 1.8 (continued) 
Details of follicle culture 
system (species) 
Follicle stage at 
start and end of 
culture 
Culture length Extra information References 
Cortical slice culture, serum-
free (P) 
Prd->2° ≤20 days Compared the use of ITS+ vs. serum.  Cortical slices cultured in the 
absence of serum exhibited higher rates of primordial follicle activation 
(Wandji et al., 
1997) 
Cortical slice culture, serum-
free (C) 
Prd->1° ≤7 days Utilised PCNA staining to distinguish between quiescent and activated 
follicles 
(Wandji et al., 
1996b) 
Cortical slice culture, serum-
free (H) 
Prd->2° ≤15 days Compared the use of ITS+ vs. serum.  Cortical slices cultured in the 
absence of serum exhibited significantly lower rates of atresia, grew 
significantly larger and were responsive to FSH  
(Wright et al., 
1999) 
Cortical slice culture, serum-
free (S) 
Prd->PA 8 days Investigated the use of NR dye as a viability stain (Chambers et al., 
2010) 
Cortical slice culture, serum-
free (S) 
Prd->EA 18 days Compared the use of a control, constant and sequential medium (Peng et al., 2010) 
Cortical slices cultured on ECM 
coated inserts, serum-free (H) 
Prd->data not 
shown 
≤14 days Compared tissue preparation methods (slices vs. cubes), ECM density 
and ECM composition.  Cubed tissue appeared optimal as the % of 
viable follicles was higher than in slices of tissue   
(Scott et al., 
2004a) 
Cortical slice culture, serum-
free (C) 
Prd->Trans 6 days Cortical pieces were cut into pyramid shapes and mechanically 
loosened.  Following cortical culture and isolation follicles were 
competent to develop up to the antral stage 
(McLaughlin and 
Telfer, 2010) 
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Table 1.9 Culture systems for the in vitro growth of preantral- antral stage follicles.  Details of the nature of the culture system, species and results are shown.  
Abbreviations; mouse (M), human (H), ovine (S), bovine (C), non-human primate (P), primordial (prd), primary (1°), transitional (T) secondary (2°), preantral (PA).  
System Follicle stage at 
the start and end 
of culture 
Culture 
length 
Isolation method Attachment- or non-
attachment-based 
system 
Results/ extra Information References 
Serum-
based 
1°/2°(85-145μm) 
(M) 
16 days Mechanical Attached - lost 3D 
structure 
Cultured in V-shaped wells in media covered by a layer of oil.  
The oocyte, GC and TC remained functional with respect to 
steroid hormone production 
(Cortvrindt 
et al., 
1996) 
PA->antral (S) 6 days Mechanical Non-attachment-
based 
Significant increases in size and antrum formation, enhanced 
by the addition of FSH and low oxygen tension 
(Cecconi et 
al., 1999) 
PA (30-70μm) (C) 30 days Mechanical (grating 
device)/ enzymatic 
(collagenase) 
Attachment- based  Follicles co-cultured with bovine somatic cells.  Follicles able 
to survive and grow when co-cultured with mesenchymal 
cells 
(Itoh and 
Hoshi, 
2000) 
1°-> Graafian, 
then fertilised (M) 
5 days 
(IVG) 
14hours 
IVM 
Mechanical Non-attachment-
based 
Fertilisation was only successful in IVG oocytes cultured in 
medium supplemented with FSH, transferrin and 5% serum 
alone. The addition of insulin, sodium pyruvate and 
glutamine slowed growth. Serum substitution for BSA-> ZP 
hardening 
(Spears et 
al., 1994) 
Serum-free 2°(150μm)-> 
antral (M) 
6-7 days Mechanical Non-attachment-
based (follicles 
cultured on Millicell 
inserts) 
Group and individual culture of follicles was compared: 
individual culture resulted in improved growth rates.  
Formation of antral cavities and E2 production resulted when 
follicles were cultured with hFSH 
(Nayudu 
and 
Osborn, 
1992) 
Trans/2°(100-
180μm)->antral 
(M) 
8-12 
days 
Mechanically 
isolated 
Non-attachment-
based.  Encapsulated 
follicles in sodium 
alginate matrix 
Antral follicles were competent to resume meiotic 
maturation. The mechanical stiffness of the support matrix 
used needs to be optimized to allow differentiation of the 
follicles.  Evidenced by the fact that the stiffness of the matrix 
altered the steroid hormone output of the follicles 
(West et 
al., 2007) 
2° (COCs) 190-
240μm-> antral 
(S) 
30 days Enzyme 
(collagenase and 
DNase) 
Non-attachment-
based 
Follicles formed antral cavities - this was enhanced by GN 
supplementation of the medium 
(Newton 
et al., 
1999b) 
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Table 1.9 (continued) 
System Follicle stage at the 
start and end of 
culture 
Culture 
length 
Isolation method Attachment- or non-
attachment-based 
system 
Extra information References 
Serum-
free 
2° (250-300μm) (P) 30 days Mechanically 
isolated (using 
needles) 
Non-attachment-
based.  Encapsulated 
follicles in alginate 
hydrogels 
Supported the growth and steroidogenic function of follicles.  
Growth was enhanced by the addition of FSH alone, in 
comparison to FSH and LH 
(Xu et al., 
2009) 
2°(125-225μm)  
-> antral (P) 
40 days Enzymatically 
isolated 
(collagenase and 
DNase) then 
needles were used 
Non-attachment-
based.  Encapsulated 
follicles in sodium 
alginate matrix 
Antral follicles were competent to undergo oocyte meiotic 
maturation. 
(Xu et al., 
2011a) 
Trans (66-132μm)  
-> antral (H) 
6 days 
(cortical) 
+ 4 days 
(PA) 
Mechanically 
isolated from 
cortical tissue 
following culture 
(using needles) 
Non-attachment-
based 
Follicles cultured in the presence of activin A exhibited 
enhanced growth and survival rates.  Furthermore the use of 
activin A resulted in antrum formation and normal 
morphology in 30% of the follicles 
(Telfer et 
al., 2008) 
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Table 1.10  Commonly used additives in follicle culture systems.  The mechanism by which the additives support and promote follicle and oocyte growth and 
development in vitro as well as the species in which these additives have been used are summarised.  Abbreviations: human (H), ovine (O), mouse (M), bovine (B) 
progesterone (P4), basement membrane (BM), extracellular matrix (ECM). 
 Additive Mechanism Extra Information Reference(s) 
Insulin Promotion of follicle activation and survival 
via the promotion of the uptake of glucose 
and amino acids by cells (H,O,B) 
Commonly used in combination with transferrin and selenium.  
Supplementation of medium with TS+ alone did not result in 
follicle activation (B) but did provide a useful system to examine 
the effects of other growth factors, such as KL 
(Czech, 1985, Louhio et al., 2000, 
Muruvi et al., 2009, Newton et al., 
1999b) 
IGF-1 and IGF-2 Enhance follicle survival and proliferation.  
Promote P4 secretion via promotion of FSHR 
expression (H,O) 
When used in combination with insulin increased the number of 
growing follicles after 14 days culture.  Effects are stage-specific 
(Monniaux and Pisselet, 1992, Newton 
et al., 1999a, Louhio et al., 2000) 
Transferrin Facilitates transport of iron to cells in culture 
(H,O,R) 
  (Demeestere et al., 2005, Louhio et al., 
2000, Newton et al., 1999b) 
 Sodium selenite 
Protects against oxidative damage via its 
incorporation into seleno-enzymes (H,O,R) 
 (Hreinsson et al., 2002) 
GDF9 Promotion of follicle viability, survival and 
development (H) 
 
 
(Telfer et al., 2008, McLaughlin and 
Telfer, 2010, Thomas et al., 2003, 
McGee et al., 1997, Mizunuma et al., 
1999, Smitz et al., 1998) 
Activin Promote follicle growth and development 
(H,O,B,R) 
Effects are species and stage specific  
cGMP Promotion of growth and development (H,R) Anti-apoptotic, promotes AC formation in larger follicles (McGee et al., 1997, Scott et al., 
2004b)  
cAMP Promotion of follicle growth, development 
and survival (H,R) 
Effects are species and stage specific (Zhang et al., 2004, Hartshorne et al., 
1994)  
Ascorbic Acid Promotion of follicle survival and 
enhancement of BM integrity (H,O,R) 
Promotes BM formation by increasing production of Matrix 
Metalloproteinase-2 (MMP-2) and Tissue Inhibitor of 
Metalloproteinases-1 (TIMP-1), key enzymes for ECM remodelling 
(Telfer et al., 2008, Peng et al., 2010, 
Murray et al., 2001) 
Pyruvate Energy source for the oocyte (H,O,R) via 
oxidative metabolism 
Somatic cells preferentially use glucose (in basal medium) as an 
energy source 
(Roberts et al., 2002, Harris et al., 
2007, Harris et al., 2009) 
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1.7.2 Culture media composition 
Basal culture media 
Commonly used basal culture media include alpha-MEM (mouse: (Spears et al., 1994), ovine: 
(Newton et al., 1999b), human: (Abir et al., 1997, Hovatta et al., 1997, Scott et al., 2004a), 
Waymouth’s medium (mouse: (Eppig and O'Brien, 1996, O'Brien et al., 2003), ovine: (Muruvi 
et al., 2009), human: (Wright et al., 1999) and McCoy’s 5a medium (ovine: (Thomas et al., 
2003, Telfer et al., 2008).  A summary of additives commonly used in IVG systems is given in 
Table 1.10, some additives will be discussed in more detail later in the text. 
 
Use of serum 
In the early studies basal media was commonly supplemented with serum.  Serum contains 
numerous components that aid follicle growth in vitro including albumin, precursors for 
steroid biosynthesis, ‘proteins, amino acids, carbohydrates, hormones, growth factors and 
extracellular matrix components’ (Picton et al., 2008).  However, due to its complex 
composition it is difficult to assess the effects of different additives on follicle development.  
Furthermore, serum has been shown to have deleterious effects when used in both mouse 
and sheep embryo culture media leading to fetal overgrowth syndrome and alterations in 
behaviour, caused by aberrant imprinting (Young et al., 1998, Fernandez-Gonzalez et al., 
2004).  In addition, Wandji et al. (1997) suggested that serum contains components which are 
inhibitory to the activation of primate pre-granulosa cells.  Culture systems in which serum has 
been replaced by insulin, transferrin and selenium (ITS) and a source of albumin (e.g. bovine or 
human serum aIbumin (BSA/HSA)) (ITS+) have been developed.  In the aforementioned study 
although the use of serum resulted in a greater increase in follicle diameter after culture the 
rates of follicle activation and development to later stages were lower than when ITS+ was 
used as a substitute (Wandji et al., 1997).  Furthermore, culture of primordial and primary 
human follicles in media supplemented with ITS and HSA were larger, more developed and 
showed fewer signs of atresia than those cultured in media supplemented with serum (Wright 
et al., 1999).  In addition, culture of ovine secondary follicles in the presence of serum resulted 
in follicle collapse as opposed to those cultured in serum-free media in which follicles 
maintained their 3D structure (Newton et al., 1999b).  Numerous studies have shown that 
follicles are able to survive and grow in serum-free culture systems, see Table 1.8 and Table 
1.9.  Early investigations conducted in mice revealed that use of serum-free media resulted in 
ZP hardening, a large decrease in both the percentage of inseminated ova that underwent 
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cleavage to the 2-cell stage and the percentage that progressed to the blastocyst stage.  
However, the addition of fetuin to the serum-free media reduced ZP hardening and improved 
cleavage rates (Eppig et al., 1992).  Furthermore, supplementation of the media with ITS was 
necessary to maintain high levels of follicular integrity. 
 
Activin A 
Activin A is an additive of particular interest as the effect of activin A on follicle growth in vitro 
has been investigated in a number of mammalian species.  Studies in rodents have provided 
evidence that activin A stimulates preantral follicle growth and differentiation, with respect to 
FSH-induced inhibin and E2 production, antrum formation and other aspects of maturation, in 
vitro (Smitz et al., 1998, Zhao et al., 2001, McGee et al., 2001).  McGee et al. (2001) showed 
that the growth seen in the preantral follicles was due to an increase in cell number and that 
activin A did not appear to have any apoptosis-inducing effects.  Whereas in the study 
conducted by (Smitz et al., 1998) activin A appeared to have a detrimental effect on follicle 
survival. 
 
Activin A has also been shown to promote the growth and survival of caprine primordial 
follicles cultured within cortical tissue pieces, and isolated primary follicles (Silva et al., 2006).  
No effects were seen with respect to primordial follicle activation.  Although the effects of 
activin A were blocked by the addition of follistatin in primary follicle culture the same effect 
was not seen with the primordial follicles.  The authors suggest that this is likely to be due to 
the concentration of follistatin being too low resulting in incomplete blockage of activin A 
(Silva et al., 2006).  More recently activin A has been shown to promote the growth and 
viability of feline preantral follicles in vitro (Wongbandue et al., 2013).  In this study the effects 
of thyroxin were also investigated and found not to be beneficial. 
 
Telfer et al. (2008) have developed an in vitro culture system in which human primordial 
follicles were activated within cortical tissue then isolated and cultured in the presence of 
activin A.  The inclusion of activin A in the culture media promoted growth and antrum 
formation in preantral follicles.  This group conducted a similar study using bovine ovarian 
tissue in which activin A and FSH inclusion increased oocyte and follicle growth, antrum 
formation and initially E2 secretion, although this final effect was not sustained after the ninth 
day of culture (McLaughlin and Telfer, 2010). However, in neither the bovine nor the human 
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study was follistatin used to determine whether these effects were reversed, which would 
have provided more convincing evidence that the aforementioned effects were due to the 
presence of activin A.  Note also that in both of these studies neither activin A nor FSH was 
added during the initial cortical culture period, rather they were added following follicle 
isolation. 
 
The effect of activin A with respect to the in vitro culture of ovine ovarian follicles has been 
studied (Thomas et al., 2003).  Culture of isolated preantral follicles in the presence of activin A 
promoted follicle growth and increased oocyte diameter.  As in the bovine investigation activin 
A initially increased E2 secretion; however this effect was not sustained after the second day 
of culture.  No effect was seen on antrum formation or follicle survival.  Thus activin A may 
promote follicle growth but not differentiation of ovine preantral follicles in vitro.   
 
Gonadotrophins – FSH and LH 
As previously mentioned gonadotrophic stimulation of follicle development is not essential 
until the EA stage, however, gonadotrophins play a permissive role at earlier follicle stages, as 
illustrated by numerous in vitro studies.  FSH has been shown to promote the growth and 
differentiation of rat preantral follicles (McGee et al., 1997).  In the sheep FSH promotes antral 
cavity formation in ovine secondary follicles in vitro (Newton et al., 1999b) and has been 
shown to promote GC proliferation in small (2-3.5mm) and large follicles in vitro (Campbell et 
al., 1996), FSH stimulates the growth of large ovine antral follicles in vivo also (Picton et al., 
2000).  In the aforementioned study in which in vitro-derived transitional bovine follicles were 
cultured to the EA stage, FSH was shown to promote follicle growth in the presence of activin 
A (McLaughlin and Telfer, 2010).  Furthermore, survival rates of secondary, non-human 
primate follicles in vitro were increased when high or medium concentrations of FSH were 
used in the presence of fetuin and 5% oxygen  (Xu et al., 2011a).  In this study FSH levels were 
also shown to affect steroidogenesis, as high levels (15ngml-1) increased the production of 
androstenedione (A4), E2 and P4.  The authors suggested that this may be due to the 
premature differentiation of GCs.  
 
More research is required to determine the optimal stage at which FSH should be added to the 
IVG system and also to define the optimal concentration to be used.  These effects may be 
species-specific as well as being dependent upon other additives in the culture system.  This is 
53 
 
 
 
evidenced by the fact that FSH has, in some studies, been shown to be detrimental to the IVG 
of follicles, at specific stages of development.  For example, although the development of 
mouse secondary follicles is FSH-dependent, high levels of FSH, of greater than 25mIUml-1 led 
to a reduction in follicle survival rates, in serum-free culture media (Kreeger et al., 2005). 
Furthermore, the addition of either 10- or 100-mIUml-1  FSH to serum-based media, during the 
in vitro development of non-human primate follicles from the preantral to EA stage has been 
shown to have detrimental effects on the oocyte—GC interactions and the meiotic spindle 
structure (Xu et al., 2011b).   
 
Evidence is emerging that a sequential culture system in which the concentrations of specific 
GNs and GFs are adjusted at specific points in the culture period may be optimal.  Peng et al. 
(2010) investigated the effect of FSH on the in vitro development of ovine preantral follicles.  
In this study the use of a control, constant and sequential media was compared.  In the 
sequential media increasing amounts of FSH and epidermal growth factor (EGF) and 
decreasing amounts of GDF-9 and bFGF were used.  Use of the sequential media resulted in 
the progression of primordial follicles to the EA stage.  Antral follicles were also found in the 
control and constant media but these were abnormal.  Furthermore, the percentage of 
secondary follicles and the growth of primary and secondary follicles increased.  Celestino et 
al. (2011) conducted a study which also supports the use of a sequential culture media.  In this 
study caprine secondary follicles were cultured in the presence of increasing concentrations of 
FSH, this promoted follicle survival, development and subsequent rates of meiotic resumption. 
 
The question of whether LH should be added in combination with FSH or in a sequential 
manner is one that remains to be answered.  In the aforementioned study conducted by 
(Newton et al., 1999b) the addition of 5ngml-1 LH to the culture media, containing 0.1ngml-1 
FSH, did not affect the rate of antrum formation in ovine secondary follicles.  However, LH did 
affect the steroidogenic activity of non-human primate preantral follicles in vitro in that A4 and 
P4 production increased in response to its addition to the culture media (Xu et al., 2011a).   
 
1.7.3 Follicle isolation method – mechanical vs. enzymatic 
Follicle isolation can be achieved via enzymatic or mechanical means.  Isolation of follicles by 
mechanical means requires the use of needles, scissors, forceps or mesh filters.  Viable follicles 
competent to survive culture have been obtained from mouse, ovine and human ovaries using 
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these methods (Spears et al., 1994, Amorim et al., 2000, Abir et al., 1997).  However, isolation 
of follicles using mechanical methods alone, particularly in larger mammals and humans in 
which ovarian stroma is tougher and more collagenous than that of rodents, can result in 
lower yields when compared to enzymatic methods (Telfer, 1996).  The age of the animal from 
which the ovary is obtained can also affect how many follicles it is possible to isolate as follicle 
density reduces with advancing age and stromal tissue becomes increasingly tough.  Enzyme 
isolation is therefore often used in combination with mechanical methods resulting in greater 
follicle yields however, the use of enzymes results in the loss of the basement membrane and 
theca cells, which could be avoided by using solely mechanical methods (Nayudu and Osborn, 
1992, Telfer, 1996, Newton et al., 1999b). 
 
Nicosia et al. (1975) were the first to show that structurally and functionally normal follicles 
could be enzymatically isolated from the ovaries of rabbits, using collagenase.  Collagenase has 
been used in numerous studies and enabled the isolation of follicles competent to grow and 
develop in culture from both ovine (Newton et al., 1999b, Nandi et al., 2009) and human (Abir 
et al., 2001, Amorim et al., 2009) ovaries.  However, it should be noted that in the latter 
mentioned study there was an increase in the number of lipid droplets in the granulosa cells 
relative to non-isolated controls, indicating that the health of the follicles may have been 
compromised (Abir et al., 2001).   
 
Liberase, an enzyme originally shown to improve the quality of human pancreatic islet 
isolation with respect to their anatomical integrity and viability compared to collagenase, has 
also been used in follicle isolation protocols from human ovarian tissue (Linetsky et al., 1997).  
Dolmans et al. (2006) presented evidence that favoured the use of Liberase over collagenase.  
They showed that although the follicle yield following ovarian tissue digestion using Liberase 
was lower than when collagenase was used, the proportion of viable and morphologically 
normal follicles was higher.  The authors attributed this to the fact that collagenase contains 
higher levels of endotoxins than Liberase.  However, in a more recent study by the same group 
conflicting evidence is presented (Vanacker et al., 2011).  In this study there was no significant 
difference in the percentage of viable follicles, isolated using either collagenase or Liberase, 
before or after 7 days of isolated follicle culture.  As Liberase does not digest the tissue as 
effectively as collagenase and collagenase may cause more morphological damage a mixture of 
both enzymes may be preferable (Kristensen et al., 2011).  It should be noted that the 
preparations of collagenase varied between studies.  In conclusion, the type and concentration 
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of the enzyme(s) used and the length of exposure time must be optimised to ensure sufficient 
follicles can be isolated without irreversibly damaging the structural integrity of the follicles. 
 
1.7.4 Isolated vs. in situ culture 
Hovatta et al. (1999) showed that the isolation of primordial, primary and transitional follicles 
conferred no advantage over in situ culture (within slices of cortical tissue) of follicles at these 
developmental stages.  However, at later developmental stages follicle growth is inhibited, 
possibly by the surrounding ovarian tissue and therefore follicle isolation is required (Hovatta 
et al., 1997).  Indeed, numerous researchers advocate the use of a multi-step system in which 
the first phase of culture is carried out in situ (Eppig and O'Brien, 1996, Picton et al., 2000, 
Telfer et al., 2008, Picton et al., 2008).  Culturing the primordial follicles in situ provides an 
environment that more closely resembles the ovary in vivo, in terms of the locally produced 
factors, and maintenance of oocyte-granulosa cell interactions which are important for their 
continued growth and maturation (Picton et al., 2000).   
 
There are various methods by which primordial follicles can be cultured in situ.  These include: 
chorioallantoic membrane grafts, whole ovary and cortical slice culture.  It is possible to 
maintain the viability of baboon and cow primordial follicles using the chorioallantoic 
membrane of chick embryos, but there was no development past the primordial stage 
(Fortune et al., 2000).  However, if the pieces were then transferred to serum-free media the 
follicles were activated and developed to the primary stage (Cushman et al., 2002).  The use of 
this culture system led to the elucidation of the inhibitory role of AMH on follicle activation 
(Gigli et al., 2005).  Therefore the in ovo method may be useful for studying regulators of 
primordial activation.  
 
The most commonly used method of in situ culture is the use of whole ovary or ovarian 
cortical slice culture.  Whole ovary culture is suitable for rodents (see Table 1.8 for examples), 
it is not suitable for larger mammals and humans as the ovaries are larger and therefore 
nutrients and metabolites cannot permeate the tissue sufficiently in vitro.  This can be 
overcome via the use of thin cortical slices whilst still providing sufficient support to maintain 
the native architecture of the follicle (Gosden, 1998).  Therefore in these species cortical slices 
are utilised, allowing the architecture of the follicles to be maintained during the culture 
period.  Cortical slices have been utilised for the IVG of primordial follicles in various species 
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some of which are detailed in Table 1.8.  Semi-permeable membrane inserts are utilised in 
some systems (e.g. Chambers et al. (2010)) to ensure that the cortical slices are covered in a 
sufficient volume of medium with respect to provision of growth factors and hormones 
without the diffusion distance for oxygen being too great (Devine et al., 2002). In the systems 
developed by Telfer’s laboratory cortical tissue was mechanically loosened prior to culture to 
reduce the amount of medulla present, as the authors hypothesise this will reduce the 
concentration of medulla-derived inhibitory factors.  As previously mentioned once follicles 
reach the transitional/ secondary stages of development further growth is inhibited, thus 
follicle isolation is required. Although it should be noted that Peng et al. (2010) reported that 
follicles were able to develop up to the EA stage in ovine cortical tissue culture.  In order to 
increase the efficiency of IVG systems the tissue selected for culture should be relatively 
follicle-rich.  Chambers et al. (2010) developed the use of neutral red dye as a method of 
identifying viable follicles prior to culture and of guesstimating viable follicle density without 
compromising the subsequent developmental competence of the follicles.  Follicles derived in 
vitro using the system developed by Telfer’s laboratory were competent to develop to the EA 
stage following isolation and individual culture (Telfer et al., 2008, McLaughlin and Telfer, 
2010).  
 
Use of extracellular matrices (ECMs) and supporting hydrogels 
Although there may be no direct advantage to isolating small preantral, growing follicles rather 
than culturing them in situ, isolated culture enables further investigation of the optimisation of 
IVG systems as the system is more easily manipulated.  The use of isolated culture of follicles 
at all stages is a useful tool for the investigation of growth factors and mechanisms involved in 
in vivo growth and development (Devine et al., 2002).  Therefore research into the 
optimisation of IVG culture systems that are able to support the growth and development of 
isolated follicles at both the earlier and later preantral follicle stages is important.  Isolation of 
follicles results in the loss of the physical support provided by the ovarian stroma.  Therefore in 
order to overcome this; researchers have developed the use of ECMs and gels in IVG culture 
systems.  Gels must provide sufficient rigidity to promote the maintenance of oocyte- GC 
interactions, but without being too rigid and inhibiting follicle growth (Smitz et al., 2010).  The 
gel must also be permeable to the culture media and factors produced by the follicle.  The gel 
must be supportive and adhesive to follicles, but not too adhesive or this may cause somatic 
cells to migrate away from the oocyte.  The use of gels may be particularly relevant to the 
culture of follicles from larger mammals and humans as the time frame of follicle growth and 
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development is much longer than in rodents and therefore it is more difficult to prevent 
follicle attachment and resultant loss of integrity during these extended culture periods.  Smitz 
et al. (2010) also suggests that pressures exerted on the follicle by the ECM in vivo as it grows 
may affect the release of paracrine factors via alterations to actin organisation.   
 
Collagen and lectin have been used as ECM components (see Table 1.8).  More recently, 
researchers have used alginates as a gel composite.  Alginate hydrogels have been shown to 
maintain the ultrastructure of follicles in vitro with respect to the general morphology and the 
oocyte- GC interactions (Pangas et al., 2003).  Xu et al. (2009) showed that alginate gels could 
be utilised for culture of non-human primate, secondary follicles allowing continued follicle 
growth and development and supporting steroidogenesis for up to 30 days.  The development 
of this system has enabled further elucidation of the requirements of follicles in IVG systems, 
with respect to, for example, the effects of GNs and GFs and oxygen tension (Xu et al., 2010, 
Xu et al., 2011a).  Furthermore, this system has been used to compare cryopreservation 
methods, revealing that vitrification methods may be a useful alternative to slow-freeze 
methods with respect to subsequent follicle survival rates in culture, as well as steroid 
hormone production and antral cavity formation (Ting et al., 2011).   
 
The development of a hydrogel that is modulated, with respect to its composition and 
therefore its rigidity, by the follicles it encapsulates has been reported (Shikanov et al., 2009, 
Shikanov et al., 2011).  In this system a fibrin – alginate -interpenetrating network (FA-IPN) is 
used.  As the follicles grow the fibrin component of the hydrogel is degraded by plasmins 
produced by the follicle, thus allowing the follicle to increase in size.  The alginate component, 
however, is biologically inert and therefore is retained and continues to support the follicle.  
The level of fibrin degradation can be regulated by the addition of plasmin inhibitor, aprotinin, 
to the culture media (Longstaff, 1994).  The authors suggested that this would provide the 
follicles with a more physiologically relevant environment as it would mimic the reduction in 
rigidity experienced as developing follicles migrated from the tougher cortex to the less tough 
medullary interior of the ovary.  The use of the FA-IPN hydrogel resulted in a significantly 
greater percentage of meiotically competent oocytes developing from secondary follicles in 
mice, than the use of a gel composed of solely alginate.  It should be noted that gels have not 
only been used for isolated follicle culture but can also be utilised for cortical slice culture.  
Kedem et al. (2011) reported that the use of an alginate rather than Matrigel ECM for the 
culture of human primordial follicles within cortical slices and that this resulted in higher 
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activation rates.  However, a recent study in non-human primates reported that the use of an 
alginate-fibrin gel was only optimal for follicles at the primary stage and conferred no 
advantage to the culture of secondary follicles in relation to ‘growth, steroidogenesis, 
AMH/vascular endothelial growth factor (VEGF) production and oocyte maturation’ (Xu et al., 
2013).  Conversely, a recent investigation has provided evidence that the use of alginate as an 
ECM may adversely affect the developmental competence of in vitro-derived oocytes as an 
increased incidence of spindle defects, chromosome misalignment and cortical granule 
biogenesis errors were observed when an alginate gel system was used to culture mice follicles 
(Mainigi et al., 2011).  Therefore, the development of alternative ECMs may be necessary.  
Although it should be noted that Xu et al. (2011b) reported a normal meiotic spindle structure 
of baboon MII oocytes derived in vitro, as long as FSH was not present in the medium.  
Hyaluranon-based gels have been proposed as an alternative to alginate (Desai et al., 2012).  
Hyaluronan is a naturally occurring ECM component and is modifiable with respect to its 
rigidity.  Although the use of hyaluronan alone and in combination with Matrigel has been 
shown to support the IVG of mouse follicles, the rate of progression to MII stage was less than 
that observed in control cultures.  The authors suggest that a more dynamic environment, 
such as the FA-IPN described above, may be needed (Desai et al., 2012). 
 
The aforementioned studies relate to the culture of transitional/ secondary- staged preantral 
follicles.  More recently a culture system that supports the survival and growth of baboon 
primordial/ primary follicles in vitro has been reported (Hornick et al., 2012).  In this system 
enzymatically isolated follicles are encapsulated in 0.5-2% alginate gels, with 2% alginate 
optimal with respect to the follicle survival and maintenance of follicle morphology.  Use of 
this system for the culture of mouse primary follicles revealed the positive effects of the co-
culture of follicles with respect to the growth and survival of follicles resulting in the formation 
of meiotically competent oocytes (Hornick et al., 2013).  The authors suggest this is due to 
exposure of the follicles to paracrine factors secreted by the other follicles in co-culture. 
 
At the later preantral stages it is possible to prevent attachment to the culture surface and 
maintain the 3D structure of the follicle without the use of gels (mouse; West et al. (2007), 
sheep; Newton et al. (1999b) and Picton (2002); human; Telfer et al. (2008).  Initial work was 
carried out using rodents, however, as the GCs of ruminant and humans remain 
morphologically and steroidogenically similar to cells in vivo as opposed to forming fibroblastic 
phenotype, maintaining the 3D structure in vitro has proved easier in these species (Picton et 
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al., 2008).  Examples of 3D, non-attachment-based systems are shown in Table 1.9 with details 
of the extra steps required to prevent attachment detailed if necessary. 
 
 An alternative approach to culturing isolated preantral follicles is the use of either 2D, 
attachment-based systems (see Table 1.9; mouse; Cortvrindt et al. (1996), bovine; Itoh and 
Hoshi (2000).  Although there has been some success using 2D culture systems, the use of 3D 
systems confers many advantages.  As previously mentioned the maintenance of oocyte-GC 
interactions is of great importance to the continued growth and development of both the 
oocyte and somatic components of the follicle.  When a 2D culture system is used the follicle is 
allowed to attach to the culture surface thus losing its native architecture and potentially 
disrupting these interactions.  Whereas, when 3D culture systems are used oocyte-GC 
interactions are more likely to be maintained.  This is of particular importance in the IVG of 
larger mammals and humans as these follicles require a much longer period to attain maturity 
in vitro. 
 
Culture timescales – accelerated vs. protracted 
As detailed earlier in this chapter the process of oocyte and follicle development in vivo is long 
and protracted.  Whether it is necessary for in vitro systems to follow a physiologically-relevant 
timescale or if a much more accelerated system would be suitable is a point of discussion 
between research groups.  The growth and development of both bovine and human follicles 
from the primordial to the EA stage has been achieved using a two-step system after culture 
periods of 12 and 10 days, respectively (Telfer et al., 2008, McLaughlin and Telfer, 2010).  
Concerns have been raised regarding the health of oocytes resulting from systems in which 
follicle growth is so greatly accelerated (Picton et al., 1998).  Although some researchers argue 
that the use of physiologically-relevant culture periods is key to producing healthy in vitro-
derived oocytes, as this would allow sufficient time for the oocytes to develop the molecular 
machinery required for normal development (Picton et al., 1998).  Others claim that extended 
culture periods are not necessary and may in fact be detrimental to oocyte health due to 
increased exposure to suboptimal conditions in vitro.  Furthermore, accelerated culture 
systems would partly overcome the difficulties associated with maintaining oocyte-GC 
interactions long-term (McLaughlin and Telfer, 2010).  In order to determine whether 
accelerated or protracted culture systems are optimal more research into the effect of each on 
the genetic health of the follicle, by comparing in vivo- and in vitro-derived counterparts, is 
required. 
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Significant progress has been made with regards to the optimisation of IVG systems, 
particularly with respect to developments in ruminants and non-human primates.  A multi-step 
strategy in which primordial follicles are first cultured in situ, then isolated and cultured 
individually, with increasing concentrations of GNs present in the culture media, prior to IVM 
may support the in vitro-derivation of MII oocytes.  However, much more research is needed 
to determine whether this would be best achieved using an accelerated or protracted culture 
system, using gels to maintain 3D structure, using a sequential or constant culture media, 
using enzymatic or mechanical isolation methods.  In addition to the optimum concentrations 
and time points at which GFs and GNs should be added to the culture media.   
 
In order to determine which culture methods are optimal there need to be clear methods of 
assessing in vitro-derived oocyte quality, not only with respect to follicle and oocyte 
morphology, survival and growth rates, progression through the various developmental stages, 
but also with respect to the genetic and epigenetic health (Picton et al., 2008). 
 
1.8 Assessment of follicle and oocyte health and viability in vitro and in vivo  
In order to ensure follicle and oocyte health both compartments must pass through the same 
check-points in terms of protein production and growth.  Furthermore, conditions in vitro must 
mimic those in vivo.  Various cellular markers can be used to aid assessment, a number of 
techniques are summarised in Table 1.11 however a more extensive knowledge of cellular 
markers and their expression patterns is required, in order to develop and validate IVG culture 
systems.  Non-invasive methods of monitoring development may be used, such as monitoring 
the levels of secreted factors in spent media when the follicles are cultured individually (Telfer 
et al., 2000).  For example, the levels matrix metalloproteinase MMP-9 and tissue inhibitors of 
metalloproteinases (TIMPs), important for basement membrane reconstruction, can be used 
as markers of follicle development (McCaffery et al., 2000).  The levels of steroids – E2 and P4, 
can be monitored in spent media also, using Enzyme-linked immunosorbent assays.  The 
concentration of E2 can be used to determine whether the aromatase enzyme complex has 
been induced in cultured cells (Newton et al., 1999b). 
 
During ART procedures women are induced to superovulate and the resultant oocytes are 
collected.  Although the majority of these are at the mature MII stage some immature oocytes 
are also retrieved (Jones et al., 2008).  These immature oocytes can be matured in vitro.  
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However, the developmental competence of these oocytes is compromised following IVM as 
evidenced by the lower rates of zygotes developing to the blastocyst stage once fertilised 
compared to oocytes matured in vivo; 12% vs. ~50%, respectively (Chen et al., 2000, Jones, 
2000).  Furthermore, the percentage of embryos developing to full term is also lower in IVM 
oocytes than in vivo matured oocytes in humans; 14% vs. 35%, respectively (Blake et al., 2005, 
Jones et al., 2008).  The compromised developmental competence of IVM oocytes has been 
linked to a number of factors including alterations in oocyte morphology, cytoplasmic and 
nuclear maturation and spindle positioning (de Loos et al., 1992, Combelles et al., 2002, Moon 
et al., 2005).   
 
Table 1.11 Summary of various cellular markers which can be used to determine whether 
follicles and oocytes are developing normally and are healthy.  The techniques by which these 
markers are assessed are also shown.  The information was collated from data published in a 
number of different sources including (Newton et al., 1999b, Picton et al., 2000, Telfer et al., 
2000, Picton et al., 2008). 
  Markers Techniques used for assessment 
Cell morphology Oocyte diameter 
 Zona pellucida thickness 
Changes in cell number Follicle diameter 
Steroid production Measure E2 and P4 levels in spent media 
Basement membrane formation Azan staining of collagen component of basement 
membrane 
Somatic cell differentiation Patterns of expression of cellular markers, eg. IGFs, activin, 
inhibin, GDF-9 
Oocyte development 
DNA analysis Fluorescence assays 
 Incorporation of thymidine 
Oocyte viability Formation of antral cavity 
 Diameter 
 Staining with vital dye (e.g. neutral red dye) 
Nuclear maturation Production of maturation promoting factor  
 Dissolution of nuclei 
 Chromosomal condensation 
  Formation of functional spindle apparatus 
 
In numerous studies changes in gene expression have been linked to reductions in 
developmental competence of IVM oocytes.  For example, in a study comparing in vitro and in 
vivo matured human oocytes many genes involved in ‘transcription, the cell cycle and its 
regulation, transport and cellular protein metabolism’ were expressed at a 2-fold higher level 
62 
 
 
 
in the IVM group (Jones et al., 2008).  Furthermore, in a different study the expression 
patterns of numerous genes involved in nuclear maturation, homeostasis and cytoplasmic 
functions observed in IVM oocytes were more similar to those in immature GV oocytes than in 
vivo matured MII oocytes (Wells and Patrizio, 2008).  Alterations in oocyte gene expression 
patterns resulting from in vitro maturation have been observed in the mouse and bovine 
species as well (Tesfaye et al., 2009, Kind et al., 2013).  In addition, differences have been 
observed between human cumulus cells from oocytes matured in vitro and those matured in 
vivo with respect to expression of genes related to oocyte maturation, cumulus expansion and 
cell cycle regulation (Ouandaogo et al., 2012, Guzman et al., 2013).  In the rhesus monkey IVM 
has resulted in differing expression patterns of genes involved in cumulus cell interactions 
between themselves and with the oocyte (Lee et al., 2008, Lee et al., 2011).  Kyasari et al. 
(2012) demonstrated how altering IVM conditions can also alter gene expression patterns, 
illustrating the importance of optimizing IVM techniques.  Interestingly, the use of slow-freeze 
or vitrification to cryopreserve human MII oocytes also affects gene expression patterns 
relative to those observed in fresh MII oocytes (Monzo et al., 2012).  
 
The use of IVM has been shown to alter gene expression patterns in numerous studies using 
both animal and human oocytes.  As IVG of oocytes is a developing technique there are fewer 
studies investigating the impact of IVG on gene expression and most of these have utilized 
murine follicle culture systems.  However, these studies have revealed differences in 
expression patterns of genes between in vivo and in vitro-derived oocytes.  In one such study 
oocytes were grown in vitro within secondary stage follicles up to the antral stages and the 
expression patterns of Bmp-15, Mater, Zar-1 and Fgf-8 were measured and compared to 
expression levels in in vivo-derived oocytes . This revealed significantly lower expression levels 
of these genes after 10 days of culture (Sanchez et al., 2009).  In more recent studies the 
concentration of FSH and insulin in the IVG medium was shown to affect the expression of 
oocyte genes including- Gdf9, BMP15 and Fgf8, as well as cumulus cell-specific genes 
including- luteinizing hormone/choriogonadotropin receptor (Lhcgr), Amh, androgen receptor 
(Ar), phosphofructokinase platelet (Pfkp) genes (Sanchez et al., 2010, Sanchez et al., 2011).  
Furthermore, in a study in which secondary follicles were cultured up to the antral stages using 
alginate gels as a support matrix the concentration of the gel was shown to affect the 
expression patterns of Gdf9, Bmp15, NOD-like receptor family pyrin domain containing 5, T cell 
leukemia/lymphoma 1, and Zp3 (Jiao and Woodruff, 2013).   
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1.9 Epigenetics 
Epigenetics is the study of the process by which gene expression patterns are regulated by 
modifications to the DNA as opposed to the underlying sequence (Qiu, 2006).  Epigenetic 
information can be conferred in the form of DNA methylation, in which a methyl group is 
added to a cytosine residue allowing subsequent recognition and binding by regulatory factors 
(Reik et al., 2001).  This form of epigenetic modification represses gene activity.  Histone 
modifications, in the form of the attachment of proteins to the histone tails, are another form 
of epigenetic regulation, which can result in either the repression or activation of gene 
expression.  A third mechanism of epigenetic regulation is the attachment of non-histone 
proteins to chromatin.  Epigenetic modifications regulate the expression of imprinted genes 
(Qiu, 2006).  Imprinted genes are expressed monoallelicallly.  Monoallelic expression patterns 
are determined by the parental origin of the allele.  This mode of regulation is key to 
embryonic growth and development, placental and postnatal growth, as well as the 
prevention of parthenogenesis.  Imprinted genes are needed for the regulation of nutrient 
supply to the embryo.  Maternally and paternally expressed genes have opposing effects with 
respect to nutrient supply to the embryo.  Paternally expressed imprinted genes tend to 
promote mechanisms that increase nutrient supply to the embryo, whereas maternally 
expressed imprinted genes reduce nutrient supply.  This helps maintain a balance in which the 
embryo is provided with sufficient nutrients without being detrimental to the mother. 
 
Genomic imprints are erased at the stage of development that the PGCs are at when they 
reach the genital ridge.  Imprints are then re-established in an asynchronous manner as the 
gametes develop.  Imprint acquisition differs between sperm and oocytes, with respect to 
timing and is completed by day E18.5 in murine sperm and just prior to ovulation in oocytes, 
see Figure 1.7.  Once genomic imprints have been established they are maintained, even 
following fertilisation when genome-wide de-methylation and re-establishment occurs 
(Morgan et al., 2005).  DNA methyltransferases (DNMTs) are key enzymes with respect to the 
establishment of imprinting marks as well as the maintenance of these (Reik et al., 2001).  The 
enzyme DNMT3a and a DNMT3-related protein, DNMT3L, are essential for the establishment 
of the maternal imprint (Hata et al., 2002).  The enzyme DNMTb is also involved, however, may 
play more of a permissive role (Kaneda et al., 2004).  Evidence suggests that DNMT3L is a key 
regulator of DNMT3a and DNMT3b activity via its co-localisation and establishment of the 
maternal imprint is not possible without this protein (Hata et al., 2002).  Once established the 
maternal imprints must be maintained.  DNMT1o is essential for the maintenance of the 
maternal imprint in oocytes and preimplantation embryos.  DNMT1o homologues have been 
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identified in the mouse, sheep and human (Hayward et al., 2003, Taylor et al., 2009).  As 
previously mentioned epigenetic reprogramming occurs at 2 points in development: during 
gametogenesis and following fertilisation.  In the mouse, once fertilisation has occurred the 
paternal genome is actively demethylated, whereas demethylation of the maternal genome is 
passive.  Once completed, de novo methylation of the embryonic genome occurs (Reik et al., 
2001). 
 
Due to the timing of epigenetic reprogramming, concerns have been raised that ARTs may 
result in epigenetic disruption.  There is evidence to suggest that the use of ARTs may increase 
the risk of epigenetic errors.  Furthermore increasing evidence of connections between 
imprinting disorders and the use of ARTs is emerging.  The incidence of Beckwith Weidemann 
syndrome (BWS), an epigenetic disorder with symptoms such as childhood tumours, fetal and 
postnatal overgrowth, macroglossia and organomegaly (Amor and Halliday, 2008) has been 
linked the use of ARTs.  Over 60 cases of BWS had been reported in ART-conceived children by 
2008 (Amor and Halliday, 2008).  In addition the incidence of ART in children with BWS is 
significantly higher (2.9%) than the general population (0.8%), which has been associated with 
both the use of ICSI and IVF (Maher et al., 2003b, Sutcliffe et al., 2006).  In a study of 25 ART-
conceived children with BWS 24 had hypomethylation of the differentially methylated region, 
KvDMR1 on chromosome 11p15 (Lim et al., 2009).  Similarly the incidence of Angelman 
syndrome (AS) in children conceived using ARTs is higher than in the general population (Amor 
and Halliday, 2008).  In addition the percentage of cases of AS resulting from an imprinting 
defect is very low (~3%) in the general population, however by 2003, 6 of the cases of AS 
reported following the use of ovarian hyperstimulation alone (1 case) or in combination with 
ICSI (5 cases) resulted from imprinting defects, which suggested that the use of these ARTs 
caused the defects (Cox et al., 2002, Orstavik et al., 2003).  It has been suggested that 
subfertility may also be a cause of the increased incidence of AS resulting from epigenetic 
disorders (Ludwig et al., 2005, Sutcliffe et al., 2006). 
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Figure 1.7 The methylation status of developing oocytes, spermatozoa and pre-implantation embryos.  The maternal imprint is mostly erased in primordial germ 
cells and then gradually re-established throughout oocyte growth; throughout the primary to antral stages, as opposed to at one specific time point.  The ARTs 
that have been implicated in the disruption of epigenetic reprogramming are highlighted (Huntriss and Picton, 2008). 
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Silver-Russell syndrome (SRS) is another epigenetic disorder that has been associated with the 
use of ARTs as SRS resulting from the hypomethylation of H19/IGF2 gene has been observed in 
ICSI/IVF-conceived children (Chopra et al., 2010).  In an isolated case the use of IVF was 
associated with the incidence of SRS resulting from the hypermethylation of the PEG/MEST 
gene, although the pattern was also observed to a lesser extent in the Father, therefore 
imprinting errors may have been related to genetic errors, possibly involved in the couple's 
subfertility (Kagami et al., 2007).  Symptoms of SRS include low pre- and postnatal growth 
rates, delayed development and learning disabilities.  A newly recognised fetal overgrowth 
syndrome that causes seizures and developmental delay has also been linked to the use of 
ICSI/IVF (Shah et al., 2006).  More recently, Retinoblastoma- a form of eye cancer that usually 
affects children under the age of 5 years old, has been linked to the use of ARTs due to the fact 
that it is more common in IVF patients and that the retinoblastoma gene is imprinted (Kanber 
et al., 2009, Marees et al., 2010).  Although the incidence of imprinting disorders following the 
use of ARTs is relatively low Maher et al. (2003a) suggests that many more epigenetic errors 
have not been identified and that these errors predispose children to certain conditions, such 
as cancer, later in life.  In Table 1.12 the findings of investigations in which the mechanisms by 
which epigenetic errors, resulting from the use of ARTs, may have occurred are summarized.  
The results of these investigations reveal numerous inconsistencies that are probably due to 
inconsistencies in the media composition and techniques used.  Therefore, it is difficult to 
directly compare each study and to ascertain the exact cause of the effects on 
epigenetics/imprinted genes.  Note that the use of IVG culture systems is not included in Table 
1.12 as this is considered in more detail below. 
 
To further complicate matters both infertility and subfertility can increase the risk of 
conceiving a child with an imprinting defect.  In the case of subfertile couples increasing time 
to pregnancy increased the relative risk.  The risk is further increased in subfertile couples that 
conceive using ART (Ludwig et al., 2005).  As briefly mentioned in Table 1.12 further evidence 
of a link between infertility and increased risk of imprinting errors is provided by a study in 
which the methylation patterns of normozoospermic and oligozoospermic patients were 
compared.  The methylation pattern of maternally expressed imprinted gene H19 was altered 
in the oligozoospermic group, changes ranging from moderate (17%) to severe (30%).  
Whereas the methylation pattern of MEST, a paternally expressed imprinted gene, was not 
affected (Marques et al., 2004).  Similarly imprinting errors were observed in tetrazoospermic 
men, in the form of demethylation in either IGF2 alone or IGF2 and H19 (Boissonnas et al., 
2010).  In addition hypomethylation of IGF2/H19 gene was observed in men with low sperm 
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counts.  Unlike the aforementioned study aberrant methylation of the MEST gene was also 
observed.  Hypermethylation of MEST was not only observed in men with low sperm counts, 
but also men with bad sperm morphology and poor sperm motility (Poplinski et al., 2010).  
 
A number of studies have been conducted which compared the epigenetic status of ART-
derived children and spontaneously conceived children with slightly conflicting results.  Studies 
have shown changes in methylation patterns of both imprinted and non-imprinted genes, 
resulting in changes in expression of certain imprinted genes (Palermo et al., 2008, Katari et 
al., 2009).  However, in a more recent study methylation patterns at DMRs of imprinted genes 
were examined and no differences were found between children conceived spontaneously or 
via the use of IVF or ICSI, other than in the DMR of MEST (Tierling et al., 2010). 
 
One of the overarching aims of this thesis is to define the culture conditions required to derive 
normal, healthy, developmentally competent oocytes in vitro.  In order to achieve this goal, 
the parameters by which normality is to be assessed need to be established.  One such 
parameter by which normality should be assessed is the establishment of epigenetic 
modifications equivalent to that observed in vivo.  In more recent years the effect of culture 
conditions on the methylation patterns of important imprinted genes has been investigated.  
Studies in mice have shown that the methylation patterns of small nuclear ribonucleoprotein-
associated protein N (Snrpn), Igf2 or H19 in MII oocytes grown in vitro from the secondary 
stage were not affected under normal culture conditions (Anckaert et al., 2009a).  
Furthermore, when follicles were subjected to suboptimal culture conditions such as the 
addition of high levels of FSH (100iUL-1, compared to 10iUL-1) to the culture media, or exposure 
to increased levels of ammonium (up to ~1500μm following 12 days culture) and significantly 
reduced levels of oestrogen and progesterone, induced by culturing under mineral oil, this did 
not affect the methylation of the aforementioned genes (Anckaert et al., 2009a, Anckaert et 
al., 2009b, Trapphoff et al., 2010).  Furthermore, embryos resulting from the fertilisation of in 
vitro-derived oocytes also exhibited normal methylation of the aforementioned genes (El Hajj 
et al., 2011).  Similarly, ovine oocytes grown from the preantral to EA stages in vitro displayed 
normal methylation patterns of IGF2R, Brain-enriched guanylate kinase-associated protein 
(BEGAIN) and H19 (Barboni et al., 2011).  Nor were the methylation patterns of IGF2R or H19 
affected following the IVM of ovine oocytes (Colosimo et al., 2009).  Conversely, although 
culturing in the presence of reduced levels of methyl donors did not affect the methylation 
levels of Snrpn, Igf2 or H19 in murine MII oocytes grown in vitro from the secondary stage, the 
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methylation levels of Mest decreased (Anckaert et al., 2010).  Therefore, the overall 
methylation patterns observed in in vitro-derived oocytes were similar to that observed in in 
vivo-derived oocytes in animal models, suggesting that the mechanisms by which DNA 
methylation patterns are established are quite robust.  Whereas studies conducted in humans 
in which oocyte are matured in vitro have resulted in aberrant methylation patterns of H19 
(Borghol et al., 2006) suggesting that these mechanisms may be less robust in humans. 
 
A limited number of studies have been conducted regarding the epigenetic status of IVG 
oocytes that are derived from early preantral stages via the use of cortical slice culture.  In a 
number of studies differences in the methylation statuses of in vivo and in vitro-derived 
follicles were observed (Lees-Murdock et al., 2008, Song et al., 2009).  However, in these 
studies the oocytes were not competent to develop to the MII stage.  Whereas in a study in 
which IVG oocytes were competent to develop to the antral stage the methylation status of all 
imprinted genes investigated was normal (Obata et al., 2002).  As mentioned previously, 
Eggbert exhibited many health problems, which may have been due to aberrant epigenetic 
modifications (Eppig and O'Brien, 1998).  However, as Eggbert was the only mouse resulting 
from that study the exact causes of his poor health were unclear.  In a subsequent study in 
which alterations to the culture media composition, which promoted the normal acquisition of 
IVG oocyte developmental competence, were made 59 live offspring were born and survived 
to adulthood (Eppig et al., 2000, O'Brien et al., 2003). 
 
A vast amount of research has been conducted to elucidate gene expression patterns during 
oogenesis and folliculogenesis in vivo, as covered in Section 1.5.  However, minimal research 
has been conducted to determine whether these gene expression patterns are the same in in 
vitro-derived oocytes.  Although some investigations have examined gene expression patterns 
in in vitro-matured oocytes, very little research has been conducted concerning IVG oocytes.  
Furthermore the majority of the research has been conducted using mice.  It is essential to 
ensure that in vitro-derived oocytes are competent to be fertilized and develop into normal 
offspring.  Therefore one of the main focuses of this thesis was the determination of 
expression patterns in in vivo-derived ovine oocytes and their stage-specific in vitro-derived 
counterparts.
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Table 1.12 Table summarising the evidence linking the use of ARTs to the incidence of imprinting errors.  Details of the species, the ART conditions implicated 
and the nature of the effect on imprinting are shown.  Abbreviations; mouse (M), sheep (S), human (H), fetal calf serum (FCS), growth factor receptor-bound 
protein 10 (Grb10). 
 ART Specific ART conditions 
(species) 
Nature of effect on imprinting Extra information References 
Embryo 
Culture 
Culture media used was 
suboptimal (M) 
Use of Whittens Medium resulted in loss of 
methylation leading to aberrant expression of 
the H19 gene 
Methylation status of Snrpn gene was unaffected 
therefore unlikely that the alterations to H19 were via 
aberrant DNMTo activity 
Doherty et al. 
(2000) 
In vitro culture (M) Aberrant expression of H19 gene in the 
extraembryonic tissue 
 Sasaki et al. 
(1995) 
Aberrant Igf2 expression at the blastocyst 
stage 
Biallelic expression rather than monoallelic Ohno et al. 
(2001) 
Aberrant H19 gene expression Aberrant gene expression resulting from abnormal 
DNA and histone methylation patterns 
Li et al. (2005) 
Exposure to high levels of 
ammonium in culture 
medium (M) 
Aberrant H19 gene expression Ammonium level also affected 'blastocyst 
differentiation, metabolism, pH regulation [and] fetal 
development' 
Lane and 
Gardner (2003) 
Addition of FCS to culture 
media of preimplantation 
embryos (M) 
Gain of methylation of Igf2 and H19 led to 
decreased expression.  Whereas Grb10 
expression decreased and Mest was 
unaffected 
Lower birth weights probably resulted from aberrant 
gene expression 
Khosla et al. 
(2001) 
Addition of FCS to culture 
media of blastocyts (M) 
Increased expression of Igf2, Grb10 and Mest.  
H19 expression not affected 
Effect of FCS on gene expression is not consistent with 
findings by Khosla et al. (2001), however, both studies 
report aberrant expression 
Fernandez-
Gonzalez et al. 
(2004) 
In vitro culture of pre-
implantation embryos (S) 
Aberrant methylation and expression of IGF2 
receptor gene 
Linked to fetal overgrowth syndrome.  This gene is not 
imprinted in humans 
Young et al. 
(2001) 
Ooplasmic 
transfer 
Transfer of ooplasm from 
donor oocyte may 
compromise recipient 
oocyte (M) 
Suggests there may be a risk with respect to 
the establishment of normal epigenetics due 
to the timing of ooplasmic transfer 
  Hawes et al. 
(2002) 
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Table 1.12 (continued) 
ART Specific ART conditions 
(species) 
Nature of effect on imprinting Extra information References 
Microinjection 
of immature 
Spermatids. 
Use of immature gametes 
(H) 
Aberrant DNA methylation patterns, due to 
immature gametes not having acquired 
epigenetic marks or the machinery required 
for their maintenance 
Long-term health of the resultant zygotes and 
offspring may be affected 
Kishigami et al. 
(2006) 
Round spermatid injection 
(M) 
No effect on expression patterns of imprinted 
genes 
Inconsistent findings compared to humans Shamanski et al. 
(1999) 
Superovulation (H,M) Disrupted methylation patterns of H19 and 
MEST genes.  Effects on H19 and SNRPN 
methylation patterns seen trans-
generationally 
Disrupted imprinting patterns and methylation in 
superovulated eggs.  Both imprinting establishment 
and factors required for maintenance are affected 
Sato et al. 
(2007) and 
Stouder et al. 
(2009)  
(M) Altered expression of imprinted genes in the 
placenta 
Resulted in biallelic expression of H19 and Snrpn genes Fortier et al. 
(2008) 
ICSI Introduction of sperm 
acrosome and digestive 
enzymes into ooplasm 
may disrupt oocyte 
activation (H) 
Link between use of ICSI and incidence of AS There may be a link between imprinting disruption and 
infertility as sperm from oligozoospermic males 
exhibited aberrant methylation of H19 gene 
Cox et al. (2002) 
and Marques et 
al. (2004) 
Oocytes were matured in 
vitro prior to fertilisation 
Aberrant imprinting of H19 and KCNQ1OT1 Expression patterns of DNMTo unaltered.  Unclear 
whether aberrant imprinting observed following IVM is 
maintained following ICSI 
Borghol et al. 
(2006) and 
Khoueiry et al. 
(2013) 
Embryo 
Transfer 
(M) Aberrant expression of imprinted genes in 
both the embryonic and placental tissues 
Disruption to gene expression patterns was 
augmented by in vitro culture prior to embryo transfer 
Rivera et al. 
(2008) 
Embryo 
Vitrification 
Embryo vitrification 
following in vitro culture 
(M) 
Vitrification resulted in lower levels of H19 
expression 
Aberrant gene expression patterns results from 
disrupted methylation patterns of the differentially 
methylated domains of both H19 and Igf2 
Wang et al. 
(2010) 
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1.10 Aims and objectives 
The information presented in this literature review summarises the highly complex nature of 
oocyte and follicle development in vivo, it shows how this information has been used to 
underpin the development and advancement of systems to preserve female fertility and it 
highlights the complexities associated with trying to develop a culture system that supports 
these processes in vitro. The importance of establishing biologically relevant parameters for 
assessing the normality of follicle and oocyte development during IVG and maturation has also 
been highlighted.  Development of techniques that facilitate the cryopreservation of ovarian 
tissue either as slices of cortex or in the form of whole ovaries and the subsequent in vitro 
growth and development of oocytes that are competent to undergo maturation and 
fertilisation in vitro to produce healthy offspring would be of great value to young girls, 
adolescents and women facing POF.  Before these techniques can be used therapeutically in 
humans it is of vital importance that markers for follicle and oocyte normality are established 
following IVG and that these are tested for throughout oocyte and follicle development in vitro 
in order to ensure the health of the resultant offspring.  
 
On the basis of the evidence presented in this review it can be hypothesised that the IVG of 
oocytes is suitable as a tool to both assess the patency of fertility preservation systems and as 
a means to restore female fertility.  
 
The main aims of this thesis were: 
i. To develop and validate a culture system that was able to support the in vitro 
activation, growth and normal development of ovine primordial follicles to the 
early antral stages within a physiologically-relevant timescale. 
ii. To measure the impact of a slow physiologically-relevant follicle growth system on 
markers of follicle and oocyte survival, yield, health and normality, as well as 
stromal health, to compare these to similar parameters measured using an 
accelerated follicle culture system. 
iii. To establish the normal expression patterns of important oocyte- and follicular 
somatic genes across oogenesis and folliculogenesis in vivo and to compare these 
to gene expression patterns in stage-matched oocytes and follicles grown in vitro. 
iv. To utilise the ovarian cortex culture system at a tool to validate WOCP as a fertility 
preservation strategy, using sheep as a model for humans. 
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2 General Materials and Methods 
 
Unless otherwise stated all reagents detailed in this thesis were purchased from Sigma-Aldrich 
Company Limited, (Sigma-Aldrich, Dorset, UK), all culture plastics were from Nunc® (Thermo 
Fisher Scientific, Hertfordshire, UK) and all pipette tips from Starlab Ltd (Milton Keynes, UK).   
All company addresses are provided in Appendix V. 
 
2.1 Use of ovine ovarian tissue 
The investigations regarding the validation and optimisation of culture techniques were 
performed using ovine ovarian tissue provided by a local abattoir (J Penny and Sons, Rawdon, 
Leeds, UK).  The ovine model was selected because it is more similar to human with respect to 
the size of the ovaries and oocytes, the developmental time frame in vivo, the fibrous nature 
of the tissue and the body temperature, than rodent model species (Campbell et al., 1996, 
Griffin et al., 2006, Lundy et al., 1999).  Furthermore, ovine tissue was relatively easy to obtain 
on a weekly basis.  As both human and sheep are predominantly monovular the mechanisms 
regulating follicle and oocyte growth and maturation in vivo will be paralleled by that in vitro. 
The sheep has previously been used as a model system for the development of IVG systems 
(Muruvi et al., 2009, Newton et al., 1999b, Thomas et al., 2003). 
 
2.2 Collection and preparation of ovarian tissue 
Reproductive tracts were collected from a local abattoir and transferred to the lab at room 
temperature within one hour.  Ovaries were dissected from the tracts using scissors, removing 
all excess tissue and fat and transferred to 200ml pre-warmed (37°C) Ovary Wash Media 
(OWM), which was comprised of: 500ml Milli-Q water, mixed with 1 phosphate buffered saline 
(PBS) tablet (Thermo Fisher Scientific) per 500ml solution, 100Uml-1 penicillin G, 0.1mgml-1 
streptomycin sulphate, 0.25μgml-1 amphotericin B (antibiotic/ antimycotic).  The OWM was 
made up in a sterile glass beaker.  The ovaries were transferred to fresh 100ml OWM 2 – 3 
times to ensure that all traces of blood and cellular debris were removed.  The ovaries were 
then transferred to 50ml cold (4°C) Rozenburgh Knife Wash Medium (RKWM), which was 
comprised of: Hepes-modified minimum essential medium (MEM), supplemented with 
100Uml-1 penicillin G/ 0.1mgml-1 streptomycin sulphate, 1mgml-1 bovine serum albumin (BSA 
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Fraction V; cell culture tested (Sigma A9418)), and stored on ice in a sterile 60ml universal 
(Scientific Laboratory Supplies (SLS), Nottingham UK). 
 
2.3 Preparation of cortical slices 
Under class I laminar flow conditions, using a skin-grafting knife (Ref 9942, Swann-Morton Ltd, 
Sheffield, UK), thin slices were carefully cut from the outer cortex of the ovary at a thickness of 
around 0.4-0.5mm (see Section 2.4).  It is important to minimise the thickness of the tissue to 
allow sufficient gas and nutrients to diffuse through the tissue whilst maximising the number 
of follicles for culture (Avgoustiniatos and Colton, 1997).  Furthermore, in early experiments it 
was found that if the tissue was too thin it was more likely to become necrotic, as perhaps the 
procedure had been too damaging.  Dissections were carried out in RKWM at 4°C, in a sterile 
glass petri dish placed on a cold ice pack.  Cortical slices were then transferred to a sterile 
universal (SLS) containing 5ml RKWM and left at 4°C until a sufficient number of slices had 
been obtained for culture.  Cortical slices were briefly washed again in RKWM.  Using a sterile 
scalpel blade and a clean glass petri dish the slices were carefully trimmed, under a stereo 
microscope (Olympus Industrial, Essex, UK), at room temperature.  Tissue pieces were 
processed using a scalpel (handle size 7 with a size 15 blade) and 26G½ needles (Terumo 
Europe N.V., Belgium).  The tissue pieces were trimmed to roughly 5mm2. 
 
2.4 Validation of cortical thickness 
In order to determine the exact thickness 5 samples of single tissue pieces were fixed (see 
Section 2.9) after they had been trimmed.  The tissue pieces were sectioned to a thickness of 
4μm and the total number of sections per piece was recorded.  The tissue pieces covered 
around a mean number of 116.6 sections ± 5.3 (n=5, range: 98-130), therefore the mean tissue 
thickness was calculated as 0.47mm ± 0.02 (n=5, range: 0.39-0.52). 
 
2.5 Quantification of viable follicle density – using neutral red (NR) dye 
The use of neutral red (NR) dye enabled the identification of viable follicles in cortical tissue 
slices prior to culture, thus reducing the chance of culturing follicle depleted cortex and/or non 
viable cortex.  Neutral red dye is water-soluble and non-toxic and it is able to pass through 
lipid membranes via non-ionic diffusion (Nemes et al., 1979).  The dye is taken up by 
lysosomes, this process is more rapid in follicular cells and oocytes than stromal cells, due to 
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the higher metabolic rate of the former cell types (Babich and Borenfreund, 1987, Chambers et 
al., 2010).  Viable tissue is stained red; this can be visualised using light microscopy.  It is 
essential to perform dissections and initial NR staining reactions at 4°C as this reduces uptake 
of the dye by the stromal tissue, ensuring that the follicles are stained more strongly and are 
therefore identifiable (Chambers et al., 2010).  
 
Table 2.1 Composition of cortical culture media.  The volumes required to make 30ml solution 
are shown, with the stock and final concentrations.  The solution was filtered and stored for up 
to 1 week at 4°C.  See Appendix I for details of the preparation of α-MEM with bicarbonate 
basal culture media, with 1% (v/v) penicillin/streptomycin and 1mg ml-1 BSA fraction V (fatty 
acid free) and additive stock solutions. 
 Component Volume (μl) 
Stock 
Concentration 
Final 
Concentration 
α-MEM with bicarbonate basal culture 
medium  29.448 ml 
  Bovine holo-transferrin 30 5mgml-1 5μgml-1 
Sodium pyruvate 30 47mM 0.047mM 
Sodium selenite 3 50μgml-1 5ngml-1 
L-glutamine 450 200mM 3mM 
Bovine insulin 30 10mgml-1 10ngml-1 
Human long-R3 IGF-1 3 100μgml-1 10ngml-1 
Ovine FSH 3 0.1iUml-1 1 x 10-5iUml-1 
Ovine LH 3 0.0023iUml-1 2.3 x 10-7iUml-1 
 
Figure 2.1 (a) Follicle assessment plate set-up. 
Stock concentration NR dye (Sigma N2889) = 3300μgml-1 
Final concentration 50μgml-1 
Top 2 wells = 492.5μl culture media supplemented with 7.5μl NR dye   
Bottom 2 wells = 500μl culture media 
(b) Representative image of NR stained ovarian cortex.  Scale bar = 1mm. 
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The composition of cortical culture media, used to prepare the NR assessment plates is 
detailed in Table 2.1.  Two Nunc®, 4-well follicle assessment plates were set up before the 
ovaries arrived in the lab and placed into the incubator at 37°C and 5% CO2 to pre-warm and 
gas for 3 hours prior to use as shown in Figure 2.1 (a).  A representative image of tissue 
following NR staining is shown in Figure 2.1 (b). 
 
2.6 Assessment of viable follicle density 
The methods of assessment of viable follicle density within cortical slices have been previously 
described (Chambers et al., 2010).  Once the cortical slices had been prepared for culture they 
were transferred to the follicle assessment plates (~25 slices per well).  The plates were then 
returned to the humidified incubator (Galaxy B) at 37°C and 5% CO2 in air and left for 2.5 - 3 
hours.  The NR staining of follicles in situ, within the fragments of ovarian cortex, was assessed 
using a stereo microscope (Olympus SZX16) fitted with a heated stage (Olympus Tokai hit) 
using 64 x magnification under sterile conditions, at 37°C.  Bright- field microscopy was used to 
visualise the red colouration.  At the end of the NR incubation period the plates were removed 
one at a time from the incubator.  The cortical tissue slices were transferred from the wells 
containing NR to those containing culture media only to wash away any crystals of dye on the 
tissue surface as these interfered with the assessment of follicle density.  Each tissue piece was 
assessed for the presence of red colouration and non-staining tissue pieces discarded. 
 
The number of red structures (follicles) present within each of the positively staining tissue 
pieces was counted and recorded.  The pieces were turned over with sterile forceps to ensure 
that all follicles had been counted.  Follicles did not always stain completely; therefore only if 
over 50% of the follicle population had stained was the tissue used for future culture or 
analysis.  Once the red colouration of all tissue pieces had been assessed they were divided 
into groups of 5 containing approximately equal numbers of follicles (which were recorded).  
The dry weight of each group of 5 tissue pieces was recorded. Excess liquid was removed from 
each tissue piece by blotting on sterile gauze (Richardson Healthcare, Borehamwood, UK) prior 
to placing on the lid of a sterile flat-cap microcentrifuge tube (Starlabs).  A microbalance 
(Sartorius Stedim UK, Surrey, UK) was used to measure the weight of the empty tube which 
was subtracted from the combined weight of the universal and tissue pieces to obtain the dry 
tissue weight.  Representative images were taken of spare tissue pieces following NR staining 
prior to culture using an inverted microscope (Olympus IX70) fitted with a camera (Olympus 
DP11) and heated stage (Linkam Scientific Instruments Ltd, Tadworth, UK).  Any spare tissue 
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pieces were discarded.  Representative images were also taken at the end of culture (see 
Section 2.8). 
  
Up to 5 extra tissue pieces were fixed in 1ml of 4% (w/v) paraformaldehyde (PFA) (see 
Appendix II) overnight then transferred to 70% (v/v) ethanol at room temperature (~20°C).  
These pieces were used as time 0 controls to allow histological comparison with tissues fixed 
at the end of culture (see Section 2.9).  Tissue pieces were stored in a plastic container, 
containing 70% (v/v) ethanol for several months prior to embedding, the ethanol was topped 
up at regular intervals. 
 
2.7 Culture of cortical slices 
Culture plates were set up prior to the ovaries arriving in the lab and transferred to the 
incubator to equilibrate for a minimum of 2.5 hours.  Nunc® 24- well culture plates were used.  
Sterile, un-coated MillicellTM culture plate inserts (0.4μm pore size, 12mm diameter, Millipore, 
Watford, UK) were carefully placed into the wells using forceps.  To the well 500μl of culture 
media was then added, the composition of which is shown in Table 2.1.  A maximum of 8 wells 
per plate were utilised for tissue culture to minimise the length of time required to perform a 
media change and thus avoid pH and temperature changes.  Only the central wells were 
utilised to reduce the potential for culture media loss by evaporation, during extended culture.  
To further prevent culture media loss the surrounding channels were flooded with sterile 
embryo tested water supplemented with Penicillin G and Streptomycin sulphate at the same 
concentration as the OWM (see Section 2.2).  Tissue slices (5 per well) were placed on the 
insert, and then a sterile gel-loading tip (Alpha Laboratories Ltd, Hampshire, UK; catalogue 
number LW1100) was used to adjust the level of the media to ensure the pieces were covered 
by a thin film.  Note that this procedure was carried out on a stereo microscope fitted with 
heated stage set at 37°C.  The plates were then returned to the humidified incubator and 
cultured at 37°C and 5% CO2 in air until the first media change was due. 
 
Media changes were carried out on a heated stage at 37°C; 50% of the media in each of the 
wells was removed and replenished during each change.  Media changes were carried out 
every Monday, Wednesday and Friday until the completion of culture.  This media change 
strategy prevented unnecessary disturbance of the cultured tissue pieces and ensured that 
locally produced factors were retained in the media.  On the morning of the media change 
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sterile aliquots containing the appropriate volume of culture media required were placed in 
the incubator to equilibrate for 2-3 hours prior to use.  A sterile gel-loading tip was used to 
carefully remove 250μl of the media from each well and replace it with 250μl of fresh media, 
ensuring that there were no bubbles under the insert and that it was not damaged; the plate 
was returned to the incubator. 
 
2.8 Tissue and follicle viability assessment at the end of culture 
At the end of the culture period the tissue pieces were removed from the culture plate one 
well at a time.  The dry weight and the number of tissue pieces present were recorded (see 
Section 2.6), before returning them to the culture plate in the incubator.  Tissue pieces were 
transferred to pre-warmed and gassed NR plates containing NR solution at 50 μg ml-1 (see 
Figure 2.1).  The NR plates were then returned to the incubator and left for 15 – 30 minutes.  
The NR viability assay incubation time for tissue at the end of culture was reduced in 
comparison to the incubation time prior to the start of culture because the tissue pieces were 
warm and less dense in structure and therefore able to take up the dye much more readily 
than fresh, cold tissue.  This made it more difficult to distinguish between stromal tissue and 
follicles, such that in many cases only global tissue viability could be recorded.  However - 
where possible - viable follicle counts were noted.  The tissue from one well of each sample 
group was then fixed in 1ml of 4% PFA for histological analysis (see Section 2.9).  The tissue 
was kept in 4% PFA overnight before being transferred to 70% (v/v) ethanol (~5ml) at room 
temperature (~20°C).  Representative images of tissue pieces at the end of culture were taken 
as described in Section 2.6. 
 
2.9 Histology 
Fixed tissue (see Section 2.8) collected before or after culture was removed from 70% (v/v) 
ethanol after a minimum of 2 hours, placed on a slide, covered and subsequently embedded in 
2% (w/v) melted agar, to facilitate handling.  The 2% (w/v) agar was prepared by dissolving 
0.4g of agar granules in 20ml PBS, whilst heating in a microwave.  Once the agar had set, after 
leaving it at room temperature, it was trimmed to ~0.5cm2 using a scalpel blade (Swann- 
Morton) to minimise the amount of agar surrounding the tissue. The agar block was wrapped 
in tissue wrapping paper (Whatman; GE Healthcare, Buckinghamshire, UK), to prevent the 
tissue from being lost and placed inside a plastic embedding cassette (Simport, Beloeil, 
Canada) and then transferred to fresh 70% (v/v) ethanol.  All tissue pieces from the same well 
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were fixed and embedded together.  After a minimum of 24 hours the tissue pieces were 
manually embedded in pastillated paraffin wax (VWR; West Sussex, UK).  The multiple steps of 
the embedding procedure are outlined in Table 2.2, including the order and timeframes in 
which the agar-surrounded tissue must be placed in the various reagents.  These steps were 
carried out in an incubator (Stuart hybridisation oven/ shaker S130H) set at the temperatures 
detailed in Table 2.2, with agitation.  The wax was melted on a hot plate at 60°C prior to its 
addition to the Histo-clear (National Diagnostics; East Riding of Yorkshire, HU139LX).  Once the 
steps in Table 2.2 were complete the agar blocks containing the tissue were then transferred 
to a 16mm by 16mm by 6mm Tissue Tek stainless steel base mould (Sakura; AJ Alphen aan den 
Rijn, The Netherlands) and blocked in molten wax.  The first 3 steps were carried out in a 
150ml sterile plastic bottle (Sterilin Ltd; Newport, UK), after which the moulds were 
transferred to a pyrex beaker (Starlabs).  The volume of each reagent used was sufficient to 
ensure all moulds were submerged.  Once set the blocks were transferred to the – 80°C freezer 
for storage. 
 
Table 2.2 Manual wax embedding protocol.  Around 100ml of each reagent was used per step.
 Reagent Time Temperature 
90% (v/v) ethanol 1 hour (at least) ~20°C 
100% (v/v) ethanol 1 hour ~20°C 
100% (v/v) ethanol (fresh) 30 minutes ~20°C 
100% Histo-clear  1 hour ~20°C 
100% Histo-clear (fresh) 30 minutes 60°C 
Add molten wax (25%) to Histo-clear (75%) 30 minutes 60°C 
Add molten wax (50%) to Histo-clear (50%) 30 minutes 60°C 
Fresh molten wax 30 minutes 60°C 
Fresh molten wax 30 minutes 60°C 
 
2.10 Tissue sectioning and staining 
Using a microtome (Ergo star HM 200; Laborgeräte, Waldorf, Germany) fitted with MB35 
premier microtome blades (Thermo Fisher Scientific; length; 80 by 8mm, thickness; 0.25mm, 
cutting angle; 37º) the blocked tissue was sectioned at 4μm thickness, and ribbons of the cut 
block were transferred to a heated water bath at 40°C to remove creases, before being 
transferred onto Superfrost+ microscope slides (VWR).  Slides were left to dry in a rack on a 
hot plate at ~40°C, for ~2-3 hours, after which they were stored at room temperature (~20°C) 
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prior to staining, for up to 2 months.  To enable histological analysis of the tissue the sections 
were stained using haematoxylin and eosin (H&E) (Culling, 1974), details of the protocol are 
shown in Table 2.3.  At the end of the staining procedures glass cover slips (VWR) were 
mounted onto the slides using Distrene, Plasticiser and Xylene (DPX) mountant (VWR). 
 
Table 2.3 Haematoxylin and Eosin staining protocol. 
Solution Time 
Xylene  (Thermo-Fisher Scientific) (x 2) 10 minutes in each 
100% (v/v) ethanol 5 minutes 
90% (v/v) ethanol 2 minutes 
70% (v/v) ethanol 2 minutes 
Wash in tap water 2 minutes 
Haematoxylin (100%) 75 seconds 
Wash in tap water 5 minutes 
Acid Alcohol (1% hydrochloric acid in 70% (v/v) ethanol) ~ 5 seconds 
Wash in tap water 2 minutes 
Scott’s tap water (1% (w/v) Sodium Hydrogen Bicarbonate  in 
distilled water (VWR)) 
30 seconds 
Wash in tap water 6 minutes 
Eosin (100%) 7 minutes 
Wash in tap water 5 minutes 
70% (v/v) ethanol (x 2) ~ 5 seconds 
90% (v/v) ethanol 30 seconds 
100% (v/v) ethanol 1 minute 
Xylene 2 minutes 
 
2.11 Histological assessment of cortical tissue 
Tissue sections were examined under an inverted light microscope (Nikon, Melville, USA).  As 
the number of follicles in tissue pieces was so high only the follicles in every fifth section were 
counted, classified and measurements of oocyte and follicle diameter were taken (Block, 1951, 
Chambers, 2002).  Absolute follicle counts were determined by multiplying the number of 
follicles by 5.  Note that in order to avoid duplication only oocytes in which a distinct nucleolus 
that was visible within the nucleus were counted (Lundy et al., 1999, Wright et al., 1999, 
Chambers, 2002).  The number of follicles per mg of tissue was determined by dividing the 
absolute number of follicles by the dry weight of the tissue at the end of culture (Section 2.8).   
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Figure 2.2  Characteristics of (a) primordial, (b) early primary, (c) primary, (d) transitional and 
(e) secondary follicles and representative histological images, taken following H&E staining.  
Mean (underlined) oocyte and follicle diameters and ranges (shown in parentheses) values 
taken from (Lundy et al., 1999).  Oocyte is indicated on the image using 0.  Scale bar = 20μm.  
 
Follicle and oocyte diameters were calculated by taking two measurements, using a calibrated 
eyepiece graticule, at 90° angles to one another and averaging them.  Note that the follicle 
diameter was measured up to the basement membrane surrounding the GC layer(s) (Wandji et 
al., 1997) and that the ZP was excluded when measuring oocyte diameter (Lundy et al., 1999).  
Follicles were classified according to the criteria presented in Figure 2.2. 
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The integrity of the stromal tissue was also analysed histologically.  Only the middle third of 
histological sections for each sample was considered to avoid any processing artefacts as the 
outer sections may have been damaged during the fixing and blocking procedures.  Every 4th 
section within the middle third of the sample was analysed.  The stromal scores used were: 
good, adequate and poor which were converted into numerical scores, 3, 2 and 1, respectively.  
These stromal scores reflected the tissue and follicle integrity.  Representative images of good, 
adequate and poor quality tissue are shown in the relevant chapters (Chapters 4 and 6).  The 
poor quality tissue had a grainier, less even appearance than the adequate and good quality 
tissue.  In the healthier and better quality tissue the cytoplasm of the oocytes was also 
smoother and more even than in the lower quality tissue and follicles.  The scores were based 
on an estimate of the density of the tissue such that tissue was classified as: (i) poor if the 
stromal density appeared to be >40% absent/degenerate structure; (ii) adequate if 20-40% of 
the tissue demonstrated a poor/degenerate structure; or (iii) good if 80-100% of the tissue 
demonstrated a consistently healthy appearance with clearly defined nuclei and tissue 
structure.  This stromal scoring system has previously been validated by Gunson (2009) when 
scoring ovarian stromal tissue in relation to the percentage positive terminal deoxynucleotidyl 
transferase dUTP nick end labeling (TUNEL) staining of the tissue. 
 
2.12 Data analysis and statistical evaluation 
Excel (Microsoft® Office Excel 2007) was used to process data and plot graphs.  All data was 
analysed using Minitab version 16 (Minitab® 16.1, Minitab Limited, UK).  Data was tested for 
normality using the Anderson-Darling test.  Details of the statistical analyses carried out are 
described in the methods section of each experimental chapter, p values ≤0.05 were 
considered statistically significant.  
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3 Development Of A Two-Step, Long-Term Culture System To Support The 
Complete In Vitro Growth And Maturation Of Ovine Oocytes From The 
Primordial To The Early Antral Stage.  
 
3.1  Introduction 
Development of an IVG system that supports the complete in vitro growth and maturation of 
oocytes from the primordial follicle stage would increase the understanding of this process in 
vivo and may facilitate the use of IVG for fertility preservation in young girls and women 
(Picton et al., 1998, Smitz et al., 2010).  Primordial follicles are present in the ovarian cortex of 
all pre-menopausal females.  These follicles are present in relatively high abundance compared 
to other more advanced stages of follicular developmental (Gosden and Telfer, 1987b).  
Ovarian cortex can be relatively easily obtained from patients, via laparoscopy, and 
subsequently cryopreserved (Davidoff et al., 1996, Weintraub et al., 2007).  Primordial follicles 
are relatively tolerant to the cryopreservation procedure (Newton et al., 1996, Oktay et al., 
1998, Kim et al., 2001, Hovatta et al., 1996, Gook et al., 1999).   
 
The activation, growth and development of oocytes and follicles from the primordial stage is a 
complex and protracted process in vivo and is not yet fully understood.  During oocyte 
development the acquisition of RNAs and proteins required for meiotic progression to the MII 
stage, fertilisation and early embryo development is essential (Picton et al., 1998).  Therefore 
replicating this process in vitro and providing the developing oocyte with a follicular micro-
environment as similar to that experienced in vivo, to promote oocyte health, is extremely 
challenging.  However, the IVG and subsequent IVM of oocytes has resulted in the birth of live 
offspring in mice (Eppig and O'Brien, 1996, O'Brien et al., 2003).  Due to the larger size and 
longer growth period of oocytes in larger mammals and humans it has proved far more 
difficult to adapt the murine culture systems to suit these species (Picton et al., 2008).  
However, some progress has been made in larger species and primates. 
 
3.1.1 Primordial follicle activation and development 
As discussed in Chapter 1 many studies have investigated the optimal conditions for the 
activation and development of primordial follicles in vitro.  The use of ECM- and serum-free 
culture media containing ITS and albumin substitutes is preferential to the use of serum-
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containing culture media with respect to the activation and growth of oocytes in vitro as well 
as the health of the oocytes and potential resultant offspring (Wandji et al., 1997, Young et al., 
1998, Newton et al., 1999b, Wright et al., 1999, Fernandez-Gonzalez et al., 2004, Fujihara et 
al., 2012).  Although the major components of serum and ECM are known their exact 
compositions are complex and ill-defined (McGuire and Seeds, 1989, Picton et al., 2008).  
Interactions between components of the serum and ECM affecting follicle and oocyte growth, 
development and health would therefore be difficult to elucidate.  Therefore, despite the fact 
that the use ECM has been shown to improve the survival of early preantral follicles in long-
term cortical culture it will not be used in this experimental series (Hovatta et al., 1997).  The 
use of serum in culture media of oocytes has been shown to result in reduced activation rates, 
decreased growth and development, increased levels of atresia and poor follicle morphology 
with respect to the collapse of 3D structure when compared to follicles and oocytes cultured in 
alternate serum-free media supplemented with ITS and albumin substitutes (Wandji et al., 
1997, Wright et al., 1999, Newton et al., 1999b).  The addition of serum has also been shown 
to inhibit the stimulatory effect of oocyte-derived factor, GDF9, on the IVG and development 
of human follicles during cortical slice culture (Hreinsson et al., 2002).  Additionally serum has 
been shown to have deleterious effects when used in both sheep and mouse embryo culture 
media leading to fetal overgrowth syndrome and alterations in behaviour, caused by aberrant 
imprinting (Young et al., 1998).  Therefore there are concerns that addition of serum to IVG 
media could result in aberrant imprinting as the maternal imprint is established during 
gametogenesis as well as following fertilisation (Reik et al., 2001). 
 
The in situ culture of preantral follicles within slices of cortical tissue has been shown to 
support follicle survival and development in the mouse (Eppig and O'Brien, 1996, O'Brien et al., 
2003), cat (Fujihara et al., 2012), dog (Fujihara et al., 2012), goat (Silva et al., 2004a, 
Magalhaes-Padilha et al., 2012), sheep (Chambers et al., 2010, Peng et al., 2010), cow 
(McLaughlin and Telfer, 2010, Wandji et al., 1996b), non-human primate (Wandji et al., 1997, 
Jin et al., 2010, Brito et al., 2013) and human (Wright et al., 1999, Hovatta et al., 1997, Scott et 
al., 2004a, Telfer et al., 2008, Parte et al., 2013, Liebenthron et al., 2013).  Culturing in situ 
provides the follicles with sufficient mechanical support to maintain oocyte-GC interactions 
and so provides an environment very similar to that of the ovary in vivo (Gosden, 1998, Picton 
et al., 2000).  Therefore in this experimental series a serum-free, in situ cortical culture system 
will be utilised to support the in vitro activation and development of primordial follicles. 
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Chambers (2002) described a serum- and ECM-free culture system in which ovine primordial 
follicles were cultured in situ within slices of cortical tissue for up to 30 days.  This culture 
system was able to support the in vitro activation and subsequent growth and development of 
some primordial follicles at a physiologically relevant rate (Sawyer et al., 2002).  Some 
researchers have reported the activation of the majority of primordial follicles present in the 
tissue within the first couple of days of cortical culture (Wandji et al., 1996b, Wandji et al., 
1997, Telfer et al., 2008, McLaughlin and Telfer, 2010).  The use of the system developed by 
Chambers (2002) resulted in a decrease in primordial follicle numbers accompanied by an 
increase in early primary (EP) follicle numbers following 15 days culture.  Following 30 days of 
culture a 17% decrease in primordial follicle population was observed.  The use of proliferating 
cell nuclear antigen (PCNA) and TUNEL staining showed that the levels of apoptosis remained 
constant throughout the IVG of follicles thus indicating the maintenance of follicular and 
stromal health.  Additionally the weight of the tissue significantly increased following 15 days 
culture, compared to day 0, showing that the tissue was healthy and the cells able to 
proliferate.   
 
The use of the culture system developed by Chambers (2002) showed that NR could be used to 
determine viable follicle counts and tissue viability in tissue without being detrimental the 
health of the follicles, oocytes or stromal tissue.  Tissue pieces were incubated with NR dye at 
the start and end of an 8-day culture period showing that 61.5% tissue pieces remained viable 
after culture (Chambers et al., 2010).  Only 25% of follicles from viable cultured tissue samples 
exhibited signs of apoptosis on day 8 of culture and the levels of GC and oocyte apoptosis were 
not significantly different from levels in day 0 tissue.  The culture system developed by 
Chambers (2002) is able to support the growth, development and survival of ovine ovarian 
follicles for up to 30 days.  The use of NR dye enables the determination of the follicle load in 
each cortical slice.  Therefore this culture system will be adapted and used in combination with 
NR dye in this experimental series. 
 
The hypothesis that oogenesis is a start-stop process resulting from the presence of inhibitory 
factors produced by follicles in vivo can be investigated using models in which either there are 
no, or very few growing follicles. Such models can be based around the culture of fetal ovaries 
which contain only primordial follicles, following ovarian tissue autografting, or when the 
number of growing follicles is very low, such as during menopause.  In these situations the 
level of inhibitory factors being produced would be lower than in a premenopausal, adult 
86 
 
 
 
ovary therefore if the hypothesis is correct, rates of follicle and oocyte development should be 
accelerated and so become more similar to that observed in vitro.  In support of this notion, 
declining levels of AMH have indeed been linked to increased levels of primordial follicle 
activation in the human ovary as they decline to undetectable levels around 5 years prior to 
menopause, as a result of the declining follicular reserve (Faddy et al., 1992, Sowers et al., 
2008, Kelsey et al., 2011).  Additionally increased rates of follicle growth and development 
have been observed in vivo in the absence of large, growing follicles.  Development of follicles 
from the primordial to the secondary stage takes around 18 days in adult mice, however, in 
newborn mice secondary follicles and antral follicles are present after 8 and 12 days, 
respectively (Gigli et al., 2005, Kerr et al., 2006).  Similarly in both ovine and human fetal 
ovaries increased rates of development of primordial follicles to the secondary stage have 
been observed  as taking 45 days (Sawyer et al., 2002, Juengel et al., 2002b) and 133 days 
(Konishi et al., 1986), in contrast to 78 days (Cahill and Mauleon, 1981) and 270 days 
(Himelstein-Braw et al., 1976, Gougeon, 1986) in the adult ovary, respectively.  Following 
grafting of frozen-thawed ovarian tissue only primordial follicles are present, thus making this 
a useful tool for studying follicle growth in the absence of growing follicles in vivo (Newton et 
al., 1996, Baird et al., 1999).  In both the sheep and human, exposure of grafts containing only 
primordial follicles to increased levels of FSH resulted in increased levels of development 
(Oktay et al., 1998, Campbell et al., 2000).  Exposure of autografted ovine ovarian tissue to 
increased levels of FSH resulting from decreased levels of inhibin and oestrogen in the absence 
of Graafian follicles resulted in the development of small and large antral follicles following 
only 3-4 months (Campbell et al., 2000).  In contrast grafts that had been exposed to 
physiologically normal levels of FSH contained a lower number of small antral follicles over the 
same time frame.  Similarly, human ovarian tissue xenografted to SCID mice and exposed to 
FSH stimulation resulted in development of follicles to the antral stage following only 129 days, 
whereas in the absence of FSH stimulation development past the secondary stage was not 
observed (Oktay et al., 1998).  It should be noted that even in the absence of FSH stimulation 
increased rates of follicle development were observed as secondary follicles were present 77 
days after grafting, compared to 270 days in the adult ovary in vivo.  Therefore a reduction in 
the follicular reserve or the absence of growing follicles can result in increased levels of follicle 
activation and development. 
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3.1.2 Isolated preantral follicle culture 
Although the earlier preantral stages of follicular development can be supported in situ once 
the transitional/ secondary stages are reached it is necessary to isolate the follicles to allow 
growth to continue (Abir et al., 1997, Hovatta et al., 1997, Telfer et al., 2008, Picton et al., 
2008).  Various systems have shown that it is possible to support the development of isolated 
preantral follicles up to the EA stage in the mouse (Nayudu and Osborn, 1992, Cortvrindt et al., 
1996, West et al., 2007), sheep (Cecconi et al., 1999, Newton et al., 1999b) cow (Itoh and 
Hoshi, 2000, McLaughlin and Telfer, 2010), non-human primate (Xu et al., 2011a) and human 
(Telfer et al., 2008).  As mentioned in Chapter 1 a large amount of research has been 
conducted to define the optimal conditions required to support preantral follicle development 
in vitro.  A major challenge during isolated preantral follicle culture is the maintenance of vital 
oocyte-GC interactions (Picton et al., 2008, McLaughlin and Telfer, 2010, Smitz et al., 2010).  As 
discussed in Chapter 1 approaches affecting the maintenance of these interactions include the 
use of 2D vs. 3D culture systems, enzymatic vs. mechanical isolation, the length of culture and 
the composition of the culture media.   
 
Newton et al. (1999b) developed a serum-free culture system that supported the induction of 
antral cavity formation and development of isolated ovine oocyte-GC complexes, following a 
period of tissue digestion using collagenase.  Follicle survival rates were dependent upon the 
size of the follicle at the time of isolation.  Around 40% of follicles sized 190-240µm on the day 
of isolation maintained their 3D structure after 120 hours in culture.  This was not however, 
observed in follicles <190µm on the day of isolation, as all follicles in this size range exhibited 
some degree of loss of 3D structure, as manifest by: extrusion of the oocyte; necrosis; collapse 
and adherence to the culture plate, after 120 hours.  It should be noted that the maintenance 
of 3D structure was also dependent upon the length of exposure to collagenase, which was 
used to soften the tissue in order to facilitate follicle isolation.  Inclusion of either FSH alone or 
in combination with LH, in the medium promoted antral cavity formation.  Culture of follicles 
isolated from fresh tissue in the presence of gonadotrophins resulted in 25±9% forming antral 
cavities, around day 14 of culture.  When the media was not supplemented with 
gonadotrophins only ~7% of follicles formed antral cavities.  Furthermore, follicles that formed 
antral cavities and were cultured in the presence of testosterone produced levels of oestradiol 
indicative of the induction of aromatase in the cells and comparable to that of follicles isolated 
from fresh tissue (Picton et al., 1990).  Progesterone production was not affected by the 
presence or absence of testosterone.  Although oocytes grew to full size after 30 days culture, 
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follicles did not: probably to minimise the diffusion distance of required metabolites.  This 
culture system is able to support the growth and development of secondary ovine follicles of 
190-240µm at the time of isolation to the EA stage.  Early antral follicles derived using this 
system exhibit normal steroidogenic function in vitro when incubated with testosterone.  
Therefore in this experimental series the preantral follicle culture system used will be based 
upon this system. 
As with cortical culture, there is some disagreement regarding the optimal length of culture 
needed to support growth and development from the preantral to EA stage.  The longer 
follicles remain in culture the more difficult it is to maintain oocyte-GC interaction integrity, 
thus in this respect accelerated culture is preferable to protracted culture (McLaughlin and 
Telfer, 2010).  However, as with cortical culture, there are concerns that accelerated culture 
may affect the developmental competence and epigenetic health of the resultant oocytes 
(Picton et al., 2008).  There are examples of the use of both long- and short-term preantral 
follicle culture periods.  In the aforementioned study (Newton et al., 1999b) the timescale of 
~14 days before antral cavity formation is observed is the same as that reported by Barboni et 
al. (2011), however, in the latter study the ovine preantral follicles were slightly smaller at the 
start of culture ~170µm.  Additionally, antral cavity formation was observed in a considerably 
higher percentage of follicles than reported by Newton et al. (1999b) (70% vs. 30%), although 
it should be noted that in the Barboni et al. (2011) study the media was not serum-free and 
the follicles were mechanically isolated, which may have affected antral cavity formation rate. 
However, Cecconi et al. (1999) used a serum-free culture system and reported a high rate of 
antral cavity formation (80%) in isolated preantral follicles, 120-260µm diameter, after only 6 
days in vitro, when cultured in 5% O2 and 1µgml
-1 FSH.  McLaughlin and Telfer (2010) observed 
the development of transitional bovine follicles, ~110µm diameter, to the EA stage after only 
12 days of isolated culture.  In a separate study this group isolated more developed bovine 
preantral follicles (~160µm) from fresh tissue and reported >40% developing to the EA stage 
by day 8 of culture (McLaughlin et al., 2010).  In both these studies the addition of a high 
concentration (100ngml-1) of activin A to the culture medium appears to be responsible for the 
accelerated growth rate.  In the absence of activin A the mean growth rates exhibited by the 
follicles was significantly lower (McLaughlin and Telfer, 2010, McLaughlin et al., 2010). 
 
The composition of the culture media affects preantral follicle growth and survival in vitro.  For 
example, in addition to the promotion of follicle growth in vitro, activin A has been shown to 
promote preantral follicle survival, potentially partly via the promotion of oocyte-GC 
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interactions (McLaughlin and Telfer, 2010, da Silva et al., 2013). Zhao et al. (2001) used 
transmission electron microscopy to assess the ultrastructure of rat preantral follicles in vitro.  
Follicles cultured in activin A- supplemented media had more developed oocyte-GC cell 
contacts than those cultured in activin A- free media.  Connexin protein, Cx43, is a key 
component of gap junctions in bovine somatic follicular cells (Vozzi et al., 2001).  Inclusion of 
activin A in the media of cultured bovine preantral follicles resulted in the promotion of Cx43 
expression, when compared to follicles cultured in the absence of activin A (McLaughlin et al., 
2010).  Ascorbic acid is another culture media additive that has been identified as being able to 
promote preantral follicle survival, which it does via its anti-oxidative actions and its capacity 
to promote basement membrane production (Murray et al., 2001, Telfer et al., 2008, Andrade 
et al., 2012, Thomas et al., 2001).   Arunakumari et al. (2010) carried out an extensive 
investigation into the determination of the optimal combination and concentrations of growth 
factors and hormones required to promote the development of secondary ovine follicles to the 
EA stage; 1% ITS, 10ngml-1 each of IGF1, and Insulin and 1mIUml-1 of GH.  Under these 
conditions ~3% of follicles, 250-400µm diameter at the start of culture, were grown and 
matured up to the MII stage and then fertilised and were competent to develop to the morula 
stage, however, none were competent to develop to the blastocyst stage.  Briefly, under these 
conditions, of the 250 preantral follicles cultured antral cavity formation was observed in 80% 
and 68% developed up to the MII stage.  Of the 170 MII oocytes 26% reached the 2-cell stage 
following fertilisation and 16% reached the morula stage.  The production of an embryo from 
an in vitro-derived oocyte, cultured for a total of 18 days from the secondary stage, has also 
been reported in the goat (Magalhaes et al., 2011).  Secondary follicles were cultured in the 
presence of 50ngml-1 GH; resulting in antral cavity formation in 93% of follicles and 50% of the 
oocytes maturing to the MII stage.  Following IVF of the 35 in vitro-derived MII oocytes one 
embryo was produced.  In the current experimental series a serum-free, 3D preantral follicle 
culture system will be utilised in order to assess ovine follicle growth and development over a 
maximum of 30 days.  
 
3.1.3 Multi-step IVG systems 
Research suggests that the IVG of oocytes will be best achieved using a multistep system in 
which conditions are altered to meet the requirements of the oocyte and somatic cells at each 
developmental stage (Picton et al., 1998, Eppig and O'Brien, 1996, Telfer et al., 2008, Smitz et 
al., 2010).  Although considerable research has been conducted with the aim of optimising 
each individual step of the IVG culture systems, limited research has been conducted in which 
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multiple steps have been linked, particularly in larger mammals and humans.  The aim of this 
chapter was therefore to develop and link the first 2 phases of a multi-step culture system that 
supports oocyte development in vitro, from the primordial follicle stage up to the EA stage in 
sheep.  The first step of this system will support the activation and development of primordial 
follicles to later preantral stages in situ.  At the end of the first stage of culture the preantral 
follicles will then be isolated and cultured individually to the EA stage.   
 
3.1.4 Aims 
The first aim of this experimental series was to compare the utility of long- and short-term 
cortical culture systems with respect to the activation, survival, growth and development of 
ovine primordial follicles.  In order to achieve this; follicles were cultured in situ for varying 
lengths of time, in order to determine optimal culture length.  At the end of the cortical culture 
period follicle population dynamics were assessed both in the fresh tissue and histologically.  
The second aim of this experimental series was to determine whether follicles grown in vitro 
using this culture system were competent to develop up to the EA stages once they were 
isolated and cultured individually.  The third aim of this experimental series was to compare 
the growth, development and survival rates of in vitro- and in vivo-derived follicles.  Preantral 
follicles derived in vitro were isolated and put into individual culture and their developmental 
competence assessed with respect to survival and growth rates as well as their ability to 
develop to the EA stages, relative to follicles isolated from fresh tissue.  
 
3.2 Materials and Methods 
3.2.1 Experiment 1 – step 1 In situ cortical culture 
Tissue culture was set up and carried out as detailed in Sections 2.1-2.7.  A diagrammatic 
representation of the basic methodology used is shown in Figure 3.1.  As described previously 
the pieces of cortical tissue were weighed at the start and end of culture.  Cultures were run 
for 6, 16, 19 or 23 days.  At the start and end of the culture period tissue pieces were 
transferred to Neutral Red dye to assess tissue viability, determine viable follicle counts and to 
aid follicle isolation, as described in Section 2.8, in preparation for Section 3.2.2, Experimental 
step 2 – preantral follicle culture.  Pieces of cortex were fixed for histological evaluation on 
days 0, 6, 16, 19 and 23 of culture, then processed and analysed as described in Sections 2.12-
2.14.  The number of viable follicles in each classification and the number of degenerating 
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follicles per mg tissue at each time point was determined as well as the diameter of each 
follicle and oocyte.  Five pieces of cortex were analysed per culture repeat and 4 culture 
repeats were performed for each time point. 
 
3.2.2   Experiment 2 – step 2 preantral follicle culture  
Follicles were isolated from both cultured cortical tissue on days 16, 19 and 23 of culture and 
from fresh day 0 tissue.  A culture period of 6 days yielded only primordial and early primary 
(EP) follicles, therefore follicles isolated from this tissue were not put into culture.  It was 
possible to isolate follicles from cultured tissue using mechanical means only, whereas follicle 
isolation from fresh tissue required the use of enzymes to digest and soften the tissue prior to 
mechanical isolation as this tissue was tougher. 
 
The process of follicle isolation from fresh tissue will be described first, which as previously 
mentioned was achieved using enzymes to soften the tissue.  The process of ovary isolation 
from the reproductive tracts was the same as described in Sections 2.1 and 2.2, except that 
the ovaries were stored in 50ml pre-warmed Follicle Isolation Media (FIM; see Appendix I) in a 
60ml sterile universal, at 37ºC rather than in RKWM.  All processing of tissue was carried out 
on a heated stage at 37ºC under laminar flow conditions.  Each ovary was transferred to a 
sterile Petri dish then sliced in half along the line of connective tissue which had previously 
connected the ovary to the tract, using a sterile scalpel (handle size 4 with a size 22 blade).  
Using the same scalpel the stromal tissue on each half of the ovary was first loosened by 
making small incisions.  Care was taken to not cut completely through the tissue thus avoiding 
any damage to the outer cortex.  The stromal tissue was then removed by slicing at an angle 
with the scalpel to leave a piece of cortex <2mm thick.  The pieces of cortex were then 
transferred to a 5ml sterile universal containing ~4ml pre-warmed FIM at 37ºC.  This process 
was repeated using 4-6 ovaries.  All of the pieces of cortex were then transferred to a new 
sterile Petri dish where the tissue was ‘minced’ into very small pieces (1-2mm-3) using 2 sterile 
scalpel blades at a 180º angle to each other to slice simultaneously.  Care was taken to apply 
an adequate amount of pressure to ensure the tissue was sliced rather than torn apart.  The 
tissue was then transferred to 10ml of pre-warmed 50-100% w/v collagenase (type 1A) 
containing 40μl DNase to give a final concentration of 2μgml-1 (see Appendix I) for 45-60 
minutes with agitation, at 37ºC in a hybridisation oven/ shaker (Stuart; S130H).  Following 
enzyme digestion tissue pieces were washed 3-4 times in cold L-15 medium containing 10% 
FCS v/v, at 4ºC.     
 
 
 
 
9
2
 
  
Figure 3.1 A flow diagram showing the basic methodology used in this experimental series.  The number of pieces of cortical tissue (p) used in each step is 
indicated, as is the number of culture repeats (n) and the number of follicles (f) following follicle isolation.                                           
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Tissue pieces were then transferred to pre-warmed and gassed NR plates containing NR 
solution at 50μgml-1 (see Figure 2.2).  The NR plates were then returned to the incubator and 
left for 40-60 minutes. As previously mentioned follicles were isolated from cultured tissue 
using mechanical means only, in the absence of enzymes therefore from this point the fresh 
day 0 tissue was processed in the same way as the tissue cultured for 16, 19 or 23 days, see 
below. 
 
After incubation in NR solution the tissue was transferred to pre-warmed FIM and positively 
stained follicles were dissected in a glass bottom dish (WillCo Wells B.V., Willco Beheer BV, 
Amsterdam, Netherlands) using 30 gauge needles attached to 1ml syringe barrels.  Care was 
taken to ensure the majority of stromal tissue was removed from each follicle. 
 
Table 3.1 Composition of preantral culture media.  The volumes required to make a 30ml 
solution are shown, with the stock and final concentrations.  The solution was filtered and 
stored for up to 1 week. 
 Additive Volume (μl) 
Stock 
Concentration 
Final 
Concentration* 
Basal culture media (see Appendix I) 9.716ml 
  Bovine holo-transferrin 10 5mgml-1 5μgml-1 
Sodium Pyruvate 10 47mM 0.047mM 
Sodium Selenite 1 50μgml-1 5ngml-1 
L-glutamine 150 200mM 3mM 
Bovine Insulin  10 10μgml-1 10ngml-1 
Human long-R3 IGF-1 1 100μgml-1 10ngml-1 
Ovine FSH 1 0.1iUml-1 1 x 10-5iUml-1 
Ovine LH 1 0.0023iUml-1 2.3 x 10-7iUml-1 
*The solution was filtered and stored for up to 1 week.  See Appendix I for details of the 
preparation of basal culture medium and additives. 
 
Following dissection, preantral follicles from EP stage onwards were transferred to a Nunc 4-
well dish containing 500µl pre-warmed and gassed culture media to wash off any FIM.  Note 
that only secondary follicles were isolated from fresh tissue.  Isolated follicle culture was 
undertaken using 96-well sterile flat-bottomed plates (Nunclon, catalogue number: 167008) 
containing 200μl preantral culture media (see Table 3.1) per well.  Note that the media used to 
culture follicles isolated mechanically also contained 50μgml-1 ascorbic acid, which was added 
immediately prior to use, to aid basement membrane remodelling (Murray et al., 2001, 
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Thomas et al., 2001).  As in vivo-derived secondary follicles had been isolated using enzymatic 
means this removed the basement membrane, therefore the addition of ascorbic acid was not 
necessary.  Plates were set-up 3 hours prior to use and placed in the incubator to equilibrate.  
Using a pipette, isolated follicles were carefully transferred to the 96 well plate in a minimal 
volume of media, one follicle was cultured per well.  Care was taken to position the follicles as 
close to the centre of the well as possible.  Follicle diameter (excluding any attached stromal 
cells) and oocyte diameter were measured using an inverted microscope (Olympus IX70) fitted 
with a calibrated eye graticule and a heated stage at 37°C. To calculate follicle and oocyte 
diameter 2 measurements were taken at 90° angles and then averaged.  The number and 
classification of the follicles at the start of the second phase of culture were also recorded.  
The follicle classification system used in this experimental series is detailed in Figure 3.2.  
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Figure 3.2 A diagrammatic representation and tabulated description of the classification and characterisation of EP, primary, transitional and secondary ovine 
follicles.  The mean diameter of follicles and oocytes is shown with ranges in parentheses.  Images are of in vitro-derived follicles, scale bar = 25µm.  Data regarding 
follicle and oocyte diameters taken from Lundy et al. (1999). 
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Preantral follicle cultures were run for a maximum of 30 days.  Media changes and follicle/ 
oocyte diameter measurements were carried out and photos were taken every Monday, 
Wednesday and Friday of culture.  Media changes were conducted on a heated stage at 37°C; 
50% of the media in each of the wells was replenished during each change.  If the follicle 
diameter did not increase across 3 consecutive media changes/diameter measurements then 
culture of the follicle was terminated as it was deemed that this follicle was either dead or 
degenerating.  Culture of the follicle was also terminated if the oocyte was completely 
extruded or the follicle had completely attached to the plate or was clearly necrotic.  
Representative images of follicles exhibiting these features are shown in Figure 3.3.   
 
In order to determine whether follicles were viable either at the end of the 30 day period or 
when they were deemed to be degenerating or dead NR staining was used. A 3µl aliquot of NR 
dye was added to the culture media in the well to give a final concentration 50μgml-1 and the 
tissue was left for 15 minutes.  The level of staining observed was recorded and photos taken 
using an Olympus DP11 attached digital camera.  Samples of viable and degenerating follicles 
were snap frozen in lysis buffer (see Appendix III) for subsequent molecular analysis (Chapter 
5). 
 
Figure 3.3 Representative images of secondary follicles exhibiting poor health in culture; 
partial oocyte extrusion (a), misshapen (b), early necrosis (c) and attachment of follicle to the 
culture surface (d).  Scale bar = 100µm.  
 
3.2.3 Statistical analysis 
The distribution of data was analysed for normality using the Anderson-Darling test.  Follicle 
counts in Experiment 1, step 1 – in situ cortical culture and increases and percentage increases 
in follicle diameter recorded in Experiment 2, step 2 were analysed using one-way ANOVA.  
Follicle proportions data in Experiment 1 was analysed using Chi-squared analysis. 
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3.3 Results  
3.3.1 Experiment 1 Cortical Slice Culture – primordial follicle activation and development 
In this experimental series 4 lengths of cortical culture were compared; 6, 16, 19 and 23 days 
over a total of 31 cultures, see Figure 3.1.  The follicle population dynamics observed in fixed 
tissue are shown in Figures 3.6 and 3.7.  Note that the term ‘fixed tissue’ refers to tissue that 
has been analysed histologically.  The follicle population dynamics observed in fresh tissue are 
shown in Figure 3.9.  Note that the term ‘fresh tissue’ refers to tissue that has been stained 
using NR dye either before or after culture.   
 
(i) Histological assessment of follicle population dynamics  
Firstly, tissue fixed either on day 0 or after culture was used to determine the relationship 
between the diameter of oocytes and follicles derived either in vivo or in vitro, respectively, 
see Figure 3.4.  Data regarding in vitro-derived follicle and oocyte diameters refers to that 
observed in tissue fixed after 6, 16, 19 and 23 days of culture.  A strong positive correlation 
between oocyte and follicle diameter was observed in both in vivo- and in vitro-derived 
primordial, EP, primary and all follicle classifications (p<0.001).  Transitional and secondary 
follicles were not considered separately as there were such low numbers of these 
classifications observed in fixed tissue samples, this data was therefore pooled before analysis. 
 
The mean diameter of oocytes and follicles within each preantral follicle classification on days 
0, 6, 16, 19 and 23 of culture are shown in Figure 3.5.  The data were analysed both across 4 
culture repeats (see (a) and (b)) and across all follicles recorded (see (c) and (d)).  Similar 
patterns were observed in all groups with very little variation in follicle and oocyte diameter in 
the primordial and EP follicle categories at any of the culture lengths considered.  Tissue fixed 
following 6 days of cortical culture did not contain follicles more advanced than the EP stages.  
In contrast in the more developed preantral follicle classifications more variation was 
observed.  For example, the mean diameter of primary follicles and oocytes observed in day 0 
tissue was significantly greater (p<0.05) than that observed on day 23.  Whereas the mean 
diameter of transitional follicles present in day 23 tissue was significantly greater (p<0.05) than 
that observed in day 16 or 19 tissue.  When the mean diameters of all oocytes and follicles 
were considered separately in Figures 3.5 (c) and (d) the overall patterns observed were 
similar. 
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Data regarding follicle population dynamics is shown in Figure 3.6 with respect to the mean 
number of follicles per mg of cultured tissue (a); determined using the tissue weight at the 
start of culture, and percentage (b) of total number of viable follicles, viable primordial and 
growing, and degenerating follicles in tissue fixed on days 0, 6, 16, 19 and 23 of culture.  Both 
methods of presenting the data show a similar pattern of a decrease in the number of 
primordial follicles on days 16, 19 and 23 of culture, compared to day 0, accompanied by an 
increase in growing and degenerating follicles.  None of these differences in the mean number 
of follicles (a) are statistically significant (p>0.05) except for the increase in number of 
degenerating follicles per mg tissue on day 16 (295), relative to days 0 and 6, 68 and 35, 
respectively (p<0.05).  The distribution of follicles on days 0 and 6 was significantly different 
(p<0.05) from that on days 16, 19 and 23.  The lower percentage of primordial follicles on days 
16, 19 and 23 relative to days 0 and 6 was the biggest contributor.  With respect to the day 6 
tissue, although the mean number of follicles in all categories decreased compared to day 0 
Figure 3.6 (a), the proportion of follicles remained similar Figure 3.6 (b).  However, a slight 
decrease in the number of primordial follicles is apparent in the cultured tissue, compared to 
the day 0 tissue.  Figure 3.6 (b) shows that the percentage of primordial follicles decreased on 
days 16, 19 and 23 of culture; 30%, 37% and 40% respectively, compared to days 0 and 6; 64%.  
This could be due to either follicle activation or atresia, or both.  As the increase in the 
percentage of degenerating follicles is greater than that of growing follicles on days 16-23, this 
suggests that follicular atresia is the greater contributor towards the decrease in percentage of 
primordial follicles.   
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Figure 3.4 Relationship between follicle and oocyte diameter of in vivo- and in vitro-derived primordial (a), EP (b), primary (c) and all follicle classifications (d) in 
fixed tissue.  A strong positive correlation (p<0.001) between follicle and oocyte diameter was observed in all data sets, analysed using analysis of covariance 
(ANCOVA).  The number of follicles analysed in each data set is shown (n) as is the R2 value for each trend line.  Note that many of the points are overlaid.   
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Figure 3.4 (contined) 
(c) Primary follicles (d) All classifications of follicles
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Figure 3.5 Mean follicle and oocyte diameter of primordial, EP, primary, transitional and secondary follicles in tissue fixed on days 0, 6, 16, 19 and 23 of culture.  
Data is presented as the mean follicle (a) and oocyte (b) diameter averaged over 4 culture repeats and as the mean follicle (c) and oocyte (d) diameter of all 
follicles (n) measured ± SEM.  Mean diameters were compared across culture lengths within each follicle classification and statistically significant differences are 
indicated with the use of different letters (p<0.05).  For example, in (a), the mean primary follicles diameter is significantly greater (p<0.05) in tissue fixed on day 0 
than in tissue fixed on day 23.  There is no significant difference (p>0.05) between the mean diameter of primary follicles fixed on days 0, 16 and 19 or between 
those fixed on days 16, 19 and 23.  Similarly there is no significant difference (p>0.05) in the mean transitional follicle diameter in tissue fixed on days 16 and 19, 
however, the mean diameter of transitional follicles in tissue fixed on day 23 is significantly greater (p<0.05) than in tissue fixed on days 16 and 19.  The same 
principle applies in (b), (c) and (d). 
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Figure 3.5 (continued) 
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Figure 3.6 Follicle population dynamics in fixed tissue samples on days 0, 6, 16, 19 and 23 of 
culture.  The total viable, viable primordial and growing and degenerating follicles are 
presented as mean number of follicles ± SEM per mg tissue at the start of culture for 4 culture 
repeats (a) and the % of follicles (b).  The mean number of follicles within each category 
between days 0, 6, 16, 19 and 23 were analysed using one-way ANOVA, with Fisher’s ad hoc 
testing.  Statistical differences (p<0.05) are indicated using different letters.  Statistically 
significant differences were only observed in the degenerating category.  The distribution of 
the % of primordial, growing and degenerating follicles between days 0, 6, 16, 19 and 23 was 
analysed using Chi-squared analysis; there were no statistically significant differences.   
 
The follicle population dynamics in fixed tissue samples were considered in more detail in 
Figure 3.7.  In this figure only viable follicles were considered and the category of growing 
follicles was broken down into EP, primary and multi-layered (transitional and secondary).  
Data regarding tissue fixed on day 6 was not included as there were no follicles more 
developed than the EP stage at this culture point.  The mean number of follicles per mg fixed 
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tissue is presented in Figure 3.7 (a).  The number of EP follicles is similar before and after 
culture. 
The number of primary follicles increased after long-term culture, although this increase was 
not statistically significant (p>0.05), see Figure 3.7.  There were no multi-layered preantral 
follicles present in day 0 tissue, however, multi-layered follicles were present after 16-23 days 
of culture.  There was no significant difference (p>0.05) in the number of multi-layered follicles 
on days 16, 19 and 23.  The percentage of primordial, EP, primary and multi-layered follicles, in 
tissue fixed on days 0, 16, 19 and 23 is shown in Figure 3.7 (b).  The percentage of primordial 
follicles decreased in the cultured tissue compared to the day 0 tissue, whereas the 
percentage of EP and primary follicles increased.  The increase in EP follicles in cultured tissue 
appears more pronounced than in Figure 3.7 (a).  Chi-squared analysis revealed that the 
distribution of the percentage of follicles in each classification on days 16, 19 and 23 was 
significantly different from the distribution on day 0 (p<0.001).  On days 16 and 19 the higher 
percentage of primary follicles, compared to day 0 was the greatest contributor.  In contrast, 
on day 23 the higher percentage of EP follicles, compared to day 0, was the greatest 
contributor (p<0.001).  The greatest increase in the percentage of primary follicles was 
observed on day 19, 4.0%, vs. 1.8% observed on day 0.  As there were no primary follicles 
observed in the day 6 tissue this suggests that the primary follicles present in the day 0 tissue 
had degenerated, thus the primary follicles observed on days 16-23 have resulted from the 
activation and growth of primordial or EP follicles in vitro.  It should be noted that secondary 
follicles were only present on day 23 of culture; 0.7%. 
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Figure 3.7 Preantral follicle population dynamics in fixed tissue samples on days 0, 16, 19 and 
23 of culture.  The total EP, primary and multi-layered follicles are presented as mean number 
of follicles ± SEM per mg tissue for 4 culture repeats (a) and the % of viable follicles of all 
preantral classifications (b).  The mean number of primordial follicles was not shown in (a) as 
this was a much larger figure than that of the multi-layered follicles and therefore made the 
graph difficult to interpret.  Furthermore, this data has already been presented in Figure 3.6.  
The mean number of follicles were analysed using one-way ANOVA, with Fisher’s ad hoc 
testing.  No statistical differences were observed when follicle numbers within each 
classification were compared at the different time points.  The distribution of the % of viable 
follicles was analysed using Chi-squared analysis.    
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(ii)  Isolation of follicles from cultured tissue 
The mean weight of the tissue was measured and calculated at the start and end of each 
culture period, as shown in Figure 3.8.  Following 6, 16 and 19 days of culture there were very 
small increases in mean tissue weight compared to the start of culture.  Following 23 days of 
culture, however, there was a larger statistically significant (p<0.05) increase in mean tissue 
weight, from 0.0109±0.0011g to 0.0198±0.0014g for 9 culture repeats.  The approximate mean 
follicle density in cortical slices selected for culture on day 0, determined using NR staining, 
was 320±209 follicles per mm3. 
 
 
Figure 3.8 Histogram showing the mean weight of tissue at the start and end of each culture 
period.  Data is shown as the mean weight ± SEM for the number of culture repeats indicated.  
Data was analysed using paired t-test to compared tissue weight at the start and end of culture 
within each culture duration tested. Statistical differences are denoted using *p<0.05.  Only on 
day 23 was a statistically significant change in tissue weight detected.  
 
Follicle population dynamics were also assessed following isolation from NR-stained cultured 
tissue, as shown in Figure 3.9.  Note that in Figure 3.9 follicle counts are presented as the 
mean number per g, rather than mg, of tissue as the number of secondary follicles present at 
the end of culture per mg of tissue was <1.  Therefore rather than present a proportion of a 
follicle, which is not very biologically relevant, follicle counts were considered per g.  The 
primordial/ EP follicle counts are not shown for fresh tissue.  This is because the tissue was 
warm after culture and therefore stained rapidly with NR dye such that it was difficult to 
discriminate between cortex staining and follicle staining.  Therefore it was not possible to 
accurately count the number of viable primordial/ EP follicles in situ in tissue immediately at 
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the end of culture.  For this reason it was not therefore possible to present the percentage of 
follicles present in fresh, cultured tissue.  The mean number of primary, transitional and 
secondary follicles present on days 16, 19 and 23 in fresh tissue is shown.  There were no 
follicles more developed than EP on days 0 and 6 of culture.  There was no difference in the 
mean number of primary, transitional or secondary follicles after each culture duration.  There 
were fewer primary follicles per g of tissue present on day 23, (87±31 follicles) compared to 
days 16 and 19, (371±101 and 272±106 follicles, respectively), although this difference was not 
statistically significant (p>0.05).  This slight decrease in primary follicle numbers may have 
been due to either the follicles developing further or degenerating.  As the transitional and 
secondary follicle counts are very similar on days 16, 19 and 23 of culture, it is most likely that 
the observed decrease in primary follicles on day 23 is most probably due to follicle 
degeneration. 
 
 
Figure 3.9 Mean number of primary, transitional and secondary follicles isolated per g of tissue 
cultured for 16, 19 and 23 days.  Values are shown as mean ± SEM per culture repeat for the 
number of repeat cultures (n) shown in the key.  Note that in this figure the mean number of 
follicles is presented per g rather than per mg of tissue.  The mean number of follicles were 
analysed using one-way ANOVA, with Fisher’s ad hoc testing.  No statistical differences were 
observed when follicle numbers within each classification were compared at the different time 
points  
 
3.3.2 Experiment 2: Preantral follicle culture using in vitro-derived follicles 
The growth rates of in vitro-derived isolated EP, primary, transitional and secondary follicles 
over a 30 day period are shown in Figure 3.10.  The percentage of follicles of each classification 
108 
 
 
 
surviving culture is shown in Table 3.2.  In this context follicle survival was determined by the 
criteria for terminating culture detailed in Section 3.2.2.  Secondary follicles had a mean 
diameter of 219.5±10.5µm on the day of isolation, i.e. day 0 of preantral culture, and reached 
a maximal diameter of 984.8µm (n=1) after a total of 43 days of culture (19 days cortical 
culture plus 24 days preantral culture).  Of the 16 secondary follicles cultured 18.8% developed 
antral cavities.  Secondary follicles exhibited the highest percentage of follicles surviving 
culture on day 21 of culture, although this was only 12.5%, and both attachment of the follicle 
to the culture surface and oocyte extrusion were very common.   
 
Table 3.2 A summary of the percentage of follicles actively growing in preantral culture on 
days 7, 14 and 21. 
Classification 
Percentage of surviving follicles 
Day 7 Day 14 Day 21 
EP 40.0 0.0 0.0 
Primary 25.6 15.4 10.3 
Transitional 31.6 10.5 8.8 
Secondary 43.8 12.5 12.5 
 
The in vitro-derived transitional follicles (diameter 96.8±3.9µm, n=57 at the start of culture) 
developed to the secondary stage following isolation, however, they failed to form antral 
cavities after a total of 42-49 days in culture.  The transitional follicles reached a maximum 
diameter of 207.1±49.5µm after 24 days of preantral culture, see Figure 3.10.  Transitional 
follicles survived for a maximum of 26 days in culture (n=3).  However, both attachment of the 
follicle to the culture surface and oocyte extrusion were more common in this classification of 
follicle than in primary follicles.   
 
The in vitro-derived primary follicles did not develop past the primary stage in preantral 
culture, and only a small increase in size from 72.5±2.2µm (n=39) to 103.5µm (n=1) was 
observed, see Figure 3.10.  Similarly the in vitro-derived EP follicles did not develop past the EP 
stage and only a small increase in diameter was observed, 53.0±2.8µm (n=5) to 68.2±10.1µm 
(n=2).  Furthermore, EP follicles only survived to day 7 of culture, although this could be 
partially due to the very small number of EP follicles cultured following isolation, see Figure 
3.10.  Only 1 primary follicle was evident in culture after 28 days, whereas 10.3% of primary 
follicles survived culture up to day 21. It is worth noting that the termination of primary follicle 
culture was usually due to the fact that follicles stopped growing as indicated by increase in 
diameter rather than exhibiting increased signs of ill health.  
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The level of growth of in vitro-derived follicles after 7 days of culture is shown in Figure 3.11.  
Only follicles that were still viable on day 7 of culture have been included in these calculations.  
All 4 classifications of follicle increased in diameter after 7 days of culture.  The mean increase 
in diameter of secondary follicles is significantly greater than that of EP, primary and 
transitional follicles (Figure 3.11 (a)).  The mean increase in diameter of transitional follicles in 
vitro was only 17.1±3.4µm compared to a mean increase of 76.4±7.5µm exhibited by 
secondary follicles, which is a 4.5 fold greater increase.  It is to be expected that a greater rate 
of growth would be observed in secondary follicles than follicles at an early stage of 
development due to their larger starting size and the fact that there are more somatic cells to 
proliferate.  Therefore the percentage increase in diameter was also taken into consideration.  
The percentage increase in diameter of secondary follicles, 36.0±4.0%, was significantly 
greater (p<0.05) than that of the primary and transitional follicles, 16.3±4.5% and 17.0±2.9%, 
respectively.  However, the percentage increase in diameter of EP follicles, 19.5±4.5%, was not 
significantly different (p>0.05) from that of any other follicle classification.  This is likely to be 
due to the very low sample number (n=2) of EP follicles, rather than the EP follicles growing at 
as high a rate as the secondary follicles.  These results show that the isolated secondary 
follicles exhibited the highest growth rates in vitro.  
110 
 
 
 
 
Figure 3.10 Growth rates of in vitro-derived preantral follicles in step 2 isolated culture over a 
period of 30 days.  Values are presented as the mean diameter ± SEM for the number of 
follicles (n) shown.  Representative images of an EA follicle (a) which developed from an in 
vitro-derived secondary follicle (b) following isolation and individual culture are shown, as well 
as images of in vitro-derived transitional (c), primary (d) and EP (e) follicles.  Scale bar = 25μm. 
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Figure 3.11 Growth of in vitro-derived follicles in preantral culture after 7 days of culture.  (a) 
The mean increase in EP, primary, transitional and secondary follicle diameter after 7 days 
preantral culture.  Values are presented as the mean diameter ± SEM for the number of 
cultured follicles shown.  Statistical differences in the mean increase in diameter between 
different follicle classifications are denoted using *p<0.05. (b) The % increase in EP, primary, 
transitional and secondary follicle diameter after 7 days preantral culture.  Values are 
presented as the mean % increase in diameter ± SEM for the number of cultured follicles 
shown.  Statistical differences in the % increase in follicle diameter between follicle 
classification are denoted using different letters (p<0.05).  
 
3.3.3 Preantral follicle culture using in vitro- vs. in vivo-derived follicles 
In this experimental series the growth and development of in vitro- and in vivo-derived follicles 
was compared.  As in vitro-derived secondary follicles exhibited the highest growth rates and 
were the only classification of follicle to develop to the next developmental stage over the 30 
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day isolated culture period then only follicles of this classification were considered in more 
detail.  Representative images of in vitro- and in vivo-derived secondary follicles that 
developed to the EA stage are shown in Figure 3.12.  The growth of isolated in vitro- and in 
vivo-derived secondary follicles over a maximum of 30 days culture is shown in Figure 3.13.  
Both sets of secondary follicles followed similar patterns of growth over the first 19 days of 
culture.  On the day of isolation the mean diameters of in vitro-and in vivo-derived secondary 
follicles were not statistically significantly different (p>0.05), 219.5±10.5µm (n=16) and 
217.7±2.6µm (n=85), respectively.  This increased to 497.4±108.6µm (n=2) and 445.0±14.9µm 
(n=49), respectively on day 19 of culture; these mean diameters were not statistically 
significantly different (p>0.05).  The terminal diameter of in vitro-derived secondary follicles 
was almost twice that of the in vivo-derived follicles, 984.8µm on day 24 (n=1) and 
557.4±29.3µm on day 30 (n=24), respectively.  This discrepancy, however, could be due to the 
fact that there was only one surviving follicle in the in vitro-derived group.  Analysis of growth 
rates using ANCOVA revealed that the effect of culture length is highly significant with respect 
to follicle diameter (p<0.001).  Comparison of growth rates of in vivo- and in vitro-derived 
secondary follicles revealed that the growth rate exhibited by the in vitro-derived follicles 
significantly higher than that exhibited by the in vivo-derived follicles (p<0.05).    
 
As previously stated, 18.8% of the in vitro-derived secondary follicles formed antral cavities, 
whereas only 7.1% of in vivo-derived secondary follicles formed antral cavities.  Analysis of 
antral cavity formation data using Chi-squared test revealed that the difference between in 
vitro- and in vivo-derived secondary follicles was not statistically significantly different 
(p=0.132).  The slightly higher percentage of in vitro-derived follicles forming antral cavities, 
compared to in vivo-derived could be due to the fact that the tissue was digested using 
collagenase in the case of the second group of follicles, thus damaging the follicles.  
Alternatively the follicles isolated from fresh uncultured tissue may have already been 
degenerating, although they showed no morphological signs of this.  Whereas the in vitro-
derived follicles had all started to grow within the last 23 days (maximum) and therefore may 
have been healthier at the start of preantral culture.  Although this may not be the case as the 
survival rate of in vivo-derived follicles up to day 24 is 35.3% compared to 6.3% of in vitro-
derived follicles. 
 
 
 
 
1
1
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Figure 3.12 Representative images of (a) in vitro-derived and (b and c) in vivo-derived secondary follicles on day 0, the day of isolation and after 14, 21 and 24 days 
of culture.  Follicle (b) appeared healthy throughout culture, whereas (c) began to extrude its oocyte, however, it was still competent to develop to the EA stage.  
The location of the oocyte and, if present, the antral cavity are indicated using the letters O and AC, respectively.  Scale bar = 50µm.  
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Figure 3.13 Growth rates of in vitro- and in vivo-derived secondary follicles in isolated culture 
for a maximum of 30 days.  Values are presented as the mean diameter ± SEM for the number 
of follicles (n) shown.  Growth rates were compared using ANCOVA; differences were not 
statistically significantly different (p>0.05). 
 
The growth of in vivo- and in vitro-derived secondary follicles in isolated culture is shown in 
Figure 3.14.  The mean increase in diameter Figure 3.14 (a) and the mean percentage increase 
in diameter relative to day 0 values Figure 3.14 (b) are shown.  Day 19 was selected as the last 
point at which to compare growth as only one in vitro-derived follicle survived past this date.  
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There was no statistical difference (p<0.05) in the mean increase in diameter or the 
percentage mean increase in diameter between the in vitro- and in vivo-derived follicles, 
determined using one-way ANOVA, on days 7, 14 and 19 of culture.   
 
  
Figure 3.14 Growth of in vivo- and in vitro-derived secondary follicles in isolated culture.  (a) 
The mean increase in follicle diameter compared to day 0 on days 7, 14 and 19 of culture. (b) 
The mean % increase in follicle diameter compared to day 0 on days 7, 14 and 19 of culture.  
Values shown as mean ± SEM for the number of follicles (n) shown on the graphs.  The mean 
increase in follicle diameter was compared between in vitro- and in vivo-derived secondary 
follicles on days 7, 14 and 19, using one-way ANOVA.  No statistically significant differences 
were observed (p<0.05).  Similarly the % increase in follicle diameter was compared between 
in vitro- and in vivo-derived secondary follicles on days 7, 14 and 19, using one-way ANOVA.  
No statistically significant differences were observed (p<0.05).  
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3.4 Discussion 
This experimental series has shown that it is possible to grow ovine oocytes from the 
primordial/ EP stage up to the EA stage using a two-step, serum-free culture system.  This 
study differs from previous studies in which primordial ovine oocytes have been grown to the 
EA stage in vitro in that follicles were isolated at the secondary stage rather than being 
cultured up to the EA stage within cortical slices (Peng et al., 2010).  A short-term culture 
period of 6 days was not sufficient to support the development of early preantral follicles up to 
the primary stage, whereas, a period of 16-23 days was sufficient to grow follicles up to the 
secondary stage, see Figures 3.6, 3.7 and 3.9.  However, a higher number and proportion of 
follicles degenerated in the longer culture periods (16-23 days) than during the 6-day culture 
period, see Figure 3.6.  Secondary follicles derived following long-term cortical culture were 
competent to develop up to the EA stage when isolated and cultured individually, see Figures 
3.10, 3.11 and 3.12, at a rate comparable to that of in vivo-derived follicles.   
 
3.4.1 Cortical slice culture – primordial follicle activation and development 
The first aim of this experimental series was to compare the use of long- and short-term 
cortical culture systems with respect to the activation, survival, growth and development of 
primordial follicles.  A long-term culture period of 16 days was selected initially as Chambers 
(2002) reported an increase in the number of primary and transitional follicles following 15 
days of cortical culture.  Extended culture lengths of 19 and 23 days were then tested to 
determine whether increasing the length of culture would increase the yield of secondary 
follicles, as Chambers (2002) has previously reported the presence of secondary follicles 
following 20 days of culture.  Culture lengths were not extended past 23 days as Chambers 
found that increasing culture length from 20 to 25 days did not increase secondary follicle 
yield.  The short-term culture period of 6 days was selected as development of transitional 
follicles from the primordial stage has been reported within this timeframe in human and cow 
(Telfer et al., 2008, McLaughlin and Telfer, 2010).  Primordial follicle activation rates were 
investigated using histological evaluation of the tissue, revealing that after 6 days of culture 
the proportion of primordial to growing follicles was very similar to that observed in day 0 
tissue (Figure 3.6 (a)).  This observation is in agreement with what has been reported 
previously in ovine ovarian tissue in which growing follicles are not present in vivo (Juengel et 
al., 2002b, Sawyer et al., 2002).  A much more accelerated rate of activation and development 
has been reported in some studies.  For example, following the in situ culture of oocytes within 
whole newborn mouse ovaries significantly increased levels of primordial follicle activation 
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were observed compared to equivalent in vivo models (Gigli et al., 2005).  Similarly in large 
mammal models higher levels of primordial follicle activation were observed following short-
term culture periods compared to levels observed in vivo.  Following 6 days of cortical culture 
the percentage of primordial/ EP follicles was reported to have decreased from around 90% to 
60% in human tissue and <40% in bovine tissue (Telfer et al., 2008, McLaughlin and Telfer, 
2010). The increased levels of follicular activation relative to those observed in the present 
study could be due to the method of cortical tissue preparation, which differed in that the 
tissue, prepared according to methods developed in Edinburgh (Telfer et al., 2008, McLaughlin 
and Telfer, 2010), was teased apart prior to culture.  Culturing ovarian tissue in fragments, 
rather than as a whole ovary has previously been shown to result in higher rates of primordial 
follicle activation, possibly via the removal of inhibitory factors, such as AMH and activin A (see 
Section 3.1.1) (Cushman et al., 2002).  Alternatively, manipulation of the tissue may result in 
increased exposure to stimulatory factors thus resulting in the increased levels of activation 
and growth observed (see Section 3.1.1).  For example, teasing the tissue apart may increase 
the level of exposure to insulin and IGFs in vitro, which may promote early preantral follicle 
development (el-Roeiy et al., 1993).  Furthermore, the shape of the tissue fragments has been 
linked to the level of follicular activation, with tissue trimmed into cubes exhibiting lower rates 
than tissue trimmed into slices (Hovatta et al., 1997, Scott et al., 2004a, Telfer et al., 2008).  
Therefore the effect of teasing the tissue apart may occur via a similar mechanism, but to a 
larger extent.  Large-scale activation of primordial follicles has been reported within 2 days of 
cortical slice culture of bovine and baboon ovarian tissue, in studies in which the tissue has not 
been teased apart, however, very few follicles progressed to multi-layered stages (Wandji et 
al., 1996b, Wandji et al., 1997).  The differences in activation rates observed in the various 
studies in vitro may also be due to species-specific differences.  The number of primordial 
follicles activating each day in vivo differs between species; 1-4 in the ovine ovary (Turnbull et 
al., 1977, Driancourt et al., 1985); around 6 in the bovine ovary (Scaramuzzi et al., 1980); and 
2-30 in the human ovary, depending on the age of the woman (Faddy and Gosden, 1995). 
 
In the current study the total number of viable follicles present in tissue fixed on day 6 had 
decreased slightly, compared to that observed in tissue fixed on day 0 (Figure 3.6 (b)).  This 
was not, however, accompanied by an increase in the number of degenerating follicles, 
suggesting that the day 6 tissue samples used for analysis were less follicle rich at the start of 
culture than the day 0 samples and not that follicle degeneration was the main cause of the 
decrease in the number of viable follicles.  The low levels of follicular degeneration exhibited in 
this study, after 6 days of culture, are in agreement with those previously reported by 
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Chambers et al. (2010) and suggest that the culture conditions in the current study promote 
follicle survival to a greater extent to those used by Telfer et al. (2008) as in the latter study 
the percentage of degenerating human follicles had almost doubled on day 6 of culture.  This 
could also be linked to the method of tissue preparation as this has previously been linked to 
follicle survival in short-term culture of human ovarian tissue, as Scott et al. (2004a) showed 
that culturing follicles within cubes of tissue resulted in higher rates of follicle survival after 7 
days of culture.  Therefore teasing tissue apart may increase levels of follicle degeneration 
relative to standard cortical slice preparation. 
 
The follicle population dynamics in tissue fixed on days 16, 19 and 23 significantly differed 
from those observed in day 0 tissue (p<0.001), with respect to follicle proportions (Figure 3.6 
(b)).  Tissue fixed at the end of long-term culture contained a higher proportion of 
degenerating follicles and lower proportion of primordial follicles than tissue fixed on day 0 
and 6.  An increase in the proportion of growing follicles could also be observed indicating that 
some degree of follicle activation had occurred and therefore the decrease in proportion of 
primordial follicles was not solely due to follicular degeneration.  However, the fact that the 
number of growing follicles per mg tissue was not significantly different from that observed in 
day 0 tissue, whereas the percentage of degenerating follicles was significantly higher suggests 
that follicular degeneration was a greater contributor to the decrease in primordial follicle 
number than primordial follicle activation (Figure 3.6 (a)).  Following long-term culture the 
percentage of viable follicles decreased to ~60% which is similar to that reported by Peng et al. 
(2010).  In the latter study the percentage of viable follicles decreased from 85% to ~50% in 
constant FSH-supplemented media, after 18 days cortical culture.  When a sequential culture 
media was used the percentage of viable follicles on day 18 was slightly higher; ~60%.  
Similarly after 16 days of culture the percentage of viable follicles decreased from 90% to ~60% 
in caprine ovarian tissue, when FSH and growth hormone were present in the culture media 
(Magalhaes-Padilha et al., 2012).  However, in this study a larger increase in the percentage of 
growing follicles was observed than in the current study, following both 8 and 16 days of 
culture, even in the control, gonadotrophin-free media.  In this study the sequential addition of 
FSH and/or GH to the culture media was shown to affect follicle activation and survival.  
Therefore modifications to the culture media used in the current system may increase follicle 
activation and growth rates.  In conclusion in order to increase the proportion and yield of 
growing follicles either a culture period longer than 6 days and/or changes to the culture 
conditions are required. 
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The effect of culture conditions on the growth and development of activated follicles was also 
considered.  The number and proportion of EP, primary and multi-layered viable follicles, in 
tissue fixed on days 0, 16, 19 and 23 of culture, are presented in Figure 3.7.  Both the number 
and proportion of primary follicles increased after long-term culture, compared to day 0 tissue.  
It should be noted that there were no primary follicles present in day 6 tissue suggesting that 
primary follicles present in tissue fixed on days 16-23 must have developed in vitro.  
Additionally, multi-layered follicles developed during long-term culture.  Increasing culture 
length therefore increased the yield of multi-layered follicles.  Increasing the duration of 
culture has previously been shown to increase multi-layered follicle yield in the sheep (Peng et 
al., 2010), goat (Magalhaes-Padilha et al., 2012), non-human primate (Wandji et al., 1997) and 
human (Scott et al., 2004a).  Both the number and proportion of multi-layered follicles were 
very similar in tissue fixed on days 16, 19 and 23.  Secondary follicles were, however, only 
present in tissue fixed on day 23 of culture, although this percentage was very low (0.7%), in 
comparison to the long-term culture studies in goat (23%) (Magalhaes-Padilha et al., 2012).  
The highest mean number of primary and multilayered follicles per mg fixed tissue was 
observed in tissue fixed on day 16 of culture; 40±13 (n=4) and 5±3 (n=4), respectively (Figure 
3.7 (a)).  The proportion of primary and multilayered follicles was similar in tissue cultured for 
16 and 19 days, ~8% and 1%, respectively (Figure 3.7 (b)).   
 
Although the speed of development of primordial follicles to the secondary stage exhibited in 
this study is much higher than that observed in the adult ovine ovary in vivo (75 days), it is 
similar to that observed in ovine ovarian tissue in vivo in the absence of growing follicles, for 
example in the fetal ovary (45 days), as discussed in the previous section on primordial follicle 
activation and development (Section 3.1.1) (Cahill and Mauleon, 1981, Juengel et al., 2002b, 
Sawyer et al., 2002).  As the method of tissue preparation resulted in reduction in the 
proportion of growing follicles relative to primordial follicles this therefore resulted in an 
environment more similar to that experienced by the follicles in the fetal ovine ovary in vivo, 
than the adult ovary.  Levels of inhibitory factors, such as AMH and activin A produced by 
growing follicles would be lower.  In addition the low levels of primordial follicle activation and 
slow, physiologically relevant rate of growth observed during cortical culture in the current 
study are similar those which were observed when the system was developed by Chambers 
(2002).  The development of secondary follicles, however, was not observed following 30 days 
in the Chambers (2002) study, unlike the current investigation.  In addition Chambers (2002) 
found that increasing culture length past 20 days did not increase the yield of secondary 
follicles.  These differences could be due to the use of the NR dye, which ensured all cortical 
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slices cultured contained a high number of primordial follicles, thus increasing the number of 
follicles able to develop to the secondary stage.  In addition in the previous study tissue 
containing growing follicles, including secondary and EA follicles, was not excluded from 
culture.  Inhibitory factors, detailed above, released by the growing follicles may have inhibited 
the activation and subsequent development of primordial follicles slightly.  In conclusion the 
slightly increased rates of development relative to those observed in the adult ovine ovary, 
exhibited in the current study can be considered physiologically normal.   
 
Numerous culture systems that support the activation and growth of primordial follicles at a 
physiological rate have been reported.  Equivalent rates of follicle development from the 
primordial to the secondary stage in situ and in vivo in the absence of growing follicles have 
been observed in the culture of whole mouse ovaries, in which a period of 8 days was required 
(O'Brien et al., 2003).  Isolated oocyte-GC complexes derived following 8 days of in situ culture 
were competent to develop and to undergo IVM, and subsequent IVF resulted in the birth of 
live offspring.  Similarly secondary follicles derived via the in situ culture of primary follicles 
within whole mouse ovaries over a physiologically relevant timeframe of 4 days exhibited high 
survival and antrum formation rates of 74% and 72%, respectively, following isolation and 12 
days culture within a fibrin-alginate hydrogel (Jin et al., 2010).  Subsequently 88% of in vitro-
derived secondary follicles developed to the MII stage and were fertilised resulting in 54% 
reaching the endpoint 2-cell embryo stage.  Hornick et al. (2012) reported the use of alginate 
hydrogels to support the survival and growth of early preantral follicles, within a 
physiologically relevant timeframe.  Higher concentrations of alginate (2%) were shown to be 
optimal with respect to follicle survival, as has also been demonstrated with human primordial 
follicles (Amorim et al., 2009).  Alginate has also been used as scaffold for human cortical slices 
in a system that supported the activation and growth of primordial follicles to the transitional 
stage after 2 weeks culture (Kedem et al., 2011). 
 
A previously mentioned a 2-step serum-free culture system has been developed which 
supports the in vitro growth of oocytes from the primordial to the EA follicle stage in both the 
bovine and human (Telfer et al., 2008, McLaughlin and Telfer, 2010).  Step 1 is described 
above.  In step two in vitro-derived transitional follicles were then isolated and cultured 
individually.  The yield of multi-layered follicles achieved in the current investigation is much 
lower than has been reported in studies utilising accelerated culture systems in which the 
percentage of multi-layered follicles increased from 0% to 10% in bovine (McLaughlin and 
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Telfer, 2010); and 15% in human (Telfer et al., 2008), in 6 days.  Note that this rate of 
development is highly accelerated even compared to that observed in vivo in the fetal bovine 
ovary in which development from the primordial to the primary stage takes 68 days (Nilsson 
and Skinner, 2009).  It is however, difficult to directly compare the results in these studies as 
the published data presented only relates to the proportion of viable follicles (Telfer et al., 
2008, McLaughlin and Telfer, 2010).  Therefore it is difficult to determine whether the 
apparent larger increase in the proportion of growing follicles compared to that reported in 
the current experimental series, is due to the primordial follicles activating or a large number 
of primordial follicles degenerating.  In the current experimental series the health of the 
stromal tissue was assessed using tissue weight as a marker.  Tissue weight had consistently 
increased at the end of the cortical culture period, to a significant extent by day 23 (p<0.05), 
see Figure 3.8.  Maintenance of the health and integrity of stromal tissue is of great 
importance to the continued development of follicles and oocytes as it provides a scaffold, 
without which oocyte-somatic cell interactions would be compromised.  In addition receptors 
and growth factors expressed by ovarian stromal cells are required for primordial follicle 
activation, such as c-kit, and development, such as BMP4 and BMP7 (Knight and Glister, 2006).  
The health of the stromal tissue following accelerated culture was not reported in the 
aforementioned studies (Telfer et al., 2008, McLaughlin and Telfer, 2010).  Therefore one of 
the aims of the future work conducted in this thesis will be to compare the use of accelerated 
and physiological culture systems with respect to the health of stromal tissue. 
   
The composition of culture media used has been shown to affect follicle yield (Peng et al., 
2010, Scott et al., 2004a).  For example, addition of GDF-9 to the media increased the yield of 
human primary follicles from 13% on day 0 to 53% after 7 days, compared to 31% in the GDF-
9-free media (Hreinsson et al., 2002).  It is important, however, to note that the effect of 
culture media composition is species-specific.  Therefore it may be possible to increase follicle 
yield by preparing the tissue using a different method and/ or by the addition of growth 
additives to the culture media.  However, as discussed previously, large-scale activation of 
primordial follicles and accelerated growth rates may be detrimental to the health of in vitro-
derived oocytes. 
 
In contrast to the fixed tissue, secondary follicles were detected in the tissue used to isolate 
follicles after 16, 19 and 23 days of culture (see Figure 3.9).  When follicle population dynamics 
were examined in fresh tissue the numbers of transitional and secondary follicles per g tissue 
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were similar on days 16, 19 and 23.  A slight decrease in primary follicles was observed on day 
23 and as this was not accompanied by an increase in the number of transitional and 
secondary follicles this was probably due to follicular degeneration, rather than progression of 
primary follicles to later preantral stages. 
 
The results of the current experimental series show that this serum-free culture system is able 
to support the activation and development of primordial follicles up to the secondary stage 
within a culture period of 16-23 days.  In addition this culture system is able to support the 
growth and survival of the ovarian stromal tissue as shown by the increase in tissue weight 
following culture (see Figure 3.8).   
 
3.4.2 Preantral follicle culture using in vitro-derived follicles 
The second aim of this experimental series was to determine whether follicles grown in situ 
within ovarian cortex, in physiological, ECM- and serum-free media, were competent to 
develop up to the EA stage once they were isolated and cultured individually.  As mentioned 
earlier 18.8% of in vitro-derived secondary follicles were competent to develop to the EA 
stage.  A similar proportion (~25%) of in vivo-derived secondary follicles were previously 
reported to have formed antral cavities in the presence of FSH and LH, or FSH alone (Newton 
et al., 1999b).  This shows that the health of the in vitro-derived follicles was not affected by 
the cortical culture conditions enough to prevent development to the EA stage.  
Developmental competence was shown to be related to the developmental stage at the start 
of isolated culture, in that the more developed follicles were more likely to survive isolated 
culture and develop to later stages than the less developed follicles, in agreement with former 
studies in mouse (Kreeger et al., 2005); sheep (Newton et al., 1999b); and human (Hovatta et 
al., 1997).  Antral cavity formation in in vitro-derived secondary follicles occurred around day 
14 of isolated culture.  This is also comparable to that reported in a previous studies in which 
in vivo-derived secondary follicles formed antral cavities around day 14 of culture (Newton et 
al., 1999b).  These results are in agreement with those observed in the ovine fetal ovary as 
development from the secondary to EA stage has been reported after 15 days (Juengel et al., 
2002a).  The increased rates of development from the secondary to the EA stage, compared to 
that observed in the adult ovine ovary in vivo may be a result of the addition of FSH to the 
media as increased rates of development have also been observed in the autografted ovine 
and human ovarian tissue, as detailed in Section 3.1.1 (Oktay et al., 1998, Campbell et al., 
2000).    
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In the current study although in vitro-derived transitional follicles were competent to develop 
to the secondary stage in isolated culture, these follicles degenerated prior to progression to 
the EA stage.  This is in agreement with previous findings that there is no advantage to 
isolating follicles prior to the secondary stage of development and that smaller follicles require 
some form of support matrix in order to survive and develop in isolated culture (Hovatta et al., 
1997, Hovatta et al., 1999).  In contrast, the development of in vitro-derived transitional 
follicles to the EA stage has been reported in both human (Telfer et al., 2008) and bovine 
(McLaughlin and Telfer, 2010) after 4 and 12 days, respectively.  The rate of development 
reported in human follicles in vitro is highly accelerated compared even to that observed in 
vivo in the adult human ovary in the presence of increased FSH stimulation, in which 
development from the primordial to the EA stage required 17 weeks (Oktay et al., 1998).  The 
accelerated growth timeframe reported in these papers and the fact that the culture system 
was able to support follicular development from the transitional stage is probably due to the 
addition of activin A to the culture media.  In the current study in vitro-derived secondary 
follicles also exhibited a significantly greater increase in diameter than EP, primary and 
transitional follicles, after 7 days isolated culture (see Figure 3.11).   
 
In vitro-derived secondary follicles exhibited the highest survival rates in this study, with 12.5% 
still actively growing on day 21 of step 2, isolated culture (see Table 3.2).  Loss of normal 
follicle morphology was often observed with follicles attaching to the culture surface and/or 
extruding their oocytes (see Figure 3.3), in transitional and secondary follicles, although, 
interestingly these phenomena were not observed in EP and primary follicles.  As mentioned 
above the termination of culture of in vitro-derived EP and primary follicles was mainly due to 
follicles deemed not be growing when no increase in diameter, over 3 consecutive media 
changes, was observed.  Researchers that advocate the use of accelerated culture systems 
suggest that shorter culture duration allows less time for the breakdown of oocyte-GC 
interactions to occur, therefore the maintenance of normal morphology is easier (McLaughlin 
et al., 2010).  Follicle attachment and oocyte extrusion, however, were most commonly 
observed during the first 5 days of culture, and follicles that had maintained a normal 
morphology up to that point continued to do so.  Alternatively, as shown in Figure 3.12 (c), 
follicles that initially exhibited signs of oocyte extrusion were occasionally able to ‘repair’ 
themselves as somatic cells continued to proliferate.  This suggests that altering the culture 
length would not improve follicle survival rates rather it is more likely that damage caused 
during the mechanical isolation process resulted in the loss of normal follicle morphology and 
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therefore altering techniques used at the isolation stage may be more beneficial.  Therefore 
the current preantral follicle system is best able to support the development of secondary 
follicles in vitro rather than early stages of follicle development. 
 
3.4.3 Preantral follicle culture using in vitro- vs. in vivo-derived follicles 
The third aim of this experimental series was to compare the growth, development and 
survival rates of in vitro- and in vivo-derived follicles.  Only secondary follicles were used in this 
comparison as these were the only follicles competent to develop to the EA stage.  The growth 
rates exhibited by in vitro- and in vivo-derived secondary follicles were similar, as shown in 
Figures 3.13 and 3.14.  The average terminal diameter of in vitro-derived secondary follicles 
was much larger than that of in vivo-derived secondary follicles however this was probably due 
to the very low sample number of in vitro-derived follicles.  As previously stated the rate of 
antral cavity formation was higher but the survival rate lower in in vitro-derived follicles than 
in vivo-derived follicles.  The lower rate of antral cavity formation in in vivo-derived follicles 
may be due to damage caused by collagenase digestion of the tissue prior to isolation (Telfer, 
1996, Abir et al., 2001).  
 
In the current study both oocyte extrusion and attachment of follicles to the culture surface 
were frequently observed.  One way in which to avoid the loss of normal follicular morphology 
during preantral follicle culture is to use hydro or alginate gels as a matrix to support the 
follicles.  Gels have successfully been utilised to support the maintenance of the morphology of 
isolated preantral follicle in vitro in the mouse (Kreeger et al., 2005, Kreeger et al., 2006, Jin et 
al., 2010) and in larger mammalian species including; dog (Songsasen et al., 2011); pig (Hirao et 
al., 1994); cow (Harada et al., 1997, Itoh et al., 2002); buffalo, (Sharma et al., 2009); non-
human primate (Xu et al., 2009, Xu et al., 2011a, Xu et al., 2011b, Hornick et al., 2012); and 
human (Amorim et al., 2009).  The exact effect of the use of gels, however, has not been 
entirely elucidated, and therefore may be detrimental to oocyte health and developmental 
competence.  Indeed although embedding murine secondary follicles in a gel resulted in the 
maintenance of normal follicular morphology, with respect to a centrally located oocyte and 
GC-oocyte interactions the composition of the gel was shown to affect the incidence of antral 
cavity formation which was delayed when gels were composed of laminin and fibronectin, 
compared to alginate (Kreeger et al., 2006).  Additionally in this study components of the 
laminin and fibronectin gel were shown to block oestrogen and inhibin secretion.   Detrimental 
effects of using alginate gels to culture murine secondary follicles have also been observed as 
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the in vitro-derived MII oocytes exhibited increased rates of spindle formation and 
chromosomal alignment defects as well as compromised developmental competence 
compared to controls (Mainigi et al., 2011).  At the end of culture removal of follicles from the 
gel can also be problematic and result in the loss of healthy follicles (Desai et al., 2010).  An 
alternative to the use of gels is the use of a rotation system to prevent follicular attachment, 
however, the stress placed on the follicles in this system can result in mechanical damage 
resulting in the loss of GC-oocyte contacts (Rowghani et al., 2004). 
 
In the current investigation the culture system utilised was able to support the growth and 
development of both in vivo- and in vitro-derived ovine secondary follicles up to the EA stage 
at a physiologically relevant rate.  Barboni et al. (2011) have recently reported a system 
capable of supporting the in vitro growth of ovine preantral follicles from 170μm to 340μm 
and the development of 70% to the EA stage within a physiologically relevant timeframe of 14 
days in vitro.  The mean diameter of oocytes derived using this system was found to be 
comparable to that of those derived in vivo (~120μm).  Although the rate of antral cavity was 
higher than reported in the current study with respect to secondary follicles derived both in 
vivo and in vitro serum was included in the culture media and therefore may have been 
detrimental to the health of the oocytes.  Physiologically relevant rates of preantral follicle 
development have also been reported following mouse (Jin et al., 2010); cow (Gutierrez et al., 
2000); non-human primate (Xu et al., 2009, Xu et al., 2011a); and human (Abir et al., 1997) 
preantral follicle culture.  The continuous growth of non-human primate preantral follicles 
from ~250μm to ~1mm and normal steroidogenic function were supported in vitro for 30 days 
(Xu et al., 2009).  Some of the examples given above will be compared to accelerated culture 
systems below. 
 
Acceleration of preantral follicle growth in vitro has been achieved via the inclusion of high 
concentrations of FSH in the follicle culture media.  This was demonstrated using baboon 
preantral follicles (~285μm), which were cultured within an alginate gel in the presence of 
10miUml-1 FSH and subsequently required only 10 days to reach the same diameter as follicles 
cultured in the absence of FSH for 14 days (Xu et al., 2011b).  The addition of FSH was, 
however, shown to be detrimental to oocyte health as upon removal from the COCs oocytes 
derived in the presence of FSH were smaller than those derived in the absence FSH.  
Additionally oocytes in the latter group had at least 1 layer of cumulus cells, unlike those in the 
former group, which were denuded.  Whereas 13 of the 16 COCs derived in the absence of FSH 
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were competent to undergo GVBD, 2 of which formed MII oocytes displaying normal spindle 
and chromosome alignment, none of the COCs derived in the presence of FSH were competent 
to resume meiosis.  Addition of high levels of FSH (≥20ngml-1) to the culture media of mouse 
COCs resulted in significantly higher levels of aneuploidy in IVM MII oocytes, compared to 
oocytes matured in the presence of lower concentrations of FSH (Roberts et al., 2005).  
Although FSH was added to the preantral culture media in the current study this was at a 
concentration 1000 fold lower than that used by Xu et al. (2011b), this more physiologically 
relevant concentration of FSH resulted in more physiologically relevant rates of growth and 
may also result in oocytes displaying higher rates of meiotic competence.  Furthermore, in the 
study conducted by (Xu et al., 2011b) follicles were encapsulated within an alginate gel and 
therefore there may be components of the gel interacting with the high concentrations of FSH 
that resulted in the detrimental effects on oocyte health.  In a study by the same group 
macaque preantral follicles (125-225μm) were cultured within an alginate gel and the effect of 
FSH concentration on follicle growth and survival demonstrated (Xu et al., 2011a).  Although 
survival rates of follicles were highest when high concentrations of FSH, in the presence of 
fetuin, were used, growth rates were highest in the presence of low FSH, without fetuin.  As 
the concentration of FSH is not presented in international units in this study it is unclear how 
the concentrations compare to those used in the aforementioned study (Xu et al., 2011a, Xu et 
al., 2011b).  The level of steroid hormone production by follicles increased with increased FSH 
concentration in the culture media.  Of the in vitro-derived oocytes 12.5% were competent to 
develop to the MII stage following IVM, whereas no follicles cultured in the presence of high 
FSH concentrations were competent to do so, unless fetuin was also included in the media, in 
which case 4% of oocytes developed to the MII stage.  Therefore the use of high FSH 
concentrations to accelerate follicle growth and development may be detrimental to oocyte 
developmental competence. 
 
The rate of antral cavity formation can also be accelerated via the inclusion of FSH or growth 
factors in the culture media.  The addition of FSH, EGF1 or IGF1 to the culture media of 
mechanically isolated bovine preantral follicles (~165μm) increased the probability of antral 
cavity formation from 20% to 50% during 28 days culture (Gutierrez et al., 2000).  In the 
presence of FSH 68% of follicles formed full antral cavities and only 16% degenerated following 
28 days culture.  Antral cavity formation is observed when preantral follicles reach 120-160μm 
in vivo and the whole process from start to full antral cavity formation takes 42 days (Lussier et 
al., 1987).  Therefore the high rates of antral cavity formation observed in the aforementioned 
study, conducted by Gutierrez et al. (2000), could be due to the fact that at the start of culture 
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the preantral follicles had reached the maximal diameter prior to antral cavity formation.  In a 
subsequent study in which bovine preantral follicles were cultured within a collagen gel highly 
accelerated rates of development were reported upon the addition of FSH, LH and insulin to 
the culture media with antral cavity formation observed following 3 days (7%) and 5 days 
(30%) of culture (Itoh and Hoshi, 2000).  Accelerated rates of antral cavity formation have also 
been reported following the in vitro growth of mechanically isolated porcine preantral follicles, 
which increased in size from 300μm to 500μm, as 90% exhibited antral cavity formation 
following only 3 days culture, in the presence of serum, FSH and LH (Wu et al., 2007).  
Additionally >50% of oocytes derived from the COCs were competent to develop to the MII 
stage of which 5-10% developed into blastocysts following IVF.  Comparable rates of meiotic 
maturation have been observed in porcine preantral follicles grown in collagen gels in vitro 
within a more physiologically relevant timescale of 16 days, with 60% of oocytes that reached 
110μm maturing to the MII stage following IVM (Hirao et al., 1994).  The number of oocytes 
which reached 110μm following 16 days culture was, however, very low, only 15/486 follicles 
cultured, although 19% of follicles formed antral cavities.  As discussed in detail in the Section 
3.1.2 the inclusion of activin A in the culture media has also been shown to promote follicle 
survival and accelerate the rate of preantral follicle development to the EA stage in the cow 
(McLaughlin et al., 2010); goat (da Silva et al., 2013); and human (Telfer et al., 2008). 
  
Survival and antral cavity formation rates in this study are lower than those that have been 
previously reported for in vitro-derived bovine and human preantral follicles (Telfer et al., 
2008, McLaughlin et al., 2010).  Telfer et al. (2008) hypothesised that the high rates of follicle 
survival compared to other studies could be due to the homogeneity of the follicular 
population at the end of cortical culture, with respect to the health of the follicles.  When 
isolating follicles from fresh tissue some follicles may have started to degenerate but are not 
yet displaying morphological signs of this and therefore are selected for culture.  Follicles that 
have activated within the last 6 days are less likely to have started to degenerate.  Similarly 
follicles that have activated during long-term culture may be more likely to have started to 
degenerate. 
 
The results of this experimental series show that the rate of growth and antral cavity 
formation of in vitro-derived secondary follicles is comparable to that of in vivo-derived 
counterparts. These results suggest that in order to increase survival, growth and antral cavity 
formation rates culture conditions, rather than the derivation of the follicles need to be 
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altered.  However, as mentioned earlier, a higher proportion of follicles derived from fresh 
tissue or following long-term culture may be degenerating, compared to short-term culture.  
Therefore if cortical culture conditions can be altered to support follicle development to the 
secondary stage within an accelerated timeframe of 6 days this hypothesis can be tested.  This 
will be the aim of Chapter 4. 
 
A physiologically relevant culture system is a useful tool for the study of follicle population 
dynamics and has the potential to advance the therapeutic application of follicle culture as a 
means to both treat female infertility and to conserve the fertility of young cancer patients.  
Indeed, Chambers (2002) utilised her system to investigate the effects of ovine ovarian tissue 
cryopreservation on subsequent follicle survival and development.  In addition this system has 
been utilised to investigate the effects of the cytotoxic chemotherapeutic chemical, cisplatin 
on ovine follicle population dynamics (Gunson, 2009).  As the culture system used does not 
support the mass activation of primordial follicles it was possible to evaluate the effect of 
cisplatin on the follicular and stromal health revealing detrimental effects on both as exposure 
to high levels of cisplatin resulted in increased levels of both follicle degeneration and lactate 
dehydrogenase (LDH) production.  The development of this system also enabled the 
investigation of the use of viability dye, NR.  One of the major obstacles of developing a 
cortical culture system is the fact that follicles are not evenly distributed throughout the ovary.  
Although the population of primordial follicles is most dense in the ovarian cortex the 
distribution is still highly uneven therefore without any way of visualising the follicles this can 
often lead to the culture of ‘empty’ tissue containing very low numbers of follicles, or no 
follicles.  
 
Oocyte and follicle development are long and protracted processes in vivo.  Whether it is 
necessary for in vitro systems to follow a physiologically relevant timescale or if a much more 
accelerated system would be suitable is a point of discussion amongst research groups working 
in this field.  As mentioned previously the growth and development of both bovine and human 
primordial follicles, from the primordial to the transitional stage has been achieved after a 
culture period of 6 days (Telfer et al., 2008, McLaughlin and Telfer, 2010).  In these studies 
researchers claim that physiologically relevant, ‘extended’ culture periods are not necessary, 
and that they may in fact be detrimental to oocyte health due to increased exposure to 
suboptimal conditions in vitro.  Telfer et al. (2008) suggest that the use of a short-term culture 
period is preferable to extended culture periods as this may result in lower proportion of 
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atretic follicles at the end of culture.  Additionally in an extended culture system the resultant 
preantral follicles may have activated at different times, the use of an accelerated culture 
system would reduce the difference in the length of time for which follicles had been 
developing thus resulting in a more homogenous follicle population. 
 
Concerns have been raised regarding the health of oocytes derived from systems in which 
follicle growth is so greatly accelerated relative to the normal developmental time frames in 
vivo (Picton et al., 1998).  Some researchers argue that the use of physiologically-relevant 
culture periods is key to producing healthy in vitro-derived oocytes, as this would allow 
sufficient time for the oocytes to develop the molecular machinery required for normal 
development (Picton et al., 1998).  Research into the nuclear maturational competence of 
nuclei obtained from non-growing oocytes has shown that following transfer to a fully-grown 
GV oocyte the nuclei are competent to complete meiotic maturation, be fertilised, develop up 
to the blastocyst stage and implant (Kono et al., 1996).  Following implantation however, 
embryos were not competent to develop to term.  Subsequent studies have revealed that this 
is due to the absence of epigenetic modifications, which are established prior to the oocyte’s 
acquisition of competence to resume meiosis I, and are essential for the establishment of the 
maternal imprint and for subsequent normal embryonic development (Obata et al., 1998, Bao 
et al., 2000, Obata and Kono, 2002).  These epigenetic modifications are established gradually 
throughout specific stages of oogenesis and they are thought to differ in juvenile and adult 
mice (Bao et al., 2000).  Therefore there are concerns that the use of an accelerated culture 
system may result in oocytes with aberrant imprinting as there will be insufficient time for the 
correct establishment of epigenetic modifications and this may result in resultant embryos 
being incompetent to complete normal development. 
 
Smitz et al. (2010) have recently introduced the hypothesis that the process of oocyte 
development in vivo is not as protracted as originally thought, and that development may not 
be a continuous process, rather a start-stop process.  These authors suggest that pauses in 
follicle development in vivo may be caused by presence of inhibitory factors, such as those 
expressed by follicles either at the primordial (Da Silva-Buttkus et al., 2009), secondary 
(Mizunuma et al., 1999) or Graafian stage.  Spatial analysis of follicle activation dynamics in 
mice has led to the conclusion that primordial follicles produce a diffusible factor or factors 
that inhibit the activation of neighbouring primordial follicles (Da Silva-Buttkus et al., 2009).  
This was evidenced by the fact that follicles with neighbouring primordial follicles were less 
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likely to activate compared to those without.  Although the identity of these factors is yet to be 
elucidated the authors have proposed the following possible candidates: TGF-β1 and TGF-β2; 
or BMP binding proteins/ antagonists of stimulatory factors such as: follistatin, noggin, gremlin 
and myostatin.  Subsequent research has ruled out follistatin and noggin as candidates, but 
highlighted the possible roles of chordin and Sclerostin domain containing 1 (Sostdc1) as 
paracrine factors capable of inhibiting follicle activation  (Fenwick et al., 2011).   
 
 It is well established that factors produced by growing follicles inhibit the growth of 
neighbouring follicles.  The GC-derived factor, AMH, is produced by the granulosa cells of 
growing follicles and has been shown to be an inhibitor of the activation of surrounding 
primordial follicles (Durlinger et al., 1999). Co-culture of small preantral follicles with 
secondary follicles revealed that activin A, produced by secondary follicles caused small 
preantral follicles to become dormant, a state that could be reversed by the removal of either 
the secondary follicles and/or activin A, or the addition of activin binding protein, follistatin 
(Mizunuma et al., 1999).  Therefore follicles that have become dormant can continue their 
development upon removal of inhibitory factors.  Inhibin and oestrogen are also examples of 
systemic inhibitory factors produced by growing follicles as these factors inhibit FSH release by 
the pituitary gland (Wildt et al., 1981, Rivier and Vale, 1989, Molter-Gerard et al., 1999).  The 
increased levels of inhibitory factors present in the ovary in vivo compared to in vitro may 
explain why the process of follicle development is a more prolonged process in vivo.  The 
removal of these inhibitory influences in vitro may result in large-scale primordial follicle 
activation followed by continuous growth and development rather than the start-stop process 
proposed to occur in vitro (Smitz et al., 2010).  The pauses in follicle development may, 
however, be vital to ensure the health of resultant oocytes.   Evidence that this may not be the 
case was presented in a study in which the rate of murine follicle development was 
accelerated in vivo, via the suppression of PTEN and subsequent promotion of the PI3K 
pathway resulted in an increased litter size (Reddy et al., 2008).  As discussed in Chapter 1, 
PTEN is a negative regulator of primordial follicle activation via its antagonism of the PI3K-Akt 
inhibition of FOXO3 action (Castrillon et al., 2003). This supports the theory that accelerating 
the process of follicle development does not affect the competence of resultant oocytes with 
respect to their ability to be fertilised and subsequently develop into live offspring (Fan et al., 
2008).  
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Comparisons of murine oocyte culture lengths have shown that increased culture length; 21 
days compared to 11 days, resulted in increased birth weights of the resultant pups, which 
authors suggest could be due to epimutations (Obata et al., 2007).  It is important to note that 
in this study the follicles cultured for 21 days were at the primordial stage at the start of 
culture, whereas the follicles cultured for 11 days were at the secondary stage at the start of 
culture.  Therefore although the authors attribute both the increased birth weights as well as 
the decreased maturation and fertilisation rates of the IVG oocytes to the use of an extended 
length of culture, the combined period of growth in vitro and in vivo in both groups is the same 
therefore it is likely that the increased length of exposure of oocytes to suboptimal culture 
conditions rather than the overall time period of follicle growth was the cause of these 
problems.  Minimal research has been conducted directly comparing the effects of altering the 
duration of culture on the developmental IVG oocytes, in large mammals and humans.  
Therefore in this experimental series the length of in situ cortical culture period was varied and 
the effect of the duration of culture on the yield, health and subsequent developmental 
competence of the resultant oocytes compared. 
 
3.4.4 Future work 
In order to further investigate the health and developmental competence of the in vitro-
derived follicles it would be interesting to measure and compare the amount of oestrogen and 
progesterone produced by antral follicles grown to the amount produced by those derived in 
vivo, in order to determine whether the induction of normal steroidogenic activity is supported 
following incubation with testosterone, as has been shown previously by Newton et al. 
(1999b).  In addition, the expression patterns of key genes required for the growth and 
development of oocytes should be compared between in vivo-derived EA follicles and EA 
follicles derived from secondary follicles in vitro.  Further work should be conducted to 
facilitate analysis of the gene expression patterns of EA follicles derived from the primordial 
stage in vitro.  Although it was possible to isolate secondary follicles from cortical tissue 
following 16-23 days culture it may be interesting to examine the effects of briefly incubating 
the tissue with low levels of collagenase to soften the tissue more as this may reduce the level 
of damage caused by follicle isolation.  It is, however, possible that this method may be more 
detrimental to follicle health than using solely mechanical means of isolation.  Alternatively, 
different types of enzyme, such as Liberase, may be less aggressive and detrimental to oocyte 
health (see Section 1.7.2), and can be used either alone or in combination with collagenase, to 
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aid the isolation of in vivo- and in vitro-derived secondary follicles and determine the effect on 
their subsequent survival and growth rates (Dolmans et al., 2006, Kristensen et al., 2011).   
 
In some of the aforementioned studies follicle count data is only presented in terms of 
proportions (Telfer et al., 2008, McLaughlin and Telfer, 2010), however, this can be misleading 
and can largely exaggerate small changes in follicle population dynamics, particularly when 
total follicle counts are low.  Therefore in the current study follicle counts were presented 
using two different methods; the data presented as either mean follicle number per mg tissue 
± SEM or as a percentage.  This is an accurate and informative way of displaying follicle counts 
as the values obtained using each method can be compared.  The method of cortical tissue 
preparation used can result in the culture of tissue pieces of varying sizes and thicknesses and 
therefore follicle number can be highly variable this is why it was necessary to standardise 
follicle counts per mg tissue culture, rather than presenting absolute follicle numbers, which 
varied widely between cultures. 
 
3.5 Conclusions 
This experimental series has shown for the first time that it is possible to grow ovine oocytes 
from the primordial/ EP stage up to the EA stage using two-steps of a serum-free culture 
system, within a physiologically relevant timeframe.  In order for in vitro-derived follicles to 
develop to the EA stage they had to be at the secondary stage at the start of preantral culture.  
In this physiological system a cortical culture period of 6 days was not sufficient to support the 
development of follicles from the primordial to the secondary stage.  However, if the cortical 
culture period was extended to 16-23 days it was possible to isolate secondary follicles from 
the tissue.  Although the percentage of degenerating follicles was greater following long-term 
than short-term cortical culture, the follicles that survived and developed to the secondary 
stage were competent to continue to develop to the EA stage.  However, it may be possible to 
increase the survival and antral cavity formation rates by deriving follicles from short-term 
culture as the population of follicles would potentially be more homogenous, with respect to 
health, at the end of culture.  Previous research suggests that alterations to the culture media 
composition and method of tissue preparation may facilitate accelerated follicle development.  
Further optimisation of the cortical culture method used for ovine tissue is therefore necessary 
and subsequent experiments should test the efficacy of published short-term, 6 day, 
accelerated growth systems that have been shown to support the development of early 
preantral follicles to the secondary stage in bovine and human.  Finally, the ability of in vitro-
133 
 
 
 
derived secondary follicles to develop to the EA stage cannot be used as the sole marker of 
follicular health.  Detailed molecular analysis of gene expression of in vivo- and in vitro-derived 
follicles is essential in future studies to confirm the developmental normality of in vitro derived 
follicles. 
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4 Comparison Of The Effects Of A Physiological, Slow-Growth System And An 
Accelerated, Rapid-Growth System On The Rates Of Primordial Follicle Activation 
And Preantral Follicle Growth And Development In Situ In Ovine Cortical Tissue. 
 
4.1  Introduction 
In Chapter 3 the first 2 steps of a serum-free, long-term, multistep culture system that 
supported the development of ovine primordial follicles to the EA stage were evaluated.  This 
system consisted of a minimum of 30 days culture in which 16 days of cortical culture and 14 
days of isolated preantral culture were required to grow follicles to the EA stage.  
Development of primordial follicles to the EA stage has been achieved in much shorter time 
periods in the bovine and human, 18 and 10 days, respectively, using a rapid growth system as 
reported by Telfer et al. (2008) and McLaughlin and Telfer (2010).  In these studies it was 
possible to develop primordial follicles to the transitional stage in 6 days.  The culture system 
presented in Chapter 3 was not able to support development at this accelerated rate. 
 
Whether an accelerated or a more physiologically relevant developmental timescale in vitro is 
optimal is a source of debate, as discussed in Chapter 3.  It can be argued that an accelerated 
culture period would result in a more homogenous population of healthy, developing follicles 
at the end of cortical culture (Telfer et al., 2008).  Only a small percentage of in vitro-derived 
secondary follicles reported in Chapter 3 were competent to develop onto the EA stage 
following isolation, possibly due to the fact that these follicles had started to degenerate. 
Further research is therefore required to test the functional significance of speed of follicle and 
oocyte development in vitro on developmental competence. To define the culture conditions 
needed to produce healthy follicles and oocytes from ovine cortex in vitro and to test the 
impact on the culture environment on follicle and oocyte growth it is necessary to compare 
the developmental competence of multi-layered follicles derived using the long-term-cortical 
culture system reported in Chapter 3 with a rapid short-term- growth system that has 
supported follicle growth and activation in the cow and human within an accelerated 
timeframe. The rapid growth system which will be adapted to support sheep follicle growth in 
cortex tissue in vitro is that based upon that previously published by Telfer et al. (2008) and 
McLaughlin and Telfer (2010).  To aid clarity from here on in this rapid growth system will be 
referred to as the ‘Accelerated Follicle Culture (AFC) system’; the slow cortical culture system 
detailed in Chapter 3 will be referred to as the ‘Leeds system’. 
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4.1.1 Comparison of AFC vs. Leeds cortical culture system 
Just as has been reported for the Leeds system, in Chapter 3, the AFC system is a 2 step 
method that supports the in vitro growth of oocytes from the primordial to the early antral 
follicle stage in both bovine and human (Telfer et al., 2008, McLaughlin and Telfer, 2010).  In 
the first step of the AFC system oocytes are cultured in situ within pieces of ovarian cortical 
tissue that had been mechanically teased apart and trimmed prior to culture in such a way as 
to reduce the amount of medullary tissue present, for 6 days.  Follicles were reported to 
activate and develop from the primordial/ early primary (EP) to the transitional stage in situ.  
In the second step, in vitro-derived transitional follicles are isolated and cultured individually, 
some of which were competent to develop to the EA stage.  Histological analysis of the tissue 
has revealed low levels of follicle degeneration/ atresia on day 6 of cortical slice culture as 
assessed by morphological analysis in both human tissue (14%) and bovine tissue (<10%).  
Furthermore, primordial follicle activation in bovine tissue was demonstrated by a significant 
increase in the proportion of growing follicles relative to control day 0 tissue and a concurrent 
significant decrease in the proportion of quiescent follicles with respect to viable follicles, as 
well as an increase in mean follicle diameter (McLaughlin and Telfer, 2010).  Similarly, in 
human tissue the percentage of quiescent follicles decreased from 90% (day 0) to 60% (day 6), 
with a subsequent increase in primary (day 0;  10%, day 6; 25%) and transitional/ secondary 
follicles (day 0; 0%, day 6; 15%), with respect to viable follicle counts (Telfer et al., 2008).  As 
described in Chapter 3 the Leeds culture system is based on a serum-free system in which 
ovine primordial follicles are cultured in situ in slices of cortical tissue for up to 30 days as 
developed initially by Chambers (2002) and subsequently repeated to evaluate the efficacy of 
NR dye as a marker of follicle viability (Chambers et al., 2010).  
 
There are a number of fundamental differences between the AFC and Leeds culture systems.  
The Leeds culture system is designed to support the physiological activation of some, but not 
all, primordial follicles and the growth of EP, primary and transitional follicles at a similar 
growth rate to that observed in vivo in the absence of large preantral follicles (Juengel et al., 
2002b).  In contrast the AFC system is designed to support the activation and development of 
the greater majority of primordial follicles up to the EA stage in an accelerated timeframe.  
Both the AFC and Leeds systems utilise a serum-free strategy in which primordial/ EP follicles 
are cultured within slices of cortical tissue although the basal culture media and additives used 
are different between the 2 approaches.  The major differences being that the AFC media does 
not contain FSH, LH or a source of pyruvate, but it does contain 50µgml-1 of ascorbic acid, 
unlike the Leeds system.  In addition the basal media used in the two systems are different; α-
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MEM and McCoy’s 5a medium with bicarbonate buffering are used in the Leeds and AFC 
systems, respectively, the compositions of these 2 base media are detailed in Appendix I.  
Furthermore, in the Leeds culture system the cortex tissue fragments are placed upon an 
insert in order to minimise the oxygen diffusion distance between the tissue and the surface of 
the media, whilst ensuring the tissue pieces are submerged in a great enough volume of media 
to provide sufficient growth factors and hormones (Devine et al., 2002, Chambers, 2002).  A 
supportive membrane is not used in the AFC system and for this reason a lower volume of 
media is used and only 1 tissue piece is cultured per well, whereas 5 tissue pieces are cultured 
per well in the Leeds system.  The tissue pieces used in the AFC system are also smaller than 
those cultured in the Leeds system, see below. 
 
In addition, the tissue preparation protocol differs slightly between the 2 culture strategies.  In 
both systems a thin layer of cortex is removed from the ovary.  In the Leeds system the cortex 
is then cut into a small square see Figure 4.1 (a).  Whereas in the AFC system the tissue is cut 
into a pyramid shape to remove excess stromal/ medullary tissue.  Preparing the tissue as in 
Figure 4.1 (b and c) increases the ratio of cortex: medullary tissue cultured, and therefore is 
proposed to increase the primordial follicle density of the tissue cultured as these follicle 
stages are located at the greatest density in the cortex, whereas more developed follicles are 
located in the medullary region of the ovary.  Furthermore, as discussed in Chapter 3 the shape 
and volume of the cortical tissue fragments has been linked to the level of follicle activation 
observed in vitro (Hovatta et al., 1997, Scott et al., 2004a, Telfer et al., 2008).  Reducing the 
amount of medullary and stromal tissue may increase the rate of follicle activation as these 
tissues may contain higher concentrations of growth factors that inhibit follicle growth, 
potentially released by growing follicles (Wandji et al., 1996b). 
 
4.1.2 Aims 
The aim of this study was therefore to determine whether the use of the physiological, slow-
growth system reported in Chapter 3 (Leeds system) is optimal for the sustained development 
of ovine follicles in situ compared to an accelerated growth system (AFC system).  Cortical 
culture systems were compared with respect to primordial follicle activation and preantral 
follicle growth, development and survival in situ for a period of 6 days.  
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Figure 4.1 Preparation of cortical tissue pieces in the (a) Leeds and (b and c) AFC systems.  In 
the Leeds system (a) cortical slices of ~ 2mm thickness were trimmed into 5mm2 squares.  
Scale bar = 2mm.  In the AFC system cortical slices were prepared as shown in (b) resulting in a 
pyramid shaped tissue piece as shown in (c).    
 
4.2 Materials and Methods 
4.2.1 Cortical culture 
This experimental series was conducted to compare 2 serum-free IVG culture systems 
developed by research groups based at Leeds University (Chambers, 2002, Chambers et al., 
2010) and Edinburgh University (Telfer et al., 2008, McLaughlin and Telfer, 2010) to evaluate 
the impact of tissue preparation techniques and culture environments on parameters of 
follicle and oocyte health and growth in situ in ovarian cortex.  In order to compare these 
systems 4 different culture treatments were tested. The 4 treatment groups were: (1) Leeds, 
(2) AFC,     (3) Leeds modified and (4) AFC modified.  The composition of the Leeds and AFC 
culture media and the methodological differences between the 4 culture treatments are 
Cortex
Medulla
0.5 – 1.0 mm
0.5 – 1.0 mm
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5.0 mm
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summarised in Table 4.1 and Table 4.2, respectively.  The unmodified Leeds system was as 
previously reported by Chambers (2002) and Chambers et al. (2010) and the unmodified AFC 
system was as previously reported by Telfer et al. (2008) and McLaughlin and Telfer (2010).  
Slight modifications were made to both the Leeds and AFC systems to further test and 
optimise the culture conditions within each system.  This strategy evaluated the relative 
importance of the basal culture media composition, volume and additives and compared 2 
methods of cortex preparation on the developmental potential of ovine follicles.  All other 
culture conditions: temperature (37°C) and 5% CO2 in the air were kept constant. 
 
Table 4.1 Composition of Leeds and AFC culture media. 
Medium 
Composition 
Leeds AFC 
Final concentration 
Basal 
medium 
composition 
Basal medium α-MEM medium 
McCoy's 5a with 
bicarbonate 
Penicillin/ Streptomycin 1% (v/v) 1% (v/v) 
BSA fraction V, fatty acid free  1mgml-1  0.1mgml-1 
Hepes - 2% (v/v) 
Additives 
Bovine holo-transferrin 5µgml-1 5µgml-1 
Sodium selenite 4ngml-1 5ngml-1 
Sodium pyruvate 0.047mM - 
L-glutamine 3mM 3mM 
Bovine insulin 10ngml-1 10ngml-1 
Human long R3 IGF1 10ngml-1 - 
Ovine FSH 1 x 10-5iUml-1 - 
Ovine LH 2.3 x 10-5 iUml-1  - 
Ascorbic acid - 50µgml-1 
*Note that – indicates the absence of the additive. 
Cortical slice cultures were set up according to methodologies detailed in Sections 2.2 and 2.5-
2.7.  The tissue pieces in the Leeds and Leeds modified systems were prepared as described in 
Section 2.3, see Figure 4.1 (a).  Whereas the tissue slices in the AFC and AFC modified systems 
were prepared, as shown in Figure 4.1(b and c).  Briefly, cortical slices were prepared as 
described in Section 2.2, then cut using a scalpel (handle size 7 with a size 15 blade) as shown 
in Figure 4.1 (b), resulting in a pyramid shaped tissue piece as shown in Figure 4.1 (c).  The 
tissue was then gently teased apart using 26½G needles (Terumo Europe N.V., Belgium).   
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Culture plates were set up as described in Section 2.8 although there were modifications to the 
composition and volume of culture media used and inserts were not used in all culture systems 
(see Table 4.2).  The cortical tissue was cultured for 6 days, with media changes performed on 
days 2 and 5 of culture.  The dry weight of the tissue was recorded on day 0 and day 6 of 
culture as described in Section 2.6.  A total of 24 replicate cultures were conducted; 6 for each 
treatment group.  Within each replicate culture of treatment group (1), (2), (3) and (4) an 
average of 104+8, 20+4, 82+6 and 18+4 tissue pieces were cultured.  
 
Table 4.2  Summary of the differences in the 4 culture treatments used.   
Treatment 
group 
Culture 
treatment 
Culture 
media 
Volume 
media 
per well 
(μl) 
Insert 
used? 
Growing 
follicles 
excluded? 
Tissue 
shape  
Number 
of tissue 
pieces 
per well 
1 Leeds Leeds 500 Yes Yes Square  5 
2 AFC AFC 300 No No Pyramid  1 
3 Leeds 
modified 
Leeds 500 Yes No Square  5 
4 AFC 
modified 
Leeds 300 No No Pyramid  1 
 
4.2.2 Analysis of follicle population dynamics 
On days 0 and 6 of culture cortical pieces were stained with NR dye enabling viable follicle 
counts to be taken in fresh tissue as described in Section 2.6-2.7.  Following NR staining tissue 
pieces were examined and any pieces that appeared to contain growing follicles were excluded 
from the Leeds treatment group (1).  The developmental stage of the follicles was estimated in 
situ by size and morphology.  Samples of day 0 and day 6 tissue were fixed and analysed 
histologically with respect to follicle population dynamics and follicle and oocyte size, as 
described in Sections 2.7 and 2.12-2.14.   
 
4.2.3 Stromal tissue scoring 
The effect of culture treatments on stromal health was analysed in fresh/cultured tissue and 
using a histological stromal tissue scoring system.  As described earlier the tissue pieces were 
stained using NR dye before and after culture.  Uptake of NR dye is indicative of cell viability 
and therefore is not only useful for assessing follicle counts but also stromal tissue health.  
Prior to culture the tissue was processed at 4°C to ensure that the NR dye uptake was primarily 
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by the follicles rather than the surrounding stroma.  Whereas at the end of culture the tissue 
was at 37°C, and the follicles and stroma both took up the NR dye at a similar rate.  Therefore, 
the pattern of NR dye uptake was very different between day 0 and day 6 tissue and could not 
be directly compared.  However, day 6 tissue from the various culture treatments can be 
compared with respect to NR dye uptake and this can be used as an indicator of tissue health 
and viability.  The percentage of the tissue pieces that stained red was recorded for all tissue 
pieces at the end of culture, for 6 culture repeats. 
  
The integrity of the stromal tissue was assessed as described in Section 2.11.  The stromal 
scores used were: good, adequate and poor which were converted into numerical scores, 3, 2 
and 1, respectively.  These stromal scores reflected the tissue and follicle integrity.  
Representative images of ‘good, adequate and poor’ quality tissue are shown in Figure 4.2.   
 
4.2.4 Statistical analysis 
Statistics were performed using the Minitab 16.1 statistical programme.  The Anderson-Darling 
test was used to determine whether the data was normally distributed.  Follicle population 
dynamics are presented as means of follicle counts per mg tissue ± SEM per culture repeat and 
mean percentage follicles ± SEM per culture repeat.  Follicle population dynamics were 
analysed within each culture system, i.e. on days 0 and 6 of culture, if the data was normally 
distributed using either paired t-test for the analysis of data from fresh tissue data, the 
Student’s t-test for fixed tissue, or Wilcoxon signed ranks test for data that was not normally 
distributed.  Follicle population dynamics were also compared between the 4 culture 
treatments using one-way ANOVA with post hoc Fisher’s test.  If the data was not normally 
distributed Kruskal-Wallis test was used.  Follicle population data which are presented as 
proportions of total follicle counts were analysed using Chi Squared statistical analysis.  In all 
analyses p<0.05 was considered to be statistically significant. Where required data was 
normalised using the following transformations, for example data on the number of 
degenerating follicles per mg of tissue was transformed by base 10 logarithmic transformation.  
Unless otherwise stated all graphs are presented are the arithmetic means ± SEMs for the 
number of replicates shown. 
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Figure 4.2 Representative histological images of poor (a), adequate (b) and good (c) quality 
stromal tissue.  All follicles are at the primordial or EP stage of development.  During 
histological analysis only follicles with a visible nucleolus were counted – the oocyte of these 
follicles is labelled ‘O’.  Scale bar = 20μm..  
 
4.3  Results 
4.3.1 Follicle population dynamics – primordial vs. non-growing 
Four cortical tissue culture treatments were compared over 6 days.  The mean number of 
viable primordial and growing follicles, per mg of tissue cultured, present on days 0 and 6 of 
culture, in fresh and fixed tissue samples are shown in Figure 4.4 and Figure 4.5, respectively.  
As in Chapter 3, follicle counts were standardised per mg tissue due to the differences in 
follicle load resulting from variability in tissue size at the start of culture, particularly in the 
current study due to differences in tissue preparation methods in the different systems.  Tissue 
weights before and after culture are shown in Figure 4.3.  There were no statistically significant 
changes (p>0.05) in tissue weight per well following culture in any treatment group, however, 
tissue weight increased slightly in the Leeds and Leeds modified treatment groups and 
decreased slightly in the AFC and AFC modified treatment groups following culture.  Mean 
tissue weight per well was significantly lower in the AFC and AFC modified treatment groups 
than Leeds and Leeds modified groups before and after culture as would be expected as there 
were more pieces per well in the latter 2 treatments groups (5 versus 1).  Fresh tissue refers to 
tissue that has been stained using NR dye either before or after culture.  Note that tissue that 
did not stain with NR dye prior to culture was discarded as only tissue containing follicles was 
cultured.  Fixed tissue refers to tissue that has been analysed histologically. 
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Figure 4.3 Mean tissue weight per well ± SEM for 6 repeat cultures on day 0 and 6 of cortical 
tissue culture using AFC, AFC modified, Leeds and Leeds modified treatments.  Analyses of 
tissue weights within treatments using paired t-test revealed no statistically significant 
differences (p>0.05).  Analysis of tissue weight between treatments using ANOVA revealed 
significantly lower weights in the AFC and AFC modified than the Leeds and Leeds modified 
treatment groups irrespective of day of culture (p<0.05). Different letters indicate significant 
differences at p<0.05.  
 
Follicles were classified as primordial or growing based on size and appearance following NR 
dye staining in situ, see Figure 4.4.  This is a rather crude method of establishing follicle 
classification and was therefore primarily used to determine which tissue pieces contained 
growing follicles in order to exclude them from the Leeds treatment group.  Follicle population 
dynamics were analysed more accurately in fixed tissue (see Figure 4.5).  The results presented 
in Figure 4.4 (a) show that in all 4 culture treatments the mean number of primordial follicles 
per mg of tissue had significantly decreased (p<0.05) after 6 days of culture.  This could be due 
to follicles activating or degenerating.  The results in Figure 4.4 (b) show that after 6 days of 
culture there were significantly fewer growing follicles in both the AFC and the AFC modified 
culture treatments (p<0.05).  Therefore, it is unlikely that the decrease in the number of 
primordial follicles was due to follicle activation alone but rather the numbers of both 
primordial and growing follicles also decreased as a result of follicular atresia.  The number of 
growing follicles did not change significantly in the Leeds modified culture treatment.  After 6 
days of culture the mean number of growing follicles present was 0.17 per mg tissue cultured ± 
0.09 for 6 culture repeats.  This evidence supports the idea that primordial follicles may be 
activating in the Leeds culture treatment.  
 
144 
 
 
 
 
Figure 4.4 Comparison of the effect of different short-term culture treatments on follicle 
population dynamics in fresh tissue stained with NR dye on days 0 and 6 of culture.  The mean 
number of viable (a) primordial and (b) growing follicles present on days 0 and 6 of culture 
using AFC, AFC modified, Leeds and Leeds modified culture treatments ± SEM per mg tissue at 
the start of culture, for 6 repeat cultures are shown.  Statistical differences in the mean 
number of viable follicles on days 0 and 6 of culture within treatment groups are denoted as * 
p<0.05, ** p<0.01. 
  
 
1
4
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Figure 4.5 Histological comparison of short-term culture treatments on follicle population dynamics in tissue fixed on days 0 and 6 of culture.  The mean number 
of viable primordial and growing follicles present on days 0 and 6 of culture using AFC, AFC modified, Leeds and Leeds modified culture treatments is shown.  
Values presented as mean ± SEM per mg of tissue at the start of culture for 4 repeat cultures.  Statistical differences in the mean number of viable follicles on days 
0 and 6 of culture within treatment groups are denoted using *p<0.05.   
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The tissue was also analysed histologically; the data presented in Figure 4.5 shows that the 
mean number of primordial and growing follicles did not change significantly in any culture 
treatment except for treatment (1)-the Leeds treatment, where tissue contained only 
primordial follicles as classified by NR staining on day 0, but which contained a significantly 
increased mean number of growing follicles after 6 days of culture.  Although the Leeds 
method aimed to exclude any growing follicles on day 0 this was not always achieved as EP and 
primary follicles were detected histologically, however, no more advanced follicles were 
detected and the mean number of growing follicles was lower than any of the other treatment 
groups on the first day of culture.  In all culture treatments the histological data mirrored the 
fresh tissue results as the mean number of primordial follicles decreased after 6 days of 
culture, although not significantly.  In all treatments groups other than Leeds treatment the 
mean number of growing follicles decreased after 6 days of culture, however due to variability 
in the data and the limited number of culture repeats, when expressed on a per culture basis 
these differences were not significant (p>0.05). In addition data regarding degenerating follicle 
counts per mg fixed tissue is presented in Figure 4.6.  Follicles were classified as degenerating 
if they either lacked a complete layer of GCs or if the oocytes had become detached from the 
GCs and appeared to be shrinking.  There was no significant change in the number of 
degenerating follicles on days 0 and 6 of culture in any of the culture treatments. 
 
Figure 4.6 Comparison of the mean number of degenerating follicles per mg of fixed tissue on 
days 0 and 6 of culture.  Values presented as log10(mean ± SEM) for 4 repeat cultures.  Follicle 
counts were not statistically different (p>0.05) on days 0 and 6 of culture in any of the culture 
treatments, as determined using Student’s t-test.  
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Follicle survival rates following the use of different culture treatments were analysed by 
considering the percentage of primordial or growing follicles that were still viable after culture.  
The data from fresh tissue is presented in Figure 4.7.  Statistical analysis of the data presented 
in Figure 4.7 (a) showed no significant difference in the mean percentage of primordial follicles 
which survived culture between the four different treatments.  In Figure 4.7 (b) only the data 
for the AFC and AFC modified culture systems is presented as only in these two groups did the 
mean percentage of follicles decrease after culture.  There was no statistical difference 
(p>0.05) in the percentage of viable growing follicles between these two culture groups.  In the 
Leeds modified culture treatment the mean percentage of viable growing follicles increased by 
156.4±117.8% (n=6 cultures).  The SEM indicates a large degree of variability in the data.  As 
previously stated tissue pieces containing more advanced growing follicles were not used in 
the Leeds treatment therefore it was not possible to calculate the percentage increase for this 
group. 
 
Figure 4.8 shows data regarding the percentage of viable (a) primordial and (b) growing 
follicles present in tissue fixed on day 6 relative to day 0.  The data concerning the percentage 
of primordial follicles (Figure 4.8 (a)) is shown for the AFC, Leeds and Leeds modified 
treatments.  In these systems the percentage of primordial follicles decreased on day 6 relative 
to day 0, however, there was no statistical difference (p>0.05) in the degree to which the 
percentage decreased.  Data regarding the AFC modified method is not shown in Figure 4.8 (a).  
This is because the mean percentage of primordial follicles was greater on day 6 of culture 
(20.3±73.9%, n=4 cultures).  This is probably due to the uneven distribution of follicles in the 
ovarian cortex and between ovaries.  The SEMs are very large which indicates substantial 
variety in the data and the need for a higher number of culture repeats.   
 
The data concerning the percentage increase in growing follicles (Figure 4.8 (b)) is shown for 
the AFC, AFC modified and Leeds treatments.  Note that the data is presented differently from 
the fresh tissue data in Figure 4.7 (a) as the mean percentage of growing follicles increased 
following culture in fixed tissue in the AFC, AFC modified and Leeds treatment groups, unlike in 
the fresh tissue where it decreased.  The percentage of growing follicles following culture was, 
however, calculated in the same way as the percentage of follicles surviving culture.  In these 
systems the percentage of growing follicles has increased on day 6 relative to day 0, however, 
there was no statistical difference in the degree to which the percentage increased.  Data 
regarding the Leeds modified method has been excluded from Figure 4.8 (b) because the mean 
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percentage of growing follicles was lower on day 6 of culture, a mean decrease of 32.2±20.6% 
for 4 culture repeats. 
 
 
Figure 4.7 Fresh tissue comparison of short-term culture systems with respect to follicle 
survival rates in tissue stained with NR dye on days 0 and 6 of culture.  The mean percentage 
of (a) primordial and (b) growing follicles present on day 6 relative to day 0 of culture using 
AFC, AFC modified, Leeds and Leeds modified culture treatments.  Values presented are mean 
± SEM for 6 cultures.    
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Figure 4.8 Histological comparison of short-term culture systems with respect to the mean 
percentage of viable follicles present on day 6 compared to day 0 of culture.  Figure (a) shows 
the mean percentage of viable primordial follicles present after 6 days of culture in the AFC, 
Leeds and Leeds modified culture treatments.  Figure (b) shows the log10 of the mean 
percentage increase in growing follicles present using AFC, AFC modified and Leeds treatment 
groups.  Values presented as the mean ± SEM for 4 cultures.   
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Figure 4.9 Percentage of (a) primordial and (b) growing follicles in fresh tissue – assessed by NR 
staining - on days 0 and 6 of culture in AFC, AFC modified, Leeds and Leeds modified treatment 
groups.  6 culture repeats were performed for each system and the total number of follicles 
recorded was used to calculate follicle proportions.  Statistical differences in the proportion of 
follicles on day 0 and 6 of culture, within each treatment group, as denoted using: *p<0.05. 
**p<0.01, ***p<0.001, were determined using Chi-squared analysis.  
 
In Figure 4.9 the percentage of viable primordial and growing follicles in fresh tissue on days 0 
and 6 of culture are shown.  Percentages were calculated from the total number of follicles 
across all 6 culture repeats for each treatment group.  Total viable follicle numbers in fresh 
tissue, on days 0 and 6 of culture, are shown in Table 4.3.  The percentage of primordial 
follicles significantly decreased after 6 days of culture following both the AFC and Leeds 
treatment.  Conversely, a significant increase in the percentage of growing follicles was seen 
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following culture using the AFC and Leeds treatments.  In both the AFC modified and Leeds 
modified systems the percentage of growing follicles relative to primordial follicles present in 
the tissue increased on day 6 relative to day 0, although this change was not statistically 
significant (p>0.05).  This method of presentation is the standard format used by numerous 
research groups to present follicle dynamics data (Hovatta et al., 1999, O'Brien et al., 2003, 
Telfer et al., 2008, Morgan et al., 2013).  Presentation of data in this way can be misleading as 
the percentages are calculated as the number of either primordial or growing follicles of the 
total follicle numbers on the day of culture.  There are far fewer follicles present in the tissue 
on day 6 of culture due to high levels of follicular atresia therefore although the total number 
of growing follicles on day 6 of culture has decreased, in all groups other than the Leeds 
treatment, the percentage relative to primordial follicles has increased.  Therefore if data is 
presented in this manner information regarding survival rates should also be shown to give a 
clearer indication of why the follicle population dynamics have changed, i.e. to determine 
whether it is due to follicle activation or atresia. 
 
Table 4.3 Total number of primordial, growing and total viable follicles in fresh tissue.  
Numbers refer to the summation of the total follicles numbers across 6 repeat cultures, in 
each culture treatment, on days 0 and 6 of culture. 
 Culture 
treatment 
AFC AFC modified Leeds Leeds modified 
Day 0 6 0 6 0 6 0 6 
Primordial 11774 3426 6570 3481 14519 2651 19895 12576 
Growing 31 19 190 114 0 1 272 193 
Total 11805 3445 6760 3595 14519 2652 20167 12769 
 
In Figure 4.10 the percentage of viable primordial and growing follicles in fixed tissue on days 0 
and 6 of culture are shown.  Percentages were calculated from the total number of follicles 
across 4 replicate cultures for each treatment.  Total viable follicle numbers in fixed tissue, on 
days 0 and 6 of culture, are shown in Table 4.4.  In the AFC modified and Leeds treatments 
there was no change in the percentage of primordial and growing follicles on days 0 and 6 of 
culture.  Whereas in the Leeds modified system the percentage of primordial follicles had 
decreased significantly (p<0.001) by day 6, relative to day 0.  This was matched to a 
subsequent significant increase (p<0.001) in the percentage of growing follicles.  However, 
following the AFC treatment there was a significant increase in the percentage of primordial 
follicles on day 0 relative to day 6 of culture and a subsequent significant decrease (p<0.001) in 
the percentage of growing follicles.   
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Figure 4.10 Percentage of (a) primordial and (b) growing follicles in fixed tissue on days 0 and 6 
of culture as assessed in AFC, AFC modified, Leeds and Leeds modified treatment groups.  Data 
from 4 replicate cultures were analysed for each treatment and the total number of follicles 
used to calculate follicle proportions.  Statistical differences in the proportion of follicles on 
day 0 and 6 of culture, within each treatment group, are denoted using: *p<0.05, **p<0.01, 
***p<0.001, with statistical significance being determined using Chi-squared analysis.  
 
The results shown in Figures 4.4-4.8 illustrate the advantages and disadvantages of analysing 
both fresh and fixed tissue and therefore the necessity of using both these methods.  The 
analysis of fresh tissue with respect to follicle counts may be less accurate than that of fixed 
tissue, due to the difficulty in determining exact numbers of primordial follicles, particularly 
after culture when the tissue is at 37 °C when both the stroma and follicles rapidly take up the 
NR dye making it more difficult to distinguish between the 2 tissue compartments.  However, 
repeated NR staining of fresh and cultured tissue allows the same tissue to be assessed on 
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both day 0 and day 6, which is not possible with the fixed tissue.  The use of different fixed 
tissue samples on days 0 and 6 of culture is probably the cause of the increase in primordial 
follicle numbers seen after culture in the AFC modified culture group.  Furthermore, the low 
number of culture repeats (n=4) analysed to generate the histological data will have 
contributed to data variability and hence the lack of statistical significance. 
 
Table 4.4 The total number of primordial, growing and total viable follicles in fixed tissue.   
Numbers refer to the summation of the total follicles from 4 culture repeats, in each culture 
system, on days 0 and 6 of culture. 
 Culture 
treatment AFC AFC modified Leeds Leeds modified 
Day 0 6 0 6 0 6 0 6 
Primordial 1355 660 1355 1360 1470 725 1470 510 
Growing 1970 640 1970 1970 510 250 2535 1740 
Total 3325 1300 3325 3330 1980 975 4005 2250 
 
The data on total follicle numbers in fresh and fixed tissue, presented in Tables 4.3 and 4.4, 
were used to determine the level of agreement between the follicle counts in fresh and fixed 
tissue, see Figure 4.11.  Regarding the total number of primordial and all classifications of 
follicles there was a weak positive correlation between the counts obtained from fresh and 
fixed tissue, which was not statistically significant (p>0.05).  Whereas with regard to the total 
number of growing follicles there was a stronger, statistically significant (p<0.05) correlation 
between counts obtained from fresh and fixed tissue.  This highlights the difficultly of using NR 
staining to accurately determine follicle loading and why it remains essential to also quantify 
follicle population dynamics in fixed tissue. 
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Figure 4.11 The relationship between the total number of (a) primordial, (b) growing and (c) all 
follicles in fresh and fixed tissue.  A weak positive correlation was observed (p<0.05) between 
follicle count in fixed and fresh tissue in (a) primordial and (c) all follicle data sets, analysed 
using Spearman’s rank order correlation.  A stronger statistically significant (p<0.05) positive 
correlation was observed between the number of growing follicles present in fresh and fixed 
tissue.  Data is presented for 8 repeats and the R2 value is shown for each line of best fit.  
R² = 0.1725
0
5000
10000
15000
20000
25000
0 500 1000 1500 2000
To
ta
l n
um
be
r 
of
 f
ol
lic
le
s 
in
 
fr
es
h 
ti
ss
ue
Total number of follicles in fixed tissue
R² = 0.664
0
50
100
150
200
250
300
0 500 1000 1500 2000 2500 3000
To
ta
l n
um
be
r 
of
 f
ol
lic
le
s 
in
 
fr
es
h 
ti
ss
ue
Total number of follicles in fixed tissue
R² = 0.2674
0
5000
10000
15000
20000
25000
0 1000 2000 3000 4000 5000To
ta
l n
um
be
ro
f f
ol
lic
le
s 
in
 fr
es
h 
ti
ss
ue
Total number of follicles in fixed tissue
(a) Primordial follicles
(b) Growing follicles
(c) All follicles
155 
 
 
 
 
Figure 4.12 Percentages of viable primordial and growing follicles, and degenerating follicles 
present in tissue fixed on days 0 and 6 of culture in AFC, AFC modified, Leeds and Leeds 
modified culture treatments.  4 culture repeats were analysed for each system and the total 
number of follicles used to calculate follicle percentages.  Statistical differences in the 
percentage of follicles between days 0 and 6 of culture within each treatment group, are 
denoted using *p<0.05, **p<0.01, ***p<0.001, determined using Chi-squared analysis.  
 
Figure 4.12 shows the percentage of follicles present in tissue fixed on days 0 and 6 of culture.  
In Figure 4.10 similar data was presented, however, only viable follicles were included in the 
analysis.  In Figure 4.12 counts of the number of degenerating follicle were used to calculate 
the relative percentages of viable primordial and growing follicles, and degenerating follicles in 
each culture system.  Presenting data in this manner allows for a much clearer representation 
of why follicle percentages have changed.  When the data presented in Figure 4.10 is 
considered the percentage of growing follicles in the AFC and Leeds modified treatment 
groups increased significantly (p<0.001) on day 6 relative to day 0.  One may conclude that this 
is due to the activation of primordial follicles in culture, supported by the fact that the 
percentage of primordial follicles significantly decreased (p<0.001).  However, when the counts 
of degenerating follicle numbers are also considered, as in Figure 4.12, the percentage of both 
primordial and growing follicles significantly decreased (p<0.001) on day 6 relative to day 0, in 
both the AFC and Leeds modified treatment groups.  In contrast the percentage of 
degenerating follicles significantly increased on day 6, following culture using these 
treatments.  This suggests that the decrease in the proportion of primordial and growing 
follicles is due to follicle loss by atresia.   
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Similarly, inclusion of the data on follicle degeneration in Figure 4.12 has aided interpretation 
of the data presented in Figure 4.9 with respect to the AFC system.  In Figure 4.9 the 
percentage of primordial follicles increases, relative to the percentage of growing follicles, on 
day 6 of culture.  In this figure the data is presented in a way that suggests the percentage of 
primordial follicles has increased on day 6 relative to day 0.  When the data on follicular 
degeneration is included in Figure 4.12, however, it is clear that both the percentages of 
primordial and growing follicles have significantly decreased (p<0.001) on day 6 relative to day 
0.  The degree to which the percentage of primordial follicles has decreased is lower than that 
of the percentage of growing follicles.  The percentage of degenerating follicles has 
significantly increased on day 6 of culture relative to day 0.  Analysis of the AFC modified and 
Leeds systems presented in Figures 4.90 and 4.12 show that the percentage of primordial, 
growing and degenerating follicles did not change on day 6 relative to day 0.  
 
Both the presentation of data as mean total follicles per mg of tissue (Figure 4.4 and 4.5) and 
as follicle proportions (Figure 4.9 and Figure 4.10) enables the comparison of follicle 
population dynamics before and after culture.  However, presenting the data per mg of tissue 
is much more informative as tissue weights varied largely and therefore it is important to 
standardise the data using this method.  It is also useful to present the data as the percentage 
change in follicles per mg of tissue (Figure 4.7 and Figure 4.8) as there are large variations in 
the numbers of follicles present on day 0 of culture therefore the percentage change data 
provided a clearer indication of the extent to which the follicle populations had changed.  
Based on these conclusions the remainder of the data regarding follicle population dynamics 
will be presented as the mean number of follicles per mg tissue in tabulated form and the 
percentage of follicles per mg tissue in graphical form.   
 
4.3.2 Follicle population dynamics – follicle classifications 
The follicle population dynamics on days 0 and 6 of culture are now considered in respect to 
follicle classification.  Table 4.5 summarises both the total and mean number of primordial and 
EP, primary, transitional and secondary follicles per gram of fresh tissue on days 0 and 6 of 
culture. 
  
  
 
1
5
7 
Table 4.5 The total number and mean number of follicles ± SEM per g of fresh tissue on days 0 and 6 of culture in the AFC, AFC modified, Leeds and Leeds modified 
treatment groups, as determined using NR staining.  The total number of follicles was not analysed statistically as this data is presented in terms of proportions in 
Figure 4.13.  The mean number of follicles data was analysed using the paired t-test and statistically significant decreases in follicle number on day 6 of culture, 
compared to day 0 are denoted using *p<0.05 and **p<0.01. 
 
Day Culture treatment 
Follicle classification 
 
Total 
Primordial and 
EP 
1° Trans 2° 
Total 
number of 
follicles per g 
tissue 
cultured 
0 
AFC 1008269 1005657 2013 599 0 
AFC modified 390490 379335 7005 4150 0 
Leeds 1299945 1299945 0 0 0 
Leeds modified 705260 695531 7003 2727 0 
6 
AFC 304505 302823 1148 451 84 
AFC modified 200045 193675 4098 2150 121 
Leeds 609420 608586 833 0 0 
Leeds modified 440142 433951 5443 613 135 
Mean 
number of 
follicles per g 
tissue 
cultured + 
SEM 
0 
AFC 167440±32170 167000±32000 340±110 100±60 0 
AFC modified 64860±5520 63000±5000 1170±380 690±140 0 
Leeds 217000±42000 217000±42000 0 0 0 
Leeds modified 117620±13550 116000±13000 1170±490 450±60 0 
6 
AFC 50750±10140 50470±10030** 190±70* 80±30 10±10 
AFC modified 33340±6500 32280±6190* 680±180 360±120* 20±10 
Leeds 101570±31860* 101430±31720* 140±140 0 0 
Leeds modified 73360±33420** 72330±16500** 910±370 100±40** 20±10 
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The data for the total number of follicles per g of cultured tissue, expressed as percentages is 
presented in Figure 4.13.  Following all 4 culture treatments the mean number of primordial 
and EP follicles significantly (p<0.001) decreased on day 6 of culture, compared to day 0 (see 
Table 4.5).  Only in the AFC, AFC modified and Leeds modified culture treatments were there 
primary and transitional follicles present on day 0.  In all these systems the number of follicles 
decreased by day 6 of culture.  Secondary follicles were not present in any culture system on 
day 0 however secondary follicles had developed by day 6 of culture in the AFC, AFC modified 
and Leeds modified culture systems.  The absence of secondary follicles from the Leeds 
treatment tissue, which contained only primordial follicles at the start of culture indicates that 
the secondary follicles present on day 6 of culture in the other treatment groups were 
probably not derived from primordial follicles that activated in vitro but rather they developed 
from more advanced follicles that were already growing at the start of culture.   
 
Figure 4.13 The percentage of primary and transitional follicles on days 0 and 6 of culture in 
fresh tissue following culture in the AFC, AFC modified and Leeds modified treatment groups.  
Chi-squared analysis of the data revealed statistically significant differences (p<0.001), 
indicated using different letters, both between and within treatment groups with respect to 
the percentage of follicles on days 0 and 6 of culture.  Note that the total numbers of all 
follicles from all classifications present per g of tissue were considered when calculating the 
percentage of follicles and when performing the statistical analysis, for 6 culture repeats.     
Follicle population dynamics are considered in terms of the percentage of follicles present in 
fresh tissue on days 0 and 6 of culture in Figure 4.13.  Only follicles at the primary and 
transitional stages are considered here, data for the Leeds treatment group is not therefore 
shown as neither of these follicle classifications were present in Leeds day 0 tissue.  Analysis of 
the data revealed that the percentage of follicles was significantly different (p<0.001) on day 0 
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and 6 of culture both within and between all treatment groups presented.  Examination of the 
data also revealed a significantly higher (p<0.001) percentage of both primary and transitional 
follicles on both day 0 and day 6 of culture in the AFC modified system than in the AFC and 
Leeds modified systems. The higher percentage of follicles seen in the AFC modified system on 
day 6 is likely to be due to the higher percentage of follicles at these stages being present in 
the day 0 tissue.  In the 3 culture treatment groups presented in Figure 4.13 secondary follicles 
were present in the tissue on day 6 of culture; AFC: 0.022%, AFC modified:  0.172% and Leeds 
modified: 0.021%.  It should also be noted that a small number of primary follicles (0.17%) 
were present in the day 6 tissue following culture using the Leeds treatment.   
 
Follicle population dynamics with respect to follicle classification were considered in fixed 
tissue samples.  Table 4.6 summarises both the total and mean number of primordial and EP, 
primary, transitional and secondary follicles per g of fresh tissue on days 0 and 6 of culture.  
There were no statistically significant (p>0.05) changes within the follicle classifications 
between days 0 and 6 of culture in any of the culture systems.  Follicle population dynamics 
were considered in terms of the percentage of follicles present in fixed tissue on days 0 and 6 
of culture, see Figure 4.14.  Only follicles at the primary, transitional and secondary stages 
were considered here and the data for the Leeds treatment group is not shown as none of 
these classifications of follicle was present in Leeds day 6 tissue.  Analysis of the data revealed 
that the percentage of follicles was significantly different (p<0.001) on day 0 and 6 of culture 
both within and between all treatment groups presented.  The proportion of primary and 
transitional follicles increased in all treatment groups presented in Figure 4.14.  A large 
increase in the percentage of primary follicles was observed in the AFC treatment group on 
day 6 of culture.  Examination of the data in Table 4.6 showed that the large increase in the 
percentage of primary follicles was accompanied by a large decrease in the percentage of 
primordial and EP follicles, suggesting that the increase was due to follicles activating and 
developing in vitro, however, the increase in number of primary follicles is much smaller (~30 
times lower) than the decrease in number of primordial and EP follicles.  Therefore the large 
increase in the percentage of primary follicles is more likely a result of high levels of follicle 
atresia than activation and development.  Although a small percentage of secondary follicles 
were present in the tissue on day 0 of culture none were present on day 6, therefore these 
culture treatments were not able to support the survival of secondary follicles in vitro.  To aid 
clarity the histological data regarding percentage of transitional and secondary follicles on days 
0 and 6 of culture is shown in Table 4.7.  The data was not normally distributed and was 
therefore analysed using non-parametric tests.   
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Figure 4.14 The percentage of primary and transitional follicles on days 0 and 6 of culture in 
fixed tissue following culture in the AFC, AFC modified and Leeds modified treatment groups.  
Chi-squared analysis of the data revealed statistically significant differences (p<0.001) both 
between and within treatment groups with respect to the percentage of follicles on days 0 and 
6 of culture.  Note that the total numbers of all follicles of all classifications present per g of 
tissue were considered when calculating the percentage of follicles and when performing the 
statistical analysis, for 4 culture repeats.     
 
The mean diameters of follicles and oocytes in tissue on days 0 and 6 of culture in each 
treatment system are presented in Table 4.8.  In all treatment groups and classifications follicle 
and oocyte diameter increased on day 6 of culture relative to day 0, with the exception of 
transitional follicles in the AFC modified treatment group in which the diameter decreased.  
Statistically significant (p<0.05) increases in diameter were observed in primordial follicles and 
oocytes and EP follicles in the AFC modified and Leeds modified treatment groups as well EP 
oocytes in the Leeds modified treatment group. 
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Table 4.6 The total number and mean number of follicles ± SEM per g of fixed tissue on days 0 and 6 of culture in the AFC, AFC modified, Leeds and Leeds modified 
treatment groups, as determined using NR staining.  The total number of follicles was not analysed statistically as this data is presented in terms of proportions in 
Figure 4.14.  The mean number of follicles data was analysed using t-test and changes in follicle number were not statistically significant (p<0.05). 
 Day Culture treatment 
Follicle classification 
 
Total Primordial EP 1° Trans 2° 
Total number 
of follicles per 
g tissue 
cultured 
0 
AFC 1534704 645559 774013 83333 24507 7292 
AFC modified 1534704 645559 774013 83333 24507 7292 
Leeds 2375758 1785985 556061 33712 0 0 
Leeds modified 1580245 927169 539300 95344 14728 3704 
6 
AFC 573366 227393 194884 129798 21291 0 
AFC modified 1043110 418075 506229 74969 43838 0 
Leeds 1416250 1059464 356786 0 0 0 
Leeds modified 1008472 645046 304280 47617 11529 0 
Mean number 
of follicles per 
g tissue 
cultured + 
SEM 
0 
AFC 383280±128510 161390±51270 193500±64940 20830±8960 6130±2270 1820±1070 
AFC modified 383280±128510 161390±51270 193500±64940 20830±8960 6130±2270 1820±1070 
Leeds 593950±274700 446500±216510 139020±56570 8430±1620 0 0 
Leeds modified 395070±105040 231790±61330 134830±30510 23840±9070 3680±3200 930±930 
6 
AFC 143340±63210 56850±22410 48720±16710 32450±21620 5320±2470 0 
AFC modified 260780±149080 104520±55850 126560±82160 18740±6150 10960±4920 0 
Leeds 354070±149690 264870±114280 89200±35410 0 0 0 
Leeds modified 252110±79950 161260±15652 76070±18100 11900±7050 2880±2540 0 
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Table 4.7 A histological comparison of the mean % of transitional and secondary follicles present per g of tissue fixed on days 0 and 6 of culture in the 4 systems 
tested.  Means ± SEMs are shown for 4 culture repeats.  There were no statistical differences within culture systems and follicle classifications on days 0 and 6 of 
culture, determined using either a paired t-test or Wilcoxon signed ranks test.  Nor were there any statistically significant differences in the mean percentage of 
follicles within each follicle classification between culture systems on days 0 and 6 of culture as determined using the Kruskal-Wallis analysis. 
 
  Mean % per g tissue fixed 
 
Follicle Classification Transitional Secondary 
  Day of Culture Day 0 Day 6 Day 0 Day 6 
Culture 
treatment 
AFC 3.2±1.8 6.4±3.9 0.3±0.2 0 
AFC modified 3.2±1.8 6.3±3.7 0.3±0.2 0 
Leeds modified 0.7±0.5 0.8±0.7 0.2±0.2 0 
 
Table 4.8 The mean diameter of primordial, EP, primary, transitional and secondary follicles and oocytes ± SEM in tissue samples across 4 culture repeats on days 0 
and 6 of culture in each treatment group.  Blanks in the table indicate that there were no follicles of that classification present in tissue cultured within that system 
at that day of culture.  Data was not normally distributed and therefore was analysed using the Mann-Whitney U test.  Mean follicle and oocyte diameters were 
compared between days 0 and 6 of culture within each follicle classification and treatment group.  Statistically significant differences are denoted using *(p<0.05).      
Culture 
treatment 
Day Primordial EP Primary Transitional Secondary 
Follicle Oocyte Follicle Oocyte Follicle Oocyte Follicle Oocyte Follicle Oocyte 
AFC 
0 23.9±0.5 20.3±0.4 27.0±0.8 21.3±0.6 35.4±1.9 25.1±1.6 80.4±4.6 41.8±2.1 140.9±13.4 56.6±11.6 
6 27.3±2 23.1±1.8 29.9±2.1 23.2±1.5 38.2±2.8 26.3±2.1 86.8±2.3 49.4±2.3     
AFC 
modified 
0 23.9±0.5 20.3±0.4 27.0±0.8 21.3±0.6 35.4±1.9 25.1±1.6 80.4±4.6 41.8±2.1 140.9±13.4 56.6±11.6 
6 27.1±0.4* 23.4±0.5* 30.4±0.6* 23.6±0.3 43.6±2.6 30.9±2.7 71.7±5.3 42.6±4     
Leeds 
0 22.0±0.4 18.6±0.3 25.8±0.6 19.7±0.6 44.3±3.5 26.7±3.1         
6 22.4±0.2 18.9±0.3 26.0±1.2 19.4±0.9             
Leeds 
modified 
0 23.2±0.4 19.6±0.4 26.7±0.4 20.9±0.3 38.3±1.5 26.5±0.7 79.7±0.9 33.4±2.2     
6 28.2±1* 23.6±0.6* 37.9±3.6* 27.3±1.8* 39.8±2.2 27.9±1.3 80.3±18.4 52.4±16.3     
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4.3.3 Stromal tissue scoring 
On day 8 of culture tissue pieces were incubated in NR dye.  Following this incubation period 
tissue pieces were assessed with respect to the percentage of the tissue that positively stained 
with NR dye.  The results are shown in Figure 4.15.  On day 8 of culture the tissue in the Leeds 
culture system had the highest percentage positively stained stroma (84.3±1.6%, n=6).  
Although this was not significantly different (p>0.05) from the tissue grown in the Leeds 
modified culture system, it was significantly greater (p<0.05) than the stroma cultured in both 
the AFC and AFC modified culture systems.  The tissue in the AFC culture system has the 
lowest percentage positively stained stroma (31.3±5.3%, n=6). 
 
The integrity of the stromal tissue was assessed histologically, as shown in Figure 4.16.  The 
difference in the integrity of the control day 0 tissue was not statistically significantly different 
(p>0.05) from the Leeds day 6 tissue.  However, the stromal tissue score of the tissue in the 
Leeds modified, AFC and AFC modified culture systems was significantly lower (p<0.05) than 
that of the day 0 control tissue.  The tissue in the AFC culture system had the lowest stromal 
tissue score.  The stromal tissue score of the Leeds and Leeds modified groups was not 
statistically significantly different (p>0.05). 
 
Figure 4.15 Analysis of tissue viability as assessed in fresh tissue by NR staining on day 8 of 
culture in all 4 culture systems.  The percentage of the tissue that stained positively is shown 
as mean ± SEM for 6 culture repeats.  Different letters represent statistically significant 
differences (p<0.05).  
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Figure 4.16 Histological analysis of stromal tissue and follicle integrity.  The overall appearance 
of the tissue and follicles in the section of tissue was rated as good (3), adequate (2) or poor 
(1).  Values are shown as mean ± SEM for 4 culture repeats.  Different letters represent 
statistically significant differences (p<0.05).  
 
4.4 Discussion 
The results show that primordial follicle activation, development and survival are supported in 
the short-term by the Leeds culture system.  The extent to which primordial follicle activation 
is supported in the AFC, AFC modified and Leeds modified systems is unclear, as it is uncertain 
as to whether primordial follicle counts and proportions decreased as a result of follicle 
activation or atresia or a combination of both.  Both primordial and growing follicle counts 
decreased following all culture treatments, except when using the Leeds system, showing that 
even if primordial follicles are activating this occurred at a lower rate than atresia was induced 
in growing follicles.  The data indicates however, that the decrease in growing follicles was 
lower in the Leeds modified system than the AFC and AFC modified systems.  This could either 
be due to a higher rate of follicle activation in the Leeds modified group, or a lower rate of 
atresia of growing follicles, or both.  This evidence suggests that the conditions in the Leeds 
and Leeds modified treatments may be preferential to those used in the AFC and AFC modified 
treatment groups.  As previously mentioned the culture systems differ in terms of media 
composition, tissue preparation, use of insert and media volume as well as the number of 
cortex pieces per well.  The potential effects of these differences will be discussed below. 
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4.4.1 Media composition 
One of the major differences with respect to media composition was the addition of 
gonadotrophins, FSH and LH to the Leeds, Leeds modified and AFC modified culture media.  LH 
receptors are not expressed until the development of the thecal cell layer in ovine follicles and 
therefore the addition of LH to the media is unlikely to affect preantral follicle growth or 
development (Carson et al., 1979).  This constituent is included to support the later stages of 
development should these be present in tissue on day 0 or be induced in culture.  Similarly, 
although FSH receptors are not expressed prior to the primary follicle stage in sheep (Tisdall et 
al., 1995) this gonadotrophin was added to the media from day 0, when the Leeds tissue 
should have only contained primordial follicles to support the progression of development. 
Primary follicles were present in the Leeds modified, AFC and AFC modified tissue on day 0.  
 
Research also suggests that FSH promotes follicle survival in vitro, this has been demonstrated 
in numerous species including rodents (Chun et al., 1996), goat (Matos et al., 2007a, Matos et 
al., 2007b), sheep (Costa et al., 2010, Peng et al., 2010), cow (Yang and Rajamahendran, 2000) 
and human (Wright et al., 1999).  Early studies by Chun et al. (1996) demonstrated the 
promotion of follicle survival via the anti-apoptotic actions of FSH in rodent early antral 
follicles.  Further evidence of FSH as a survival factor has been produced by more recent 
studies in various species.  Numerous studies have been conducted regarding the effect of FSH 
on caprine preantral follicles in vitro.  Earlier studies provided evidence of the promotion of 
preantral follicle survival by FSH in cortical slice culture (Matos et al., 2007a).  Prior to these 
studies research suggested that there was no link between the inclusion of FSH in the culture 
media and caprine follicle viability in short-term cortical culture (Silva et al., 2004b).  However, 
subsequent research by the same group has lead authors to suggest that FSH is actually 
essential for the maintenance of caprine follicle viability in vitro (Matos et al., 2007b).  
Differences in these findings probably arose from the differences in concentration of FSH 
added to the culture media 50ngml-1 (Matos et al., 2007b) vs. 100ngml-1 (Silva et al., 2004b).  
Studies have also been conducted to elucidate the effects of FSH inclusion in in situ ovine 
follicle culture.  In a study conducted by Costa et al. (2010) the inclusion of FSH in the media 
did not appear to promote ovine follicle survival compared to the control.  However, when 
indole-3-acetic acid (IAA) was included in the media at deleterious concentrations that induced 
apoptosis, FSH was able to reduce these effects.  One mechanism by which FSH has been 
shown to promote follicle survival in rodents is via the promotion of glutathione production by 
follicles, which suppresses reactive oxygen species production, thus reducing the level of 
apoptosis occurring due to oxidative damage (Tsai-Turton and Luderer, 2006).  This is likely to 
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be the mechanism by which FSH counteracted the effects of IAA in the aforementioned study 
(Costa et al., 2010).  Furthermore, Peng et al. (2010) showed that FSH promoted preantral 
follicle survival in ovine cortical culture when added to the culture media with epidermal 
growth factor (EGF) and ascorbic acid.  In addition, the use of FSH combined with EGF was also 
shown to promote ovine primordial follicle viability in vitro when assessed using transmission 
electron microscopy (Andrade et al., 2010).  
 
Addition of FSH to the culture media has also been shown to promote follicle growth and 
development.  Inclusion of FSH in media promoted the in situ growth of caprine preantral 
follicles (Matos et al., 2011).  When combined with fibroblast growth factor-2 (FGF2) FSH was 
also shown to promote caprine primordial follicle activation (Matos et al., 2007a, Matos et al., 
2007b).  In ovine cortical culture FSH was shown to increase follicle size and promote GC 
proliferation, when used in combination with ascorbic acid or EGF (Peng et al., 2010).  Addition 
of FSH alone to the culture media promoted the development of ovine primary follicles to the 
secondary stage in situ (Costa et al., 2010).  Furthermore, inclusion of FSH increased the 
percentage of developing follicles present in cultured ovine cortical tissue, although not 
significantly when compared to the FSH-free control media (Andrade et al., 2005).  FSH 
inclusion in the culture media also promoted the growth of human preantral follicles in situ 
(Wright et al., 1999).  There is conflicting evidence regarding the ability of FSH to promote 
growth and development of bovine preantral follicles in vitro.  With respect to bovine follicles, 
FSH receptors are expressed from the primary stage (Wandji et al., 1992).  However, FSH did 
not promote follicle development from the primary to secondary stage or follicle growth in 
short-term bovine cortical tissue culture, nor did FSH promote primordial follicle activation 
(Fortune et al., 1998, Derrar et al., 2000).  Whereas, inclusion of FSH during isolated preantral 
follicle culture, has been shown to promote preantral follicle growth and proliferation of GCs 
(Wandji et al., 1996a, Saha et al., 2000).  It should also be noted that in the isolated follicle 
cultures mentioned above the media contained serum, whereas the media in the cortical 
tissue cultures was serum-free.  Therefore, there may have been some component present in 
the serum that interacted with FSH and resulted in the promotion of follicle development.  
Also the effects of FSH may differ between ovine and bovine preantral follicle development in 
vitro.  Thus the inclusion of FSH in the culture media of the cortical culture system developed 
by McLaughlin and Telfer (2010) may not promote bovine follicle growth.  However, when the 
culture system was adapted for use with ovine tissue the inclusion of FSH may be optimal to 
promote follicle survival, growth and development. 
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Therefore the impact of inclusion of FSH in the culture media could partly explain the data 
presented in Figure 4.4 (b) and Figure 4.9 which revealed a lower significant decrease in 
number of growing follicles observed in the Leeds modified group, compared to the AFC and 
AFC modified groups as well as a concomitant increase in the percentage of growing follicles 
rather than a decrease.  As previously mentioned this may be due to either higher levels of 
follicle activation in this culture system, or higher growing follicle survival rates, or a 
combination of both.  It is possible that the inclusion of FSH in the culture media may have 
promoted preantral follicle survival, growth and development.  However, as FSH was included 
in the culture media used in the AFC modified system, the results observed cannot be due to 
FSH inclusion alone.  The histology data presented in Figure 4.5 shows there was a significant 
increase in the number of growing follicles per mg tissue on day 6 of culture, relative to day 0 
(p<0.05).  Furthermore, the number of non-viable follicles decreased after culture in the Leeds 
system, see Figure 4.12.   
 
Pyruvate 
Both types of basal media, α-MEM and McCoy’s 5a, used in this experimental series contain 
glucose as an energy source.  In addition, sodium pyruvate was added as an additional energy 
source in the Leeds, Leeds modified and AFC modified culture media.  Pyruvate was absent 
from the AFC culture media.  Previous research has shown that follicles utilise both glucose 
and pyruvate (Boland et al., 1994b, Boland et al., 1994a, Biggers et al., 1967, Harris et al., 
2007).  Energy production from glucose is achieved both via glycolysis, which is non-oxidative 
as demonstrated experimentally in mice by assaying for lactate production and via the pentose 
phosphate pathway, an oxidative process (Boland et al., 1993, Harris et al., 2007).  More 
specifically glucose metabolism is favoured by the somatic cells of the follicle, whereas 
pyruvate is utilised as the primary energy source during oocyte metabolism.  Oocytes can be 
supplied with pyruvate by their supporting somatic cells however experimental evidence has 
also shown that pyruvate is taken up from the culture media during in vitro follicle culture 
(Leese and Barton, 1985, Harris et al., 2007, Harris et al., 2009).  Experimental studies have 
shown that pyruvate consumption from the culture media by primordial follicles in culture is at 
a high level, such that it is 2-fold higher than glucose consumption (Harris et al., 2009).  This 
could be due to the high energy demands of the oocyte at this stage of development, or 
indicative of the reduced ability of the somatic cells to provide sufficient pyruvate.  Therefore, 
although it is not essential to add pyruvate to the culture media as it can be provided by the 
somatic cells, and/or glucose can be used as an alternative energy source the lack of pyruvate 
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supplementation may be detrimental to primordial follicle survival.  This could partly explain 
the decrease in number of primordial follicles observed in the AFC culture system. 
Furthermore, when oocyte cellular volume is accounted for, pyruvate consumption by the 
oocyte is highest at the primary stage of follicular development (Harris et al., 2009).  Authors 
suggest that this may be due to the increased energy requirements as the follicle goes through 
this transitory stage.  
 
In addition, pyruvate acts as a free radical scavenger thus it is able to protect against oxidative 
damage caused by reactive oxygen species produced as a result of mitochondrial energy 
production (O'Donnell-Tormey et al., 1987, Van Blerkom, 2004, Picton and Hemmings, 2013).  
Therefore, although pyruvate supplementation in the culture media is not essential evidence 
suggests that its inclusion may provide more optimal culture conditions for follicle growth and 
development.  This could further explain the decrease in numbers of early stage follicles 
observed in the AFC culture system and explain why this occurred to a greater extent than in 
the Leeds system. 
 
IGF1 
The media used in all systems except the AFC culture conditions reported here, contains a 
synthetic analogue of IGF1- Long R3 IGF1.  This analogue does not bind to the IGF binding 
proteins so remains biologically active in vitro.  IGF1 has been shown to promote GC 
proliferation in small ovine follicles (Monniaux and Pisselet, 1992).  However, in bovine 
preantral follicle culture although the addition of recombinant human IGF1 and Long R3 IGF1 
increased follicle diameter the rates of oocyte degeneration were also increased (Thomas et 
al., 2007).  Therefore species-specific differences may exist and this may somewhat explain the 
discrepancies in the results reported for the AFC system in this experimental series and by 
McLaughlin and Telfer (2010).  The major active IGF species is, however, the same in both cow 
and sheep, IGF2, the actions of which are mediated predominantly through IGF2R (Armstrong 
et al., 2000, Armstrong et al., 2002, Monget et al., 2002, Silva et al., 2009).  It is unclear 
whether the inclusion of Long R3 IGF1 had any effect on the promotion of follicular growth in 
this experimental series as GC proliferation was not directly measured.  
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4.4.2 Tissue preparation 
A major difference between the Leeds and AFC culture systems is the method of cortical tissue 
preparation, see Figure 4.1.  Telfer and McLaughlin (2012) suggest that by teasing the cortical 
tissue apart and cutting the tissue in such a way as to reduce the amount of medulla present 
promotes primordial follicle activation, potentially via the reduction in concentration of 
inhibitory substances.  This hypothesis is not supported by work conducted by Derrar et al. 
(2000) in which levels of primordial follicle activation and preantral follicle growth and 
development were not affected by the co-culture of bovine cortical slices with medullary slices 
or cortico-medullary slices. In the current experimental series the method of cortical tissue 
preparation advocated by Telfer and McLaughlin (2012) appears to have affected the health of 
the tissue, as shown by the data presented in Figures 4.3, 4.15 and 4.16.  The strategy of 
cutting the tissue pieces into squares, as utilised in the Leeds and Leeds modified treatments 
resulted in the highest rates of viability and integrity of the tissue on day 6 of culture 
compared to that observed in the AFC and AFC modified systems, in which the tissue was cut 
into pyramid shapes and teased apart with needles.  It is likely that the increased manipulation 
of the tissue caused mechanical damage resulting in higher rates of necrosis in the surrounding 
stroma and the follicles (Benaglia et al., 2009). 
 
As discussed in Chapter 3 maintenance of the health and integrity of ovarian stromal tissue 
during cortical culture is of great importance to the health of the follicles and their continued 
growth and development (Knight and Glister, 2006).  In the previous studies - on which the 
current AFC system was based - stromal health and integrity was not assessed (Telfer et al., 
2008, McLaughlin and Telfer, 2010).  Recognition of the importance of the health of stromal 
tissue is becoming increasingly evident, however, most of the studies in which the health of 
ovarian stromal tissue has been assessed focus on the effects of exposure to CPAs and 
cryopreservation (Faustino et al., 2010, Oskam et al., 2010, Oskam et al., 2011, Maffei et al., 
2013).  The latter will be discussed in more detail in Chapter 6.  In the current chapter, changes 
in tissue weight following culture, level of NR staining and histological assessment of stromal 
tissue integrity were used as markers of stromal health.  Therefore this is the first study to 
directly report on the effect of short-term accelerated cortical culture system on stromal tissue 
health.  The results of all these parameters indicate that the method of cortical tissue 
preparation prior to culture in the Leeds system is more optimised with respect to the health 
of the stromal tissue than the AFC system.  Note that the method of tissue preparation was the 
same in the Leeds and Leeds modified treatment groups, in which tissue was trimmed into 
squares, and the AFC and AFC modified treatment groups, in which tissue was trimmed into 
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pyramid shapes and teased apart using needles (see Table 4.2).  Although changes in tissue 
weight following culture were not significant (p>0.05), the fact that tissue weight increased in 
the Leeds and Leeds modified treatment groups indicates some level of stromal and follicular 
growth in contrast to the decrease in tissue weight observed in the AFC and AFC modified 
treatment groups which indicates some level of degeneration of both cellular compartments 
(see Figure 4.3).  This hypothesis is supported by the results of NR staining and stromal health 
scores following culture in which the score for both parameters was significantly higher in 
treatments in which tissue had been trimmed into squares at the start of culture compared to 
pyramids (see Figures 4.15 and 4.17).  This is not unexpected as the reason for teasing the 
pyramid shaped tissue apart was to reduce the density of the tissue thus reducing the 
concentration of inhibitory factors present in the medullary tissue, which has been proposed 
to promote global primordial follicle activation (Telfer and McLaughlin, 2012) and also 
facilitate gas and nutrient penetration into the tissue during culture.  In the current chapter, 
however, this did not appear to promote follicle activation, growth and survival and was in fact 
detrimental to both these processes and stromal health thus resulting in increased levels of 
follicle apoptosis and stromal death.  When follicle and oocyte diameters were analysed, 
however, an increase was observed on day 6 relative to day 0 in all treatment groups, 
indicating that they were healthy and able to grow (see Table 4.8).  Therefore, the detrimental 
effects of teasing the tissue apart are not completely preventing follicle survival and growth.  
The development of additional methods of quantifying follicle, oocyte and stromal health 
would be helpful to determine the exact effects of the different methods of tissue preparation 
(see Section 4.4.5). 
 
4.4.3 Use of NR dye 
In all culture treatments NR staining was used to assess the number of viable follicles present 
in the tissue at the start of culture.  The use of this technique ensures that all tissue cultured 
contained viable follicles.  Following NR incubation ~72% of all tissue pieces stained positively 
(data not shown) and tissue that did not stain positively was discarded.  This result confirms 
the utility of NR staining as a crude means of screening viable follicle loading density in ovarian 
cortex prior to culture such that follicle depleted tissue can be discarded. However the data 
also show that NR staining of follicles in situ overestimated the number of primordial follicles 
and the total number of follicles present in the tissue when compared to the accurate follicle 
counts provided following detailed histological analysis of fixed tissue after culture, as follicle 
counts were ~5 and ~10 orders of magnitude lower, respectively.  In contrast, the use of NR 
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dye lead to an underestimation of the number of growing follicles as the number in fixed tissue 
was ~10 orders of magnitude higher than that recorded using fresh tissue.  This evidence 
highlights the importance of examining follicle population dynamics in both fresh tissue and 
histologically.  Although the results showed that it was difficult to distinguish between 
primordial and growing follicles in fresh NR stained tissue, there was however, always a 
positive correlation between the number of follicles recorded following NR staining and 
histological analysis.  Therefore, the results presented in this chapter are in agreement with 
previous studies in that the use of NR dye facilitates the rapid estimation of the number of 
follicles prior to culture so that the follicle rich tissue can be selected for culture (Chambers, 
2002, Chambers et al., 2010, Kristensen et al., 2011).  The histological examination of the 
tissue then enables a more accurate assessment of the follicle population dynamics.  The 
results presented in this chapter also show that the use of NR dye does not appear to have any 
detrimental effects on the subsequent health and development of follicles and stromal tissue 
in vitro, as has been shown in previous studies using both ovine and human ovarian tissue 
(Chambers, 2002, Chambers et al., 2010, Kristensen et al., 2011). 
 
4.4.4 Use of culture inserts 
Use of a culture insert allows the tissue pieces to remain fully hydrated and covered with a film 
of culture media which facilitates gaseous diffusion and the transfer of nutrients, growth 
factors and gonadotrophins into and out of the tissue in vitro.  If an insert is not used the tissue 
pieces must sit at the bottom of the culture dish resulting in an increased diffusion distance for 
gases between the surface of the media and the tissue.  Therefore it is more likely that tissue 
pieces will experience hypoxic conditions if a culture insert is not used.  The process of 
pyruvate metabolism requires high levels of oxygen therefore it is possible that this metabolic 
process and subsequently oocyte developmental competence may be compromised in systems 
where the tissue is potentially experiencing hypoxic conditions (Van Blerkom, 1998, Harris et 
al., 2007).  This could further explain the decrease in numbers of early stage follicles observed 
in the AFC culture system and explain why this occurred to a greater extent than in the Leeds 
system.  In order to investigate this hypothesis the expression levels of genes and/or proteins 
associated with apoptosis – Bax, Bcl2 and Caspase 6 (Casp6) and hypoxia - thrombospondin 1 
(THBS1), Ki67, endothelins (ET)-1 and ET-2 could be monitored (Onions et al., 2013).  In 
addition to assessing gene expression profiles to determine whether the tissue encountered 
hypoxic conditions the levels of metabolites in spent culture media collected following 
perfusion could be measured.  An enzyme-linked ultramicrofluorescence assay has previously 
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been used to assess the consumption and/ or production of glucose, pyruvate and lactate by 
murine oocytes and embryos (Leese and Barton, 1984, Harris et al., 2005, Harris et al., 2009).  
This method could be developed to assess the levels of metabolites in spent media on days 0, 
2, 5 and 8 of culture using each of the culture treatments.  The level of LDH, a cytoplasmic 
enzyme, in spent culture media can be used as a measure of cell damage as LDH present in the 
cell cytoplasm will be released into the media upon damage to the cell membrane (Decker and 
Lohmann-Matthes, 1988, Koukourakis et al., 2003).  Therefore LDH assays could also be used 
to compare the levels of damage caused by the various culture treatments. 
 
4.4.5 Future work 
In order to extend this study it would be interesting to use a wider variety of markers to assess 
both follicle and stromal health and normality.  For example, the process of assaying for the 
production of steroid hormones, such as oestradiol and progesterone has previously been 
used to assess the health and normality of ovine, bovine, porcine and human follicles (Newton 
et al., 1999b, McCaffery et al., 2000, Oktay, 2001).  Similarly assaying for the levels of peptides, 
such as MMPs and TIMPs, in the spent media during in vitro culture of bovine follicles has been 
used to assess normality (Telfer et al., 2000).  In addition levels of AMH in the spent media 
could be used to assess the number of growing follicles in cortical tissue during culture (Kelsey 
et al., 2011, Nelson et al., 2012, Morgan et al., 2012).  Additionally, levels of steroid hormones, 
such as progesterone and factors such as interleukin-1 and prolactin in the FF can be indicative 
of oocyte developmental competence (Mendoza et al., 1999).  Therefore it would be 
interesting to repeat this experimental series and assess the levels of key steroid hormones 
and peptides to determine whether the culture systems used have an effect on these 
parameters.  The level of thymidine incorporation is often used as a marker of somatic cell 
proliferation (Oktay et al., 1995), it would be interesting to assess TUNEL staining to determine 
which culture system is optimal for somatic cell proliferation.  Similarly immunohistochemical 
assessment of PCNA or Ki-67, which are both markers of early follicle growth, could be used 
(Oktay et al., 1995). 
 
In future studies it would also be interesting and informative to assess ovarian tissue, follicle 
and oocyte quality using markers of apoptosis.  For example, the use TUNEL is common, 
however, is better used in combination with other apoptotic markers as this method detects 
DNA fragmentation, which is not solely observed in apoptotic nuclei (Fujino et al., 1996, Kockx 
et al., 1998).  Assessment of the expression of apoptotic genes, such as anti-apoptotic BCL2 
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and pro-apoptotic BAX and FAS and its ligand, FAS-LIGAND can also be used to determine 
oocyte normality (Liu et al., 2000).  Another hallmark of apoptosis is the translocation of 
phosphotidylserine from the inner to the outer layer of the cell membrane and this can be 
detected using annexin V staining (Van Engeland et al., 1998).  Fluorescence analysis of pro-
apoptotic caspase activity can also be used as an apoptotic marker in oocytes (Perez et al., 
1999).  Assessment of the levels of poly(adenosine diphosphate-ribose) polymerase-1 (PARP) 
cleavage, a process indicative of apoptotic cell death in response to major breaks in DNA 
detected in cells, have previously been used to examine the effects of chemotherapeutic 
agents, such as cisplatin, on ovarian tissue via protein extraction and western blotting methods 
(Morgan et al., 2013).  
 
The vast majority of research conducted regarding the development of IVG culture systems has 
focussed on the health and survival of follicles and oocytes in vitro.  Recent work conducted by 
Morgan et al. (2013), however, has highlighted the importance of determining the mechanisms 
by which follicle loss occurs in vitro.  Potential mechanisms of follicle loss include damage, 
induced by the culture conditions, to the either the oocyte alone or to the follicular somatic 
cells and subsequently the oocyte, resulting in follicular atresia (Morgan et al., 2012).  It is also 
possible that damage to the ovarian stroma could result in follicle loss, therefore the current 
study could be extended by investigating this possibility.  Follicle loss may also occur as a result 
of the induction of atresia in all classes of follicles, in primarily primordial follicles or 
alternatively primarily in growing follicles thus resulting in increased levels of primordial follicle 
activation in response to decreasing levels of inhibitory factors released by growing follicles, 
such as AMH (Morgan et al., 2012, Morgan et al., 2013).  Follicle loss in ovarian tissue can be 
induced by follicle culture, as evidenced in the current chapter, by exposure to 
chemotherapeutic drugs, such as cisplatin (Gunson, 2009, Morgan et al., 2013) and by ovary 
perfusion and cryopreservation protocols, as evidenced in Chapter 6.  It is unlikely that the 
same mechanisms of follicle loss are operating in these incidences.  In order to determine the 
mechanisms of follicle loss, levels of apoptosis and the specific cell types as well follicle 
classifications affected must be identified.  In order to determine the different mechanisms of 
follicle loss operating in murine ovarian tissue as a result of exposure to chemotherapeutic 
agents cisplatin and doxocyclin Morgan et al. (2013) assessed levels of apoptosis in follicles of 
different stages using TUNEL staining and assessing levels of PARP cleavage.  This revealed that 
primordial follicle loss occurred as a result of damage to and subsequent loss of growing 
follicles thus inducing an increase in primordial follicle activation.  It would be interesting to 
use these techniques to compare the mechanisms of follicle loss exhibited in response the use 
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of the AFC and Leeds systems.  This study could be further extended by using similar methods 
assessing the levels of apoptosis exhibited by the stromal tissue in order to determine whether 
this was having a major effect on follicle loss.  Gunson (2009) developed and validated 
methods of isolating stromal tissue then assessing levels of damage in response to cisplatin 
exposure via the histological assessment of the tissue to determine the level of TUNEL staining 
as well as the level of LDH production in culture.  In order to ensure the stromal tissue was not 
contaminated with ovarian surface epithelium antibodies specific to vimentin and cytokeratin, 
expressed by the stroma and ovarian surface epithelium, respectively, were used in situ.  In 
order to further investigate the effects of stromal health it would be useful to indentify factors 
expressed solely by the ovarian stromal cells.  For example, the expression of Sialic acid-
binding Immunoglobulin Superfamily Lectin (Siglec)-11 by human ovarian stromal cells has 
been detected and identified as a regulator of the expression levels of cytokines, IL-7 and -10, 
TGF-β and TNF-α, all of which are important regulators of folliculogenesis (Wang et al., 2011).  
Therefore the expression levels of Siglec-11 could be used as a marker for the health and 
normality of stromal tissue in vitro when cultured using the Leeds and AFC systems.  
Unfortunately, Siglec-11 expression was not detected when ovarian tissue was put into 
culture, however, it is possible that it would be detected using a different culture system or 
species.  The identification of various markers of stromal normality is essential for the 
assessment of stromal health and the effect of follicle survival.    
 
Alternatively levels of expression of genes encoding key oocyte and somatic cell specific 
proteins could be analysed.  In order to achieve this, normal patterns of gene expression in 
vivo would need to be established to which the patterns observed in vitro could be compared.  
Similarly analysis of the levels of expression of key imprinted genes encoding proteins that 
have been implicated as regulators of folliculogenesis, oogenesis and embryogenesis as well 
genes encoding enzymes responsible for the establishment and maintenance of the 
methylation patterns of imprinted genes, would be a useful method of examining whether 
folliculogenesis and oogenesis are progressing normally in vitro.  In Chapter 5 patterns of 
normal gene expression in vivo are established and compared to those observed in follicles 
derived from the long-term, physiological cortical culture system and isolated preantral follicle 
culture system described in Chapter 3.  In the future it would be useful to perform the same 
analyses to determine whether follicles derived from a short-term cortical culture system are 
displaying normal patterns of gene expression. 
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4.5 Conclusion 
The results reported in this experimental series show that it is possible to activate and grow 
ovine primordial follicles in vitro up to the primary stage using the Leeds cortical culture 
system in the short-term.  However, the yield of growing follicles after 6 days of culture using 
the Leeds culture system was very low, 0.17±0.09 follicles per mg tissue cultured for 6 culture 
repeats.  Furthermore, over this timeframe follicles only reached the primary stage of 
development.  As was shown in Chapter 3 in vitro-derived primary follicles were not 
competent to develop to the EA stage in isolated culture.  Therefore when the sheep is used as 
a model species, short-term accelerated growth systems, such as the AFC system tested here 
are suboptimal for the activation and sustained growth of healthy follicles whereas a long-
term, more physiological, gentle growth environment better supports growth activation and 
the needs of growing oocytes and somatic cell division during cortical culture. 
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5 Comparison of the Expression Patterns of Key Genes Implicated in the 
Regulation of Folliculogenesis, Oogenesis, and Imprint Establishment and 
Maintenance in Ovine Follicles and Oocytes Grown In Vivo and In Vitro. 
 
5.1  Introduction 
The development of multiphase culture systems that enable the complete in vitro growth and 
maturation of oocytes would be hugely beneficial with respect to developing methods of 
fertility preservation and restoration.  As discussed in Chapter 1 although the IVG, IVM and 
subsequent IVF of oocytes has successfully resulted in the birth of live offspring in rodents, the 
resultant offspring exhibited health problems (Eppig and O'Brien, 1996).  Therefore prior to 
use in humans it is vital that in vitro-derived oocytes are tested for markers of normality that 
reflect gamete health and developmental competence and confirm the safety of the 
technology.  In addition, testing for normality during oocyte development in vitro may 
facilitate further improvement of the culture conditions.  
 
Chapter 3 documents the development of step 1 of a multistep culture strategy and recorded 
the development and testing of a long-term, cortical culture system that supported the 
activation and development of primordial follicles and facilitated the in vitro-derivation of 
primary, transitional and secondary follicles.  The health of oocytes, follicles and stromal tissue 
was assessed both in fresh tissue and histologically.  In fresh tissue NR staining, tissue weight 
and follicle population dynamics before and after culture were used as preliminary indicators 
of normal development in vitro.  Follicle and oocyte diameter as well as follicle population 
dynamics relative to in vivo-derived controls at time 0 were used as histological indices of 
normality.  Additionally, stromal health was assessed histologically.  The step 1 long-term in 
situ cortex cultures generated in vitro-derived secondary follicles which could be isolated and 
cultured in the second step system up to the EA stage.  The health of the oocytes and follicles 
generated in steps 1 and 2 were analysed during culture using NR viability staining, by 
morphological assessment with respect to the presence of a ZP, antral cavity and oocyte colour 
(dark patches indicating necrosis), and growth and somatic cell proliferation were quantified 
via the measurement of follicle and oocyte diameter.  In the current chapter the health of the 
in vitro-derived primary, transitional, secondary and EA follicles documented and archived in 
Chapter 3 as well as GV and MII oocytes and somatic CCs will be evaluated in greater depth by  
the analysis of molecular markers of normality relative to stage matched in vivo-derived 
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controls.  The expression patterns of key genes implicated in the regulation of folliculogenesis, 
oogenesis, embryogenesis and imprint establishment and maintenance will be used to 
investigate the normality of in vitro-derived samples.  Genes encoding key oocyte- and somatic 
cell-specific proteins will also be considered.  The third group of genes to be investigated 
include key imprinted genes encoding proteins that have been implicated as regulators of 
folliculogenesis, oogenesis and embryogenesis as well genes encoding enzymes responsible for 
the establishment and maintenance of the methylation patterns of imprinted genes.  The 
expression patterns of some of the candidate genes have previously been established in vivo in 
ovine follicles and oocytes as will be discussed in detail below.  
 
Commonly used markers of normality in vitro include assaying for the production of steroid 
hormones, such as E2 and P4, and peptides such as MMPs and TIMPs in the spent media 
(Newton et al., 1999b, McCaffery et al., 2000, Telfer et al., 2000).  Additionally, levels of steroid 
hormones, such as P4 and factors such as IL-1 and prolactin in the FF can be indicative of 
oocyte developmental competence  (Mendoza et al., 1999).  The level of thymidine 
incorporation is often used as a marker of somatic cell proliferation (Oktay et al., 1995).  
Tissue, follicle and oocyte quality can also be assessed using markers of apoptosis.  The use of 
TUNEL is common, however, is better used in combination with other apoptotic markers as 
this method detects DNA fragmentation, which is not solely observed in apoptotic nuclei 
(Fujino et al., 1996, Kockx et al., 1998).  Assessment of the expression of apoptotic genes, such 
as anti-apoptotic BCL2 and pro-apoptotic BAX and FAS and its ligand, FAS-LIGAND can also be 
used to determine oocyte normality (Liu et al., 2000).  Another hallmark of apoptosis is the 
translocation of phosphotidylserine from the inner to the outer layer of the cell membrane 
and this can be detected using annexin V staining (Van Engeland et al., 1998).  Fluorescence 
analysis of pro-apoptotic caspase activity can also be used as an apoptotic marker in oocytes 
(Perez et al., 1999). 
 
As discussed in Chapter 1 a number of studies have investigated the impact of IVG on gene 
expression, the results of which have shown that culture conditions can affect the expression 
of important regulatory genes (Sanchez et al., 2009, Sanchez et al., 2010, Sanchez et al., 2011, 
Jiao and Woodruff, 2013). 
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5.1.1 Somatic cell-specific genes 
The expression patterns of 8 primarily somatic cell-specific genes thought to be important in 
oogenesis and folliculogenesis have been determined throughout ovine follicular development 
in vitro and in vivo. The justifications for selecting these genes as candidates for developmental 
normality analysis are detailed below. 
 
The GC-derived factor- AMH, exerts an inhibitory effect on follicle development via its 
autocrine and paracrine actions on GCs and TCs, respectively.  AMH is expressed from the 
primary to the antral stage in mice, sheep and humans (Bezard et al., 1987, Durlinger et al., 
1999, Weenen et al., 2004, Bonnet et al., 2011).  The inhibitory effects of AMH have been well 
characterized in rodents with respect to the inhibition of follicle activation via suppression of 
the expression of genes encoding stimulatory factors (Durlinger et al., 1999, Weenen et al., 
2004).  Additionally, AMH decreases the sensitivity of antral follicles to FSH thus weakening the 
gonadotrophins’s effects.  In contrast, in sheep, AMH does not appear to inhibit primordial 
follicle recruitment, but rather the inhibitory effects of AMH are observed at later stages of 
follicle development with respect to the desensitisation of GCs and TCs to FSH and LH, 
respectively (Campbell et al., 2012).  
 
The actions of FSH are mediated through its transmembrane receptor, FSHR, expressed by GCs 
(Meduri et al., 2008).  The FSHR is a G-protein coupled receptor (Meduri et al., 2008).  Binding 
of FSH to its receptor promotes follicular development and the dependence on FSH for the 
continued development of antral follicles has been demonstrated in sheep (Campbell et al., 
1999).  Expression of the FSHR has been detected from the primary follicle stage onwards in 
sheep (Tisdall et al., 1995).  
 
One of the aims of the experiments in this chapter was to investigate the expression patterns 
of inhibins, activins and activin inhibitor – follistatin (FST) during ovine folliculogenesis.  
Studying the expression patterns of inhibins and activins is complex as these proteins are each 
composed of two subunits (Vale et al., 1988).  Inhibin A and B are composed of an α subunit 
and a βA or βB subunit, respectively.  Whereas activins are composed of only β subunits: 
activin A (βAβA), activin AB (βAβB) and activin B (βBβB).  Furthermore glycosylation of the 
subunits determines expression patterns and association of subunits (Antenos et al., 2007).  
The subunits comprising activin and inhibin as well as FST are expressed by GCs and act upon 
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the oocyte, GC and TC.  With respect to expression patterns in sheep, FST mRNA has been 
detected in GCs of preantral and antral follicles, the CL and the pre-ovulatory follicle, but at a 
reduced level in the latter (Tisdall et al., 1994).  Whereas α and βA subunit mRNA has been 
detected only in antral follicles.  Co-expression of these subunits in sheep forms inhibin A.  
Inhibin A production by the dominant follicle inhibits FSH release thus inhibiting the continued 
development of the subordinate follicles, as evidenced by a study in which the ablation of the 
dominant follicle leads to an acute decrease in inhibin A and a subsequent increase in FSH 
levels (Evans et al., 2002).  As inhibin B has not been detected in ovine FF the expression of the 
inhibin subunits in this experimental series will indicate the levels of inhibin A, activin A and 
activin B expression (McNeilly et al., 2002).  Briefly, activins in humans and rodents act to: 
increase GC proliferation and FSHR expression in both preantral and antral follicles; increase 
LHR expression; and to decrease both FSH-stimulated E2 and inhibin A production and LH-
stimulated androgen production in antral follicles (Knight et al., 2012).  In contrast, the role of 
inhibin is to promote androgen production indirectly, via the suppression of activin action 
(Knight et al., 2012).  Similarly, in sheep activin inhibits androgen production, whereas inhibin 
promotes it via inhibition of activin action (Young et al., 2012).  Follistatin blocks the actions of 
activin with respect to the inhibition of androgen production.  As follicle development 
progresses in humans and rodents the ratio of α subunit to β subunit expression increases thus 
the concentrations of activin relative to inhibin is higher in earlier stage follicles than in larger, 
antral follicles.  This is thought to prevent production of androgens in smaller follicles that may 
lead to premature differentiation of somatic cells (Knight et al., 2012).  In this chapter the 
expression pattern of the α, βA and βB subunits were analysed throughout ovine follicular 
development.  Determination of the expression pattern of activin is of particular interest as it 
has been used as a media supplement in a number of follicle culture systems and has been 
shown to promote follicle growth in vitro in bovine and human, see Chapter 1 (Thomas et al., 
2003, McLaughlin et al., 2010).  
 
The expression patterns of IGF1 and its receptor, IGF1R in ovine follicles were selected for 
analysis in this chapter.  The binding of TC-derived IGF1 to its receptor on follicular somatic 
cells promotes follicle development via the promotion of somatic cell proliferation and GC 
differentiation, with respect to FSHR expression (see Chapter 1) (Perks et al., 1995, Monget 
and Bondy, 2000).  The exact expression patterns of IGF1 and its cognate receptor in the early 
stages of preantral follicle development are yet to be elucidated as most research conducted 
has been concerning only the later stages of development, with follicles smaller than 2-4mm 
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grouped together (Perks et al., 1995, Spicer et al., 1995, Monget and Bondy, 2000).  The 
activity and bioavailability of both IGF1 and IGF2 are regulated by IGFBPs (Monget et al., 1993).  
 
5.1.2 Oocyte-specific genes 
As detailed in Chapter 1 oocyte-GC interactions are of vital importance to the continued 
growth and development of germ cells.  Although previously thought to play a passive role in 
its own development, increasing information is emerging that supports the oocyte’s role in 
regulating its own microenvironment and therefore its own development.  Numerous studies 
have been conducted into the role of 3 important oocyte-derived growth factors: GDF9, 
BMP15 and BMP6.  Briefly the role of these factors is to regulate the differentiation and 
proliferation of the somatic cells to ensure that this occurs at a rate that compliments oocyte 
growth and so ensures that the gamete is able to mature and achieve competence.  Much 
research has been conducted in a number of species concerning the roles of these growth 
factors, however, species-specific differences have been highlighted thus hindering the 
elucidation of the exact roles (Lin et al., 2012, Rouhollahi Varnosfaderani et al., 2013).  To 
summarise, in sheep both GDF9 and BMP6 are expressed by oocytes from the primordial stage 
and throughout antral follicle development, whereas BMP15 expression starts at the primary 
stage and progresses until ovulation.   
 
Briefly GDF9, BMP15 and BMP6 promote GC proliferation and regulate GC differentiation in 
the mouse, pig, cow sheep and human (Colonna and Mangia, 1983, Vanderhyden et al., 1992, 
Joyce et al., 2000, Otsuka et al., 2000, Vitt et al., 2000, Otsuka et al., 2001, Gilchrist et al., 2004, 
Dragovic et al., 2005, Hussein et al., 2005, Sugiura et al., 2005, Thomas and Vanderhyden, 
2006, Gilchrist et al., 2008, Su et al., 2008, Su et al., 2009).  In sheep GDF9, BMP15 and possibly 
to a lesser extent BMP6 have mitogenic effects on GCs.  Unlike in rodents, in which GDF9 alone 
is sufficient, both GDF9 and BMP15 are required to promote GC proliferation in sheep, as 
evidenced by the level of thymidine incorporation (Lin et al., 2012).  It is interesting to note 
that GDF9 derived from rodents is sufficient to increase thymidine incorporation in ovine GCs 
whereas ovine GDF9 is not.  Conflicting evidence exists regarding the mitogenic effects of 
BMP6.  In a study conducted by Juengel et al. (2006) BMP6 did not appear to promote GC 
proliferation.  The authors, however, suggested that this might be due to the timing, culture 
length or conditions and highlight the fact that localization of BMP6 suggests that this factor 
does play a mitogenic role.  Furthermore, in a study conducted by Campbell et al. (2009) BMP6 
did appear to have a mildly mitogenic effect on GCs. 
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In mice GDF9 has been shown to promote CC mucification and expansion, however, in a recent 
study exogenous GDF9 did not affect the expression of genes, such as HAS2 linked to the 
aforementioned processes (Rouhollahi Varnosfaderani et al., 2013).  Nor was the expression of 
apoptotic genes greatly affected by the addition of exogenous GDF9.  Authors suggest that 
although GDF9 may play a minor role in these processes it is likely that other factors, such as 
BMP15, play a more important role.  Indeed in a recent study ewes were immunized against 
BMP15 resulting in increased levels of cAMP, which were associated with increased levels of 
CC luteinisation, suggesting that BMP15 inhibits CC luteinisation (Juengel et al., 2011). 
 
Oocyte-derived factors GDF9 and BMP6 in sheep regulate GC differentiation with respect to 
the production of steroid hormones and inhibin.  Ovine GDF9 has been shown to both inhibit 
the FSH-stimulated production of P4 and to stimulate inhibin A production by GCs (McNatty et 
al., 2005).  Whereas ovine BMP15, either alone or in combination with GDF9, did not affect P4 
or inhibin production by GCs (McNatty et al., 2005).  The mechanism of BMP6 action on GC 
differentiation has not been fully elucidated in sheep.  That fact that BMP6 regulates follicle 
development has been evidenced by its regulation of ovarian steroid hormones, A4, P4 and E2, 
and inhibin A production.  In sheep BMP6 inhibits P4 production but promotes E2 and inhibin A 
production by GCs (Juengel et al., 2006, Campbell et al., 2009).  The effect of BMP6 on A4 
production by TCs is dose-dependent and is stimulatory at low concentrations but inhibitory at 
high concentrations (Campbell et al., 2009, Webb and Campbell, 2006).  The promotion of A4 
production at low BMP6 levels may occur via the promotion of TC proliferation, thus increasing 
the number of cells producing this hormone.  It is also important to note that the effects of 
BMP6 on the production of E2, A4 and inhibin A are transitory (Campbell et al., 2009).  In 
addition, the actions of BMP6 are also dependent upon the concentrations of IGF1 with 
respect to the promotion of the differentiative actions of FSH (Webb and Campbell, 2006). 
 
The transcription factor FOXO3 is expressed by the oocytes of primordial and primary stage 
follicles in mice (Castrillon et al., 2003).  Less information exists regarding the exact expression 
patterns of FOXO in sheep and pigs however, it has been shown to be expressed by the 
oocytes of preantral follicles in both species (Baillet et al., 2008, Ding et al., 2010).  As FOXO is 
an inhibitor of primordial follicle activation elucidation of its expression patterns in ovine 
follicles both in vivo and in vitro may indicate why higher levels of follicular activation are 
observed following cortical culture (Liu and Lehmann, 2006).  Expression of GTSF1 in human, 
ovine, bovine and murine oocytes has been detected throughout oogenesis, with the highest 
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levels of expression in secondary GV oocyte (Krotz et al., 2009, Lu et al., 2009, Liperis et al., 
2013, Liperis, 2014).  The localization of GTSF1 has implicated it as a potential regulator of 
oogenesis and folliculogenesis.  In contrast to male murine Gtsf1 mutants which are infertile, 
the fertility of female mutants does not seem to be affected (Yoshimura et al., 2009).  
Knockdown of GTSF1 in ovine oocytes however, resulted in the genes associated with 
processes such as post-translational modification and cytoskeleton organisation being down-
regulated, which led authors to conclude that GTSF1 may be involved in ‘post-transcriptional 
control of RNA processing, translational regulation and RNA storage’ (Liperis et al., 2013, 
Liperis, 2014). 
 
The composition of the ZP has been well characterized in a range of species including human 
and mouse (Wassarman, 1988, Lefievre et al., 2004, Gupta and Bhandari, 2010).  Zona 
pellucida formation occurs at the primary stage in mice and humans (Zamboni, 1974, Epifano 
et al., 1995), see Chapter 1 for the composition and expression patterns of the ZP proteins.  
Information regarding the composition of the ovine ZP is however, scarce.  Therefore the 
expression patterns of ZP proteins by the ovine oocyte are of value as an index of oocyte 
development. 
 
5.1.3 Imprinted genes and the regulation of epigenetic modifications 
The expression of imprinted genes is regulated by epigenetic modifications to the DNA (Qiu, 
2006).  The establishment of these modifications occurs during gametogenesis and following 
fertilisation.  Therefore determining the in vivo expression patterns of imprinted genes known 
to be important for oogenesis and folliculogenesis and comparing these to patterns observed 
in follicles derived in vitro is of particular interest as there are concerns (discussed in Chapter 
1) that long-term culture and/or the use of IVG and micromanipulation techniques could result 
in epigenetic disruption (Amor and Halliday, 2008).  One form of epigenetic modification is the 
methylation of cytosine residues (Reik et al., 2001).  The establishment and maintenance of 
DNA methylation requires DNA methyltransferases (DNMTs), therefore the expression 
patterns of 2 forms of these key enzymes identified in sheep will also be analysed, DNMT1 and 
its splice variant DNMT1(12b).  DNA methyltransferase 1 (DNMT1) was first detected in mice. It 
was found to maintain methylation patterns in hemimethylated regions, and also to exhibit 
some de novo activity (Goll and Bestor, 2005).  Disruption of DNMT1 expression in the mouse 
has lead to H19 expression by both alleles and IGF2 and IGF2R expression by neither allele (Li 
et al., 1993).  The expression patterns of H19, IGF2 and IGF2R will also be analysed in this 
184 
 
 
 
chapter.  An oocyte-specific form, DNMTo was identified in mice and found to be vital for 
embryogenesis.  Similarly both somatic- and oocyte-specific forms of DNMT1 have been 
identified in humans (Bestor, 2000, Hayward et al., 2003).  In the porcine model 3 DNMT1 
isoforms have been identified – DNMT1o1, DNTMT1o2 and DNMT1s, all of which are 
expressed by the oocyte, but only DNMTs is expressed by somatic cells (Giraldo et al., 2013).  
In the ovine model two DNMT1 isoforms- DNMT1s and DNMT1(12b) have been identified, 
both of which are expressed by somatic cells and oocytes, unlike that observed in humans and 
mice (Taylor et al., 2009).  Disruption of DNMT1(12b)- a splice variant of DNMT1, caused arrest 
of embryonic development thus indicating that it is likely to be the main isoform present which 
is required to maintain methylation patterns.  In addition, higher levels of DNMT1(12b) were 
detected in GV oocytes than at later embryonic stages.  This led authors to conclude that 
DNMT1(12b) is the main DNMT1 isoform in the oocyte, therefore from here on in it will be 
referred to as DNMT1o.  One of the aims of this experimental series is to determine the 
expression patterns of ovine DNMT1s and DNMT1o throughout follicle development in vivo 
and in vitro. 
 
As alterations to the methylation status of imprinted genes can be caused by ARTs and the fact 
that imprints are established during gametogenesis suggests that the use of IVG may 
potentially alter oocyte methylation patterns and therefore the expression of imprinted genes, 
see Chapter 1.  Differences in expression levels of imprinted genes between in vivo and in vitro 
derived oocytes may indicate aberrations in methylation patterns.  The expression patterns of 
paternally imprinted H19 and IGF2R, and maternally imprinted MEST and IGF2 during ovine 
folliculogenesis were therefore analysed.   
 
Alterations in the methylation status of these 4 imprinted genes have been associated in 
epigenetic disorders SRS and BWS as well as male sub/infertility (Chapter 1 and Chang et al. 
(2005).  The use of mouse models has enabled the elucidation of 2 roles for H19.  It is both a 
tumour suppressor gene and a regulator of the expression of other imprinted genes, including 
IGF2 and its receptor (Gabory et al., 2010).  The methylation status of a DMR between IGF2 
and H19 determines which gene is expressed on that allele, as both use the same set of tissue-
specific enhancers and the genes are therefore co-ordinately transcribed throughout 
embryonic development. In the maternal allele the DMR is demethylated therefore the 
enhancers favour the expression of H19 over IGF2 (Cerrato et al., 2003).  The methylation 
status of the DMR is established during oogenesis.  Binding of IGF2 to its receptor elicits a 
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response required for normal fetal growth (Obata et al., 1998).  The actions of IGF2 are 
reviewed in detail in Chapter 1.  Briefly IGF2 stimulates mitosis, DNA synthesis, steroidogenesis 
in GCs and TCs and nuclear maturation of the oocyte. 
 
5.1.4 Aims 
The first aim of this experimental series was therefore to map the normal expression patterns 
of key genes implicated in the regulation of folliculogenesis, oogenesis, embryogenesis and 
imprinting establishment and maintenance in ovine follicles and oocytes grown in vivo.  This 
work established the normal pattern of gene expression as a marker of oocyte and follicle 
development in vivo which could be used as a bench mark for gene expression following 
growth in vitro.  Secondly, the expression patterns of the same genes were investigated in in 
vitro-derived follicle somatic cells and oocyte samples in order to determine the impact of 
extended serum-free culture on gene expression.  The third aim of the experiment was to 
directly compare stage-matched in vivo- and in vitro-derived samples to determine whether 
the in vitro growth of oocytes lead to changes in gene expression, within specific follicle 
classifications.  The IVG-derived follicles and oocytes analysed here were archived from the 
studies reported in Chapter 3. 
 
5.2 Materials and Methods 
This experimental series was conducted to compare the expression patterns of genes key to 
oocyte and follicle growth, development and health in in vivo- and in vitro-derived follicles and 
oocytes.  A summary of the classifications of follicles analysed is shown in Table 5.1.  It was not 
possible to obtain in vivo- and in vitro-derived counterparts for all follicle classifications studied 
as the starting point for all the proposed studies were in vivo-derived primordial follicles.  
Similarly, MII oocytes and cumulus cells were obtained following 24 hours of maturation in 
vitro.  No in vivo-derived MII oocytes were available for study.  The in vitro-derived primary, 
transitional and secondary follicles refer to follicles isolated following long-term (16-23 day) 
cortical culture as detailed in Chapter 3.  The term secondary degenerating refers to follicles 
that were isolated from fresh tissue then put into isolated preantral follicle culture where they 
then started to degenerate as evidenced by either a decrease in diameter or no increase in 
diameter after 3 consecutive media changes, as described in Chapter 3.  Early antral follicles 
were derived in vitro from in vivo-derived secondary follicles as detailed in Chapter 3.   
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Table 5.1 A summary of in vivo- and in vitro-derived samples analysed in this experimental 
series.  The total number of oocytes and follicles used and the number of cells pooled per 
sample is shown.  With respect to the number of CC samples this refers to the number of COCs 
from which samples were obtained.  Samples which could not be obtained are denoted using -.
 Follicle Classification In vivo- derived In vitro- derived 
Total Number per sample 
(Number of replicate 
samples/stage) 
Total Number per sample 
(Number of replicate 
samples/stage) 
Primordial 120 40 ( 3 ) - - 
Primary 40 10 ( 4 ) 24 10,10, 4 (3) 
Transitional 20 5 (4) 24 10, 5, 5, 4 (4) 
Secondary 40 10 (4) 17 10, 5, 1, 1 (4) 
Secondary degenerating - - 21 9, 5, 4, 3 (4) 
Whole EA follicle 4 1 (4) 4 1 (4) 
GV Oocyte 12 3 (4) x x 
GV CC 12 3 (4) x x 
MII Oocyte x x 20 5 
MII CC x x 4 1 
 
 
Figure 5.1 A diagrammatic representation of the set-up of the plates used (a) to denude COCs 
from GV and MII oocytes and (b) for IVM.  All media in the plates was pre-warmed to 37°C and 
pre-gassed.  In plate (a) the COCs were first transferred to an outer drop and rinsed in fresh 
medium, then transferred to a second drop in which a Flexipet with a 130µm tip attached was 
used to denude the oocyte, by repeatedly pipetting until all somatic cells had been removed.  
Denuded oocytes and counterparts were then washed a further 3 times in the central wells.  
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5.2.1 Collection of samples for molecular analysis 
All in vivo-grown, preantral follicle isolations were carried out in pre-warmed FIM (37°C), as 
described in Chapter 3, Section 3.2.2, with care being taken to remove all stromal tissue.  In 
order to obtain denuded GV oocytes and their CC counterparts 21G needles attached to 5ml 
syringe where used to trim GCs from the EA follicle.  Follicles were then transferred to a sterile 
Petri dish, set up as shown in Figure 5.1 (a), denuded and washed.    
 
5.2.2 In vitro-maturation of oocytes 
GV oocytes, in vitro-derived MII oocytes and their counterpart unexpanded and expanded CCs, 
respectively, were obtained as follows.  Ovaries were obtained as described in Sections 2.1 and 
2.2.  Ovaries were transferred to pre-warmed FIM (see Appendix I).  All processing of the tissue 
was carried out under laminar flow conditions and on a heated stage (37°C).  Antral follicles of 
approximately 2-5mm diameter were aspirated using a sterile 20ml syringe and 19G needle.  
The entire contents of the aspirate, i.e. the cumulus-oocyte complexes (COCs) and follicular 
fluid, was transferred to a sterile 90mm Petri dish.  In order to obtain the GV and counterpart 
GV-CC samples ~20-30 ovaries were used per collection, for 4 replicate collections.   
 
Table 5.2  Composition of IVM culture media.  The volumes required to make a 10ml solution 
are shown, with the stock and final concentrations as detailed.  The solution was filtered and 
stored for up to 1 week.  See Appendix I for details of the preparation of the basal culture 
media and additive stocks. 
 Additive 
Volume 
(μl) 
Stock 
Concentration 
Final 
Concentration 
Basal culture media (see Appendix I) 9.768ml 
  Bovine holo-transferrin 10 5 mgml-1 5 μgml-1 
Sodium Pyruvate 100 47mM 0.47mM 
Sodium Selenite 1 50μgml-1 5ngml-1 
L-glutamine 100 200mM 2mM 
Bovine Insulin 10 10μgml-1 10ngml-1 
Human Long-R3 IGF-1 1 100μgml-1 10ngml-1 
Ovine FSH 5 2iUml-1 0.001iUml-1 
Ovine LH 5 2iUml-1 0.001iUml-1 
 
For the in vitro-derived MII oocytes this was repeated for ~30-50 ovaries per IVM culture for 2 
replicate cultures.  Cumulus-oocyte complexes with homogenous cytoplasm and 3-4 layers of 
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cumulus cells were selected and transferred to a 4-well Nunc dish containing fresh, pre-
warmed FIM, before being washed a third time in fresh FIM.  Finally COCs were transferred to 
a second, 4-well dish containing ~50μl of pre-warmed and gassed in vitro-maturation (IVM) 
medium per COC, the composition of which is shown in Table 5.2.   
 
A 90mm Petri dish was set-up as shown in Figure 5.1(b).  Five COCs were added to each 20µl 
drop of IVM media.  Plates were transferred to an incubator set at 38.6°C for 22-24 hours.  
Following this incubation period COCs were transferred to plates set up as shown in Figure 5.1 
(a).  In the first well needles (21G) were used to trim CCs from the oocyte.  The oocytes were 
then transferred to a separate 90mm Petri dish containing 20µl drops of pre-warmed (37°C) 
80IUml-1 hyaluronidase (see Appendix III) overlaid with pre-warmed mineral oil, using a 
Flexipet with a 140µm tip attached.  The COCs were pipetted up and down 5-10 times for a 
maximum of 60 seconds to remove all CCs.  The fully denuded oocyte was then transferred to 
the second well on the original plate (Figure 5.1).  The oocytes were then examined to 
establish their meiotic stage, which was indicated by the presence or absence of a polar body.  
If a polar body was observed the oocyte and counterpart CCs were used for molecular analysis.  
Following isolation, and if relevant, denudation samples were washed 3 times in Dulbecco’s 
PBS (Gibco® 14190-136, Invitrogen), snap frozen using liquid nitrogen in 10µl lysis buffer (see 
Appendix I), in thin-walled Eppendorf tubes, then stored at -80°C until analysed. 
 
5.2.3 Gene specific primer design 
The National Centre for Biotechnology Information website (http://www.ncbi.nlm.nih.gov/) 
was used to obtain sequence information required to design gene specific primers.  A search 
for the mRNA sequence information of each gene of interest for sheep was carried out, which 
could then be used to design primers within an appropriate coding region.  If sequence 
information for a particular gene of interest did not exist for sheep, the information for bovine, 
human or mouse was used as appropriate.  Primers pairs of around 20 base pairs (bp) in 
length, as this length is sufficient to ensure only the target gene is amplified due to the level of 
homology, were selected manually to ensure similar annealing temperatures.  Primer pairs 
were then ordered from Invitrogen Ltd (http://www.lifetechnologies.com/uk/en/home.html).  
The 3 housekeeping genes selected, see Table 5.3 were as recommended by O'Connor et al. 
(2012) to ensure accurate, relative quantification of transcript abundance in ovine 
oocytes/follicles.  The housekeeping genes were glyceraldehyde-3-phosphate dehydrogenase 
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(GAPDH), tyrosine 3-monooxygenase/ tryptophan 5-monooxygenase activation protein, zeta 
polypeptide (YWHAZ) and histone 2 alpha (H2A) (Radonid et al., 2004, Nygard et al., 2007). 
 
Table 5.3 Real time housekeeping primer sequences. 
Gene Primer sequence Size (base pairs) Reference/ 
Species 
GAPDH F: 5’ TGATTCCACCCATGGCAAGT 3’ 93 AF030943 
(ovine) 
R: 5’ CGCTCCTGGAAGATGGTGAT 3’ 
H2A F: 5’ GAGTAGGCGGCTGGTTCTC 3’ 109 AY074805 
(ovine) 
R: 5’ GGAGTCCTTCCCAGCCTTAC 3’ 
YWHAZ F: 5’ACTGGGTCTGGCCCTTAACT3’ 98 NM_00126788
7.1 (ovine) 
R: 5’TGGCTTCATCAAATGCTGTC3’ 
 
Table 5.4 Real time somatic cell-specific gene primer sequences. 
Gene Primer sequence Size (base pairs) Reference/ 
Species 
AMH F: 5’ TGGTGCTGCTGCTAAAGATG 3’ 99 NM173890 
(bovine) 
R: 5’ GACAGGCTGATGAGGAGCTT 3’ 
FSHR F: 5’ CAGGACAGCAAGGTGACAGA 3’ 188 NM1009289 
(ovine) 
R: 5’ GGCAGGTTGGAGAACACATT 3’ 
IGF1 F: 5’GATGTACTGTGCGCCTCTCA3’ 120 NM_00100977
4.3 (ovine) 
R: 5’GCACTCCCTCTGCTTGTGTT3’ 
IGF1R F: 5’AGCCCGAGAACATGGAGAG3’ 91 AF025303.1 
(ovine) 
R: 5’TCAGCCTTGTGTCCTGAGTG 
INHα F: 5’GAGCCCGAGGACCAAGATGTCTCC3’ 91 NM_174094.3 
(bovine) 
R: 5’CCTCAGCCTCTCCAGCATCTGGC3’ 
INHβA F: 5’ACCCTCCCAAAGGATGTACC3’ 94 NM_174363.1 
(bovine) 
R: 5’CGGGTCTCTTCTTCAAGTGC3’ 
INHβB F: 5’ATGGCCTGGCCTCCTCCCG3’ 101 NM_176852.1 
(bovine) 
R: 5’CTTCAGGTAGAGCCACAGGCTGGC3’ 
FST F: 5’CAACACGCTCTTCAAGTGGA3’ 85 NM_00125709
3.1 (ovine) 
R: 5’ACAGTCCACGTTCTCACACG3’ 
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Table 5.5 Real time oocyte-specific gene primer sequences. 
Gene Primer sequence Size (base 
pairs) 
Reference/ 
Species 
ZP2 F: 5’GCCCCAGTTGTCTCTCACTT3’ 113 XM_00402082
7.1 (ovine) 
R: 5’CTGCTTCTGGATGACCCAAG3’ 
GDF9 F: 5’ AGTAAGCTGGAACCGGAATCG 3’ 95 AF078545 
(ovine) 
R: 5’ GGTGGCCGACAAGAGAAGTCT 3’ 
GTSF1 F:5’CTCTGGACCCTGAAAAGCTG3’ 120 NM_00103427
3.2 (bovine) 
5’GTTTGTTTGCGACATCAGGA3’ 
BMP6 F: 5’TGTGACGGAGAATGTTCGTT3’ 83 XM_00401936
0.1 (ovine) 
R: 5’ATGAGGTGAACCAGGGTCTG3’ 
BMP15 F: 5’GGCAAAAGCTCTGGAATCACA3’ 102 NM_00111476
7.1 (ovine) 
R: 5’TGCCATGCCACCAGAACTC3’ 
FOXO3 F: 5’ATGGGAGCTTGGAATGTGAC3’ 120 NM_00126788
9.1 (ovine) 
R: 5’CCACGTTCAAACCAACAACA3’ 
 
Table 5.6 Real time imprinted genes primer sequences. 
Gene Primer sequence Size (base 
pairs) 
Reference/ 
Species 
IGF2 F: 5’TTCTGCCAAGTGACACCATC3’ 87 NM_00100931
1.1 (ovine) 
R: 5’GGACGGTACAGGGATTTCAG3’ 
IGF2R F: 5’ATGCTTTCATCATCCGCTTC3’ 91 AF353513.1 
(ovine) 
R: 5’ATCCCCAGGCTAGAGTCGAT3’ 
MEST F: 5’AGCCTCTGTGCCAGAGATTTA3’ 113 XM_00400807
0.1 (ovine) 
R: 5’CTAGCTCAGGAGGGACATGC3’ 
H19 F: 5’CCCTCCTTTCCCTCTTTTTC3’ 83 AF105429.1 
(ovine) 
R: 5’GCTCTGGACGCTCTGAGTCT3’ 
DNMT1o F: 5’CAATTCACATATCAAAGTACCAGCA3’ 83 FJ976676.1 
(ovine) 
R: 5’CGAGTCATTTTCTTCTCAGTTAGTTC3’  
DNMT1s F: 5’AGCCTGAAAGAGCAAAACCA3’ 110 EF601875.1 
(ovine) 
R: 5’CGAGTCATTTTCTTCTCAGTTAGTTC3’  
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5.2.4 mRNA isolation 
Procedures from previously described protocols were modified and used as these methods 
enabled the creation of cDNA libraries from very small numbers of cells (Huntriss et al., 2002, 
Huntriss et al., 2004).  Isolation of mRNA from the in vivo- and in vitro-derived samples was 
achieved as follows.  Cells were completely lysed by heating samples from -80°C to 80°C for 20 
minutes, using an Applied Biosystems® 60 well Thermal Cycler (Life Technologies, Paisley, UK).  
Reagents from Dynabeads® mRNA DIRECTTM kit (Invitrogen) were warmed to room 
temperature prior to use.  A 20μl volume of Dynabeads® Oligo(dT)25 per sample was 
transferred to a sterile microcentrifuge tube in a Dynal-MPC®, Magnetic Particle Concentrator 
(Invitrogen, Ltd), resulting in the beads concentrating against the back of the tube thus 
allowing the supernatant to be removed using a pipette.  The beads were then washed twice 
in a volume of Dynal® Lysis Buffer equal to that of the volume of beads originally used.  A final 
volume of Dynal® Lysis Buffer was then added and the beads re-suspended then 20μl added to 
each sample following lysis.  The tubes were then transferred to a blood wheel (Baird and 
Tatlock (London) Ltd, Romford, UK) and rotated for 20-30 minutes at room temperature.  This 
allowed the oligo(dT)25 on the magnetic beads to bind to the poly(A) tail of the mRNA sample.  
Samples were then briefly centrifuged then washed 3 times with 100μl of buffer A, then 100μl 
of buffer B (supplied by the Dynabeads® mRNA DIRECTTM kit), prior to resuspension in 3μl of 
sterile RNAse/DNase free water.  Samples were then stored at -80°C until future use.   
 
5.2.5 cDNA synthesis 
Procedures previously described were modified and used to design primers (see Table 5.7) and 
create cDNA libraries (Eberwine et al., 1992, Wang et al., 2000).  A 20μl volume of reaction mix 
per sample containing; 4μl (5x) first strand reaction buffer, 1μl diothiothreitol (DTT;0.1M), 1μl 
dNTP mix (10mM), 1μl RNAse outTM, 1μl Superscript reverse transcriptase RNase-H (200Uμl-1) 
and 10μl RNase/DNase-free water, plus 1μl of both the Oligo(dT)24 primer and template 
switching primer to give a final concentration of 10pM, was prepared at room temperature, 
then added to the sample.  All reagents were supplied by Invitrogen Ltd.  The sample with the 
added reaction mix was then heated to 42°C for 90 minutes, then cooled to 4°C for 2 minutes, 
using an Applied Biosystems® 60 well Thermal Cycler.  
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Table 5.7 The primer sequences used for cDNA synthesis.  The oligo(dT)24 primer binds the 
mRNA poly(A) tail and the template switching primer ensures the transcription of full length 
transcripts only. 
 Primer Sequence 
Oligo(dT)24 primer AAACGACGGCCAGTGAATTGTAATACGACTCACTATAGGGCGCT
TTTTTTTTTTTTTTTTTTTTTTT 
Template switching primer AAGCAGTGGTATCAACGCAGAGTACGCGGG 
 
5.2.6 Amplification of cDNA using long distance PCR 
As the initial amount of cDNA in the samples was very low, amplification using long distance 
(LD) PCR was required.  A volume of 30μl LD reaction mix containing: 5μl 10x Advantage 2 PCR 
buffer, 1μl 50x Advantage 2 Polymerase Mix (both Takara Bio Europe/ Clontech), 1μl dNTP mix 
(10mM), 21μl DNase/RNase free water (Invitrogen) plus 1μl of both the Oligo(dT)24 primer and 
template switching primer to give a final concentration of 10pM, was prepared at room 
temperature, then added to the 20μl cDNA library.  Using an Applied Biosystems® 60 well 
Thermal Cycler samples were heated to 95°C for 2 minutes, followed by 35 cycles of 95°C for 
30 seconds and 6 minutes at 65°C, before cooling and holding at 4°C overnight.  Samples were 
then stored at -20°C until future use.  
 
5.2.7 Verification PCR 
Housekeeping gene primers for GAPDH and YWHAZ genes were used to ensure the successful 
creation of a cDNA library.  All reagents were supplied by Invitrogen Ltd unless specified 
otherwise.  A 1μl sample of the LD PCR product was added to a verification PCR reaction mix 
containing 14.9μl DNase/RNase free water, 2μl 10x NH4 Reaction Buffer, 0.6μl MgCl2 (50mM), 
0.8μl dNTP mix (10mM), 0.1μl of both the forward and reverse housekeeping primers plus 1μl 
Taq Polymerase source.  A positive control was set up in which a 1μl sample of an ovine 
ovarian cortex cDNA library containing a range of follicles and somatic tissue was added to the 
reaction mix.  A negative control was also set-up which consisted of the verification PCR 
reaction mix with no added cDNA.  Using an Applied Biosystems® 96 well Thermal Cycler 
samples were heated to 95°C for 5 minutes, followed by 40 cycles of 95°C, 60°C, 72°C for 30 
seconds each, then holding at 72°C for 10 minutes.  Samples were then stored at -20°C until 
future use.  
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5.2.8 Agarose gel electrophoresis 
A 1% (w/v) agarose gel was prepared as detailed in Appendix III.  Following verification PCR 4μl 
gel loading buffer (see Appendix III) was added to each 20μl cDNA sample and mixed, then 
12μl of each was added to the individual wells of the sample.  A 5μl volume of Quick-Load® 
100bp DNA ladder (New England Bio Labs Ltd., Hitchin, UK) was added to one well to aid the 
determination of fragment size in the cDNA samples.  Gels were run in a Sub Cell GT connected 
to a Powerpac 300 (Bio-rad Laboratories Ltd, Hemel Hempstead, UK), through 1x 
trisaminomethane, borate, EDTA (TBE) electrophoresis buffer (see Appendix III) at 90V for 60 
minutes.  The gel was transferred to the molecular imager Gel DocTM XR+ imaging system (Bio-
Rad; CA, USA) to check for the presence of bands corresponding to either GAPDH or YWHAZ 
expression, and an absence of bands for the negative control.  If bands of the correct size were 
present then the cDNA samples were used as libraries.  If bands were not present where 
appropriate the cDNA samples were discarded.  All gel images were captured using Image 
LabTM Software version 2.0 (Bio-Rad). 
 
5.2.9 Real time PCR (RT PCR) analysis 
A 480 Lightcycler (Roche, West Sussex, UK) and SYBR green technology (Applied Biosystems®) 
were used to perform real time PCR (RT PCR) analysis.  Amplification of the cDNA in each 
sample for 40 PCR cycles was used to increase the amount of cDNA per sample exponentially.  
The SYBR green assay enabled the quantification of the amount of double stranded nucleic 
acids present relative to housekeeping genes.  The web-based programme, primer3, 
(http://primer3.sourceforge.net/) was used for primer design (Rozen and Skaletsky, 1999).  
Primers with a melting temperature of around 60°C and around 20 base pairs in length were 
selected.  The primer information for somatic cell-specific and oocyte-specific genes, genes 
involved in imprinting are shown in Tables 5.4, 5.5 and 5.6. Forward and reverse primers for 
each gene were dissolved in RNase/DNase free water (Invitrogen) to give a final concentration 
of 100μM.  The forward (F) and reverse (R) primers were then combined and diluted to a final 
concentration of 0.25μM using RNase/DNase free water in a 1.5ml microcentrifuge tube.  A 
number of primers were designed which successfully and specifically amplified cDNA however, 
when used for RT PCR analysis of the melting curve along with high levels of expression in 
negative samples lead to these genes being excluded from the study: primer design detailed in 
Appendix III. 
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The reaction mix used for the RT PCR was composed of 12.5μl SYBR green master mix (Applied 
Biosystems), 5μl of 50 times diluted test template, 5.5μl DNase/RNase free water and 2μl of 
0.25μM primer.  The reaction mix was loaded into 96 well PCR plates for 480 Lightcycler 
(Roche) then the plates were covered in sealing foil (Roche).  Three replicates were analysed 
for each primer set and sample combination on the same 96 well plate.  Four staged libraries 
were analysed for each follicle/ oocyte/ somatic cell classification.  A representative image of 
the output data following a completed RT PCR is shown in Figure 5.2.  Melting curve analysis 
was performed following the completion of RT PCR to ensure that unspecific amplification had 
not taken place.  The presence of multiple peaks indicated that non-specific amplification had 
occurred as the mixture was heated and cooled allowing the release of SYBR green dye from 
the PCR products, therefore if products were present at different melting temperature this 
indicated the presence of multiple products.  A clear single peak on the melting curve indicated 
the presence of a single PCR product and therefore a specific amplification as shown in Figure 
5.3.  The efficiency of every primer pair was not checked individually as there were so many; 
however, as the same primer pairs were used in all samples then they should exhibit the 
standard level of efficiency each time. 
 
 
Figure 5.2 A representative image of the output data obtained for GAPDH following a RT PCR 
experiment, with each line representing a separate sample. 
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Figure 5.3 A representative image of the melting curve obtained for 3 repeats of a sample in 
which the primers showed high specificity.  The absorbance value at a given temperature is 
shown for each sample.  In this image the amplified gene is GAPDH.  
 
5.2.10 Normalisation of data using RT PCR 
Due to the nature of the study regarding the collection of in vitro-derived samples being 
dependent upon the follicle yield of each culture, which was very variable, the number of 
follicles and oocytes collected in each sample and therefore the amount of transcript in each 
sample varied.  The 3 house keeping genes that were selected - GAPDH, H2A and YWHAZ (see 
Table 5.3) were used to standardise samples on the basis that the transcript levels of each of 
these should be similar within each oocyte or follicular somatic cell.  The cycle threshold (Ct) 
value, the number of RT PCR cycles at which the levels of fluorescence crosses the threshold 
was determined for all genes for all samples.  Three repeats were conducted for each sample 
and the mean calculated per sample.  The geometric mean of the mean Ct values of the house 
keeping genes was calculated for each sample as shown in Equation 1.  
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Equation 1 
Geometric mean(HK genes) = (mean Ct(GAPDH)*mean Ct(H2A)*mean Ct(YWHAZ))^(1/3) 
 
Using the geometric mean of the housekeeping genes for each sample the change in Ct value 
(ΔCt) for each gene of interest (GOI) was calculated as shown in Equation 2, then the value of 
2(ΔCt) was calculated for each GOI.  Where HK = housekeeping gene, mean = arithmetic mean 
and * = multiply.  
 
Equation 2 
ΔCtGOI-HK = mean Ct(GOI)- geometric mean(HK genes) 
 
A reference sample with relatively low levels of variability within all genes tested was selected 
and used as a standard from which the ΔΔCt(GOI) could be calculated, as shown in Equation 3.  
The sample selected was sample 1 of in vivo-derived secondary follicles, against which all other 
samples, including the 3 other in vivo-derived samples, were compared.  The ratio of 
INHα:INHβA expression was also calculated for each sample. 
   
Equation 3 
ΔΔCtGOI-HK relative to in vivo secondary 1 = 2
(ΔCt GOI-HK)/ 2(ΔCt Reference-HK) 
 
5.2.11 Statistical analysis 
Statistics were performed using the Minitab 15 statistical programme (Minitab limited, UK).  
The Anderson-Darling test was used to determine whether the data was normally distributed.  
As the majority of the gene expression data was not normally distributed it was necessary to 
transform the data using log10(1+ΔΔCtGOI-HK relative to in vivo secondary 1) and present data in 
this way ± SEM  per sample repeat.  The ratio of INHα:INHβA expression is presented as the 
mean ± SEM per sample repeat.  Levels of gene expression were compared between samples 
using one-way ANOVA.  When data yielded significance, comparisons between samples were 
conducted using Fisher’s post hoc test.  In all analyses p<0.05 was considered to be statistically 
significant.  
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5.3 Results 
In this experimental series the expression patterns of candidate genes that have been 
identified as important regulators of follicle and oocyte growth and development were 
established in vivo and in vitro, at various stages of follicle and oocyte development.  Genes 
were classified as somatic cell-specific, oocyte-specific or imprinted, based on results from 
previous publications.  The gene expression patterns in in vivo-derived samples were used to 
determine patterns of normality across oocyte and follicle development.  Expression patterns 
in in vitro-derived samples were then analysed.  Note that the samples differ in the in vivo- and 
in vitro-derived groups, as it was not always possible to obtain equivalent sample numbers, see 
Section 5.2.  Classifications of follicles for which equivalent in vitro- and in vivo-derived 
samples had been obtained were directly compared, with respect to the expression patterns of 
the selected genes.  Changes in the relative patterns of gene expression across the different 
developmental stages were also investigated.  The validation of all primer sets used is shown in 
Figure 5.4. 
 
5.3.1 Expression patterns of key somatic cell-specific genes 
Firstly, the expression patterns of key somatic cell-specific genes were considered; see Figures 
5.5, 5.6 and 5.7.  Levels of AMH expression varied in vivo with statistically higher (p=0.015) 
levels of expression being detected in transitional follicles and GV CCs, than primordial and EA 
follicles or GV oocyte samples, see Figure 5.5.  These discrete variations in expression pattern 
were not seen to such a great an extent in the in vitro-derived samples, however, there was a 
trend towards significance (p=0.083), with MII oocytes and CCs being the biggest contributors 
as the level of expression of AMH in these groups was much lower than in the other samples 
analysed, see Figure 5.6.  Direct comparison of AMH levels, in stage matched in vivo- vs. in 
vitro-derived samples, revealed that in levels of AMH expression in EA follicles were 
significantly higher (p=0.007) in the in vitro-derived samples, see Figure 5.7.  Note that the 
higher expression levels of AMH in in vivo-derived primary and transitional samples 
approached significance (p=0.082 and p=0.065, respectively). 
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Figure 5.4 Validation of primers.  Representative images of each primer set with a positive and 
negative control and the position of the band with respect to the DNA ladder.  Positive 
controls contained cDNA from a range cell types in cortical tissue, including oocytes and 
follicular somatic cells.  Negative controls contained water in place of cDNA.  
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Figure 5.5 Histograms mapping the changing expression patterns of key somatic cell-specific 
genes- AMH, FSHR, IGF1, IGF1R, INHα, INHβA, INHβB and FST in in vivo-derived samples.  Data 
is presented as log10 (mean expression relative to the level of expression in the control in vivo-
derived secondary sample) ± SEM for 4 independent samples.  Levels of expression were 
compared using one-way ANOVA.  Statistically significant differences (p<0.05) are indicated 
using different letters.  For example, in (a) the values obtained for primordial, primary, 
secondary, EA and GV oocyte samples are not significantly different (p>0.05), nor are the 
values for primary, transitional, secondary and GV CC samples.  The values for primordial, EA 
and GV oocyte samples are, however, significantly different (p<0.05) from those obtained for 
transitional and GV CC samples.  This applies to all data presented in this way.  Note that the 
scales used for AMH, FSHR and INHβA are different from those used for all other genes due to 
lower levels of expression.  Abbreviations: primordial (Prd), primary (1°), transitional (T), 
secondary (2°), early antral (EA), GV oocyte (GV) and CCs from GV oocytes (GV CC).  
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Figure 5.6 Histograms mapping the changing expression patterns of key somatic cell-specific 
genes- AMH, FSHR, IGF1, IGF1R, INHα, INHβA, INHβB and FST in in vitro-derived samples.  Data 
is presented as log10 (mean expression relative to the level of expression in the control in vivo-
derived secondary sample) ± SEM for 4 independent samples with the exception of primary 
stage follicles of which there were only 3 repeats.  Levels of expression were compared using 
one-way ANOVA.  Statistically significant differences (p<0.05) are indicated using different 
letters.  Note that it was necessary to use different scales because of the large variations in 
expression levels of the genes analysed in this series. Abbreviations: primary (1°), transitional 
(T), secondary (2°), secondary degenerating (2D°), early antral (EA), MII oocyte (MII) and CCs 
from MII oocytes (MII CC).  
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Figure 5.7 Histograms comparing the expression patterns of key somatic cell-specific genes: 
AMH, FSHR, IGF1, IGF1R, INHα, INHβA, INHβB and FST in in vivo- and in vitro-derived samples.  
Data is presented as log10 (mean expression relative to the level of expression in the control in 
vivo-derived secondary sample) ± SEM for 4 independent samples with the exception of in 
vitro-derived primary stage follicles of which there were only 3 repeats.  Levels of expression 
were compared using one-way ANOVA.  Statistically significant differences between in vivo- 
and in vitro-derived follicles of the same classification are indicated using * (p<0.05) and ** 
(p<0.01).  Note that it was necessary to use a different scale for FSHR due to its low expression 
levels compared to the other genes analysed in this series.  Abbreviations: primary (1°), 
transitional (T), secondary (2°), early antral (EA).  
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Levels of INHβA were significantly higher (p=0.037) in CCs from GV oocytes than in primordial, 
secondary and EA follicles, in vivo, see Figure 5.5.  The expression pattern of INHβA observed in 
vitro was slightly different, with significantly higher (p<0.001) levels of expression in secondary 
degenerating, EA and MII oocyte and cumulus cell samples, than primary, transitional and 
secondary follicle samples, see Figure 5.6.  Expression of INHβA in in vitro-derived EA follicle 
samples was significantly higher (p=0.016) than that observed in in vivo-derived samples, see 
Figure 5.7. 
 
Levels of expression of FSHR, IGF1, IGF1R, INHα, INHβB and FST remained relatively consistent 
across all in vivo-derived samples tested, with no statistically significant differences (p>0.05) 
found, see Figure 5.5.  Levels of INHα expression were lowest in primordial, EA and possibly 
secondary follicle samples.  Similarly FST expression levels were lowest in primordial, EA and 
secondary follicles however, there were large variations in the data.  Conversely, in the in vitro-
derived samples expression levels of INHα, INHβB and FST in different follicle classification 
differed significantly, see Figure 5.6.  For INHα, the levels of expression were significantly lower 
in transitional and secondary follicle samples, than primary, degenerating secondary, EA and 
MII oocyte samples (p=0.003).  Levels of INHβB expression were highest in the in vitro-derived 
primary follicles, decreasing slightly at the transitional stage, although not significantly 
(p>0.05).  Levels of expression were however significantly lower (p<0.001) than that observed 
in the primary, secondary, secondary degenerating, EA and MII CC samples.  Levels of 
expression of FST were also significantly lower (p=0.032) in transitional and secondary follicle 
samples, although not secondary degenerating samples, than the other in vitro-derived 
samples. 
 
In 5 out of the 8 key somatic cell-specific genes analysed, expression levels in the in vitro-
derived EA follicle samples differed significantly from those observed in the in vivo-derived 
samples, see Figure 5.7.  Expression of AMH and INHβA were significantly higher (p<0.05) in 
the in vitro-derived EA follicle samples.  This was also observed with respect to levels of INHα 
and FST expression (p=0.001 and p=0.016, respectively).  Whereas levels of IGF1 expression in 
EA follicles were significantly lower (p=0.045) in the in vitro-derived samples, compared to the 
in vivo-derived samples, only the levels of IGF1R expression differed significantly in a follicle 
classification other than EA, as levels of expression were significantly higher (p=0.018) in in 
vivo-derived transitional follicle samples when compared to their in vitro-derived counterparts.  
It is worth noting that in a number of genes different trends in the expression levels between 
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in vitro- and in vivo-derived samples were observed such that higher levels of FSHR expression 
were observed in in vivo-derived transitional, secondary and EA samples.  Higher levels of INHα 
expression were also observed in the in vitro-derived primary and transitional follicle samples, 
than in their in vivo-derived counterparts.  The difference in expression patterns of INHβB in 
vivo and in vitro showed no clear pattern, however, expression was higher in vitro in primary 
follicle samples, to a level approaching statistical significance (p=0.06).  In all follicle 
classifications analysed FST expression was consistently higher in vitro than in vivo, with the 
exception of transitional follicles in which the converse was true, although variability in the 
data meant these differences were not significant. 
 
 
Figure 5.8 Histograms comparing the expression patterns of key somatic cell-specific genes: 
AMH, FSHR, IGF1, IGF1R, INHα, INHβA, INHβB and FST in samples of (a) in vivo-derived GV 
oocytes and in vitro-derived MII oocytes (black lines) and (b) in vivo-derived CCs from GV 
oocytes and in vitro-derived CCs (black lines) from MII oocytes.  Data is presented as log10 
(mean expression relative to the level of expression in the control in vivo-derived secondary 
sample) ± SEM for 4 independent samples.  Levels of expression were compared using one-
way ANOVA.  Statistically significant differences between in vivo- and in vitro-derived samples 
are indicated using * (p<0.05).   
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Expression levels of key somatic-cell genes were compared between GV and MII oocytes and 
GV and MII oocyte-derived CCs, in Figure 5.8.  Levels of INHβA expression were significantly 
higher (p<0.05) in MII oocytes than GV oocytes.  Levels of expression of all genes except INHβA 
was lower in CCs derived from MII oocytes than those derived from GV oocytes, but due to 
variability in the data this was only significant (p<0.05) in the case of AMH.  
 
The ratio of the relative expression levels of INHα:INHβA subunits were analysed to indicate 
the levels of inhibin A and activin A (see Figure 5.9).  The ratio of INHα:INHβA expression in 
vivo was lowest in primordial follicles; the ratio then increased throughout preantral follicle 
development prior to decreasing in EA follicle samples and remaining low in GV oocyte and CC 
samples (see Figure 5.9 (a)).  The ratio of INHα:INHβA expression was similar in primary, 
transitional and secondary follicles and there were no statistically significant differences 
(p>0.05) between any of the samples.  The pattern of the ratio of INHα:INHβA expression 
observed in vitro was slightly different to that observed in vivo (see Figure 5.9 (b)), in that a 
significantly higher level of expression (p=0.0009) was observed in secondary follicles than all 
other samples, although interestingly not in secondary degenerating follicles.  The lowest 
levels of expression were observed in transitional and MII CC samples.  When the in vivo- and 
in vitro-derived samples were directly compared (Figure 5.9 (c)) the greatest differences in the 
ratio of INHα:INHβA expression were observed in the primary and transitional samples with 
lower levels observed in vitro, statistical significance was approached in the latter (p=0.059). 
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Figure 5.9 The ratio of INHα:INHβA expression in (a) in vivo-derived samples, (b) in vitro-
derived samples and (c) in vivo- and in vitro-derived samples.  Data is presented as mean 
log10(1+ INHα:INHβA) ± SEM for 4 independent samples.  Ratios were compared using one-way 
ANOVA and statistically significant differences indicated with the use of different letters 
(p<0.05).  Abbreviations: primary (1°), transitional (T), secondary (2°), early antral (EA). 
 
Finally in Figure 5.10 (a) levels of expression of key somatic cell-specific genes in growing in 
vivo- and in vitro-derived secondary follicles, as well in vitro-derived degenerating follicles, 
were analysed.  Interestingly, expression levels of INHα, INHβA and FST were significantly 
higher in the samples of degenerating secondary follicles compared to either the in vivo- or in 
vitro-derived growing secondary follicles (p=0.001, p=0.0009, p=0.003, respectively).  Higher 
levels of FSHR expression were also observed in degenerating secondary follicles compared to 
growing follicles, to a degree approaching statistical significance (p=0.057).  
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Figure 5.10 Summary comparison of the expression patterns of key (a) somatic cell- (b) oocyte- 
derived and (c) imprinted genes in in vivo- and growing and degenerating in vitro-derived 
secondary follicle samples.  Data is presented as log10 (mean expression relative to the level of 
expression in the control in vivo-derived secondary sample) ± SEM for 4 independent samples 
with the exception of in vitro-derived primary stage follicles of which there were only 3 
repeats.  Levels of expression were compared using one-way ANOVA.  Statistically significant 
differences between in vivo- and in vitro-derived follicles of the same classification are 
indicated using * (p<0.05), ** (p<0.01) and *** (p<0.001).  Note that in vitro D refers to 
secondary follicles derived in vivo, then cultured in isolated culture in vitro, where they started 
to degenerate. 
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5.3.2 Expression patterns of key oocyte-specific genes 
Expression patterns of key oocyte-specific genes in vivo and in vitro were considered in Figure 
5.11, Figure 5.12 and Figure 5.13.  In all oocyte-specific genes analysed expression levels were 
highest in the GV oocyte samples in vivo, with the exception of GDF9, and MII oocyte samples 
in vitro, see Figure 5.11 and Figure 5.12.   
 
The level of expression of ZP2 was significantly higher in GV oocytes than all other in vivo-
derived samples, except primary follicles, see Figure 5.11.  The level of ZP2 expression in 
primary and transitional follicles in vivo was significantly higher (p<0.001) than all other 
samples considered.  Similarly, ZP2 expression in vitro was significantly higher (p<0.001) in MII 
oocyte samples, however, other than this the levels of expression remained relatively 
consistent across all samples compared to that observed in vivo, see Figure 5.12.  Direct 
comparison of in vivo- and in vitro-derived samples in Figure 5.13, with respect to ZP2 
expression, revealed consistently higher levels of expression in the in vivo-derived samples.  
This difference was statistically significant in primary and secondary follicle samples (p=0.001 
and p=0.002, respectively).  Interestingly levels of ZP2 expression in degenerating secondary 
follicles were not significantly different from those observed in vivo, however they were 
statistically significantly different (p=0.006) from those observed in vitro, see Figure 5.10.  
Therefore this suggests that the reduced levels of expression observed in the in vitro-derived 
samples occur earlier in development, possibly as a result of suboptimal cortical culture 
conditions. 
 
Expression of oocyte GDF9 was highest in transitional follicles in vivo and in vitro, this 
observation was statistically significant in the former (p=0.014), see Figure 5.11 and Figure 
5.12.  Levels of GDF9 expression in EA follicle samples were significantly higher (p<0.05) than 
those observed in GV oocyte and CC samples.  These high levels of GDF9 expression were not 
observed in the in vitro derived samples, as shown in Figure 5.13, as expression levels were 
significantly higher in vivo (p=0.021).   
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Figure 5.11 Histograms mapping the changes in expression patterns of key oocyte-specific 
genes; ZP2, GDF9, GTSF1, BMP6, BMP15 and FOXO3 in in vivo-derived samples.  Data is 
presented as log10 (mean expression relative to the level of expression in the control in vivo-
derived secondary sample) ± SEM for 4 independent samples, except where indicated.  Levels 
of expression were compared using one-way ANOVA.  Statistically significant differences 
(p<0.05) are indicated using different letters.  Note that the scales used for AMH, FSHR and 
INHβA are different from those used for all other genes due to lower levels of expression. 
Abbreviations: primordial (Prd), primary (1°), transitional (T), secondary (2°), early antral (EA), 
MII oocyte (MII) and CCs from MII oocytes (MII CC).  
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Figure 5.12 Histograms mapping the changes in expression patterns of key oocyte-specific 
genes; ZP2, GDF9, GTSF1, BMP6, BMP15 and FOXO3 in in vitro-derived samples.  Data is 
presented as log10 (mean expression relative to the level of expression in the control in vivo-
derived secondary sample) ± SEM for 4 independent samples with the exception of primary 
stage follicles of which there were only 3 repeats.  Levels of expression were compared using 
one-way ANOVA.  Statistically significant differences (p<0.05) are indicated using different 
letters.  Note that it was necessary to use different scales because of the large variations in 
expression levels of the genes analysed in this series.  Abbreviations: primary (1°), transitional 
(T), secondary (2°), secondary degenerating (2D°), early antral (EA), MII oocyte (MII) and CCs 
from MII oocytes (MII CC).  
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Figure 5.13 Histograms comparing the expression patterns of key oocyte-specific genes; ZP2, 
GDF9, GTSF1, BMP6, BMP15 and FOXO3 in in vivo- and in vitro-derived samples.  Data is 
presented as log10 (mean expression relative to the level of expression in the control in vivo-
derived secondary sample) ± SEM for 4 independent samples with the exception of in vitro-
derived primary stage follicles of which there were only 3 repeats.  Levels of expression were 
compared using one-way ANOVA.  Statistically significant differences between in vivo- and in 
vitro-derived follicles of the same classification are indicated using * (p<0.05) and ** (p<0.01).  
Note that it was necessary to use a different scale for GDF9 due to its high expression levels 
compared to the other genes analysed in this series.  Abbreviations: primary (1°), transitional 
(T), secondary (2°), early antral (EA) 
 
With the exception of GV oocytes, expression of GTSF1 in vivo was significantly higher 
(p=0.0009) in transitional follicle samples than all other samples considered, see Figure 5.11.  
Similarly, with the exception of MII oocyte samples, expression was highest in transitional 
follicles in vitro, however, this was not statistically significant (p<0.05), see Figure 5.12.  
Expression levels of GTSF1 in primary follicles in vivo were significantly higher than those 
observed in EA and GV CC samples, whereas in vitro expression levels were similar in primary 
and EA samples; see Figure 5.11 and Figure 5.12.  In addition, when in vitro- and in vivo-
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derived samples were directly compared expression levels of GTSF1 were significantly higher in 
vivo-derived primary follicle samples (p=0.005) as well as in secondary follicle samples 
(p=0.047).  Similarly, expression of GTSF1 was significantly higher (p=0.025) in in vivo-derived 
secondary follicles than degenerating secondary follicles, see Figure 5.10. 
 
With respect to levels of BMP6 expression in vivo the highest levels were observed in GV 
oocytes (p<0.001), see Figure 5.11.  In addition, expression of BMP6 was significantly higher in 
transitional follicle samples than EA and GV CC samples.  Whereas in vitro expression of BMP6 
was lower in transitional follicle samples than in primary follicle samples, although this was not 
significant, see Figure 5.12.  The levels of expression in vivo and in vitro did not differ in 
primary and transitional samples (p>0.05), when directly compared, see Figure 5.13.  However, 
BMP6 expression in secondary follicles was significantly higher (p=0.016) in the in vivo- than in 
vitro- follicles.  Significantly lower (p=0.004) levels of BMP6 expression were also observed in 
degenerating secondary follicles than those observed in vivo, see Figure 5.10. 
 
In the in vivo- and in vitro-derived samples expression of BMP15 was significantly higher 
(p<0.001) in GV oocyte and MII oocyte samples, respectively, whereas levels remained 
relatively consistent in all other classifications considered, see Figure 5.11 and Figure 5.12.  
Expression of BMP15 was consistently higher in vivo than that observed in vitro, reaching 
statistical significance in secondary follicle samples (p=0.033) and a trend for higher expression 
was observed in EA samples, see Figure 5.13.  However, levels of expression in degenerating 
secondary follicles did not differ from that observed in growing follicles (Figure 5.10).   
 
Expression of FOXO3 in vivo did not vary significantly across development although the highest 
levels observed were from primordial to transitional stages and in GV oocyte samples, see 
Figure 5.11.  There were, however, large variations within follicle stages, and more repeats, 
possibly using different primers are required to give some more convincing results.  Expression 
of FOXO3 in vitro grown cells were significantly higher (p<0.001) in MII oocyte samples than all 
other classifications analysed, see Figure 5.12.  Similarly, expression of FOXO3 was slightly 
higher in in vivo- than in vitro- derived cells.  These differences were not however, statistically 
significant, see Figure 5.13.   
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Expression patterns of key oocyte-specific genes were compared between GV and MII oocytes 
and GV and MII oocyte-derived CCs, in Figure 5.14. Oocyte-specific gene expression was similar 
in GV and MII oocyte samples, with the exception of GTSF1 in that a significantly higher 
(p<0.001) level of expression was detected in the GV oocytes, than the MII oocytes.  With 
respect to the CC samples, levels of expression of all oocyte-specific genes were similar with no 
significant differences (p>0.05) observed between GV and MII oocyte-derived samples, with 
the exception of BMP15 expression, which was significantly lower (p<0.05) in GV oocyte 
samples.   
 
 
Figure 5.14 Histograms comparing the expression patterns of key oocyte-specific genes; ZP2, 
GDF9, GTSF1, BMP6, BMP15 and FOXO3 in samples of (a) in vivo-derived GV oocytes and in 
vitro-derived MII oocytes and (b) in vivo-derived CCs from GV oocytes and in vitro-derived CCs 
from MII oocytes.  Data is presented as log10 (mean expression relative to the level of 
expression in the control in vivo-derived secondary sample) ± SEM for 4 independent samples.  
Levels of expression were compared using one-way ANOVA.  Statistically significant differences 
between in vivo- and in vitro-derived samples are indicated using *** (p<0.001).   
 
5.3.3 Expression patterns of key imprinted genes and genes involved in the regulation of 
epigenetic modifications 
Finally the expression patterns of key imprinted genes in vivo and in vitro were considered, see 
Figures 5.15, 5.16 and 5.17.  Expression of IGF2 was highest in preantral follicles both in vivo 
and in vitro although differences were not significant (p>0.05), see Figures 5.15 and 5.16.  
Expression of its receptor, IGF2R, was relatively consistent both in vivo and in vitro, with no 
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statistically significant differences (p>0.05) observed, see Figures 5.15 and 5.16.  Expression of 
IGF2R was highest in GV and MII oocyte samples.  Direct comparison of in vivo- and in vitro-
derived samples did not reveal any significant differences (p>0.05), with respect to either IGF2 
or its receptor, see Figure 5.17.   
 
Similar patterns of MEST expression were observed in vivo and in vitro, see Figures 5.15 and 
5.16, in that a transient increase was observed during preantral follicle development, followed 
by a slight decrease as follicle development progressed.  This increase occurred at the 
transitional stage in vivo and appeared to be delayed to the secondary stages in the in vitro-
derived follicles.  Additionally, the level of MEST expression was significantly higher in in vitro-
derived primary and transitional follicle samples, p=0.009 and p=0.017, respectively (see Figure 
5.17).  Similarly in EA follicle samples expression of MEST was higher in vitro, but this 
difference did not reach significance (p>0.05) due to sample variability. 
 
The level of H19 expression in vivo increased from the primordial stage to the transitional 
stage of development, before decreasing transiently at the secondary stage, and increasing 
again at the EA stage (see Figure 5.15).  Expression was lowest in the GV oocyte and CC 
somatic samples.  The difference in level of expression of H19 between transitional and 
primordial, secondary, GV oocyte and CC samples was statistically significant (p<0.001).  The 
expression pattern observed in vitro was very different to that observed in vivo.  Relatively 
high levels of expression were consistently observed across all preantral follicle samples in vivo 
and in vitro, although there was a slight and non-statistically significant increase (p>0.05) in 
expression in transitional follicle samples.  In the in vitro-derived EA, MII oocyte and CC 
samples expression of H19 was significantly lower (p<0.001) than that observed in the 
preantral follicle samples, see Figure 5.16.  This discrepancy between the in vivo- and in vitro-
derived EA samples became even more apparent when the 2 were directly compared in Figure 
5.17, showing a significantly lower level of H19 expression in vitro (p=0.001).  A lower level of 
expression in vitro was observed across all follicular classifications analysed, especially 
secondary follicles however, the differences were not significant due to variability between 
samples. 
 
The highest level of expression of oocyte-specific DNMT1o in vivo was observed in GV oocytes 
(p=0.0009) compared to other developmental stages, see Figure 5.15.  Expression levels in GV 
oocytes were over 9-fold higher than that observed in all other samples.  Whereas in the in 
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vitro-derived samples there were no significant differences in the level of expression, see 
Figure 5.16.  Unfortunately there were no in vitro-derived GV oocytes to enable comparison.  
Comparison of DNMT1o expression levels in in vivo- and in vitro-derived samples revealed 
similar levels of expression (p>0.05), although a higher level of DNMT1o expression was 
recorded for in vivo transitional follicle samples, however, this difference was not significant 
due to variability between samples.  Expression of somatic cell-specific gene DNMT1s 
progressively increased from the primordial to the transitional stage, then progressively 
decreased up to the EA stage, in vivo, see Figure 5.15.  Expression in vivo was significantly 
higher (p=0.007) in the transitional follicle and GV oocyte samples, than all other stages.  
Similarly a small increase in DNMT1s expression from the primary to the transitional stage, 
followed by a decrease at the secondary stage was observed in vitro, although this difference 
was not significant (p>0.05), see Figure 5.16 (f).  However, unlike that observed in vivo 
expression levels of DNMT1s were significantly higher (p<0.05) in in vitro-derived EA follicles 
than those observed in all preantral follicle stages.  This can also be observed in Figure 5.17 (f) 
as expression of DNMT1s was significantly higher (p=0.011) in vitro than in vivo.  Interestingly 
in degenerating secondary follicles expression of DNMT1s was also higher than that observed 
in transitional follicles, although these differences were not significant. 
 
The data shown in Figure 5.10 shows that expression of the key imprinted genes analysed 
remained relatively consistent across in vivo- and in vitro-derived growing follicles and in vitro-
derived degenerating follicles.  
 
215 
 
 
 
 
Figure 5.15 Histograms mapping the changes in expression patterns of key imprinted genes; 
IGF2, IGF2R, MEST, H19, DNMT1o and DNMT1s in in vivo-derived samples.  Data is presented 
as log10 (mean expression relative to the level of expression in the control in vivo-derived 
secondary sample) ± SEM for 4 independent samples.  Levels of expression were compared 
using one-way ANOVA.  Statistically significant differences (p<0.05) are indicated using 
different letters.  Note that it was necessary to use different scales because of the large 
variations in expression levels of the genes analysed in this series.  Abbreviations: primordial 
(Prd), primary (1°), transitional (T), secondary (2°), early antral (EA), GV oocyte (GV) and CCs 
from GV oocytes (GV CC).  
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Figure 5.16 Histograms mapping the changes in expression patterns of key imprinted genes; 
IGF2, IGF2R, MEST, H19, DNMT1o and DNMT1s in in vivo-derived samples.  Data is presented 
as log10 (mean expression relative to the level of expression in the control in vivo-derived 
secondary sample) ± SEM for 4 independent samples with the exception of primary stage 
follicles of which there were only 3 repeats.  Levels of expression were compared using one-
way ANOVA.  Statistically significant differences (p<0.05) are indicated using different letters.  
Note that it was necessary to use different scales because of the large variations in expression 
levels of the genes analysed in this series.  Abbreviations: primary (1°), transitional (T), 
secondary (2°), secondary degenerating (2D°) early antral (EA), MII oocyte (MII) and CCs from 
MII oocytes (MII CC).  
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Figure 5.17 Histograms comparing the expression patterns of key imprinted genes; IGF2, 
IGF2R, MEST, H19, DNMT1o and DNMT1s in in vivo- and in vitro-derived samples.  Data is 
presented as log10 (mean expression relative to the level of expression in the control in vivo-
derived secondary sample) ± SEM for 4 independent samples with the exception of in vitro-
derived primary stage follicles of which there were only 3 repeats.  Levels of expression were 
compared using one-way ANOVA.  Statistically significant differences between in vivo- and in 
vitro-derived follicles of the same classification are indicated using * (p<0.05) and ** (p<0.01).  
Note that it was necessary to use a different scale for IGF2R and DNMT1o due to their low 
expression levels compared to the other genes analysed in this series.  
 
 
 
 
 
 
0
0.5
1
1.5
2
2.5
3
3.5
1° T 2° EA
Lo
g 1
0(
1+
Δ
Δ
C
t G
O
I-
H
K 
re
la
ti
ve
 
to
 in
 v
iv
o
se
co
n
d
ar
y 
1)
 
Follicle classification
In vivo
In vitro
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0.4
1° T 2° EA
Lo
g 1
0
 (1
+
Δ
Δ
C
t G
O
I-
H
K
 re
la
ti
ve
 
to
 in
 v
iv
o
se
co
n
d
ar
y 
1)
 
Follicle classification
In vivo
In vitro
0
0.5
1
1.5
2
2.5
3
3.5
1° T 2° EA
Lo
g 1
0
 (1
+
Δ
Δ
Ct
G
O
I-
H
K 
re
la
ti
ve
 
to
 in
 v
iv
o
se
co
n
d
ar
y 
1)
 
Follicle classification
In vivo
In vitro
0
0.5
1
1.5
2
2.5
3
3.5
1° T 2° EA
Lo
g 1
0
 (1
+
Δ
Δ
C
t G
O
I-
H
K
 re
la
ti
ve
 
to
 in
 v
iv
o
se
co
n
d
ar
y 
1)
 
Follicle classification
In vivo
In vitro
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0.4
1° T 2° EA
Lo
g 1
0
 (1
+
Δ
Δ
C
t G
O
I-
H
K
 re
la
ti
ve
 
to
 in
 v
iv
o
se
co
n
d
ar
y 
1)
 
Follicle classification
In vivo
In vitro
0
0.5
1
1.5
2
2.5
3
3.5
1° T 2° EA
Lo
g 1
0
 (1
+
Δ
Δ
C
t G
O
I-
H
K
 re
la
ti
ve
 
to
 in
 v
iv
o
se
co
n
d
ar
y 
1)
 
Follicle classification
In vivo
In vitro
(a) Expression of IGF2 (b) Expression of IGF2R
(c) Expression of MEST (d) Expression of H19
(e) Expression of DNMT1o (f) Expression of DNMT1s
**
* **
*
218 
 
 
 
 
Figure 5.18 Histograms comparing the expression patterns of key imprinting genes; IGF2, 
IGF2R, MEST, H19, DNMT1o and DNMT1s in samples of (a) in vivo-derived GV oocytes and in 
vitro-derived MII oocytes and (b) in vivo-derived CCs from GV oocytes and in vitro-derived CCs 
from MII oocytes.  Data is presented as log10 (mean expression relative to the level of 
expression in the control in vivo-derived secondary sample) ± SEM for 4 independent samples.  
Levels of expression were compared using one-way ANOVA.  Statistically significant differences 
between in vivo- and in vitro-derived samples are indicated using *** (p<0.001).  
 
Expression levels of key imprinting genes were compared between GV and MII oocytes and GV 
and MII oocyte-derived CCs, in Figure 5.18.  Higher levels of expression of both IGF2 and H19 
were observed in the MII oocytes than the GV oocytes, however, due to variability in the data 
these differences were not significant (p>0.05).  Levels of both MEST and DNMT1s were similar 
in MII and GV oocyte samples.  Expression of both IGF2R and DNMT1o is higher in GV oocytes 
than MII oocytes although only statistically significantly in the latter, (p>0.05) and (p<0.001), 
respectively.  There were no statistically significant differences (p>0.05) observed in the levels 
of expression of imprinting genes between GV and MII oocyte-derived CC samples. 
 
Levels of expression of all oocyte-specific genes were similar in GV and MII oocyte samples, 
with the exception of GTSF1 in that a significantly higher (p<0.001) level of expression was 
detected in the GV oocytes, than the MII oocytes.  With respect to the CC samples levels of 
expression of all oocyte-specific genes were similar with no significant differences (p>0.05) 
observed between GV and MII oocyte-derived samples.  
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5.4 Discussion 
In this experimental series the expression patterns of 20 key genes implicated in the regulation 
of folliculogenesis, oogenesis, embryogenesis and imprint establishment and maintenance in 
vivo were elucidated and compared to that observed in oocytes and follicles derived in vitro. 
  
5.4.1 Somatic cell-specific genes 
Firstly, the expression patterns of key somatic cell-specific genes were considered. In this study 
very low levels of AMH expression by ovine primordial follicles were detected in vivo in 
contrast to that reported in previous studies, in which AMH expression was detected from the 
early primary stage (Bezard et al., 1987, Bonnet et al., 2011).  In addition low levels of AMH 
expression were detected in the GV oocytes.  This was unexpected as AMH is somatic cell-
derived.  It is possible that the primordial follicle and GV oocyte samples were contaminated 
with early primary follicles and GV CCs, respectively.  It is also possible that the high sensitivity 
of the analytical methods used in the present study compared to published works resulted in 
the amplification and detection of very small amounts of cDNA present in the samples which 
had hitherto been undetectable.  Alternatively the observed discrepancy in the AMH results 
for primordial follicles as reported here is due to a species-specific difference in gene 
expression.  For example, the study conducted by Bonnet et al. (2011) used a bovine array to 
analyse gene expression profiles of ovine oocytes and somatic cells.  It is possible that the use 
of a heterologous array meant that low levels of AMH expression were not detected, however  
Bezard et al. (1987) also reported the absence of AMH protein in ovine primordial follicles 
when analysed using immunohistological techniques.  In the aforementioned studies 
increasing levels of AMH expression were detected with the progression of follicle 
development.  This was observed to an extent in the current experimental series however 
levels of AMH expression detected in the EA follicle samples were very low.  Interestingly, the 
expression pattern of AMH in vitro was more similar to that reported previously with respect 
to increasing levels of expression with progression of follicular development.  When the 
expression patterns of AMH in vivo and in vitro were directly compared lower levels were 
detected in vitro across all stage-matched samples.  This may partly explain the increased 
levels of primordial follicle activation exhibited in vitro, as AMH is an inhibitor of this process, 
although evidence suggests this may be species-specific and not the case in the ovine model 
(Campbell et al., 2012).  Furthermore, the levels were not significantly lower until the EA stage.  
It is interesting to note that the expression of Amh by CCs in mouse preantral follicles, cultured 
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in the presence of ‘low’ levels of FSH (minimum 3.6 miUml-1) were significantly lower than 
those in vivo, and in the presence of high levels FSH (25miUml-1), expression stopped (Sanchez 
et al., 2010).  It is therefore possible that exposure to FSH, although at a much lower 
concentration (1x10-5iUml-1), in the current investigation may have resulted in the decreased 
levels of AMH expression.  In addition comparison of Amh expression levels by CCs from 
mouse preantral follicles cultured in the presence of low (5ngml-1) and high (5μgml-1) insulin 
concentration resulted in a significantly higher level of expression in the former group 
(Sanchez et al., 2011).  It is possible that the slightly higher concentration of insulin used in the 
current study (10ngml-1) resulted in the decreased levels of AMH observed in vitro compared 
to in vivo.  The lower levels of AMH expression observed in in vitro-derived EA suggest that 
these follicles may be more responsive to gonadotrophin-stimulation, which may result in 
precocious luteinisation if follicle culture was continued (Campbell et al., 2012).   
 
It would be interesting to assess the levels of AMH expression in accelerated culture systems, 
particularly those using tissue derived from species in which AMH has been shown to inhibit 
activation, such as human, in order to determine whether this could be a contributing factor.  
As discussed above Amh expression in mouse preantral follicles in suppressed by the addition 
of FSH to the culture media (Sanchez et al., 2010).  In Chapter 4 an accelerated system 
developed in Edinburgh was tested, in this system FSH is not added to the cortical culture 
media therefore it is possible that levels of AMH expression by the ovine somatic cells may 
have been higher than in those cultured using the Leeds system.  As AMH inhibits follicle 
activation lower levels of primordial follicle activation could be expected, however, this is 
contrary to what was observed in the AFC system (Chapter 4) and in previous studies by the 
Edinburgh group (Telfer et al., 2008, McLaughlin and Telfer, 2010), in which higher levels, 
compared to the Leeds physiological system were reported.  This may be due to species-
specific differences with respect to the actions of AMH (Campbell et al., 2012).  Alternatively 
the method of tissue preparation or the effect of the culture system on the expression levels 
and/or bioavailability of other regulatory factors may also have resulted in increased levels of 
follicle activation.  The findings in this study could be extended by monitoring AMH expression 
levels in somatic cells of ovine follicles grown in vitro using the AFC system (see Chapter 4) if it 
is possible to obtain sufficient numbers of follicles. 
 
The pattern of FSHR expression observed in this study was similar to that reported previously 
in sheep, in that it was clearly evident from the primary stage onwards (Tisdall et al., 1995).  
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Very low levels of expression were also detected in the primordial follicle samples.  Levels of 
expression were consistently higher in in vivo follicles than in vitro, although not significantly, 
particularly in secondary follicles.  Lower levels of FSHR expression may hinder the 
development of IVG follicles once they become dependent upon gonadotrophin-stimulation if 
culture is continued (Campbell et al., 1999). 
 
This study is the first to report the exact patterns of IGF1 and IGF1R expression during in vivo 
growth of ovine oocytes from the primordial to the antral stage.  Expression of both IGF1 and 
its receptor remained relatively consistent throughout follicle development in vivo and in vitro 
(see Figures 5.5 and 5.6).  When directly compared the levels of IGF1 and IGF1R expression in 
vitro and in vivo fluctuated.  Levels of IGF1R expression in transitional follicles were 
significantly lower in vitro.  This may have had an effect on somatic cell proliferation and 
therefore follicle development (Perks et al., 1995, Monget and Bondy, 2000).  The significantly 
lower levels of IGF1 and non-significantly lower levels of IGF1R expression observed in EA 
follicles in vitro compared to in vivo may have more of a detrimental effect with respect to 
follicle development.  This is particularly because IGF1 promotes FSHR expression and at this 
developmental stage follicles are becoming dependent upon gonadotrophin-stimulation.  
Therefore this may need to be taken into account when developing IVG systems, although 
IGF1 and its analogues are often included in the culture media (see Chapter 1).  Although it 
should also be noted that increased levels of IGF1 expression in small antral ovine follicles has 
been linked to increased levels of atresia.  Therefore there might have been a greater 
proportion of atretic follicles derived in vivo (Hastie and Haresign, 2006). 
 
Interestingly, the in vivo patterns of expression exhibited by INHα, INHβA and FST reported 
here are quite similar in that expression increased from the primordial to the transitional 
stage, decreased at the secondary stage then subsequently increased following cumulus cell 
differentiation as demonstrated by the GV CC stage, except in the case of INHα where a 
further decrease occurred at the EA stage (see Figure 5.5).  The expression pattern of INHβB in 
vivo is more constant; however there also appeared to be a transient decrease in the level of 
expression at the secondary stage, although there was a lot of variability in the data.  The fact 
that relatively high levels of expression of all inhibin subunits and FST were detected in GV 
oocytes suggests the methods used may have been too sensitive.  It is possible that somatic 
cell gene contamination of both the GV and  MII oocyte samples could have arisen from 2 
sources: the first explanation is technical and could be accounted for by the failure to remove 
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all CCs during the denudation process; whereas the second explanation is biological transfer 
and is due to the potential to transfer cumulus expressed genes to the oocytes via transzonal 
processes and gap junctions which link the 2 cellular compartments in vivo and in vitro (Bortvin 
et al., 2003).  In addition, although expression of FST has been detected throughout the 
development of ovine follicles, with a slight decrease at the pre-ovulatory stage, similar to that 
observed in Figure 5.6, the expression of inhibin subunits has not been detected in preantral 
follicles (Tisdall et al., 1994).  During antral follicle development as increasing amount of 
inhibin A production relative to activin A was expected (Young et al., 2012).  When the ratio of 
INHα: INHβA expression was analysed in Figure 5.9 this was not observed.  The pattern of 
expression of inhibin subunits is complex and dependent upon the stage of the oestrous cycle 
and the level of E2 produced by the follicle, thus hindering the elucidation of expression 
patterns (Young et al., 2012).  The ratio of INHα: INHβA expression in in vivo-derived EA 
follicles, shown in Figure 5.9, was most similar to that observed previously in GCs of small 
ovine antral follicles with low E2 concentration in the FF (Young et al., 2012).  Therefore 
perhaps it would be useful to repeat the current experiment and determine the levels of E2 
present in the FF or spent culture media.  Within the current experimental series the methods 
of processing the follicles differed as in vivo-derived samples and in vitro-derived degenerating 
secondary and EA follicle samples were isolated enzymatically and so lacked a basement 
membrane and theca layer (Newton et al., 1999b), whereas the in vitro-derived preantral 
follicle samples were isolated mechanically and so contained a basement membrane and theca 
layer.  This could possibly account for the differences in expression patterns of INHα observed 
between in vitro-derived secondary and degenerating secondary follicles, although this may 
not be the case as expression of neither INHα nor INHβA has been detected in the thecal layer 
of ovine follicles <1cm diameter (Nagamine et al., 1998).  Note that the presence or absence of 
a theca layer may have also affected the apparent levels of expression of IGF1 and its receptor, 
as these are expressed by theca cells (el-Roeiy et al., 1993, Qu et al., 2000, Armstrong et al., 
2002).   
 
The similarity in expression patterns exhibited by INHα, INHβA and FST both in vivo and in vitro 
suggests that some form of common regulatory mechanism exists (see Figure 5.5 and 5.6).  
This may explain why significantly higher levels of expression of INHα, INHβA and FST were 
observed in in vitro-derived EA follicles, compared to in vivo-derived (see Figure 5.7).  As 
inhibin A production is promoted by both FSH and GDF9 it was possible that a link between the 
expression patterns of INHα and FSHR and ratio of INHα and GDF9.  Significantly lower levels of 
FSHR and GDF9 expression in in vitro-derived EA follicles did not however affect INHα 
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expression as this was significantly higher in in vitro-derived EA follicles, compared to those 
derived in vivo (see Figure 5.7 and 5.13). 
It is interesting to note that when stage-matched in vitro- and in vivo-derived follicles were 
compared the gene expression patterns displayed by follicles derived from isolated preantral 
culture were more likely to be affected than follicles derived using cortical slice culture (see 
Figure 5.7).  Of the somatic genes analysed, 5 out of 8 (AMH, IGF1, INHα, INHβA and FST) were 
statistically different (p<0.05) when the in vitro-derived EA follicles, grown from the secondary 
stage in isolated culture were compared to in vivo-derived EA follicles.  This may be because by 
isolating follicles and culturing individually rather than in situ the follicles are provided with an 
environment that is even more different from that in vivo.  Alternatively removal of the theca 
layer when enzymatically isolating secondary follicles may have affected the levels of gene 
expression in in vitro-derived EA follicles compared to in vivo-derived EA follicles.  As discussed 
in Chapter 1, theca cells possess receptors for inhibin, activin and IGF1 therefore it is possible 
that in ‘theca-free’ follicles production of these factors by the GCs was down-regulated.  The 
expression of FST by GCs may also have been affected as this factor is involved in the 
regulation of the actions of activin. 
 
5.4.2 Oocyte-specific genes 
Expression of GDF9 and BMP6 were observed in vivo from the primordial to the antral stage in 
agreement with previous reports (Bodensteiner et al., 1999, Bodensteiner et al., 2000, Juengel 
et al., 2006).  The expression of BMP15 was also detected from the primordial stage in vivo 
rather than from the primary stage as has been previously reported (Galloway et al., 2000).  
Direct comparison of the expression levels of these oocyte-derived growth factors in vivo and 
in vitro was quite revealing.  The significantly lower levels of BMP15 and possibly BMP6 in in 
vitro-derived secondary follicles may have resulted in lower levels of GC proliferation 
(Campbell et al., 2009, Lin et al., 2012).  Although the levels of GDF9 expression observed in 
vitro were very similar to those observed in vivo in secondary follicles this is unlikely to have 
counteracted the potential effects of low BMP15 and BMP6 expression on GC proliferation as 
ovine GDF9 without BMP15 is not mitogenic (Lin et al., 2012).  In addition levels of BMP15 
expression in EA follicles were lower, although not significantly, in vitro and were accompanied 
by a decrease in GDF9 expression levels compared to those observed in vivo which may have a 
largely detrimental effect on GC proliferation.  Although in vitro-matured MII oocytes - derived 
following 24 hours of IVM culture of in vivo grown GV oocytes - exhibited high levels of BMP15 
expression this might not be the case when mature MII gametes are derived from IVG EA 
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follicles as the levels of BMP15 expression are already lower at this stage than in vivo-derived 
equivalent staged follicles.  Therefore, this may be an important consideration when 
developing IVG culture systems as low levels of BMP15 could result in premature follicular 
luteinisation (Juengel et al., 2011).  Similarly, lower levels of GDF9 expression in in vitro-
derived EA follicles may lead to prematurely increased levels of P4 and therefore precocious 
differentiation of the follicle (McNatty et al., 2005).  In a number of species GDF9 has been 
shown to be important in terms of the regulation of CC metabolism in mouse, cow and human 
(Colonna and Mangia, 1983, Sugiura et al., 2005, Su et al., 2008, Su et al., 2009) and potentially 
mucification in mice (Gilchrist et al., 2008), therefore compromised levels of GDF9 in vitro may 
adversely affect these processes.  This may be of particular importance with respect to energy 
requiring processes such as meiotic progression and cytoplasmic maturation, which involve 
both the oocyte and CCs, as these may potentially be compromised in in vitro-derived oocytes 
(Picton et al., 1998, Conti et al., 2012).   
 
Expression of Gdf9 and Bmp15 by mouse oocytes in vitro has been shown to increase in 
response to increasing levels of FSH (from 10- to 25miUml-1), whereas they were unaffected by 
changes in insulin concentrations (10ngml-1 vs. 10μgml-1) (Sanchez et al., 2010, Sanchez et al., 
2011).  In order to extend the current investigation and compare the physiological slow growth 
system developed in Chapter 3 with the accelerated growth system used in Chapter 4 it would 
be interesting to monitor changes in expression levels of GDF9 and BMP15 in order to 
determine whether they are affected by the presence or absence of FSH in the culture media.  
Levels of Gdf9 and Bmp15 expression by secondary mouse oocytes in vitro are affected by the 
concentration of alginate gel used as a scaffold, with expression decreasing with increasing 
alginate concentration (0.25% vs. 1.5%) (Jiao and Woodruff, 2013).  This suggests that the use 
of gel matrices may suppress the expression of oocyte-specific genes key to folliculogenesis 
and oogenesis.  It would be interesting to test this theory by comparing gene expression 
patterns of ovine secondary follicles cultured in the absence of support matrices, as in Chapter 
3 vs. those encapsulated in a gel, in vitro.  
 
Although the levels of BMP6 expression in EA follicles were similar in vivo and in vitro the 
lower levels of IGF1 expression in in vitro-derived follicles of this classification may affect the 
promotion of the differentiative actions of FSH by BMP6 (Webb and Campbell, 2006).  Levels of 
BMP15 and GDF9 expression in degenerating secondary follicles did not differ from those 
observed in vivo, whereas levels of BMP6 were lower although no different from levels 
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observed in vitro.  In contrast, relatively high levels of GDF9 expression were detected in GV CC 
and MII CC samples.  Although BMP6 expression in mice has been previously detected in GCs, 
expression of neither BMP15, nor GDF9 has been detected in the somatic follicular cells in any 
specie (Elvin et al., 2000).  Low levels of BMP15 and BMP6 expression relative to that observed 
in other samples were detected in both GV CC and MII CC samples.  In addition to this the 
detection of BMP15 expression in primordial follicles calls into question the validity of these 
results. 
 
Zona pellucida formation occurs at the primary stage in mice and humans (Zamboni, 1974, 
Epifano et al., 1995), however, in this experimental series expression of ZP2 was detected in 
ovine primordial follicles, indicating a possible species-specific difference.  The expression of 
ZP2 has, however previously been detected in primordial human follicles analysed using similar 
methods of sample preparation as used here suggesting that the previously reported 
expression patterns may be due to differences in sensitivities of the methods used (Huntriss et 
al., 2002).  Levels of ZP2 expression in vivo significantly increased at the primary and 
transitional stages suggesting that these are the main stages at which ZP formation occurs in 
sheep.  As the level of ZP2 expression is very high in primary follicles it is possible that ZP2 was 
detected in primordial samples because they were contaminated with primary follicles.  As the 
expression of a number of other genes, including BMP15, IGF1, IGF1R and IGF2R, has been 
detected in primordial follicles when previous reports have evidenced their expression from 
the primary stage at the earliest (see Chapter 1), this further suggests that there may have 
been some contamination of the primordial follicle samples with primary or EP follicles as the 
primordial and EP follicle populations are the most difficult to classify accurately.  Levels of ZP2 
expression in vitro were consistently lower than those observed in vivo, to a statistically 
significant level in the primary and secondary follicle samples (p<0.01).  Therefore in vitro-
derived ovine oocytes may not exhibit adequate ZP formation and this may lead to fertilisation 
problems.  In mice and humans ZP2 acts as a secondary sperm receptor and is not involved in 
the acrosome reaction (Wassarman, 1988).  Furthermore, the use of ICSI may overcome any 
potential problems.  Despite this alterations in gene expression levels by the oocyte indicate 
that culture conditions are not optimal.  
 
Details regarding the expression patterns of FOXO3 during folliculogenesis in sheep have not 
previously been reported.  In the current experimental series FOXO3 expression was observed 
throughout follicle development in vivo (see Figure 5.11) and high levels of expression were 
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observed in MII oocytes (see Figure 5.12).  Consistently higher levels of FOXO3 expression 
were observed in in vivo- compared to in vitro-derived follicles.  This could be one of the 
factors that results in higher levels of primordial follicle activation in vitro compared to in vivo 
(Liu and Lehmann, 2006).  The expression pattern of GTST1 in vivo (see Figure 5.11) is similar to 
that reported in murine, human, bovine and ovine ovarian follicles in that expression was 
detected from the primordial stage then onwards throughout development, with the highest 
levels of expression observed in the GV oocyte (Krotz et al., 2009, Lu et al., 2009, Liperis et al., 
2013, Liperis, 2014).  The fact that lower levels of GTST1 were consistently observed in vitro 
compared to in vivo, particularly in primary (p<0.01) and secondary (p<0.05) follicle samples 
indicates that in vitro culture conditions were not optimal resulting in aberrant oocyte-specific 
gene expression.  As GTSF1 has been implicated as being involved in the post-transcriptional 
control of RNA processing and storage as well as translational regulation these processes may 
be disrupted in in vitro-derived oocytes (Liperis et al., 2013, Liperis, 2014). 
 
In contrast to that observed with somatic cell-specific genes the in situ culture of preantral 
follicles appeared to affect the expression of oocyte-specific genes.  Significant decreases 
(p<0.05) in ZP2, GTSF1, BMP6 and BMP15 expression were observed in in vitro-derived 
secondary follicles and in ZP2 and GTSF1 expression in in vitro-derived primary follicles 
compared to their in vivo-derived counterparts (see Figure 5.13).  This suggests that the oocyte 
is more sensitive to changes in culture conditions in the early stage of follicular development 
than the somatic-cells of the follicle. 
 
5.4.3 Imprinted genes and genes involved in the regulation of epigenetic modifications 
In this experimental series the expression patterns of ovine DNMT1o and DNMT1s in vivo were 
determined (see Figure 5.15).  In agreement with previous research expression of both genes 
was detected in both ovine oocyte and somatic cell samples (Taylor et al., 2009).  Expression of 
both genes was also detected throughout follicle development with highest levels of 
expression being recorded for GV oocytes.  Levels of expression of both genes were also 
slightly elevated in secondary follicles and, of DNMT1s only in the transitional and GV CC cells.  
The expression of DNMT1o in all in vitro-derived samples was relatively low, except in 
degenerating secondary follicles, although as could be expected there were high levels of 
variation in this group (see Figure 5.16).  Slightly elevated levels were observed in MII oocytes. 
In contrast, the level of expression of DNMT1s was highest in EA and MII oocyte in vitro-
derived samples.  When directly compared levels of DNMT1o expression were similar in vivo 
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and in vitro with the exception of the secondary follicle samples in which higher levels of 
expression were recorded in vitro, albeit the differences were not significant (p>0.05).  Levels 
of DNMT1s expression were significantly higher (p<0.05) in EA follicle samples in vivo 
compared to in vitro.   
 
As discussed in Chapter 1, DNA methyltransferases are key enzymes with respect to the 
establishment of imprinting marks as well as the maintenance of these (Reik et al., 2001).  
Increased levels of expression of Dnmt1 have previously been reported in in vitro-derived 
mouse embryos, compared to in vivo-derived (Wang et al., 2005).  The enzyme DNMT1 is 
essential for the maintenance of the maternal imprint in oocytes and preimplantation embryos 
(Hayward et al., 2003, Taylor et al., 2009).  Therefore the differences in expression levels 
observed in the current study may lead to alterations in methylation patterns as the lower 
levels of DNMT1s expression levels may result in the maternal imprint not being adequately 
maintained thus resulting in aberrant expression of imprinted genes throughout oogenesis and 
embryonic development (Reik et al., 2001, Goll and Bestor, 2005).  It is possible that the 
decrease in levels of DNMT1o expression may be embryonic lethal as this has previously been 
observed in mutant Dnmt1 mice (Li et al., 1992).  It is interesting to note that the higher levels 
of DNMT1s expression in in vitro-derived EA follicles were accompanied by lower levels of 
expression of all imprinted genes analysed in vitro than in vivo, to a level approaching 
significance with respect to IGF2 (p=0.076), IGF2R (p=0.133) and MEST (0.090) and significantly 
with respect to H19 (p=0.001).  Therefore, it is possible that aberrant DNMT1s expression 
affected the expression of these other imprinted genes in vitro, which is concerning as these 
genes are important regulators of normal oogenesis, folliculogenesis and embryogenesis (Li et 
al., 1993).   
 
This is the first investigation to document the exact pattern of IGF2 and IGF2R expression in 
preantral ovine follicles.  Expression of both genes was detected throughout in vivo follicle 
development, shown in Figure 5.15.  Expression of IGF2 decreases with progressive follicle 
development as has been described previously (Hastie and Haresign, 2006).  The levels of 
IGF2R expression remained relatively constant throughout follicle development.  Similar 
patterns of expression of both genes were observed in vitro, shown in Figure 5.16.  Surprisingly 
high levels of IGF2 and IGF2R were detected in the GV and MII oocyte.  When the levels of IGF2 
expression in vivo and in vitro were directly compared differences fluctuated in the preantral 
stage, however, at the EA stage expression was higher in vivo to a level approaching 
228 
 
 
 
significance (p=0.076).  As significantly higher levels of IGF2 expression have been detected in 
healthy compared to atretic small ovine follicles (<2mm) this suggests that there was a higher 
proportion of atretic EA follicles in the in vitro-derived samples (Hastie and Haresign, 2006).  
Throughout development levels of IGF2R expression were consistently higher in vivo- than in 
vitro-derived follicles however not to a statistically significant extent.  Changes in expression 
patterns of Ifg2 and Igf2r have been detected in numerous studies as a result of embryo 
culture in the mouse (Khosla et al., 2001, Ohno et al., 2001, Fernandez-Gonzalez et al., 2004) 
and sheep (Young et al., 2001).  Reduced levels of IGF2R expression, resulting from aberrant 
imprinting, have previously been associated with large offspring syndrome (LOS) in ovine 
foetuses, therefore it is possible that, as techniques progress, the slightly reduced levels of 
IGF2R expression observed in in vitro-derived oocytes may subsequently result in LOS if the 
oocytes are successfully fertilised  (Young et al., 2001).  One of the roles of the IGF2R is to 
regulate IGF2 levels via the endocytosis and degradation of excess extracellular IGF2 (Ludwig 
et al., 1995), therefore the reduced levels of IGF2R expression may have resulted in increased 
circulating levels of IGF2 – it would be interesting to repeat the process of IVG and assay for 
levels of IGF2 to determine whether this is the case.  As discussed in Chapter 1, it has also been 
postulated that BWS in humans may result from excess IGF2 levels during human 
embryogenesis (Eggenschwiler et al., 1997).  Studies in mice suggest that the increase in IGF2 
levels may be a result of reduced Igf2r and H19 expression (Eggenschwiler et al., 1997).  
Abnormal patterns of methylation of the IGF2R gene have also been observed in patients with 
BWS that were conceived using ARTs (Rossignol et al., 2006).  Therefore the reduced levels of 
IGF2R expression observed in the current experimental series are concerning in terms of the 
potential subsequent effect on the health of embryos derived from IVG oocytes.  
 
The expression of MEST was highest in transitional follicles in vivo, and was also high in GV 
oocytes in vivo, as shown in Figure 5.15.  A similar pattern of expression was observed in vitro 
except that highest levels of expression were observed in secondary follicles.  High levels were 
also observed in MII oocytes (see Figure 5.16).  Direct comparison of expression levels in in 
vivo- and in vitro-derived samples revealed significantly higher levels of expression in in vivo-
derived primary (p<0.01) and transitional (p<0.05) follicles.  Previous work concerning the 
methylation patterns of in vitro-derived humans embryos has shown a considerable degree of 
variation in MEST methylation patterns which is of concern as aberrant expression has been 
linked to SRS, altered growth patterns and cancers, including colorectal and lung (Huntriss et 
al., 2013, Koza et al., 2006).  In the aforementioned study authors propose that the variation in 
methylation patterns may also be observed in in vivo-derived embryos (Huntriss et al., 2013).  
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Therefore it is interesting that in the current study differences in patterns of MEST expression 
were observed between the in vivo- and in vitro-derived samples.   
Subfertility/infertility and the use of ARTs have been linked to alterations in H19 methylation 
and expression.  Alterations in expression patterns of H19 have been observed in numerous 
studies as a result of embryo culture in mice (Doherty et al., 2000, Khosla et al., 2001, Lane and 
Gardner, 2003).  Additionally gain of methylation of the H19 gene has been linked to both 
ovarian stimulation and subfertility/ infertility in humans (Borghol et al., 2006, Al-Khtib et al., 
2011).  Observations regarding the effect of IVF and ICSI on the methylation status of H19 have 
not been consistent with gain of methylation, loss of methylation and no change in 
methylation being observed in different studies (Denomme and Mann, 2012).  In the current 
investigation the expression of H19 was highest in transitional follicles in vivo whereas in vitro 
levels were consistently high throughout preantral follicle development (see Figures 5.15 and 
5.16).  Significantly lower levels of expression were observed in EA follicles and MII oocytes 
and CCs than preantral follicles in vitro (p<0.05).  When compared directly to levels of 
expression in vivo, shown in Figure 5.17, the level of expression in EA follicles was significantly 
lower than that observed in vivo (p<0.01). As both MEST and H19 have been implicated as 
important regulators of embryonic development and aberrant expression has been linked to 
the incidence of epigenetic disorders the fact that in vitro-derived follicles exhibit altered 
expression patterns is a potential cause for concern (Kagami et al., 2007, Chopra et al., 2010).  
Additionally, as H19 regulates the expression of IGF2 and IGF2R it is possible that the 
significantly lower levels of expression of H19 in vitro are the cause of the lower levels of IGF2 
and IGF2R observed in vitro.  
 
As discussed above it may be a concern that the expression patterns of imprinted genes - that 
have been linked to the incidence of epigenetic diseases and LOS when aberrantly expressed - 
differed in numerous in vivo- and in vitro-derived equivalent follicle samples.  It is possible that 
the changes in expression patterns of these genes may be a result of aberrant imprinting.  
However, as discussed in Chapter 1, previous research suggests that the mechanisms by which 
DNA methylation patterns are established are quite robust in murine and ovine models.  
Studies in mice have shown that the methylation patterns of Igf2 and H19 in MII oocytes 
grown in vitro from the secondary stage were not affected under normal culture conditions 
(Anckaert et al., 2009a).  Furthermore, when follicles were subjected to suboptimal culture 
conditions such as the addition of high levels of FSH (100iUL-1, compared to 10iUL-1) to the 
culture media, or exposure to increased levels of ammonium (up to ~1500μm following 12 
days culture) and significantly reduced levels of E2 and P4, induced by culturing under mineral 
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oil, this did not affect the methylation of the aforementioned genes (Anckaert et al., 2009a, 
Anckaert et al., 2009b, Trapphoff et al., 2010).  In addition embryos resulting from the 
fertilisation of in vitro-derived oocytes also exhibited normal methylation of the 
aforementioned genes (El Hajj et al., 2011).  Similarly, ovine oocytes grown from the preantral 
to EA stages in vitro displayed normal methylation patterns of IGF2R and H19 (Barboni et al., 
2011). Nor were the methylation patterns of IGF2R or H19 affected following the IVM of ovine 
oocytes (Colosimo et al., 2009).  Conversely, although culturing in the presence of reduced 
levels of methyl donors did not affect the methylation levels of Igf2 or H19 in murine MII 
oocytes grown in vitro from the secondary stage, the methylation levels of Mest decreased 
(Anckaert et al., 2010).  In order to establish whether the changes in gene expression observed 
in vitro relative to in vivo were due to aberrations in the imprinting process it would be 
interesting to extend this investigation in order to determine and compare the methylation 
patterns of these genes in stage-matched in vitro- and in vivo-derived follicles. 
 
When the expression patterns of imprinted genes were compared between in vivo- and in 
vitro-derived counterparts only MEST was significantly affected by the in situ cortical culture 
conditions, as lower levels of expression were observed in in vitro-derived primary (p<0.01) 
and transitional (p<0.05) follicles compared to in vivo-derived counterparts (see Figure 5.17).  
Isolated preantral culture of follicles resulted in a significant decrease (p<0.01) in H19 
expression and a significant increase (p<0.05) in DNMT1s expression. 
 
5.4.4 Future work 
Due to the small number of replicates there was a large amount of variability in much of the 
data presented here– therefore in order to determine whether the differences in expression 
patterns observed between follicular stages and in vivo- and in vitro-derived samples were 
significant it would be necessary to increase the number of independent replicate samples 
analysed at all stages of development as well as and in the in vivo- vs. in vitro-derived 
follicle/oocytes analyses.  The quality of the data could also be improved by altering the 
sequences of some of the more sensitive primers to ensure expression patterns are being 
interpreted correctly.  As mentioned above the expression of numerous genes at the 
primordial stage contradicted previous reports, suggesting that the methods used in this 
chapter may have resulted in the amplification and detection of cDNA that did not result from 
the target gene.  Reducing the number of RT PCR cycles from 40 to 35 may reduce the risk of 
this in the future.  Furthermore, repetition of samples in which contamination may have 
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occurred would be necessary.  In addition it would be interesting to extend the culture series 
in order to generate in vitro-derived samples of follicles and oocytes of all stages which have 
developed from the primordial stage in vitro i.e. to complete the growth trajectory of in vitro 
derived follicles and oocytes up to mature stages and then to progress the gametes so derived 
through IVM.  In addition, the comparison of IVG MII oocytes with both IVM MII oocytes and in 
vivo matured MII oocytes would be very valuable in order to extend this field of research.   
 
Ultimately, the comparison of full gene expression patterns (for example, using next 
generation sequencing techniques such as RNA-seq (Yan et al., 2013) as well as DNA 
methylation analysis (for example, using pyrosequencing techniques) (El Hajj et al., 2011, 
Huntriss et al., 2011) between embryos derived from i) IVG oocytes, ii) IVM oocytes, iii) in vivo-
derived oocytes matured in vitro, iv) in vivo-derived MII oocytes fertilised in vitro as compared 
to v) in vivo-derived ovine blastocysts would be conducted in future experiments.  Whole 
methylome analysis is extremely challenging in oocytes and preimplantation embryos due to 
the very small amount of genetic material present.  Progress has been made using reduced 
representation bisulphite sequencing (RRBS) in murine oocytes and preimplantation embryos, 
as it is easier to obtain much larger numbers of murine oocytes/embryos (Smallwood et al., 
2011).  Some progress has been made regarding the use of this technique to analyse the whole 
methylome of small numbers of pooled and even single human and bovine blastocysts 
(Huntriss and Picton, unpublished data), the use of this technique to analyse the methylome of 
single or small numbers of oocytes of larger mammals and humans is highly challenging, due to 
the low amount of DNA available.  Adaptations of the RRBS technique have however been 
used recently to assess the methylome of single embryonic stem cells, suggesting oocyte 
whole methylome analysis is feasible (Guo et al., 2013).  In addition it would be a great benefit 
to perform a more detailed experiment by extending the studies to compare the full gene 
expression patterns and complete methylome of stage matched in vivo- and in vitro-derived 
ovine oocytes.  It would also be essential to extend this work to the analysis of in vitro-derived 
human oocytes before these gametes can be used therapeutically. 
 
It is interesting to note that the expression of the majority of genes (AMH, FSHR, IGF1, IGF1R, 
INHα, INHβA, ZP2, GDF9, GTSF1, BMP15, FOXO3, IGF2R, MEST, DNMT1o and DNMT1s) was 
higher in vivo than in vitro in stage-matched follicles.  One possible explanation for this could 
be a difference in mean follicle size, and therefore a difference in the number of follicular 
somatic cells, between the in vivo- and in vitro-derived samples.  Unfortunately the diameters 
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of the follicles samples collected were not recorded in this chapter.  The diameters of in vivo- 
and in vitro-derived secondary follicles were recorded in Chapter 3, however, and therefore 
could be used as an indicator of whether there was likely to be a difference in size dependent 
on derivation.  There was, however, no statistical difference (p>0.05) in the mean follicle 
diameter of in vivo- and in vitro-derived secondary follicles, 217.7±2.6μm (n=85) and 
219.5±10.5μm (n=16), respectively.  In addition there was no statistical difference (p>0.05) in 
the mean oocyte diameter, 101.8±3.4μm (n=85) and 106.9±2.0μm (n=16), of in vivo- and in 
vitro-derived secondary follicles, respectively.  Therefore the possibility that the similarities in 
follicle size may be concealing a difference in follicular somatic cell number due to differences 
in the oocyte diameter can be ruled out.  It is, however, possible that the in vivo- and in vitro-
derived follicles used for the current chapter did differ in size, therefore it may be worth 
repeating the experiments and measuring the follicle and oocyte diameter of all samples. 
 
One of the aims of the current chapter was to determine which genes would be most useful as 
molecular markers of normality.  Genes that display discrete patterns of expression 
throughout follicle development would be useful – in the current investigation these included; 
AMH, INHα, INHβA, FSHR, IGF1R, FST, ZP2, GDF9, GTSF1, BMP6, BMP15, MEST, H19, DNMT1o 
and DNMT1s.  Genes that display interesting differences when in vivo- and in vitro-derived 
stage-matched samples are compared are also likely to be useful markers as these are the 
genes that are sensitive to changes in the environment in which they are grown – in the 
current investigation these included; AMH, IGF1, IGF1R, INHα, INHβA, FST, ZP2, GDF9, GTSF1, 
BMP6, BMP15, MEST, H19, DNMT1o and DNMT1s.   Although the expression patterns of a 
number of genes (AMH INHα, INHβA, FST, INHβB, GDF9, BMP6 and BMP15) vary a little from 
what has previously been reported alterations to the techniques used (discussed above) may 
alleviate these problems somewhat.  Therefore, in conclusion, the genes identified as the most 
useful as molecular markers of normality are  AMH, IGF1R, INHα, INHβA, ZP2, GDF9, GTSF1, 
BMP6, BMP15, MEST, H19, DNMT1o and DNMT1s. 
 
5.5 Conclusion 
The first aim of this experimental series was to define molecular markers of normal follicle and 
oocyte development by examining the expression patterns of 20 candidate genes implicated in 
the regulation of folliculogenesis, oogenesis, embryogenesis and imprinting establishment and 
maintenance in vivo-derived ovine oocytes and follicles.  For a number of the genes analysed 
the expression patterns had previously been reported, however, this is the first report of the 
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pattern of IGF1, IGF1R, INHα, INHβA, INHβB, ZP2, FOXO3, GTSF1, DNMT1o, DNMT1s, IGF2, 
IGF2R, H19 and MEST expression throughout preantral and antral follicle development in the 
sheep.  As expression patterns of some genes, such as AMH differed from previous reports it is 
possible that the methods used in this experimental series were more sensitive than those 
used previously.  It is also possible that the methods used were too sensitive.  The expression 
patterns of these genes in oocytes and follicles derived in vitro using a long-term, physiological 
culture system is also reported.  The direct comparison of in vivo- and in vitro-derived samples 
revealed significant changes in the expression patterns of AMH, IGF1, IGF1R, INHα, INHβA, FST, 
ZP2, GDF9, GTSF1, BMP6, BMP15, DNMT1o, DNMT1s, H19 and MEST in at least one 
developmental stage although further replicate analyses are needed it would appear the 
expression of a large proportion of the genes analysed was adversely affected by the culture 
conditions to which the oocytes and follicles were exposed.  Different stages of follicle culture 
appeared to have different effects on gene expression patterns as in situ culture mainly 
affected the expression patterns of oocyte-specific genes, whereas isolated preantral follicle 
culture mainly affected the expression patterns of somatic cell-specific genes.  
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6 Use of Follicle Culture as a Tool to Quantify the Impact of Cryoprotectant 
Perfusion for Whole Ovary Perfusion. 
6.1  Introduction 
The development and optimisation of IVG techniques as a means of fertility preservation has 
been investigated in the first 3 experimental chapters of this thesis.  It is important to note 
that underpinning these techniques is the cryopreservation of ovarian tissue, without which 
these techniques would be of no use.  In some patients the cryopreservation and subsequent 
autotransplantation of thawed ovarian tissue without the combined use of IVG techniques is a 
potential suitable means of fertility preservation for women with primary ovary insufficiency 
(POI) or women requiring sterilising treatment (Donnez et al., 2013, Onions et al., 2013).  In 
some patients, however, it is not possible to autotransplant the ovarian tissue; therefore in 
these cases the development of IVG techniques would be of great value.  For example, fertility 
preservation by ovarian cryopreservation and autografting is not suitable for patients in which 
transplantation of tissue back to the body following treatment risks reintroducing the disease 
(Shaw et al., 1996).  Ovarian tissue can be easily obtained via laparoscopy and cryopreserved 
then, when appropriate, the tissue can then be thawed and transplanted back into the patient 
when she wishes to start or complete her family (Newton et al., 1996, Davidoff et al., 1996).  
The vast majority of follicles present in the ovary are at the primordial stage and follicles at this 
stage exhibit a high survival rate following cryopreservation, due to the fact that they are 
relatively tolerant to the procedure (Newton et al., 1996, Oktay et al., 1998, Kim et al., 2001).  
Although when secondary follicles are present they can also survive the freeze-thaw process 
(Newton et al., 1996).  Therefore this technique is preferable to the cryopreservation of GV 
and MII oocytes, which are less tolerant to the cryopreservation procedure, and are unsuitable 
for fertility preservation strategies in prepubertal girls.  The development and optimisation of 
WOCP techniques would be a highly beneficial alternative to the traditional methods of 
cryopreserving then transplanting fragments of ovarian tissue as this can be wasteful and 
result in the loss of a significant proportion of the ovarian follicle reserve.  
 
6.1.1 Ovarian tissue vs. whole ovary cryopreservation 
The use of ovarian tissue cryopreservation and orthotopic transplantation has resulted in the 
transient restoration of ovarian function in numerous patients, in some cases enabling 
pregnancy and live birth as discussed in Chapter 1 (Meirow et al., 2005, Demeestere et al., 
2007, Andersen et al., 2008, Demeestere et al., 2010, Jadoul et al., 2010, Donnez et al., 2012, 
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Revelli et al., 2013).  However, long-term restoration of ovarian function using this technique is 
unlikely due to the low number of follicles transplanted back into the patient compared to the 
follicle reserve prior to treatment (Baird et al., 1999, Salle et al., 2003).  The follicle reserve is 
initially reduced simply because only the follicles present within the slice of cryopreserved 
tissue are transplanted back into the patient.  The follicle reserve is further reduced by the 
cryopreservation and transplantation processes.  A histological comparison of fresh and 
frozen-thawed slices of human ovarian tissue revealed no significant differences in the number 
or proportion of primordial and primary follicles, until the tissue was transplanted into SCID 
mice when the follicle density in the frozen-thawed tissue decreased significantly compared to 
the fresh tissue grafts (Nisolle et al., 2000).  These findings support the hypothesis that the 
period of ischaemia to which the ovarian tissue is subjected following transplantation of the 
graft and prior to revascularisation is the major cause of follicular reserve depletion (Newton 
et al., 1996, Liu et al., 2002, Israely et al., 2004, Israely et al., 2006).  For these reasons 
transplantation of frozen-thawed tissue is only a viable option, with respect to fertility 
preservation, for younger women, as the follicle reserve in the ovaries of women over 35 years 
has already been depleted - due to reproductive ageing - to such an extent that there would be 
too few follicles present in slices of ovarian tissue to restore ovarian function for a significant 
period of time (Onions et al., 2013).  In contrast the use of WOCP techniques overcomes some 
of the problems associated with ovarian tissue slice cryopreservation as the entire follicular 
reserve is cryopreserved and then transplanted back to the patient.  Therefore although 
follicular loss may still occur following freezing and thawing and transplantation a greater 
number of follicles are still transferred and fewer follicles are lost as a result of ischaemia 
following transplantation.  Indeed, if both the whole ovary and its vasculature is cryopreserved 
the level follicular depletion as a result of ischaemia is significantly reduced as the graft can be 
immediately revascularised via surgical anastomosis (Onions et al., 2009).  
 
There are a number of challenges associated with WOCP.  Whole ovary cryopreservation 
requires protection of the tissue via the use of a CPA suitable for the range of cell types 
comprising both the ovary and its vasculature.  DMSO is often used for whole ovary 
cryopreservation (Onions et al., 2009, Onions et al., 2013), and will be used in this 
experimental series, as it has a relatively high permeation rate at low temperatures and is 
suitable for the range of ovarian cell types (Newton et al., 1996, Newton et al., 1998).  
Histological evaluation of ovine ovarian tissue, with respect to the proportions of healthy and 
degenerating oocytes present following exposure to various CPAs including; DMSO, PROH, EG 
and glycerol at 1.5M and 3M concentrations; and subsequent cryopreservation, revealed that 
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1.5M DMSO exposure was the least detrimental to follicle and oocyte health (Santos et al., 
2006).  Additionally whereas EG and PROH were found to be genotoxic to Chinese hamster 
ovarian cells, in that exposure caused ‘DNA damage leading to chromosomal mutations’ (Aye 
et al., 2010).  Prior to cortex cryopreservation slices of ovarian tissue are soaked in CPA to 
allow tissue permeation via diffusion.  This CPA has also been utilised successfully during 
WOCP in rodents where orthotopic transplantation of frozen-thawed ovaries has resulted in 
the restoration of fertility, although decreases in the follicle reserve resulting from ischaemic 
damage were reported (Harp et al., 1994, Candy et al., 2000, Yin et al., 2003).  However, this 
method of permeating the ovary with CPA by diffusion is not suitable for larger mammals as 
their ovaries are too large and would therefore have to be exposed to the cytotoxic CPA for a 
long period of time to ensure full permeation.  This could be highly detrimental to the tissue.  
Partial permeation would also be highly detrimental as this may allow ice formation to occur 
during the cryopreservation procedure (Wolfe and Bryant, 1999, Meryman, 2007).  This can be 
overcome by perfusing the ovary with CPA via the cannulation of the native vasculature 
supplying the ovary resulting in a shorter CPA exposure time.  This was first carried out in 
sheep by Bedaiwy et al. (2003), and has subsequently been used by (Onions et al., 2008, 
Onions et al., 2009, Onions et al., 2013, Arav et al., 2010).  The ovine model will be used in the 
current investigation as it similar to human with respect to the size of the ovaries in girls and 
the fibrous nature of the human ovary (Gosden et al., 1994, Onions et al., 2008). 
 
There have been a number of successful attempts at transferring whole fresh ovaries in sheep 
and humans, resulting in the restoration of ovarian function (Jeremias et al., 2002, Courbiere 
et al., 2009, Mhatre et al., 2005, Imhof et al., 2006, Laufer et al., 2010).  Furthermore, 
autotransplantation of ovaries that had been cryopreserved using slow-freezing methods then 
thawed, into ewes resulted in limited restoration of ovarian function and in one case a 
spontaneous live birth 545 days after transplantation (Bedaiwy et al., 2003, Imhof et al., 2006).  
However, major depletion of the follicle reserves was observed in the frozen-thawed ovaries.  
Following transplantation a comparison of perfused fresh and frozen-thawed ovine ovaries 
revealed ‘similar follicle losses and endocrine disruption’ in both (Onions et al., 2009).  In this 
study the fresh ovaries were perfused with L-15 medium plus 10% FCS, not CPA.  This suggests 
that the large loss of follicles can be attributed to the perfusion and cannulation techniques, as 
opposed to the cryopreservation techniques and use of CPA per se, as shown by the use of 
fresh ovary controls.  Although long-term patency following cryopreserved whole ovary 
grafting has been achieved, damage to the microvasculature, caused by the perfusion process, 
is probably a major contributor to the high levels of follicle depletion (Onions et al., 2009).  
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Indeed, a recent study has shown that whole ovine ovary cryopreservation and perfusion 
procedures can lead to alterations in the expression levels of numerous endothelial cell-
related genes, including those associated with vascular tone regulatory pathways (e.g 
endothelial nitric oxide synthase), endothelin (ET)-1 and ET-2 as well as alterations to 
expression levels of genes which lead to increased levels of apoptosis, e.g. up-regulation of Bax 
(pro-apoptotic) and down-regulation of Bcl2 (anti-apoptotic) (Onions et al., 2013).  However, 
ovarian function and full vascular patency has been reported in ewes 6 years after the 
orthotopic transplantation of whole frozen-thawed ovaries, using slow-freeze protocols (Arav 
et al., 2010).  In this study the ovary was perfused with 1.3M DMSO for only 3 minutes.  This 
may explain the long-term restoration of fertility, although it should be noted that a novel 
multithermal gradient freezing methodology was utilised in this study, unlike in the 
aforementioned examples.  In conclusion it is necessary to minimise the length of time spent 
perfusing the ovary with CPA in order to reduce the level of damage to the vasculature during 
preservation.  One of the aims of the current experimental series was therefore to use follicle 
culture as a tool to determine the minimum perfusion period required to fully permeate the 
ovary with CPA prior to WOCP by slow freezing whilst retaining maximal follicle and oocyte 
viability.  Nuclear magnetic resonance (NMR) spectroscopy was used to directly quantify CPA 
permeation.  The basic principles of NMR spectroscopy are covered in Section 6.1.2. 
   
6.1.2 Basic principles of NMR spectroscopy 
NMR spectroscopy enables the determination of the composition of a sample via the 
measurement of energy absorption and emission of nuclei within the sample when a magnetic 
field is applied externally.  The information regarding NMR spectroscopy provided in this 
section has been adapted from Pavia et al. (2001) and Lambert and Mazzola (2004).  Some 
atomic nuclei process a property called ‘spin’ and can occupy a specific number of spin states.  
In the absence of a magnetic field all the spin states of a given nucleus are of equal energy with 
an equal number of atoms occupying each of the spin states.  Charged nuclei generate a 
magnetic field when spinning and possess a magnetic moment.  When an external magnetic 
field (B0) is applied, in the direction of the z axis, the magnetic moments of the nuclei will 
precess in either the same or opposite direction as B0, +z or –z, respectively.  The nuclei 
opposed to B0 (-z) will be in a higher energy state and the nuclei aligned with B0 (+z) in a low 
energy state.  The greater the external magnetic field the greater the energy difference 
between the spin states.  Nuclei have a tendency towards the +z precession in the presence of 
B0 therefore more nuclei will be in a lower energy state.  The processional motion of the 
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magnetic moment around B0 occurs with angular frequency, known as Larmor frequency.  
Note that Larmor frequency is directly proportional to B0.  If a second magnetic field (B1) is 
applied at a radio frequency equal to that of the Larmor frequency of the nuclei this results in a 
spin state change.  Nuclei aligned with B0 absorb energy and change to the opposing spin state, 
whereas nuclei opposed to B0 emit energy and change to the aligned spin state.  As there is an 
excess of nuclei in the spin state aligned with B0 there is a net absorbance of energy, known as 
resonance, which can be detected electronically.  Nuclei in different environments will absorb 
radio waves at different frequencies; this allows the determination of the structure of a 
compound. 
 
 
Figure 6.1 Diagrammatic representation of the effect of the application of B0 and B1 on the net 
magnetisation (M) during NMR spectroscopy.  Application of B0 results in net M in the 
direction of the z axis (a).  A 90º B1 pulse results in alignment of M with the y axis (b).  Over 
time (M) in the direction of the y axis decreases and subsequently increases in the direction of 
the x axis as a result of spin-lattice and spin-spin relaxation (c).  Diagram adapted from 
Lambert and Mazzola (2004).  
 
The excess nuclei in the lower energy spin state are excited to the higher energy spin state via 
the application of pulses of B1.  In an NMR experiment when B0 is applied there is a net 
magnetisation (M) in the direction of the z axis, due to the excess of nuclei in the +z spin state 
(see Figure 6.1).  As the spins are randomly distributed about the z axis there is no net 
magnetisation in the x or y direction.  However, when B1 is applied along the x axis, at a radio 
frequency equal to the Larmor frequency of the nuclei, some of the excess nuclei are excited 
to the higher spin state thus a force is exerted on M resulting in it tipping towards the y axis.  
This can be detected electronically.  During a pulsed experiment B1 is pulsed for a sufficient 
length of time to align M with the y axis (a 90º pulse), at which point M can be detected.  
Magnetisation decays over time via ‘spin-lattice’ and ‘spin-spin’ relaxation, resulting in a 
decrease in y magnetisation with time, referred to as free induction decay (FID).  Spin lattice 
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relaxation is the reappearance of M along the z axis and is characterised by time constant T1.  
Spin-spin relaxation decay is the of magnetisation along the xy axis and is characterised by 
time constant T2.  In order to analyse the FID signal it must be Fourier transformed.  Fourier 
transformation is the numerical conversion of data from the time domain to the frequency 
domain (see Figure 6.2). 
 
 
Figure 6.2 Diagrammatic representation of the (a) FID signal collected following an NMR run 
and (b) data following Fourier transformation.  Adapted from Newton (1998).  
 
Following transformation of data in this experimental series 2 peaks should be observed for 
each sample; the water and the CPA; DMSO.  Known concentrations of DMSO were used to 
calibrate the data to enable quantification of the level of DMSO present.  This enabled the 
determination of the level of CPA permeation following perfusion times of 10, 30 and 60 
minutes. 
 
6.1.3 Assessment of the effect of CPA perfusion time on ovarian tissue and follicle survival 
and developmental potential  
As discussed in Chapter 1, the exposure of ovarian tissue, oocytes and follicles to CPAs can be 
detrimental to their health, as CPAs have cytotoxic effects (Meryman, 1971).  There are also 
risks that if CPAs are not used at the optimal concentration and/or applied/ removed at the 
correct rate their use can cause cell shrinkage prior to cryopreservation and the swelling of 
cells once they are thawed and returned to hypotonic solution, possibly leading to cell lysis 
(Picton et al., 2000).  The use of DMSO as a CPA during the cryopreservation of mature murine 
oocytes has led to zona hardening and disruption of the plasma membrane and cytoskeleton 
(Trounson and Kirby, 1989).  Additionally, histological evaluation of ovine ovarian tissue 
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revealed that exposure to 1.5M DMSO resulted in significantly fewer normal preantral follicles 
compared to control tissue, which had not been exposed to any CPA (Santos et al., 2006).  
Furthermore the percentage of follicles in which oocyte damage was observed doubled, and 
the percentage with degenerating GCs and oocytes tripled in DMSO-exposed tissues compared 
to control tissues, as a result of osmotic stress and the chemical toxicity of DMSO.  Therefore, 
in the current study in addition to direct quantification of CPA penetration by NMR 
spectroscopy, the effects of varying lengths of DMSO exposure on follicle and oocyte health 
will also be assessed histologically and compared to control tissue perfused with either L-15 
medium for an equivalent length of time and to control tissue that has not been perfused with 
either 1.5 M DMSO or L-15 medium with 10% FCS.  Follicle survival and growth in DMSO 
perfused and control tissues will be assessed using the cortex culture methodologies detailed 
in Chapters 3 and 4.  During in vitro culture the level of release of the enzyme- lactate 
dehydrogenase (LDH), into spent culture media. The enzyme LDH is present in the cell 
cytoplasm and it will be released into the media upon damage to the cell membrane (Decker 
and Lohmann-Matthes, 1988, Koukourakis et al., 2003).  In this experimental series the level of 
LDH in the spent culture media will therefore be used as an indicator of the level of ovarian cell 
membrane damage caused by exposure to cytotoxic DMSO for varying lengths of time.  Details 
of the principles of the assay used to quantify LDH concentrations in spent culture media are 
provided in Section 6.2.7. 
 
6.1.4 Aims 
The first aim of this experimental series was to determine the minimum perfusion time needed 
for 1.5M DMSO to fully permeate the sheep ovarian cortex and the vascular pedicle in whole 
ovaries using NMR spectroscopy.  The second aim of this experimental series was to assess the 
effects of tissue perfusion on the level of tissue damage and follicle and cortex health using the 
LDH assay of cell membrane damage in conjunction with NR staining as acute assays of tissue 
damage/ health, and 8 day cortex culture and histological analysis to assess the longer term 
impact of CPA cytotoxicity on follicle and oocyte health and developmental competence. 
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6.2 Materials and Methods 
6.2.1 Preparation of equipment 
To reduce the risk of contamination all white paper towel referred to in this method was 
soaked in 70% alcohol and left to dry prior to use.  All re-usable equipment used to perform 
cannulations, dissections and perfusions was sterilised by soaking in 70% alcohol prior to the 
tissue arriving in the lab.  This includes all catheters, metal guides and three-way taps.  
Following soaking equipment was flushed through; using a syringe, with 70% alcohol followed 
by and excess volume of sterile culture water (W3500) to remove any residual alcohol. 
 
6.2.2 Tissue preparation 
Ovarian tracts were transported to the laboratory at room temperature where they were 
examined on clean white paper towel to enable full inspection.  Tracts with both ovaries intact 
and with sufficiently large vasculatures, to enable the cannulation to be performed, were 
selected.  Once selected the uterus and fat were trimmed from the tracts using scissors, with 
care being taken to not cut off the ovarian pedicle or any of the ovarian or uterine vasculature.  
The tracts were then washed in pre-warmed (37°C) OWM (see Section 2.2) to remove any dirt 
and transferred into a sterile beaker containing 100iuml-1 (v/v) heparinised Ringer’s solution 
(see Appendix IV).  A summary of the protocol used in the current study is provided in Figure 
6.3. 
 
6.2.3 Ovarian artery cannulation 
Cannulations were performed under laminar flow conditions using a dissecting microscope 
(Olympus).  Individual reproductive tracts were placed on white paper towel to aid 
visualisation and to help hold the tissue in place.  Throughout the cannulation procedure the 
ovary and artery were kept hydrated using fresh heparinised Ringer’s solution.  Once the 
ovarian artery had been identified, a Mersilk 45mm suture needle and prolene/ polypropylene 
thread (Ethicon, Somerville, US) were used to tie off any arterial branches which led to the 
uterus and/or oviduct.  Using forceps blunt dissections were carried out to remove connective 
tissue above and surrounding the artery, with care being taken not to cut through the artery.  
The ovarian vein and artery were then separated, thus creating an exposed loop through which 
the handle of a scalpel could then be inserted to aid further manipulations by creating tension.   
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Figure 6.3 Summary of the protocol used in the current study with the number of repeats (n) shown at each stage. 
 
Cannulation of ovarian 
artery followed by 10 
mins perfusion with 
Ringer’s solution 
(at 4°C)
(n=24)
One ovary 
perfused with 
1.5 M DMSO 
(at 4°C) for 0, 
10, 30 or 60 
mins (n=6)
One ovary 
perfused with 
L-15 medium + 
10% FCS (at 
4°C) for 0, 10, 
30 or 60 mins
(n=6) NMR 
analysis
Take 
pedicle 
biopsies
Take 
cortex 
biopsies
CPA removal 
via washing in 
thawing 
solutions (CPA-
perfused 
ovaries only)
8 day 
culture
LDH assay –
spent medium 
collected on 
days 0, 2, 5 and 
8 of culture 
(n=6)
Histology – day 
0 (n=6) and 8 
(n=4) tissue
Weigh tissue 
and record 
follicle 
number 
following NR 
staining
Transfer 
into D20 
and store at 
-20 C (n=6)
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Figure 6.4 Image of an ovine reproductive tract with a cannulated ovarian artery.  Image is 
taken from (Onions et al., 2008).  The cannulation (C) of the dorsal aorta (DA) of the ovarian 
artery is shown with the ovary (O), vascular pedicle (VP), and uterine horns (UH), body (UB) 
and artery (UA) also labelled.  
 
Using iris scissors a small V-shaped incision of around 10-15 mm was made in the arterial wall.  
Through this incision a vascular catheter with metal guide (Leaderflex 22G (0.7 mm x 200 mm; 
Vygon Ltd, Wiltshire, UK) was inserted a distance of approximately 1cm into the artery.  Once 
in place the metal guide was pulled out of the cannula slightly.  Two prolene/ polypropylene 
sutures (Ethicon) were tied around the cannula and the ovarian artery, just above the entry 
point, in order to secure it.  In order to ensure that the cannula had been inserted in the 
correct direction- which is necessary as the artery is very convoluted, and that there were no 
leaks through arterial branches that had not been tied off, 2-5mls of Ringer’s solution was 
flushed through the cannula and vasculature using a sterile syringe via a 3-way tap.  Once the 
cannulation was complete the ovary and vasculature were dissected from the uterus and 
placed into a sterile Nunc 90mm Petri dish on ice (4°C).  This procedure was then repeated for 
the second ovary of the tract. 
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6.2.4 Ovary perfusions 
All perfusions were carried out on ice at 4°C.  Two syringe-driven perfusion pumps (Precidor) 
were used in this investigation.  The pumps were supplied by ChemLab Scientific Products 
(Essex, UK).  The pumps were set up as shown in Figure 6.5.  Note that although 50ml syringes 
were initially used these were prone to sticking.  It was also found that if the syringes were 
kept in the fridge for too long before use the rubber seal would lose some of its elasticity and 
the syringes again would be prone to becoming stuck.  After this was discovered 20ml syringes 
were set-up just prior to use to eliminate this problem.  In order to ensure that the pump was 
working correctly such that the cannulae were not occluded and that media was being 
pumped through the ovary from the very start of the perfusion time, each time a new syringe 
was attached to the pump it was tested immediately prior to perfusion using a spare catheter. 
 
All perfusions were carried out on ice at 4°C and all solutions used were kept at 4°C until use to 
minimise the cytotoxic impact of DMSO.  The ovaries were first perfused with Ringer’s solution 
(see Appendix IV) for 10 minutes, at a rate of 1mlmin-1. During the perfusion the Petri dishes 
were tilted slightly with the ovary positioned in the lower half of the dish in the used media to 
help keep it hydrated. Following perfusion with Ringer’s solution one ovary from each tract 
was then perfused with CPA solution containing 1.5M DMSO at a rate of 0.5mlmin-1 (see 
Appendix IV) and the other, control ovary was perfused with Leibovitz L-15 medium 
supplemented with 10% heat-inactivated Fetal Calf Serum (FCS), from here on in referred to as 
L-15 medium, at a rate of 0.5mlmin-1.  Perfusions were run for 0, 10, 30 and 60 minutes.  Once 
the perfusion was complete the ovary was transferred to the flow hood, the cannulae 
removed and the vasculature trimmed away.  The ovaries were then transferred to sterile 5ml 
universals before processing.  Two punch biopsies were taken from the vasculature, using a 
4mm biopsy punch (Glaxosmithkline, Middlesex, UK) and stored individually in 400μl D20 in 
0.5ml eppendorf tubes, sealed immediately using parafilm, at -20°C for later NMR assay 
analysis (see Section 6.2.8). 
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Figure 6.5 Diagram showing how the pumps were set-up for the ovary perfusion.   Pairs of 
ovaries from the same reproductive tract were simultaneously first perfused with (a) Ringer’s 
solution for 10 minutes, then with (b) either 1.5M DMSO (pink) or L-15 medium + 10% FCS 
(orange) for 0, 10, 30 or 60 minutes.  
 
6.2.5 Processing of ovaries and culture setup 
Ovaries were processed on ice at 4°C, under laminar flow conditions.  The ovaries perfused 
with CPA solution were processed before those perfused with L-15 medium.  The ovaries were 
dried using sterile tissue before processing.  In both series of experiments a skin graft knife was 
used to slice thin sections from the outer cortex of the ovary.  Punch biopsies of 4mm 
diameter were then taken from the harvested cortex.  The number of biopsies possible to 
obtain per ovary varied with ovary size - between 7 and 10 biopsies.  The maximum number of 
biopsies possible was collected.  Two biopsies obtained from each ovary were immediately 
transferred to a labelled 0.5ml eppendorf tube containing 400μl of D20, which were sealed 
immediately using parafilm and stored at -20°C for later NMR assay analysis (see Section 
6.2.8).  The remaining biopsies taken from the CPA perfused ovary were washed in 5ml 
solutions of progressively decreasing DMSO concentration (1.0M, 0.5M and 0M DMSO plus 
0.1M sucrose and 10% FCS in L-15 medium) in a 5ml universal.  This was necessary as if the 
discs were placed directly into culture media this would have caused the cells to swell and 
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potentially burst due to the changes in osmolality.  The discs were placed in each solution and 
shaken using a mini-orbital shaker (Stuart; VWR) set at 80 revolutions per minute (rpm) for 
10minutes each, on ice.  All biopsies from the same ovary were incubated in 500μl of 50μgml-1 
NR dye for 2½ hours, the solution had been placed into the incubator at 37°C and 5% CO2 to 
pre-warm and gas for 3 hours prior to use, to enable viable follicle quantification (see Section 
2.5-2.6).  Note that phenol red-free basal culture media was used in the current series of 
experiments, with the same additives as detailed in Table 2.1 as the LDH assay has previously 
been validated for use with sheep cortex and phenol red present in culture media has 
previously been shown to interfere with the LDH assay (Gunson, 2009).  Of the most follicle 
rich biopsies tissue weight was recorded (see Section 2.6) and 4 biopsies were put into culture 
(2 biopsies per well), 1 biopsy – was retained as an uncultured control and was transferred to 
4% (w/v) PFA (see Appendix II) for histological analysis (see Section 6.2.9).  
  
6.2.6 Ovarian cortical culture 
Ovarian cortical culture was set up as described in Section 2.7. The only modification in the 
present experiments was that the phenol red-free α-MEM basal culture media (Invitrogen) was 
used in the cortical culture media.  Tissue was cultured for 8 days, with media changes being 
carried out on days 2 and 5 and the spent media (250μl) was stored in eppendorfs at 4°C  for 
up to 4 weeks prior to analysis using the LDH assay (see Section 6.2.7).  A 250μl sample of 
tissue free media was also taken on day 0 and at the end of culture for use as controls in the 
LDH assay. 
 
At the end of culture the tissue weight was recorded (see Section 2.6).  A note of the general 
appearance of the tissue was also made.  The tissue was then transferred to NR solution (see 
Section 2.5) for an hour at 37°C to enable the assessment of the level of NR staining and the 
number of viable follicles.  Note that at the end of culture it was often not possible to count 
the follicles due to the more intense level of NR staining that was achieved as the tissue had 
not initially been kept at 4°C, as at the start of culture.  The tissue had also often thickened due 
to cell proliferation and/or balled up after culture which further hindered follicle counting.  
The cultured biopsies were transferred to 4% (w/v) PFA (see Appendix II) for future histological 
analysis following NR staining (see Section 6.2.9). 
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6.2.7 Lactate dehydrogenase assay 
The level of the enzyme LDH in the spent culture media can be used as a measure of cell 
damage as LDH present in the cell cytoplasm will be released into the media following damage 
to the cell membrane (Decker and Lohmann-Matthes, 1988, Koukourakis et al., 2003).  The 
amount of LDH was measured using an assay kit (Cytotoxicity Detection Kit, Roche Applied 
Sciences) on an MRX plate reader (Dynex Laboratories Chantilly, Virginia, USA).  The level of 
LDH in the culture media was determined using a coupled enzymatic reaction (see Figure 6.6), 
in which LDH catalyses the conversion of lactate to pyruvate resulting in the reduction of NAD+ 
(nicotinamide adenine dinucleotide) to NADH/H+.  The catalyst (diaphorase) present in the kit 
then transfers the H/H+ from the NADH/H+ to the tetrazolium salt thus forming formazan, 
resulting in a colour change from pale yellow to red.  The level of LDH activity directly 
correlates to the level of formazan formed.  Formazan absorbs light at a wavelength of around 
500nm.  Therefore the absorption of the sample at a wavelength of 490nm was measured 
using a MRX plate reader (Dynex Laboratories, Virginia, USA) to determine the level of LDH in 
the sample.  A reference wavelength of 630nm was used to determine and subtract 
background absorbance.    
 
 
Figure 6.6 Summary of the coupled enzyme reaction used in the LDH assay to determine the 
level of lactate in the media.  Enzymes are highlighted in purple boxes.  
 
Quality controls (QCs) and standards were prepared as detailed in Appendix IV.  Prior to use 
1ml of distilled water was added to the catalyst then stored for up to 1 month at 4ºC.  
Immediately prior to the assay 11.25ml of the dye solution (iodotetrazolium chloride and 
sodium lactate) was added to 250µl of catalyst to produce the reaction mix.  Standards of LDH, 
of concentrations: 0.625Uμl-1, 1.25Uμl-1, 2.5Uμl-1, 5Uμl-1, 10Uμl-1, 20Uμl-1 and 40Uμl-1, and LDH 
QCs 1-4 of concentration: 1Uμl-1, 2Uμl-1, 4Uμl-1 and 8Uμl-1, respectively, and blanks were 
measured in triplicate. Test samples were assayed in duplicate in optically clear 96 well 
microtitre plates (Greiner Bio-one, Frickenhausen, Germany).  Firstly, 100µl of standard/ 
sample was added to each well, then using an eight channel, multichannel pipette (Invitrogen) 
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150µl of reaction mix was added per well.  The plate was then placed in a foil covered box to 
shield it from light and left for 30 minutes before being transferred to the MRX plate reader.  
The assay management software; Biolinx 2.21 (Dynex Laboratories) was used to analyse the 
data.  In total 22 assays were conducted and the intra and inter assay coefficient of variance 
(CV) were calculated for QCs 1-4 using the formula shown in Equation 6.1, values are shown in 
Table 6.1. 
Equation 6.1 
% CV = standard deviation for QC x 100/mean for QC 
 
Table 6.1 Inter and intra assay coefficients of variation for 22 assays. 
     QC QC1 QC2 QC3 QC4 
Inter assay % CV 12.5 13.2 10.4 11.1 
Intra assay % CV 14.7 13.7 11.0 11.5 
 
6.2.8 Nuclear magnetic resonance assay 
As described in Sections 6.2.4 and 6.2.5 punch biopsies were taken from the pedicle and ovary 
cortex immediately following perfusion and stored in deuterium oxide (D2O) for NMR analysis.  
Samples were removed from the freezer the night before analysis and left to defrost at room 
temperature on a mini-orbital shaker (Stuart) set at 100-120rpm to allow equilibration of the 
water and CPA (if present) between the tissue and D2O.  Following equilibration 300µl of the 
sample was transferred to a fresh eppendorf and 300µl of D2O added.  Eppendorfs were 
inverted to mix, then 350µl of the diluted sample was transferred to a 5mm diameter glass 
NMR tube (Wilmad Glass Company, New Jersey, USA). 
 
NMR analyses were conducted in the laboratories of Dr. Julie Fisher, School of Chemistry, 
University of Leeds.  Assays were carried out as previously described and validated for sheep 
cortex by Newton et al. (1998).  All the spectra were recorded on a Varian Unity Inova 500 (1H 
frequency 500MHz).  Prior to running the time course experiments, the T1’s (longitudinal 
relaxation times) were measured using an inversion recovery experiment.  Spectra were then 
acquired over 64 transients with spectral width of 3000Hz in 16,384 pairs of data points, 
resulting in an acquisition time of 5.5 seconds.  The relaxation delay between transients was 10 
seconds and a 20 degree pulse width (2.5µs duration) was employed.  The time period for each 
transient was approximately 3 times the longest T1 measured.  The data were recorded at 
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20oC, and were processed remotely using the NMR package ACD (ACD Labs, Ontario, Canada).  
Prior to Fourier transformation the FIDs were multiplied by an exponential line-broadening 
factor of 1Hz.  The area under each peak was measured using the standard procedures within 
ACD.  Calibration data were obtained by recording the spectra of 1.5M DMSO to give a 
cryoprotectant to water ratio of 0.0339.  A tube containing only D20 was also analysed to 
obtain a value for the background water signal, which was subtracted from all the water peaks.  
The uptake of CPA was calculated by dividing the test values by the calibration value.  The 
detection threshold of the assay was a cryoprotectant to water ratio of 0.00001. 
 
6.2.9 Histological analysis 
All histological analyses were performed with the assistance of Mrs Ping Jin, as described in 
Sections 2.9-2.11.  The effect of varying the length of perfusion on the integrity of stromal 
tissue and follicles was assessed histologically, as described in Section 2.11.  Representative 
images of good, adequate and poor quality stroma are shown in Figure 6.7. 
 
 
Figure 6.7 Representative images of (a) good, (b) adequate and (c) poor quality stromal tissue.  
All follicles are at the primordial or EP stage of development.  During histological analysis only 
follicles with a visible nucleolus were counted – the oocyte of these follicles is labelled ‘O’.  
Tissue samples are taken from (a) non-perfused ovary on day 0, (b) an ovary perfused with CPA 
for 30 minutes after 8 days of culture and (c) an ovary perfused with L-15 medium for 60 
minutes after 8 days of culture.  Scale bar = 20μm. 
 
6.2.10 Statistical analysis 
The distribution of data was analysed for normality using the Anderson Darling test.  Data was 
then analysed across all treatments using one-way ANOVA and between equivalent tissue 
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samples at the start (day 0) and end (day 8) of culture using the Student’s t-test.  The LDH 
assay data presented in Figures 6.9 and 6.1 and the mean number of EP and primary follicles 
per mg tissue presented in Figure 6.14 was not normally distributed therefore was log-
transformed to achieve normality. 
   
6.3 Results 
6.3.1 Nuclear magnetic resonance data 
In this experimental series ovaries were perfused with CPA or L-15 medium to determine the 
minimum length of time required for the CPA to fully permeate the different tissue types in 
the ovary and pedicle whilst maintaining cell viability.  The relative level of CPA permeation in 
tissue perfused with Ringer’s solution for 10 minutes followed by either CPA or L-15 medium 
for 0, 10, 30 or 60 minutes is shown in Figure 6.8.  In Figure 6.8 data is separated into pedicle 
and cortex samples obtained immediately after perfusion, within these categories data is 
subdivided into non-perfused tissue (i.e. tissue perfused with only Ringer’s solution), tissue 
perfused with L-15 medium for 10, 30 and 60 minutes and tissue perfused with CPA for 10, 30 
and 60 minutes.  In the pedicle tissue samples there is a clear and significant increase (p<0.01) 
in the level of CPA permeation after 10 minutes.  Increasing the perfusion time to 60 minutes 
did not significantly increase the level of CPA permeation suggesting that the tissue was 
saturated with CPA after the shortest, 10 minute time period.  In contrast in the cortical tissue, 
a perfusion length of 60 minutes was required to significantly increase (p<0.01) the level of 
CPA permeation over all other CPA infused time points, as well as the time 0 controls and the 
L-15 treated tissues. After 60 minutes of perfusion the level of CPA permeation in the cortical 
tissue was not significantly different (p>0.05) from that observed in the pedicle tissue 
suggesting that 60 minutes perfusion was sufficient to allow the CPA to fully saturate the 
ovary. 
 
Low levels of CPA permeation were observed in some of the cortical tissue samples, which 
were perfused with L-15 medium only indicating that there must have been some cross-
contamination with CPA during tissue processing. However, as indicated in Figure 6.7, it is 
important to note that the levels of CPA penetration recorded at each perfusion time point 
were vary variable between samples and none of the levels recorded were significantly 
different (p>0.05) to the non-perfused, time 0 controls. The explanation for this observation is 
unclear as no contamination was detected in the equivalent pedicle samples after L-15 
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treatment for any length of perfusion.  This suggests that limited cortex contamination with 
CPA must have occurred when the ovaries were processed immediately following the 
termination of the perfusion. The CPA contamination could have occurred if the blades used to 
slice cortical tissue from the ovary were not changed between the CPA- and L-15 medium-
perfused tissue as it is possible that some residual CPA may have been transferred between 
the 2 ovaries as the CPA- perfused ovaries were always processed first.  Therefore levels of 
CPA found in the CPA-perfused cortical tissue would not have been affected as fresh blades 
were always used for the preparation of each pair of ovaries.  Alternatively, residual CPA 
exposure may have been incurred in the tissue processing dish. The latter explanation is 
unlikely as although the same Petri dishes were used to process all of the ovaries recovered on 
the same day, the dishes were always wiped dry with sterile tissue paper between samples so 
CPA carry over is unlikely to have been sufficient to contaminate the samples. 
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Figure 6.8 Histogram showing the relative level of CPA permeation in tissue perfused with Ringer’s solution for 10 minutes followed by either CPA or L-15 medium 
for 0 (non-perfused control), 10, 30 or 60 minutes.  Data shown are mean relative CPA permeation ± SEM for 6 replicate samples, unless otherwise indicated on 
the graph (n).  Statistically significant differences are indicated by different letters across all treatments and tissue types (p<0.01).  
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6.3.2 Lactate dehydrogenase assay data 
The concentration of LDH in spent culture media per g of tissue at the start of culture, for 
media collected on days 2 and 5 and the end of culture for media collected on day 8 , was used 
as an indicator of the level of damage to the ovarian tissue and follicles following perfusion.  
Figures 6.9 and 6.1 show that in all treatment groups, independent of perfusion length, the 
concentration of LDH in spent culture media increased with increasing time in culture, as in all 
tissue groups the concentration of LDH was significantly higher (p<0.001) in spent media 
collected on day 5 than day 2 and that collected on day 8 compared to days 2 and 5, with the 
exception of the tissue perfused with CPA for 30 minutes in which there was no statistical 
difference (p>0.05) in the concentration of LDH in media collected on days 5 and 8, although 
there was a significantly higher (p<0.05) concentration than in media collected on day 2.  There 
were no significant differences in the concentration of LDH in spent media, between different 
treatment groups on days 2 and 5 of culture.  However, the concentration of LDH in spent 
culture media of non-perfused tissue was significantly higher (p<0.05) than that of tissue 
perfused with either CPA or L-15 for 10 or 30 minutes, by day 8 of culture.  This high 
concentration of LDH in the spent culture media of non-perfused tissue after 8 days of culture 
was unexpected and after this time frame is likely due to subtle differences/stressors in the 
culture environment rather than differences in tissue treatment at the start of culture as no 
significant differences were observed between treatments after 2 and 5 days in vitro.  
Furthermore, the LDH concentration in the spent culture media collected on day 8 of culture 
was not significantly different (p>0.05) in tissue perfused for 10 or 30 minutes.  However, 
although the LDH concentration in spent media of tissue perfused for 10 minutes was not 
significantly different (p>0.05) from that in the spent media of tissue perfused for 60 minutes, 
the LDH concentration in spent media of tissue perfused for 30 minutes was significantly lower 
(p<0.05).  It is interesting to note that the patterns of LDH concentration increase with 
increasing length of culture observed in the CPA perfused ovaries are very similar to those 
observed in the L-15 perfused ovaries within each time category.  As counterpart CPA and L-15 
ovaries were taken from the same tract this suggests that the source of the ovary impacts on 
LDH release.  This could also explain the relatively high concentration of LDH observed in the 
non-perfused tissue and why the lowest concentration of LDH was observed in the tissue 
perfused for 30 minutes.  To aid clarity of interpretation, these results are also presented in 
Figure 6.10 in line graph form, which demonstrates the strong positive relationship (p>0.05) 
between the duration of culture and the concentration of LDH in spent media. 
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Figure 6.9 Histogram showing the concentration of LDH present in spent culture media/g of tissue on days 2, 5 and 8 of culture following whole ovary perfusion 
with either CPA or L-15 for 0, 10, 30 and 60 minutes.  Data is presented as mean ± SEM for 6 culture repeats.  Data was analysed using one-way ANOVA within 
each time point.  Statistical differences are denoted using different letters (p<0.05).   
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Figure 6.10 Concentration of LDH present in spent culture media of tissue on days 0, 2, 5 and 8 
of culture following whole ovary perfusion with either CPA or L-15 for non-perfused control 
tissue and tissue perfused for (a) 10, (b) 30 and (c) 60 minutes.  Data is presented as mean ± 
SEM for 6 culture repeats.  A strong positive correlation (p<0.05) between duration of culture 
and LDH concentration in the spent media was observed in all data sets, analysed using 
ANCOVA.  The data was also analysed using one-way ANOVA.  Statistical differences in LDH 
concentrations between different lengths of culture, within treatment groups are shown using 
different lower case letters (p<0.001) and upper case letters (p<0.05).  Note that the statistical 
differences observed are the same in Figures (a) and (c) therefore the black letters are 
representative of all treatment shown on those graphs, whereas black, teal and white letters 
were used in Figure (b) to represent non-perfused control, CPA and L-15 perfused data, 
respectively.  Statistical differences within culture lengths and between treatments are 
denoted using * (p<0.05).  
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6.3.3 Tissue viability following perfusion 
Immediately prior to culture tissue biopsies were incubated in NR dye in order to determine 
the number of viable follicles present (see Figure 6.11).  In all treatment groups, with the 
exception of the 30 minute CPA perfused group, 95-100% of biopsies contained viable follicles.  
Following 30 minutes perfusion with CPA a lower percentage (86%) of biopsies contained 
viable follicles, which was due to biopsies obtained from one ovary in which only 37.5% 
contained viable follicles.  Hence, this highlights the importance of the use of NR staining prior 
to cultures to screen for dead tissue and tissue with depleted follicles counts.  Only tissue 
biopsies containing viable follicles were used for cortical culture.  Following 8 days of culture 
tissue biopsies were incubated in NR dye in order to determine the level of tissue viability (see 
Figure 6.11).  The percentage of the tissue biopsy positively stained with NR was scored and 
the mean for all biopsies from ovaries treated in the same way was obtained and presented in 
Table 6.2.  The lowest percentage of NR positive staining was observed in the tissue obtained 
from ovaries perfused for 30 minutes with CPA, however, unlike prior to culture, this was due 
to low percentage staining observed in a number of samples. 
 
Table 6.2 Mean percentage NR stain of tissue pieces cultured for 8 days following whole ovary 
perfusion with either CPA or L-15 for 0, 10, 30 and 60 minutes.  The SEM is shown for the 
number of repeat cultures indicated.  The data was normally distributed and analysis using 
one-way ANOVA revealed no statistically significant (p>0.05) differences. 
 Treatment 
Perfusion 
length 
(minutes) 
% NR stain in tissue pieces on 
day 8 of culture 
SEM  
Number of 
repeats 
Non-perfused 
control 
0 76.7 6.7 5 
CPA 
10 78.3 7.3 5 
30 58.3 12.0 6 
60 79.9 6.8 6 
L-15 
10 77.8 6.3 6 
30 90.3 5.5 6 
60 90.0 3.1 5 
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Figure 6.11 Representative images of biopsies after whole ovary perfusion and following NR 
incubation on days 0 (a and b) and 8 (c and d) of culture.  The tissue biopsies in (a) and (c) are 
primordial follicle rich, whereas the tissue in (b) does not contain any follicles and therefore it 
was not used for culture.  Due to the intensity of staining in (d) it was not possible to identify 
and/or count the number of follicles present after culture, however, the stromal tissue in both 
(c) and (d) has a relatively high level of NR staining and was therefore considered as viable.  In 
addition the stromal tissue had proliferated after 8 days culture as the edges of the tissue have 
curled and thickened.  Scale bar = 500μm.  
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6.3.4 Histological analysis 
In this experimental series the effect of perfusing ovaries with either CPA solution or L-15 
control medium on the follicle health and population dynamics in cortical tissue, before and 
after culture, was investigated.  Three different perfusion times were compared relative to 
time 0, namely 10, 30 and 60 minutes.  Paired ovaries from the same reproductive tract were 
first perfused with Ringer’s solution for 10 minutes, then with either CPA or control medium, L-
15 for the lengths of time stated above.  Non-perfused tissue obtained from ovaries that were 
perfused with Ringer’s solution alone was also used as a control for all comparisons.  Follicle 
population dynamics were analysed in tissue samples from all treatment groups described 
above; obtained on days 0 and 8 of culture.  A summary of all the types of samples used for 
histological analysis is provided in Table 6.3 and the total numbers of follicles of each 
classification analysed in each treatment group and provided in Table 6.4. 
 
Table 6.3 Summary of all the types of samples used for histological analysis. 
Treatment Non-perfused tissue Perfused tissue 
Medium N/A CPA L-15 
Perfusion time 
(minutes) 
0 10 30 60 10 30 60 
Day of culture 0 0 8 0 8 0 8 0 8 0 8 0 8 
 
Table 6.4 Total number of each classification of follicle analysed histologically following each 
treatment. 
Treatment 
Perfusion length 
(minutes) 
Day 
Follicle classification 
Prd EP 1° Trans 2° EA 
Non-perfused control 0 
0 3890 1615 170 90 35 5 
8 5715 2115 60 35 5 0 
CPA 
10 
0 1370 1380 315 50 15 0 
8 2660 1000 80 190 40 0 
30 
0 680 440 28 36 4 0 
8 1400 725 30 45 25 0 
60 
0 805 805 50 90 5 0 
8 670 300 10 5 0 0 
L-15 
10 
0 1870 700 40 45 15 0 
8 2765 621 19 5 0 0 
30 
0 1333 898 117 114 29 0 
8 2030 1165 100 240 60 0 
60 
0 1355 920 115 85 10 0 
8 1210 480 10 20 5 0 
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Follicle population dynamics were analysed histologically.  The mean number of follicles 
present in day 0 and day 8 tissue is presented in Figure 6.12.  The mean number of follicles in 
all groups on days 0 and 8 were compared.  When all day 0 tissue samples were compared, 
although the mean number of follicles in all perfused tissue samples was lower than in the 
non-perfused tissue this was not statistically significant (p>0.05).  However, the p value 
showed a trend towards significance (p=0.059) therefore if more repeats had been carried out 
these differences might have reached statistical significance.  This suggests that the process of 
perfusing the ovary with either CPA or L-15 damaged the tissue and caused more follicles to 
degenerate than in the non-perfused tissue.  The mean number of follicles in CPA or L-15 
perfused tissue was significantly lower (p=0.002) than in the non-perfused tissue on day 8.  
Therefore the level of follicular degeneration during culture was consistently higher in the 
ovaries that had been perfused with CPA or L-15, compared to non-perfused control tissues 
that had been washed with Ringer’s solution only.  The lower mean follicle number in all 
perfused tissues on day 0 could partly account for this observation.  In order to examine this 
further the mean number of follicles on days 0 and 8 of culture within each perfusion time 
group were compared.  In all perfusion groups the number of follicles decreased after 8 days of 
culture via follicle degeneration.  However, only in the tissue perfused for 30 and 60 minutes 
with CPA (p=0.042 and p=0.003, respectively) and 60 minutes with L-15 (p<0.001) was the 
decrease significant.  Therefore, treatment with CPA consistently resulted in higher levels of 
follicle degeneration and loss than L-15 following a 30 minute perfusion period.  Whereas a 60 
minute of perfusion, regardless of whether the media contained only L-15 or CPA, resulted in 
higher levels of follicular degeneration and loss. 
 
Follicle population dynamics were examined in Figure 6.13 with respect the percentage of 
primordial follicles present in tissue on days 0 and 8 of culture following whole ovary 
perfusion.  The percentage of primordial follicles was higher in tissue fixed on day 8 compared 
to day 0 in all CPA and L-15 perfused tissue and non-perfused tissue.  This suggests that the 
proportion of primordial follicles relative to growing follicles increased after culture.  As the 
mean number of follicles is lower in day 8 tissue, compared to day 0 tissue (see Figure 6.12) 
this suggests that the growing follicles are more susceptible to atresia during culture following 
L-15 or CPA perfusion.  The increase in the proportion of primordial follicles on day 8 was not 
statistically significant in any treatment group except the 60 minutes CPA perfusion group 
(p<0.05).  This suggests that 60 minutes of CPA perfusion is the most damaging treatment for 
growing follicles. 
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Figure 6.12 Mean number of follicles present in tissue on fixed days 0 and 8 following whole ovary perfusion with either CPA or L-15 for 0, 10, 30 and 60 minutes.  
Data is presented as mean ± SEM for the number of culture repeats (n) indicated.  Statistical differences between follicle counts in day 0 and 8 tissue within each 
perfusion time were analysed using the Student’s t-test and are indicated using * (p<0.05) or ** (p<0.001).  Statistical differences between the day 8 follicle counts 
between different perfusion times were analysed using one-way ANOVA and are indicated by different letters (p<0.05).  
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The population dynamics of EP and primary follicles present in tissue on days 0 and 8 are 
presented in Figures 6.14 and 6.15, as the mean number and mean percentage of follicles, 
respectively.  The population dynamics of multi-layered follicles are shown in Table 6.5.  
Following 10 minutes perfusion there was no difference in the mean number of EP, primary or 
multi-layered follicles on days 0 and 8 between treatment groups (see Figure 6.14 and Table 
6.5).  Although the number of follicles decreased in day 8 tissue relative to day 0 tissue this 
difference was not significant (p>0.05).  However, when the mean percentage of follicles was 
considered there was a significant decrease (p=0.028) in the tissue perfused for 10 minutes 
with L-15 relative to both its day 0 counterpart and all other EP follicle counts (see Figure 
6.14).  It is unclear why perfusion with L-15 would have caused a decrease in EP follicle counts.  
The SEM for 10 minute CPA EP follicle percentage is quite high therefore it is possible that if 
more repeats were carried out a decrease would also be seen in this category.  There were no 
significant differences in the mean percentage of primary or multi-layered follicles following 10 
minutes perfusion (see Figure 6.14 and Table 6.5).   
 
Following 30 minutes of perfusion there were no statistically significantly changes (p>0.05) in 
the percentage of EP, primary and multi-layered follicles, relative to non-perfused control 
tissue or on days 0 and 8 of culture (see Figure 6.7 and Table 6.1).  It should be noted, 
however, that all follicle counts decreased on culture day 8 relative to equivalent culture day 0 
samples.  There was also no significant decrease (p>0.05) in the mean number of EP, primary 
and multi-layered follicles, relative to non-perfused control tissue in CPA and L-15 perfused 
tissue on days 0 and 8 of culture, apart from the tissue perfused with L-15 for 30 minutes 
which had, after 8 days in vitro, a significantly lower (p<0.05) number of EP follicles relative to 
non-perfused control, 30 minute L-15 perfused day 0 tissue (see Figure 6.14 and Table 6.5).  
The number of primary follicles present in tissue perfused for 30 minutes with L-15 was not, 
however, significantly lower (p>0.05) than that observed in non-perfused tissue on day 8 or 
tissue perfused for 30 minutes with CPA and analysed on days 0 or 8 of culture.  Furthermore, 
the number of primary follicles did not decrease after 8 days of culture relative to that 
observed in the same treatment group on day 0 therefore these findings are unlikely to be 
indicative of a higher level of damage to the tissue.  Again it should be noted that the mean 
number of follicles in tissue perfused for 30 minutes decreased on day 8 of culture relative to 
their day 0 counterparts, although not significantly (p>0.05). 
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Following 60 minutes of perfusion there were no statistically significant (p>0.05) changes in 
the percentage of EP, primary and multi-layered follicles, relative to non-perfused control 
tissue or to perfused tissue fixed on days 0 and 8 of culture (see Table 6.5 and Figure 6.15).  
However, just as was observed for the 30 minute perfusions, detailed above, it was noted that 
all counts decreased on culture day 8 relative to culture day 0.  There was also no significant 
decrease (p>0.05) in the mean number of EP follicles, relative to non-perfused control tissue or 
on days 0 and 8 of culture (see Figure 6.14 and Table 6.5). However, there were significantly 
fewer primary (p=0.011) and multi-layered (p=0.036) follicles present in tissue cultured for 8 
days, which had been perfused with either L-15 or CPA for 60 minutes relative to non-perfused 
tissue follicle counts on day 0 and 8.  Additionally, the number of primary follicles in day 8 
tissue had decreased significantly relative to their day 0 culture control counterparts, following 
60 minute perfusion with L-15 or CPA.  However, although the absolute number of multi-
layered follicles in day 8 cultured tissue decreased relative to their day 0 culture control 
counterparts, following 60 minute perfusion with L-15 or CPA, this difference was not 
statistically significant (p>0.05). 
 
Table 6.5 Histological data regarding the mean multi-layered follicle number per mg of tissue 
and mean percentage of multi-layered follicles in tissue fixed on days 0 and 8 of culture 
following treatment with Ringer’s solution only (non-perfused control) or whole ovary 
perfused with Ringer’s solution followed by perfusion with either CPA solution or L-15 for 10, 
30 or 60 minutes.  The values are mean ± SEM for the 6 and 4 culture repeats, for days 0 and 8, 
respectively.  Data were analysed using one-way ANOVA.  No statistical differences (p>0.05) in 
number or percentage of multi-layered were found between treatments. 
 Perfusion time 
(minutes) 
Treatment Day 
Mean per 
mg tissue 
SEM of 
mean per 
mg tissue 
Mean % 
SEM of 
mean % 
0 
Non-perfused 
control 
0 9.0 2.4 5.0 3.0 
8 0 0 0 0 
10 
CPA 
0 5.8 3.0 1.5 0.5 
8 8.3 2.8 7.3 3.1 
L-15 
0 7.2 3.2 4.3 2.2 
8 1.1 0.7 1.5 1.3 
30 
CPA 
0 3.8 1.8 0.8 0.4 
8 2.9 1.8 2.0 1.0 
L-15 
0 10.3 2.1 4.4 2.8 
8 2.9 1.8 1.8 0.9 
60 
CPA 
0 9.7 2.7 3.8 1.1 
8 2.9 1.8 7.7 4.7 
L-15 
0 10.3 2.7 2.9 1.6 
8 2.9 1.8 2.0 1.0 
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Figure 6.13 Mean percentage of primordial follicles present in tissue fixed on days 0 and 8 of culture following whole ovary perfusion with either CPA or L-15 for 0, 
10, 30 and 60 minutes compared to non-perfused tissue exposed to Ringers’ solution only.  Data is presented as mean ± SEM for the number of culture repeats (n) 
indicated.  Statistical differences between follicle counts in day 0 and 8 tissue within each perfusion time are indicated using * (p<0.05), data was analysed using 
one-way ANOVA.  
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Figure 6.14 Mean number of EP and primary follicles per mg of tissue fixed on days 0 and 8 of 
culture that has been exposed to Ringer’s solution only (Non-perfused - NP) or whole ovary 
perfusion with CPA solution or L-15 for (a) 10 minutes, (b) 30 minutes and (c) 60 minutes.  Data 
is presented as mean number ± SEM for the number of repeats shown (n).  Data was analysed 
using one-way ANOVA, statistical differences between day 0 and day 8 tissue are indicated 
using * (p<0.05).  
 
 
 
 
 
266 
 
 
 
 
Figure 6.15 Mean % of EP and primary follicles present in tissue fixed on days 0 and 8 of 
culture that has been exposed to Ringer’s solution only (Non-perfused - NP) or whole ovary 
perfusion with CPA solution or L-15 for (a) 10 minutes, (b) 30 minutes and (c) 60 minutes.  Data 
is presented as mean % ± SEM for the number of repeats shown (n).  Data was analysed using 
one-way ANOVA, statistical differences between day 0 and day 8 tissue are indicated using * 
(p<0.05).  
 
The integrity of follicles and stromal tissue was assessed histologically in samples fixed on days 
0 and 8 of culture, as shown in Figure 6.16.  The stromal tissue score decreased on day 8, 
compared to day 0 of culture within each treatment group, however, this was only statistically 
significant (p<0.05) following 10 minutes perfusion with L-15, and 60 minutes perfusion with 
either L-15 or CPA.  The effect of whole ovary perfusion and subsequent cortical culture on 
tissue weight was examined in Figure 6.17.  Neither ovary perfusion nor culture had a 
significant effect on tissue weight at the start or end of culture (p>0.05). 
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Figure 6.16 Histological analysis of stromal tissue integrity in tissue fixed on days 0 and 8 of 
culture that has been exposed to Ringer’s solution only (Non-perfused - NP) or whole ovary 
perfusion with CPA solution or L-15 for (a) 10 minutes, (b) 30 minutes and (c) 60 minutes.  The 
overall appearance of the tissue and follicles in the section of tissue was rated as good (3), 
adequate (2) or poor (1).  Values are shown as the mean ± SEM for 4 culture repeats.  Stromal 
tissue score was compared across all treatments using one-way ANOVA and statistically 
significant differences relative to all other treatments (p<0.05) are denoted using *. 
 
 
 
Figure 6.17 Mean tissue weight on days 0 and 8 of culture of tissue that has been exposed to 
Ringer’s solution only (Non-perfused - NP) or whole ovary perfusion with CPA solution or L-15 
for 0, 10, 30 and 60 minutes.  Data is presented as mean ± SEM for 6 culture repeats.  Data was 
analysed using one-way ANOVA.  No statistical differences (p>0.05) were found either within 
treatment groups between day 0 and 8 tissue, or between treatment groups.  
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Figure 6.18 Representative images of tissue fixed following perfusion with either L-15 medium 
or CPA for 0, 10, 30 and 60 minutes either on day 0 or day 8 of culture compared to non-
perfused control tissues.  All follicles are at the primordial or EP stage.  During histological 
analysis only follicles with a visible nucleolus were counted – the oocyte of these follicles is 
labelled ‘O’.  Scale bar = 20μm.   
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Table 6.6 Mean diameter of primordial and EP follicles fixed on days 0 and 8 of culture 
following whole ovary perfusion with either CPA or L-15 for 0, 10, 30 and 60 minutes 
compared to non-perfused control tissues.  The mean and SEM for the number of culture 
repeats indicated (n) are shown.  Data was analysed using one-way ANOVA.  No statistical 
differences in follicle diameter were found between all treatments within all day 0 and all day 
8 data in either primordial or EP follicles. 
 Perfusion 
time 
(minutes) 
Treatment Day  Primordial 
diameter  
(µm) 
Primordial 
diameter 
SEM 
EP 
diameter 
(µm) 
EP 
diameter 
SEM 
0 Non-
perfused 
control 
0 (n=6) 24.3 0.9 31.4 0.7 
8 (n=4) 24.2 0.1 30.7 0.4 
10 CPA 0 (n=6) 24.8 0.4 29.2 2.8 
L-15 23.3 0.3 32.4 0.4 
CPA 8 (n=4) 24.9 0.6 32.6 0.8 
L-15 24.2 0.3 30.9 0.7 
30 CPA (n=4) 0 24 0.4 31.7 0.6 
L-15 (n=6) 24.9 0.2 33 0.5 
CPA 8 (n=5) 24.5 0.4 32.5 0.1 
L-15 24.8 0.2 32.8 0.4 
60 CPA 0 (n=6) 24.5 0.4 31.6 0.5 
L-15 24.4 0.4 32.8 0.5 
CPA 8 (n=4) 24.6 0.2 32 0.3 
L-15 24.2 0.1 31.7 0.2 
 
In order to examine whether perfusing the ovary with CPA had any dehydrating effects that 
would cause cell shrinkage, the diameter of oocytes (see Figure 6.19) and follicles (Table 6.6) at 
the primordial and EP stages was analysed histologically.  Data regarding diameters of follicles 
more developed than the EP stage is not shown because the vast majority of follicles present 
in the ovary are the earlier preantral stages.  Follicles at primordial and EP stages are more 
resistant to cryopreservation procedures and therefore more likely to survive, thus 
dehydration effects upon follicles of these stages are more relevant.  In addition, as follicle 
development progresses there is more variation in size within each category and it becomes 
more difficult to determine whether differences in size were due to osmotic effects or normal 
variability, especially as there were fewer primary, transitional, secondary and EA follicles 
present.  Analysis revealed that perfusion of the whole ovary, regardless of the presence or 
absence of CPA or of the perfusion duration, did not affect the diameter of primordial or EP 
oocytes or follicles.  Therefore, the rehydration steps following CPA perfusion prior to culture 
were sufficient to ensure the cells did not sustain permanent damage due to dehydration as a 
result of the perfusion technique and/or CPA exposure.  
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Figure 6.19 Mean oocyte diameter of (a) primordial and (b) EP follicles present in tissue fixed 
on days 0 and 8 of culture following whole ovary perfusion with either CPA or L-15 for 0, 10, 30 
and 60 minutes or following exposure to Ringer’s solution only (non-perfused controls).  Data 
is presented as mean ± SEM for 6 culture repeats.  Data was analysed using one-way ANOVA.  
No statistical differences in oocyte diameter were found between any of the treatments within 
all day 0 and all day 8 data in primordial and EP follicles.  
  
6.4 Discussion 
The data obtained via NMR analysis indicates that the level of DMSO detected in the pedicle 
tissue increased significantly after a much shorter perfusion time than the cortical tissue, 10 
and 60 minutes respectively.  This is to be expected as the pedicle tissue is much softer and 
more permeable than the more fibrous cortical tissue (Bedaiwy et al., 2003).  The increased 
length of exposure to the CPA, when the pedicle already has a high level of DMSO permeation, 
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is therefore likely to contribute towards to the micro-vascular damage that has previously 
been observed and thought to result in the high levels of follicle depletion following re-
transplantation  of frozen-thawed whole ovaries (Onions et al., 2009).  Note that the process 
of cannulating the ovary may also have mechanically damaged the pedicle vasculature, but this 
parameter was not analysed.  In a recent study the effect on the permeability of blood vessels 
in ovine ovaries was assessed using fluorescent microspheres 7 days after autotransplantation 
(Onions et al., 2013).  The ovaries were either fresh (i.e. they had not been perfused), perfused 
with 1.5M DMSO but not cryopreserved, or perfused with 1.5M DMSO and cryopreserved.  
Subsequent analysis of ovarian sections showed that the perfusion process itself damaged the 
ovarian vasculature as in 50% of ovarian medullae from perfused but not cryopreserved 
ovaries, unlike in non-perfused ovaries; the 100nm fluorescent microspheres were able to 
penetrate the smooth muscular wall of the blood vessel.  Ovaries that were both perfused and 
frozen-thawed prior to autotransplantation exhibited even greater signs of microvascular 
damage as the 100nm fluorescent microspheres were detected in the smooth muscular wall of 
the blood vessel in 80-90% of ovarian medullae from these ovaries.  It would be interesting to 
use this technique to assess the level of damage to the pedicle vasculature following the 
different perfusion times used in the present studies. 
 
Surprisingly, successful cryopreservation of whole ovine ovaries has been reported following 
only 3 minutes of perfusion with 1.3M DMSO (Arav et al., 2010).  The fact that the ovaries 
remained functional for 6 years suggests that this was a sufficient length of time to fully 
permeate the ovarian tissue.  However, the details of the perfusion rate are not given and CPA 
penetration was not reported and therefore it is difficult to directly compare the two studies.  
Furthermore a novel multithermal gradient freezing methodology was used in this study, 
whereas the protocol being developed and tested in the current study is being optimised for 
whole ovary, slow-freezing methods.  In addition, the animals used in the published study 
were all ~9 months of age, whereas older animals were used in the current study, therefore 
the ovaries perfused in the current study were larger, more fibrous and less permeable to 
DMSO, thus it was expected a longer perfusion time would be required.  In addition the 
ovaries of lambs have a larger primordial follicle reserve than the ovaries of older animals. 
 
The length of time and the rate at which ovaries are perfused with DMSO varies between 
studies, furthermore some studies utilised pumps (Onions et al., 2008, Onions et al., 2009) 
whereas others performed perfusion manually (Imhof et al., 2006).  There are a number of 
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studies in which ovaries were perfused with 1.5M DMSO at the same rate as used in our study 
(Onions et al., 2008, Onions et al., 2009, Onions et al., 2013).  In these investigations ovaries 
were perfused with DMSO for 60 minutes and the data should be directly comparable to that 
obtained in the current investigation. 
 
The highest level of DMSO permeation was reported after 60 minutes perfusion in the current 
study.  Histological examination of the tissue indicated that the length of perfusion per se had 
a detrimental effect on subsequent follicle survival after 8 days of culture in both the CPA and 
L-15 perfused ovaries (see Figure 6.12).  Indeed, CPA perfusion for only 30 minutes significantly 
reduced follicle numbers on day 8 of culture.  This is unsurprising as DMSO is known to have 
cytotoxic effects via its chemical toxicity and the osmotic stress experienced by exposed cells, 
as detailed in Section 6.1.3 (Meryman, 1971).  As the follicle counts on day 0 did not 
significantly differ between the non-perfused tissue and the perfused tissue in any treatment 
group this shows that the effects of CPA exposure on follicle survival are not immediate, rather 
the damage is sub-lethal.  This is similar to observations in previous studies in which primordial 
follicle density, assessed histologically, was not significantly different in perfused and non-
perfused ovine ovaries (Courbiere et al., 2005).  The data regarding oocyte and follicular 
diameter shows that there are no obvious short-term or long-term dehydration effects of 
perfusion or CPA exposure resulting in cell shrinkage at the start or end of culture (see Figure 
6.19 and Table 6.6).  Therefore the method of rehydration utilised was adequate and unlikely 
to be the cause of the increased levels of follicle degeneration in CPA perfused tissue. 
 
Information from small rodent models regarding follicle population dynamics is scarce as many 
articles focus on the presence or absence of follicles at different stages, rather than the actual 
follicle counts (Harp et al., 1994, Candy et al., 2000).  However, Yin et al. (2003) reported a 
significant decrease in number of both primordial and growing follicles following the 
orthotopic transplantation of cryopreserved whole ovaries, compared to fresh ovaries in rats.  
Similarly, a reduction in the number of primordial and growing follicles was reported following 
the WOCP and orthotopic transplantation of mouse ovaries, with primordial follicles exhibiting 
a higher survival rate than growing follicles (Candy et al., 1997). 
 
Previous studies have shown a decrease in follicle number following CPA exposure and 
cryopreservation of ovine ovarian tissue (Newton et al., 1996, Amorim et al., 2003).  Although, 
Hovatta et al. (1996) reported no significant difference in the level of follicular atresia in 
273 
 
 
 
human tissue following 1.5M DMSO exposure and cryopreservation compared to fresh tissue.  
The use of DMSO as a CPA ameliorates these effects on follicle survival to a greater extent than 
other CPAs in ovine ovarian tissue (Amorim et al., 2003, Santos et al., 2006).  Less research has 
been conducted regarding CPA exposure alone, however, exposure to 1.5M DMSO has been 
shown to significantly reduce the proportion of viable isolated ovine primordial follicles and 
primordial follicles in situ in cortex, both prior to and after 5 days culture (Santos et al., 2007).   
 
The increase in the percentage of primordial follicles after 8 days of culture compared to day 0, 
shown in Figure 6.13, is most pronounced in the 60 minute CPA perfused tissue and reached 
statistical significance only in this group (p<0.05).  As cortical tissue culture is not optimal for 
follicles that have progressed past the transitional stage of development (see Chapter 4) the 
more developed follicles present on day 0 were more prone to degeneration than primordial 
and EP follicles (Hovatta et al., 1999).  Furthermore, follicles that activated prior to culture may 
have started to degenerate in vivo but were not yet displaying any morphological signs of 
atresia (Telfer et al., 2008).  The data presented here support the notion that primordial 
follicles are more tolerant to the perfusion process and cytotoxic insults than other 
classifications of follicles.  This finding is advantageous in terms of fertility preservation 
strategies for a number of reasons. Firstly primordial follicles are the most abundant follicles 
present in the ovaries (Gosden and Telfer, 1987b) and secondly they display the highest level 
of tolerance to the cryopreservation procedure (Newton et al., 1996).  Furthermore, previous 
studies utilising ovine ovarian tissue slices have shown that more developed preantral follicles 
can survive the cryopreservation procedure (Newton et al., 1999b) but that these follicles 
degenerate soon after grafting due to ischaemia (Gosden et al., 1994, Baird et al., 1999). 
 
Follicle losses following orthotopic transplantation of whole ovaries have been attributed 
partly to the cannulation and perfusion procedure, as these processes can result in poor 
vascular patency so affecting follicle survival following grafting (Bedaiwy et al., 2003).  
However, more recent research has shown that full patency of the vasculature can be achieved 
following whole ovary perfusion and cryopreservation (Onions et al., 2009).  Despite this, 
significant primordial follicle loss was still observed following grafting.  It should be noted that 
there was some evidence of damage to the microvasculature of the pedicle (Onions et al., 
2013) that may have been the cause of this effect and that this damage can be overcome by 
use of anti-thrombotic agents (BK Campbell and HM Picton, unpublished data).  In a more 
recent study whole ovine ovaries were perfused with Indian ink following 1.5M DMSO 
274 
 
 
 
perfusion, cryopreservation and thawing (Maffei et al., 2013).  This revealed that the 
vasculature in the cortex and medulla appeared to remain intact.  The perfusion duration used, 
however, was only 5 minutes therefore, in light of the present findings it would be essential to 
repeat this investigation to assess the impact of increasing the perfusion duration to 60 
minutes to match the optimal time for penetration of the whole ovary by DMSO.  
 
Collectively, the results presented in the current study, along with previous investigations 
which utilise a similar perfusion protocol suggest that it may not be damage to the vasculature 
that results in the large loss of follicles following grafting, but some other aspect of the 
perfusion process itself (Onions et al., 2009, Onions et al., 2013).  In this investigation 
increasing the perfusion duration rather than the cannulation process resulted in increasing 
levels of follicle loss (see Figure 6.12).  Indeed, mechanical damage to the pedicle vasculature 
and capillaries cannot have caused the follicular loss observed in the current culture 
experiments as increasing the length of the perfusion increased the level of follicle loss, in both 
the CPA and L-15 medium.  It would be interesting to explore the use of other markers of cell 
stress and damage to assess the effects of perfusion pressure and cryopreservation on follicle 
number and health and cortex integrity.  
 
While the focus of many of the earlier studies into the effects of ovarian tissue 
cryopreservation has been the survival, health and developmental competence of follicles and 
oocytes, a novelty of the current work is the investigation of the impact of CPA exposure and 
perfusion on stromal integrity.  The importance of maintaining the health of the stroma is 
increasingly being recognised.  Maintenance of stromal tissue integrity and morphology is of 
great importance to both the maintenance of the primordial reserve and to primordial 
activation and continued development as it provides the scaffold for the follicles and oocytes, 
without which oocyte-somatic cell interactions may be compromised.  Receptors and growth 
factors expressed by ovarian stromal cells are required for primordial follicle activation, such a 
c-kit, and development, and BMP4 and BMP7 (Knight and Glister, 2006).  Therefore, more 
recent studies of ovarian tissue health and whole ovary cryopreservation have used methods 
to assess stromal viability.  In the current study the health of the stromal tissue was assessed 
both in fresh tissue and histologically.  As described earlier the process of whole ovary 
perfusion with either CPA or L-15 medium for 0-60 minutes did not have an immediately 
apparent detrimental effect on follicle viability.  Nor did it appear to affect long-term stromal 
tissue viability following 8 days culture (see Table 6.2).  Similarly, when stromal tissue and 
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follicle integrity were assessed histologically, there was no apparent immediate effect on 
stromal health (see Figure 6.16).  Tissue fixed after 8 days culture, however, exhibited loss of 
integrity, particularly following 60 minutes perfusion with either CPA or L-15 medium (p<0.05).  
A significant decrease in integrity was also observed in day 8 tissue that had been perfused 
with L-15 medium for 30 minutes.  Although it is unclear why the follicle and tissue integrity 
was this poor in this group as the variation in the data is low, in support of the ideas presented 
here, stromal tissue damage has been proposed to be a major contributing factor in follicular 
burn out and premature ovarian failure following exposure to chemotherapeutic agents 
(Gavish et al., 2014).  Furthermore, a decrease in ovine ovarian stromal tissue integrity 
following exposure to cryoprotectants has been observed in a number of previous studies.  
Faustino et al. (2010) used light microscopy to determine the mean number of stromal cells 
per 100μm in ovine ovarian tissue following exposure of fragments to 1.0M or 1.5M EG 
followed or not by cryopreservation.  A significant reduction in density was observed following 
CPA exposure alone for 5-20 minutes and a further reduction was observed following 
cryopreservation.  The effect of CPA exposure and cryopreservation was also assessed by 
Oskam et al. (2010) using a slightly more rigorous methodology.  Ovine ovarian tissue was 
assessed histologically.  Acid Fuchsin Orange G was used to stain the tissue which was then 
examined using transmission election microscopy and scored according to the percentage of 
pyknotic stromal cells and the level of oedema.  Tissue fragments were exposed to either 1.5M 
EG or 1.5M PROH for 30 minutes.  Although an increase in the percentage of pyknotic cells and 
the level of oedema was observed this was not significantly higher than that observed in 
control tissue.  Exposure of ovarian tissue to PROH, however, resulted in a significant increase 
in the aforementioned parameters.  More recently the same group extended this study by 
using similar techniques to assess the quality of ovine stromal tissue following 1.5M PROH 
exposure and subsequent cryopreservation followed by either in vitro culture or 
xenotransplantation into SCID mice, which revealed an irreversible level of damage to the 
stromal tissue (Oskam et al., 2011).  The effect of WOCP on the health of stromal tissue has 
also been previously investigated (Maffei et al., 2013).  Here whole ovine ovaries were 
perfused with 1.5M DMSO for 5 minutes then cryopreserved using conventional freezing.  
Ovaries were then thawed and analysed histologically.  Stromal density was assessed by 
counting nuclei, revealing a significant reduction in the cryopreserved compared to the control 
tissue.  The level of proliferation was also analysed using a polyclonal antibody for Ki67, with 
no significant effect observed on day 0 but a significant reduction in expression observed 
following 7 days in vitro culture, compared to control tissue. On this basis it would be of value 
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to conduct a more detailed evaluation of stromal cell number in the tissue for the different 
CPA and perfusion treatments used in the current series of experiments. 
 
As discussed in detail in Chapter 4 the identification of markers of stromal normality and 
health would be highly useful in determining the effect of damage to stromal tissue on follicle 
loss as a result of ovarian perfusion, CPA exposure and freeze-thaw protocols.  In addition 
determination of the exact mechanisms of follicle loss induction may enable the development 
of methods to reduce/ counteract said mechanisms (Morgan et al., 2012, Morgan et al., 2013). 
  
In a recent study conducted by Onions et al. (2013) the expression levels of genes and/or 
proteins associated with apoptosis – Bax, Bcl2 and Casp6; shear stress – ET-1; wound repair- 
thrombospondin 1 (THBS1); and hypoxia - THBS1, Ki67, ET-1 and ET-2, were quantified in 
response to the whole ovary perfusion and cryopreservation.  Up-regulation of ET-2 expression 
by the cells in the pedicle accompanied by the down-regulation of THBS1 expression in both 
the pedicle and medulla suggests that these cells experienced hypoxia as a result of the 
perfusion process.  In addition increased levels of Ki67 were observed in the ovarian stromal 
cells.  Up-regulation of Ki67 is observed in cells in hypoxic conditions.  Up-regulation of Ki67, 
however, is also a sign of cell proliferation, as mentioned above, suggesting that the stromal 
cells were healthy and able to proliferate following whole ovary perfusion and 
cryopreservation.  Although expression of Bax was up-regulated and Bcl2 down-regulated in 
response to perfusion and cryopreservation in both the pedicle and medulla, thus promoting 
apoptosis, the level of Casp6 expression was down-regulated in the medulla suggesting that in 
this tissue type apoptosis was suppressed.  As mentioned above THBS1 expression was down-
regulated in both the pedicle and medulla in response to ovary perfusion suggesting that this 
process results in injury and induces wound repair.  It would be interesting to combine the 
methods utilised in the current study and that conducted by Onions et al. (2013) in order to 
determine the effects of varying perfusion duration on the expression levels of genes 
associated with the stress response of cells at the start and end of cortical culture.  Finally, the 
process of transferring the ovarian tissue, which was kept at 4°C throughout the perfusion 
process, to media, pre-warmed to 37°C immediately prior to auto-transplantation of the tissue 
may result in heat shock.  In order to further evaluate this the expression levels of heat shock 
proteins could be analysed (Samali and Orrenius, 1998).   
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In addition to assessing gene expression profiles to determine whether the tissue encountered 
hypoxic conditions the levels of metabolites in spent culture media collected following 
perfusion could be measured.  An enzyme-linked ultra-microfluorescence assay has previously 
been used to assess the consumption and/ or production of glucose, pyruvate and lactate by 
murine oocytes and embryos (Leese and Barton, 1984, Harris et al., 2005, Harris et al., 2009) 
and it has been used as a means of assessing glucose metabolism as an index of tissue stress 
during ovine cortex culture (Gunson, 2009)  This method could be developed and adapted for 
the current experimental series to quantify the levels of metabolites in spent media following 
0, 10, 30 and 60 minutes perfusion such that levels of pyruvate consumption relative to 
glucose consumption could be used to determine whether the duration of perfusion affects 
which energy production pathway is favoured- namely glycolytic conversion of glucose to 
lactate or the Krebs cycle (Berg et al., 2002, Harris et al., 2009).  Decreasing levels of pyruvate: 
glucose consumption would be indicative of increasingly hypoxic conditions.  The ratio of 
glucose consumption to lactate production could also be used as an indicator of the level of 
anaerobic glycolysis, with increasing levels of lactate production relative to glucose 
consumption being observed in increasingly hypoxic conditions (Berg et al., 2002, Harris et al., 
2009). 
 
One of the causes of increased follicular loss observed in the current experimental series may 
have been the increased length of time the tissue was kept in either CPA or L-15 medium plus 
10% FCS, both of which are utilise L-15 as the basal medium. The composition of L-15 medium, 
Ringer’s solution and partial composition of the ovine oviduct plasma (Black et al., 1970) is 
shown in Appendix IV.  L-15 medium is not of the exact same composition as blood and 
therefore is not optimal for maintenance of the health of the ovarian somatic cells and 
follicles.  The metabolic needs of the oocytes may not have been met during this period 
although this is unlikely as L-15 medium contains 9mgml-1 galactose, which can be converted 
into glucose and used as a metabolite (Berg et al., 2002).  The final concentration of galactose 
in both perfusion media used is ~8mgml-1 which is therefore much higher than the 
concentration of glucose (0.000285mgml-1) in blood in the ovine oviduct (Brackett and 
Mastroianni Jr, 1974).  The concentrations of ions in the medium are different to that in the 
blood (Black et al., 1970).  For example, the concentration of chloride ions in the oviduct blood 
is 3.94gL-1, which differs slightly from that of the culture media (4.40gL-1) and the both 
perfusion media (5.4gL-1).  Therefore differences in the composition of the blood and perfusion 
media used, with respect to ions, metabolites and amino acids, as well as differences in the 
viscosity and flow rate in vivo compared to in vitro, may have a detrimental effect on the 
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stromal tissue and/or the follicles and oocytes (Onions et al., 2013).  Note that maintaining the 
health of the stromal tissue is of great importance for the continued development of the 
follicles (Onions et al., 2013).  In a recent study ovine ovaries were perfused with blood, 
however, the ovaries were not then grafted back into the animal (Onions et al., 2013).  It 
would be interesting to investigate the effects of perfusing the ovaries with ovine blood and 
also of adjusting the perfusion flow rates and hence pressure and then either grafting the 
ovaries or culturing the cortical tissue and assessing follicle dynamics in order to determine 
whether this improves the subsequent follicle survival rate.   
 
The increased length of time for which the ovaries were kept at 4°C may have had a 
detrimental effect on the subsequent health of the follicles in vitro.  However, previous 
research suggests this may not be the case.  In a similar investigation, conducted by Onions et 
al. (2008), in one group cannulations were performed immediately after oophorectomy 
whereas in another group cannulations were delayed whilst ovaries were transported from the 
abattoir to the laboratory.  If the follicles in ovaries in the former group exhibited higher rates 
of survival than in the latter, following orthotopic transplantation this may suggest that the 
lack of metabolites during this short period of time does have a detrimental effect on follicle 
survival.  However, this was not the case and similar levels of follicle survival were exhibited in 
both groups.   
 
It is possible that the ovaries started to ‘dry-out’ during the perfusion process.  Even though 
care was taken to pipette media over the ovaries throughout the perfusion period this may not 
have been sufficient.  Therefore in order to optimise the protocol it may be better to 
completely submerge the ovary in the perfusion media throughout the entire perfusion period.  
As one of the aims of this investigation was to determine the level of DMSO permeation into 
the cortical tissue from the ovarian artery this was not appropriate in the current experimental 
series.  It is also possible that the perfusion process did not allow the media to effectively 
penetrate all areas of the ovary.  Never-the-less the perfusion method utilised here has been 
successfully used to cryopreserve ovaries therefore it is unlikely that the permeation was 
incomplete (Onions et al., 2008, Onions et al., 2009, Onions et al., 2013).  This protocol could, 
however, be improved via better optimisation of flow rate and pressure in combination with 
perfusion time. 
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6.5 Conclusion 
This experimental series has confirmed that the ovarian pedicle and cortex have different 
optima for CPA penetration following perfusion. To maximise follicle health and stromal 
integrity following WOCP it is therefore necessary to consider the needs of the different key 
tissues in complex organs such as the ovary as well as the supporting vasculature of the 
ovarian pedicle.  We have successfully used cortex culture as a means to evaluate ovary health 
and follicle developmental competence after perfusion with CPA.  The results of this 
investigation suggest that a minimum length of 60 minutes perfusion is required to 
significantly increase the level of DMSO permeation in the cortical tissue.  However, perfusing 
the ovaries for 60 minutes with CPA is detrimental the subsequent health of the follicles in 
vitro such that perfusion time and CPA exposure time must be balanced against perfusion flow 
rate and temperature to maximise penetration but minimise cytotoxic damage.  These results 
also suggest that it is some aspect of the perfusion process, other than damage to the 
vasculature per se, that results in the increased follicle loss observed in vitro.  In order to 
determine the cause of the increases in follicle loss it would be interesting to repeat the 
investigation with a number of variations.  Perfusion of the ovary with blood, rather than L-15 
control medium would help elucidate whether the composition of the perfusion medium has a 
detrimental effect on follicle survival.  Additionally submerging the ovaries in media to ensure 
the tissue does not dry-out whilst facilitating CPA penetration from the outside into the tissue, 
in conjunction with CPA permeation from inside the medulla outwards towards the outer 
cortex may also help to improve follicle survival and development rates.  More detailed 
measurements of cell and molecular markers of cortex integrity and/or stress and 
measurement of molecular and functional markers of follicle, oocyte apoptosis and hypoxia 
would be of value.   
280 
 
 
 
 
 
281 
 
 
 
7 General Discussion 
7.1 Introduction 
Oogenesis and folliculogenesis are complex and protracted processes.  Increasing survival rates 
of cancer patients, who have been exposed to aggressive treatments that can cause infertility, 
as well as the increased incidence of POF as a result of trauma, disease or the use of ablative 
therapies to treat genetic conditions mean that the development of fertility restoration 
techniques for young girls and women will become increasingly valuable in the future.  Current 
methods of fertility preservation, such as oocyte or embryo cryopreservation are not suitable 
for prepubertal girls, nor are they ideal for women of reproductive age who do not have a life 
partner.  Recent advances in cryobiology have meant that it is now possible to freeze-store 
intact ovarian tissue for girls and young women requiring fertility preservation.  The 
development of methods that facilitate the complete in vitro growth of oocytes from the 
primordial to pre-ovulatory stages, from frozen-thawed tissue for fertility restoration would 
overcome many of the problems posed by the alternative fertility restoration methods.  It is 
essential that prior to the therapeutic use of these methods in humans, parameters for 
determining the normality and competence of in vitro-derived oocytes are established and 
that following fertilisation the health of the resultant offspring can be guaranteed.  In addition 
to this an IVG system that is able to support the normal growth and development of oocytes 
would be an invaluable tool for the advancement and testing of novel freezing methods and as 
a means to quantify the ovotoxicity of new chemotherapy agents and combination therapies. 
 
Therefore the overall aim of this thesis was to develop and validate an IVG culture system that 
could be used to validate and develop new and existing therapies, such as WOCP.  The culture 
system should be able to support the in vitro activation, growth and development of ovine 
oocytes from the primordial follicle stage to produce EA oocytes that are normal and healthy, 
within a physiologically-relevant timeframe.  In order to achieve this goal the first aim of this 
thesis was to optimise the separate steps required to support a multistep IVG culture system 
and then link the steps together, which had not yet been achieved using ovine oocytes.  The 
second aim of this thesis was to compare the use a physiologically-relevant IVG system with an 
accelerated IVG system, with respect to the effects on follicle and oocyte activation, growth 
and normality as well as stromal tissue health and normality.  In addition the third aim of this 
thesis was to identify cellular, histological and molecular markers of follicle and oocyte 
development which could be used to characterise the health and assess the normality of the 
resultant in vitro-derived oocytes.  In order to achieve this it was necessary to establish the 
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normal in vivo expression patterns of oocyte- and somatic cell-specific genes which have been 
identified as key to the process of oogenesis and folliculogenesis, as well as to evaluate 
imprinted gene expression and genes encoding enzymes that regulate the imprinting process, 
the aberrant expression of which has previously been linked to epigenetic and growth 
disorders.  Once the normal expression patterns of candidate oocyte, somatic and epigenetic 
markers were established in vivo these could then be compared to those exhibited by in vitro-
derived oocytes and follicles. 
 
Current methods of ovarian tissue cryopreservation have been optimised for the storage of 
slices of ovarian tissue.  Cryopreserving the whole ovary and its vasculature would greatly 
increase the number of follicles that are preserved and potentially transplanted back into the 
patient.  The process of optimising WOCP is challenging particularly in terms of establishing the 
length of time for which the ovary should be perfused with the CPA.  The perfusion time must 
be sufficient for complete permeation of the ovary to occur however as CPAs have cytotoxic 
effects exposure must be kept to a minimum.  Therefore the final aim of this thesis was to use 
the follicle culture system developed in earlier chapters as a tool to evaluate WOCP for fertility 
preservation and to help define the optimal perfusion time for penetration of whole ovaries 
with CPA by using follicle development in vitro to assess the level of damage to the ovarian 
tissue following CPA perfusion. 
 
7.2 Development of a multi-phase culture system 
Previous research suggests that the IVG of oocytes from the primordial follicle stage will best 
be achieved using a multi-step, serum-free culture system in order to support the changing 
needs of the oocytes and follicles as growth and development progresses (Wandji et al., 1997, 
Wright et al., 1999, Newton et al., 1999b, Hreinsson et al., 2002, Picton et al., 2008).  The 
conditions in the first phase of the culture system must support the activation, growth and 
development of primordial follicles to the preantral stage.  As primordial follicles are not able 
to survive in isolated culture some form of support matrix is required, such as a gel matrix, 
ECM or - as utilised in this thesis - the ovarian cortex itself (Hovatta et al., 1997, Hovatta et al., 
1999).  An in situ ovarian cortical slice culture system was selected in this investigation as in 
previous studies it has been shown to support the growth and development of oocytes and 
provides an environment similar to that encountered by the oocytes in vivo (Eppig and O'Brien, 
1996, Wandji et al., 1996b, Wandji et al., 1997, Wright et al., 1999, Scott et al., 2004a, Telfer et 
al., 2008, McLaughlin and Telfer, 2010, Chambers et al., 2010, Chambers, 2002, Peng et al., 
283 
 
 
 
2010, Magalhaes-Padilha et al., 2012, Fujihara et al., 2012, Liebenthron et al., 2013, Parte et 
al., 2013).  Chapters 3 and 4 of this thesis confirmed and considerably extended previous 
studies which used an ovarian cortical slice culture system to support the activation, growth 
and development of ovine primordial follicles and oocytes over extended periods in vitro. 
 
The rates of primordial follicle activation and development observed in vitro are often greater 
than those observed in the adult ovary in vivo (Wandji et al., 1996b, Wandji et al., 1997, 
McLaughlin and Telfer, 2010, Telfer et al., 2008).  In some culture systems the increased rates 
observed are similar to those observed in ovarian tissue in which few or no developing follicles 
are present, such as the fetal ovary or in frozen-thawed ovarian tissue which has subsequently 
been grafted back into an ovariectomised animal (Chambers, 2002, Kerr et al., 2006, Sawyer et 
al., 2002, Konishi et al., 1986, Oktay et al., 1998, Campbell et al., 2000).  In other culture 
systems a much more accelerated rate of development is observed.  The optimal rate of follicle 
development in vitro is a point of discussion amongst research groups working in this field.  
Some research groups propose that the use of accelerated culture systems reduce both the 
length of time for which the oocytes are exposed to suboptimal conditions and the proportion 
of atretic follicles at the end of culture (Telfer et al., 2008, McLaughlin et al., 2010), thus 
resulting in a greater yield of competent oocytes capable of developing further in vitro.  
Advocates of the use of a physiologically-relevant timescale to support the IVG of oocytes 
suggest that increasing the rate of development to an extent greater than that observed in 
vivo may be damaging to the health and developmental competence of in vitro-derived 
oocytes, as insufficient time would be provided for the necessary accumulation of RNAs and 
proteins required for oocyte maturation to occur (Picton et al., 1998).  In addition there are 
concerns that the epigenetic modifications that occur during oogenesis will not be correctly 
established if there is insufficient time during the period of accelerated growth and 
development, which could be highly detrimental to the subsequent health and developmental 
competence of oocytes and embryos (Kono et al., 1996, Obata et al., 1998, Bao et al., 2000, 
Obata and Kono, 2002).   
 
The aim of Chapter 3 was therefore to determine whether ovine primordial follicles which 
have activated and developed to the preantral stage at a physiological rate in situ (Chambers, 
2002, Chambers et al., 2010) were competent to develop to the EA stage when isolated and 
put into individual culture (Newton et al., 1999b).  The results presented here clearly 
demonstrate that the first step of this multi-phase culture system was able to support the 
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growth and development of ovine primordial follicles up to the multi-layered preantral stages.  
Follicles, EP to secondary- staged, derived following a culture period of 16-23 days were 
isolated and cultured individually.  Only follicles at the secondary stage at the point of isolation 
were competent to develop to the EA stage in individual culture, in agreement with what has 
previously been reported with in vivo-derived follicles (Hovatta et al., 1999, Newton et al., 
1999b).  This is the first report of a 2-step culture system able to support the growth and 
development of ovine primordial follicles to the EA stage at a physiological rate.  Similar 
survival, growth and development rates were exhibited by in vivo- and in vitro-derived 
secondary follicles up to day 19 of preantral culture.  It may be interesting to use transmission 
electron microscopy to assess the effects of both length of isolated preantral follicle culture 
and follicle derivation (i.e. in vivo or in vitro) on the maintenance of oocyte-GC interactions 
during culture, as has been done previously in rats (Zhao et al., 2001). 
 
The duration of the first phase of in situ culture was evaluated in Chapter 3 to test how the 
length of cortex culture would impact on the yield and health of the preantral follicles so 
derived.  To address one of the outstanding questions highlighted above regarding the optimal 
developmental time frame in vitro (i.e. rapid/ accelerated growth rates vs. slow/ physiological 
growth rates) cultures were conducted over a 6 day period in order to determine whether 
follicle activation, growth and development to the secondary stage could be supported in 
defined, serum-free conditions over this short period as has previously been advocated by 
Telfer et al. (2008). Indeed, previous studies utilising bovine and human ovarian tissue have 
reported the development of primordial follicles to the transitional stage following cortical 
culture for 6 days, using an accelerated culture system developed in Edinburgh (Telfer et al., 
2008, McLaughlin and Telfer, 2010).  Therefore in order to determine whether this was 
possible using ovine tissue and to assess the effects on oocyte, follicle and stromal health using 
an accelerated culture, the system developed by the Edinburgh group was adapted and 
compared to the physiologically-relevant, slow growth rate culture system developed in Leeds, 
in Chapter 4. 
 
One parameter by which the physiological and accelerated culture systems were compared 
was the follicle population dynamics at the end of culture.  Collectively, the data reported in 
this thesis (Figure 7.1) clearly show that the overall mean number of primary, transitional and 
secondary follicles present at the end of short-term accelerated culture is significantly reduced 
compared to the numbers generated following long-term physiological rate culture, after 
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correction for tissue weight in vitro.  Use of the long-term physiological rate culture system 
resulted in significantly more transitional (p<0.01) and secondary (p<0.05) follicles at the end 
of the culture period than the short-term accelerated system.  The number of secondary 
follicles derived using the accelerated 6 day system was simply too small to progress to step 2 
and conduct meaningful isolated follicle cultures, therefore it was not possible to compare the 
developmental competence of in vitro-derived secondary follicles, grown using the 
accelerated- or the physiological culture systems.  
 
 
Figure 7.1 Histogram comparing the effect of the use of a short-term accelerated system to a 
long-term physiological system, in which tissue was cultured for 6 or 16-23 days, respectively, 
on follicle population dynamics.  The mean number of primary, transitional and secondary 
follicles per g of tissue present at the end of the culture period ± SEM for the number of 
culture repeats (n) indicated, is shown * and ** indicate statistical significance at p<0.05 and 
p<0.01, respectively. 
 
As previously mentioned, advocates of the use of an accelerated culture system suggest that a 
lower proportion of follicles would be degenerating at the end of short-term culture, 
compared to long-term culture.  Collation of the results from Chapters 3 and 4 of this thesis 
with regard to the mean number of degenerating follicles per mg tissue at the end of culture 
(Figure 7.2), shows that this is not necessarily the case.  While it must be acknowledged that 
increasing the length of cortical culture from 6 to 16-23 days resulted in a significant increase 
(p<0.05) in the mean number of degenerating follicles when using step 1 of the physiological 
culture system, the short-term 6 day accelerated culture system resulted in a higher mean 
number of degenerating follicles both before and after culture, than any of the culture 
durations tested in the physiological culture system. The large amount of variability in the data 
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mean that these differences are not statistically significant (p>0.05).  Therefore it is likely that 
the combination of the method of tissue preparation and/or suboptimal culture conditions 
have resulted in the increased levels of follicle degeneration in the accelerated culture system.  
As described in Chapter 4 the method of tissue preparation used in the studies published by 
the Edinburgh group for bovine and human tissues differs substantially from the method used 
by the Leeds group in that the majority of medulla is removed and the tissue is teased apart 
prior to culture, in order to reduce the concentration of inhibitory factors present.  This 
strategy appeared to be very damaging to the ovine cortical tissue and could be one of the 
causes of the increased rates of follicle degeneration observed when the accelerated culture 
approach was applied to this species.  It is possible that the bovine and human tissue used in 
previous published studies was tougher and therefore less susceptible to mechanical damage.  
The results presented suggest that it would be of value to conduct further studies to 
investigate the impact of methods of reducing damage and/or reducing or conversely 
increasing the amount of medullary or stromal tissue present at the start of culture on follicle 
and oocyte health per se and the developmental potential of primordial follicles and hence 
yield of in vitro- derived secondary follicles.  
 
 
Figure 7.2 Histogram showing the effect of culture system conditions on levels of follicle 
degeneration assessed histologically.  The mean number of degenerating follicles per mg fixed 
tissue at the start and end of culture ± SEM for the number of culture repeats (n) indicated.  
Data was analysed using one-way ANOVA and statistical differences are denoted with the use 
of different letters (p<0.05).  
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Overall the results presented in Chapters 3 and 4 indicate that in the ovine model a 
physiologically-relevant 2-step system is able to support the activation and development of 
primordial follicles to the secondary stage within a period of 16-23 days, and that these 
follicles can then be isolated and put into individual culture and that ~19% are competent to 
develop to the EA stage.  In order to further assess the developmental competence and 
normality of the in vitro-derived follicles and oocytes, in Chapter 5, expression patterns of a 
panel of candidate genes which are central to oogenesis and folliculogenesis were mapped 
across development in vivo and compared to that observed in vitro.  
 
7.3 Assessment of the effect of culture conditions on the health of stromal tissue 
The maintenance of the health and integrity of ovarian stromal tissue during cortical culture is 
of great importance to the health of the follicles and oocytes and their continued growth and 
development (Knight and Glister, 2006).  Therefore a secondary aim of Chapters 3 and 4 was to 
evaluate the effect of different culture environments on the health of the ovarian stromal by 
comparing tissue weight at the start and end of culture.  The ovarian stroma provides a 
biological scaffold essential for the maintenance of oocyte-GC interactions within primordial 
and early preantral follicles, and the stroma is thought to contribute regulatory factor(s) with 
various functions, including the inhibition of primordial follicle assembly (AMH (Nilsson et al., 
2011)), the maintenance of primordial follicle arrest (Telfer and McLaughlin, 2012) and the 
activation primordial follicle growth in vivo, such as KL, KGF, BMP4 and BMP7 (Knight and 
Glister, 2006, McLaughlin and McIver, 2009, Monget et al., 2012).  In addition ovarian stromal 
cells are essential for folliculogenesis as they are the precursors of theca cells (Orisaka et al., 
2006) and produce steroid hormones, A4 and testosterone which promote continued follicle 
growth and development (Qiu et al., 2013)  The survival and growth of the ovarian stroma 
during in situ cortex cultures is therefore of great importance.   
 
The mean tissue weights at the start and end of culture were used an index of stromal viability 
in vitro following cortex exposure to the accelerated 6 day culture system, or short-term 
culture in the slow growth, physiological system for 6 days or long-term culture in the slow 
growth, physiological system for 16-23 days (Figure 7.3).  In none of the culture systems or 
timeframes was the change in cortex tissue weight at the end of culture statistically significant 
(p>0.05) when compared to tissue weights at time 0.  It is however worth noting, that an 
increase in tissue weight indicative of stromal proliferation and/or follicle and oocyte growth 
was recorded at the end of culture for both the short- and long-term time points in the 
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physiological, slow-growth culture system, in contrast the accelerated culture environment 
resulted in a small decrease in weight.  These preliminary findings suggest that the culture 
environment provided by the physiological culture system is better able to support the survival 
and growth of the stromal tissue.  The increase in tissue weight observed using the 
physiological culture system was greater following 16-23 days, than 6 days, which further 
supports the idea that stromal tissue survival and growth continues throughout the culture 
period. 
 
In order to further investigate the effects of tissue preparation and culture conditions on 
stromal tissue proliferation additional markers of stromal health and development are 
required.  In Chapters 4 and 6 the level of stromal cell division was crudely assessed using 
histological techniques.  These methods could be developed in order to determine stromal cell 
density, for example by counting stromal cell nuclei (Maffei et al., 2013).  In addition to this 
stromal cell proliferation could be assessed using polyclonal antibodies for Ki67 or by assessing 
levels of thymidine incorporation (Maffei et al., 2013).  As discussed in Chapter 4, the use of 
stromal cell specific markers, such as vimentin, and the identification of other potential 
markers would aid investigations (Gunson, 2009). 
 
 
Figure 7.3 Effect of culture system on tissue weight at the start and end of the cortical culture 
period.  The effect of using either a system designed to support the accelerated growth of 
follicles over 6 days or the physiological growth of follicles over 6 (short-term) or 16-23 days 
(long-term) on mean tissue weight per well ± SEM for the number of culture repeats (n) 
indicated, is shown.  Data were analysed using one-way ANOVA and statistical differences are 
denoted with the use of different letters (p<0.05).  
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As discussed in Chapters 4 and 6 the health of the stromal tissue was also assessed in fresh 
tissue, via assessment of NR staining.  As discussed above the method of trimming the tissue 
into pyramid shapes, rather than squares and use of needles to tease the tissue apart was 
shown to have a significantly detrimental effect on tissue health in Chapter 4.  Follicle viability 
has been linked to stromal tissue proliferation in feline ovarian tissue in vitro (Fujihara et al., 
2014).  Addition of EGF to the culture media of feline ovarian tissue indirectly resulted in an 
improvement in primordial follicle viability via the activation of the MAPK and PI3K signalling 
pathways which promoted stromal cell proliferation.  Levels of primordial follicle activation, 
however, did not increase.  Thus these results highlight the importance of stromal tissue 
health and proliferation in maintaining follicle viability and supporting physiologically-relevant 
rates of growth and development.  Additionally the increased rates of follicle activation 
observed using the accelerated system compared to the physiological system (See Chapter 4) 
are likely to have resulted from the method of tissue preparation as reducing the thickness of 
cortical tissue has been shown to result in an increase in levels of follicle burnout in both fresh 
and frozen-thawed bovine ovarian tissue, possibly as a result of a reduction in the 
concentration of stromal-derived inhibitory factors (Gavish et al., 2014).  This theory could be 
further tested by manipulating the physiological culture system developed in Chapters 3 and 4 
to determine the effects of cortical slice size, thickness and shape on levels of follicle burnout 
in ovine ovarian tissue. 
 
The methods of stromal health assessment used in Chapters 4 and 6 were not used on tissue 
cultured for 16-23 days therefore in the future it would be interesting to assess the tissue in 
this manner to determine whether the culture conditions are capable of supporting the 
maintenance of stromal integrity for a period of up to 23 days.  It is possible that the increasing 
rates of follicle degeneration observed following long-term culture compared to short-term 
culture are due to decreasing stromal integrity.  As the primordial and small preantral follicles 
require more support and are less able to survive and grow in isolated culture compared to 
multi-layered follicles, as shown in Chapter 3 (Hovatta et al., 1999) it is likely that these follicles 
were degenerating towards the end of the culture period, whereas the multi-layered follicles 
were still provided with sufficient support and therefore were able to survive and grow.  As the 
aim of the cortical culture was to produce competent, healthy multi-layered follicles a culture 
system that supports the integrity of the stromal health for a sufficient length of time for 
primordial follicles to activate and grow to a stage at which less support is required may be 
adequate.  Indeed a slight reduction in stromal integrity may be preferable to ensure follicle 
growth is not restricted.  It would be interesting to investigate these hypotheses in the future.  
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The effects of culture conditions could also be assessed using PCNA/ TUNEL staining 
(Chambers, 2002). 
 
A couple of recent studies have focused on the interaction between caprine GCs and stromal 
cells during co-culture in vitro (Qiu et al., 2013, Qiu et al., 2014).  Regulation between the GCs 
and stromal cells is bidirectional.  Co-culture of stromal cells with GCs resulted in increased 
levels of A4 and testosterone production, STAR and BCL-2 (anti-apoptotic) expression and LH 
responsiveness as well as a decrease in BAX and BAD (pro-apoptotic) expression in stromal 
cells (Qiu et al., 2013).  Similarly the effects of stromal cell co-culture on GCs included 
increased E2 production, STAR expression, cell proliferation, BCL-2 expression as well as a 
decrease in BAX and CASPASE 3 expression (Qiu et al., 2014).  It would be interesting to extend 
these methods using these markers of stromal health (i.e. A4 and testosterone production, LH 
responsiveness, expression of steroidogenic enzymes and pro-/anti-apoptotic genes) to 
ascertain the effects of culture conditions, tissue preparation, exposure to chemotherapeutic 
agents and novel freezing methods on stromal tissue health.  
 
7.4 Analysis of gene expression patterns 
The level of expression of key genes in in vivo- and in vitro-derived follicles was also used as a 
measure of normality.  Analysis of gene expression patterns suggest that the in situ cortical 
physiological culture system utilised in Chapter 3 was able to provide an environment similar 
to that encountered by the follicular somatic cell compartment in vivo as the expression 
patterns of key somatic cell genes in primary, transitional and secondary follicles were similar 
in vivo and in vitro.  The only statistically significant (p<0.05) difference observed was the 
decrease in IGF1R expression in in vitro- compared to in vivo-derived transitional follicles.  In 
contrast the conditions encountered by the follicles during individual preantral culture appear 
to have resulted in the aberrant expression of AMH, IGF1, INHα, INHβA and FST as statistically 
significant increases (p<0.05), with the exception of IGF1 expression, which significantly 
decreased (p<0.05), in levels were detected in in vitro-derived compared to in vivo-derived EA 
follicles.  The fact that the expression patterns of genes were altered to a greater degree 
following exposure to isolated culture, compared to in situ culture is unsurprising as the 
conditions were more different in the former environment to those the follicles are exposed to 
in vivo.  It is also possible that some/all of these changes may be due in part to the impact of 
the removal of the theca cell layer during enzyme isolation and the subsequent growth of 
‘theca-free’ follicles, as discussed in Chapter 5.  It is interesting to note that secondary follicles 
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that were isolated from fresh ovarian tissue and individually cultured until they stopped 
growing and were deemed degenerating also exhibited a significant (p<0.01) increase in INHα, 
INHβA and FST gene expression.  Therefore some of the effects of preantral culture conditions 
on the levels of gene expression in in vitro-derived EA follicles can also be observed in 
secondary follicles.  Although these secondary follicles were degenerating, the fact that INHα, 
INHβA and FST gene expression was higher in follicles that were able to progress to the EA 
stage in vitro show that these aberrations do not necessarily prevent continued growth and 
development.  It would be interesting to investigate the effects of isolated culture on EP, 
primary and transitional follicles in the future.   
 
The expression patterns of oocyte-specific genes, however, were affected by in situ culture 
conditions to a greater extent than somatic-cell specific genes.  Significant decreases (p<0.05) 
in ZP2, GTSF1, BMP6 and BMP15 expression were observed in in vitro-derived secondary 
follicles and in ZP2 and GTSF1 expression in in vitro-derived primary follicles compared to their 
in vivo-derived counterparts.  Of the imprinted genes only the expression of MEST was 
significantly affected by the in situ cortical culture conditions, as lower levels of expression 
were observed in in vitro-derived primary (p<0.01) and transitional (p<0.05) follicles compared 
to in vivo-derived counterparts.  In order to extend this investigation the levels of DNA 
methylation of key imprinted genes could be assessed in in vivo- and in vitro-derived 
counterpart samples. 
 
As discussed in Chapter 5, based on the expression patterns observed in vivo and in vitro the 
genes selected as molecular markers of normality are AMH, IGF1R, INHα, INHβA, ZP2, GDF9, 
GTSF1, BMP6, BMP15, MEST, H19, DNMT1o and DNMT1s.  These are the genes that would 
therefore be used to screen all IVG-derived follicles and oocytes in the future. 
 
In this thesis the molecular techniques developed were utilised to compare the expression of 
genes in in vivo- and in vitro-derived follicles.  In order to extend this work it would also be 
interesting to compare levels of primordial follicle activation in accelerated and physiological 
rate culture systems by analysing the expression patterns of genes associated with follicle 
activation, such as GDF9, LHX8, AMH, mTOR and PTEN (McLaughlin et al., 2011, Parte et al., 
2013).  Additionally, if sufficient numbers of preantral follicles could be derived using an 
accelerated cortical culture system, it would be interesting to compare levels of gene 
expression between both in vivo-derived follicles and follicles derived in vitro using the long-
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term physiological rate system in equivalently staged follicles.  It would also be interesting to 
compare the gene expression patterns exhibited by follicles grown in vitro following 
mechanical isolation (i.e. theca intact) vs. enzymatic recovery (theca free), and the effects of 
using different types of enzymes.  In support of this idea, altering ovarian cortical culture 
conditions has previously been shown to affect the expression levels of genes involved in early 
folliculogenesis in human tissue (Liebenthron et al., 2013).  In this study a conventional cortical 
culture system and a fluidic dynamic cortical culture system were compared.  The expression 
levels of KL, GDF9 and INHB were analysed using RT-PCR.  Use of the dynamic fluidic system 
resulted in a higher number of healthy follicles after 6 days culture as well as increased levels 
of KL, GDF9 and INHB.  Authors suggested that the increased expression of these genes 
indicated increased levels of follicle activation.  Therefore it would be interesting to explore 
methods of optimising particularly the second step of the culture system, in which preantral 
follicles are cultured whilst using a combination of morphological markers, growth and survival 
rates, antral cavity formation rates, steroid hormone assays and gene expression analysis to 
assess the effects of any changes. 
 
7.5 Use of follicle culture as a tool to quantify the impact of cryoprotectant perfusion for 
whole ovary cryopreservation  
The physiological, cortex culture system developed and validated in Chapters 3 and 4 was 
utilised to assess the effects of whole ovary perfusion on stromal tissue health and follicle 
population dynamics in Chapter 6.  It is well established that primordial follicles display the 
highest levels of tolerance to the cryopreservation procedure and therefore their health and 
developmental competence following the perfusion process which precedes WOCP is of great 
importance.  As previously discussed the culture system developed in Chapter 3 supports the 
activation, growth and development of primordial follicles at a physiological rate as well as 
maintaining the health of the stromal tissue, it is therefore a useful tool to quantify the effects 
of CPA exposure and whole ovary perfusion on the immediate health of the stromal tissue and 
its ability to support the growth and development of the early-staged follicle population.   
 
The main aim of Chapter 6 was to determine the minimum perfusion time required for 1.5M 
DMSO to fully permeate the ovine ovarian cortex and vascular pedicle in whole ovaries using 
NMR spectroscopy.  As exposure to DMSO is cytotoxic to ovarian tissue (Meryman, 1971, 
Trounson and Kirby, 1989, Picton et al., 2000, Santos et al., 2006) the second aim of Chapter 6 
was to assess the level of damage to the stromal tissue and follicles using the LDH assay of cell 
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membrane damage in conjunction with NR staining as acute assays of tissue damage/ health, 
in conjunction with 8 day cortex culture and histological analysis as a means to assess the 
longer term impact of CPA cytotoxicity on follicle and oocyte health and developmental 
competence.  In order to significantly increase the level of DMSO permeation in the cortical 
tissue a perfusion period of 60 minutes was required.  It was found that it was the perfusion 
timeframe and/or the perfusion pressure used, rather than the CPA exposure per se that was 
detrimental to the subsequent health of the follicles and stromal tissue in vitro. 
 
In order to extend the findings of this experiment it would be necessary to further analyse the 
integrity or conversely damage to the pedicle tissue by assessing its permeability with 
fluorospheres (Onions et al., 2013).  It would also be of value to use the molecular markers of 
normality developed in Chapter 5 to assess the normality of gene expression, in addition to 
assessing the expression of genes and proteins associated with apoptosis, such as BAX, BCL2 
and CASP6 and hypoxia, such as THBS1, Ki67, and ET-2 (Onions et al., 2013).  As discussed in 
Chapter 6 changes in the expression patterns of THBS1 and ET-2 have been detected following 
whole ovine ovary perfusion and cryopreservation in a manner that suggests the cells of the 
ovarian medulla and pedicle experienced hypoxia.  In addition to this the use of these 
procedures resulted in the up-regulation of pro-apoptotic gene, BAX and down-regulation of 
anti-apoptotic gene, BCL2, in both the pedicle and medulla, however, pro-apoptotic gene, 
CASP6 was down-regulated in the medulla, suggesting that in this tissue type apoptosis was 
suppressed.  Down-regulation of THBS1, which is also associated with wound repair, also 
suggests that this process was induced in the pedicle and medulla.  Further experiments must 
be conducted to balance the perfusion time against perfusion pressure and CPA penetration in 
order to better optimise WOCP.  The next step in optimising this protocol for sheep and/or 
human ovaries is to use the multi-phase follicle culture techniques developed in Chapter 3 to 
test the integrity, health and developmental competence of follicles and oocytes after WOCP.  
 
7.6 Final conclusions 
The research presented in this thesis supports the hypothesis that the complete in vitro 
growth of oocytes is suitable as a tool to both assess the patency of fertility preservation 
systems and as a means to restore female fertility.  
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The first aim of this thesis was to develop and validate a culture system that supports the 
activation, growth and normal development of ovine primordial follicles to the EA stage of 
development within a physiologically relevant timescale.  This was partly achieved in Chapter 3 
as the 2-step system was able to support the activation and development of primordial follicles 
to the secondary stage in situ, within slices of ovarian cortex, then following follicle isolation 
the in vitro-derived secondary follicles were competent to develop to the EA stage.  However, 
although the second step of the system was able to support the growth and development of in 
vivo- and in vitro-derived secondary follicles, the rates of survival and antral cavity formation 
were low.  The second aim of this thesis was to compare the physiologically-relevant IVG 
system developed in Chapter 3 with an accelerated IVG system using various markers of 
normality and in terms of the effects on the rates of follicle activation, growth, development 
and survival.  From the evidence presented in Chapter 4 it can be concluded that the 
activation, growth and development of ovine oocytes is better supported using a 
physiologically-relevant IVG system.   
 
The third aim of the thesis was to identify and establish the normal expression patterns of 20 
important oocyte- and follicular somatic genes across oogenesis and folliculogenesis in vivo 
and to compare these to gene expression patterns in stage-matched oocytes and follicles 
grown in vitro.  The comparison of gene expression patterns in stage-matched follicles 
developed in vivo and in vitro gave an indication of why rates of development and antral cavity 
formation in isolated preantral culture were low as the analysis of gene expression profiles 
revealed aberrant expression of numerous somatic cell genes.  In the future gene expression 
analysis could be used to optimise the preantral follicle culture conditions as culture conditions 
that support normal patterns of gene expression may also result in increased rates of 
development and survival.  If sufficient EA follicles could be derived in vitro following the 
implementation of improvements to the conditions in the first 2 steps the system could be 
extended and ultimately the in vitro growth and development of primordial follicles up to the 
MII mature oocyte stage achieved.  Continued use of markers of normality could be used to 
develop this technique in order to optimise it for the use in humans.  The fourth aim of this 
thesis was to utilise the ovarian cortex culture system at a tool to validate WOCP as a fertility 
preservation strategy, using sheep as a model for humans.  This enabled the investigation of 
the effects of whole ovary perfusion on the growth and survival rates of follicles within the 
perfused ovarian tissue in vitro.  In addition the impact of ovarian tissue preparation and 
culture conditions on stromal tissue integrity in vitro was evaluated.  The results presented in 
Chapters 4 and 6 suggest that the aforementioned factors have a significant effect on stromal 
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tissue integrity.  In the future it would be interesting to extend these findings to determine the 
importance of stromal tissue integrity.  Hopefully eventually the combination of whole ovary 
perfusion and cryopreservation and in vitro growth, maturation and fertilisation of oocytes 
could be used as a safe and reliable method of fertility preservation in large mammals and 
humans.   
 
The development of the technology to support the IVG and development of oocytes is integral 
to improving existing methods of fertility reservation and restoration, but it is also vital to 
assisting in quantifying the likely risk of ovarian tissue and follicle/ oocyte damage or loss 
following cytotoxic insult - in vivo or in vitro - and in developing new and improved methods of 
ovarian preservation, see Figure 7.4.  
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Figure 7.4 Summary of the uses of a physiological IVG culture system. 
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Appendix I. Solutions for Culture Media 
Basal Culture Media 
To make a final volume of 50ml 0.5ml Penilcillin G/ streptomycin solution was added to 49.5ml 
α-MEM with bicarbonate, to give a final concentration of 1%(v/v).  BSA Fraction V (0.05g), fatty 
acid free (A6003);cell culture tested was then added to give a final concentration of 1mgml-1.  
The solution was filter sterilised and stored for up to 2 weeks. 
 
Human Transferrin (5mgml-1) 
Human Transferrin (100mg) was dissolved in 20ml α-MEM containing 0.1% BSA then filtered 
and aliquoted in to 25μl volumes and stored at -20ºC. 
 
Sodium Pyruvate (0.47mM) 
Sodium pyruvate (51.7mg) was dissolved in 10ml of tissue culture grade water, filtered and 
stored at 4ºC until use, for up to one week. 
 
Sodium Selenite (50μgml-1) 
Sodium selenite (1mg) was dissolved in 20ml α-MEM containing 0.1% BSA then filtered and 
aliquoted in to 10μl volumes and stored at -20ºC. 
 
L-Glutamine (200mM) 
L-Glutamine (200mM) was placed in a sonicator bath to ensure full dissolution then aliquoted 
into 500μl volumes and stored at -20ºC.  This solution was not filtered. 
 
Bovine Insulin (10μgml-1) 
Bovine insulin (100mg) was dissolved in 10ml 3% acetic acid in tissue culture grade water (pH 
2-3) then filtered and aliquoted in to 10μl volumes and stored at -20ºC, this is stock 1.  
Immediately prior to use add 1μl of stock 1 to 999μl α-MEM containing 0.1% BSA (10μgml-1). 
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Long R3 IGF-1 (10ngml-1) 
Long R3 IGF-1 (1mg) was added to 10mM Hydrochloric acid (1ml).  Secondly α-MEM (9ml) 
containing 0.1% BSA was added.  The solution was filtered and aliquoted in to 10μl volumes 
and stored at -20ºC. 
 
Ovine FSH for IVG (0.1Uml-1)  
Ovine FSH (50U per vial) was added to α-MEM (500ml) containing 0.1% BSA then filtered and 
aliquoted in to 10μl volumes and stored at -20ºC. 
 
Ovine FSH for IVM (200μgml-1) 
Ovine FSH (9mg) was first dissolved in 4.5ml 10% BSA, then added to 40.5ml M199 (M2154 
bicarbonate-buffered) then filtered and aliquoted in to 250μl volumes and stored at -20ºC. 
 
Ovine LH (0.0023Uml-1) 
Ovine LH (25U per vial) was added to α-MEM (10.87ml) containing 0.1% BSA, this is stock 1.  
Stock 1 (50μl) was added to α-MEM (49.5ml) containing 0.1% BSA then filtered and aliquoted 
in to 10μl volumes and stored at -20ºC. 
 
Ovine LH (200μgml-1) 
Ovine LH (9mg) was first dissolved in 4.5ml 10% BSA, then added to 40.5ml M199 (M2154 
bicarbonate-buffered) then filtered and aliquoted in to 250μl volumes and stored at -20ºC. 
 
Solutions for Enzymatic Isolation of Follicles 
Hyaluronidase Stock (80IUml-1) 
Bovine hyaluronidase (12.1mg) was added to 50ml Hepes-MEM then filtered and aliquoted in 
to 1ml volumes and stored at -20ºC. 
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Collagenase (478.7Uml-1) 
Collagenase (100mg of 478.7Umg-1 solid) was added to Leibovitz L-15 medium containing 10% 
fetal calf serum, then filtered and aliquoted in to 20ml volumes and stored at -20ºC. 
 
Bovine Deoxyribonuclease (DNase; 0.5mgml-1) 
To one vial of DNase (0.5mg/ ~2,000 Kunitz units per vial) sterile PBS (1ml) was added.  The 
solution was then aliquoted in to 42μl volumes and stored at -20ºC. 
 
Bovine Serum Albumin (BSA) Stock (2% (w/v) 
Bovine Serum Albumin (A6003; 5mg) was added to Hepes-MEM (250ml), then filtered and 
aliquoted into 26ml volumes and stored at -20ºC. 
 
10x Buffer Stock 
The 10x buffer stock was made up in a 500ml volumetric flask.  Sodium Bicarbonate (1.6802g), 
Hepes (free acid; 12.51g) and Hepes (sodium salt; 13.665g) were added to the volumetric flask.  
Culture tested water was then added to make up a final volume of 500ml.  The flask was 
inverted 3-5 times to mix, then the solution was filtered and kept at 4ºC for up to 3 months. 
 
Follicle Isolation Medium (FIM) 
Follicle isolation medium was made up in a 500ml volumetric flask as detailed in the table 
below.  Note that the culture tested water was added last to make the solution up to a final 
volume of 500ml.  The flask was inverted 3-5 times to mix, then the solution was filtered and 
stored at 4ºC for up to 2 weeks. 
Additive Volume (ml) 
Stock 
Concentration 
Final 
Concentration 
MEM 10x Stock 50 10x 1x 
Buffer 10x Stock 50 10x 1x 
Penicillin G/ Streptomycin 5 100% 1% 
Sodium Pyruvate 0.5 47mM 0.047mM 
BSA Stock 25 2% (w/v) 1mgml-1 
Heparin 0.2 5000Uml-1 20Uml-1 
Culture tested water Make up to 500ml     
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Composition of basal culture media 
  α - MEM Media (M4526) McCoy's 5a Media (M8403) 
  [1x] [1x] 
COMPONENT 
  Inorganic Salts g/L g/L 
CaCl2•2H2O 0.2 0.132432 
MgSO4 (anhydrous) 0.09767 0.097688 
KCl 0.4 0.4 
NaHCO3 2.2 2.2 
NaCl 6.8 6.46 
Na2HPO4 (anhydrous) 0.122 0.504 
Amino Acids 
  L-Alanine 0.025 0.01336 
L-Arginine • HCl 0.126 0.04214 
L-Asparagine • H2O 0.05 0.04503 
L-Aspartic Acid 0.03 0.01997 
L-Cysteine - 0.02424 
L-Cysteine • HCl •H2O 0.1 - 
L-Cystine • 2HCl 0.0313 - 
L-Glutamic Acid 0.075 - 
L-Glutamine - - 
Glycine 0.05 0.00751 
L-Histidine • HCl • H2O 0.042 0.02096 
Hydroxy-L-proline - 0.01967 
L-Isoleucine 0.052 0.03936 
L-Leucine 0.052 0.03936 
L-Lysine • HCl 0.0725 0.03654 
L-Methionine 0.015 0.01492 
L-Phenylalanine 0.032 0.01652 
L-Proline 0.04 0.1787 
L-Serine 0.025 0.02628 
L-Threonine 0.048 0.01787 
L-Tryptophan 0.01 0.00306 
L-Tyrosine • 2Na • 2H2O 0.0519 0.0261 
L-Valine 0.046 0.01757 
Vitamins 
  Ascorbic Acid - 0.000563 
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L-Ascorbic Acid • Na 0.05 - 
D-Biotin 0.0001 0.001 
Choline Chloride 0.001 0.0002 
Folic Acid  0.001 0.005 
myo-Inositol 0.002 0.01 
Lipoic Acid 0.0002 - 
Niacinamide 0.001 0.036 
Nicotinic Acid - 0.0005 
D-Panthothenic Acid • 
1/2Ca 0.001 0.0002 
Pyridoxal • HCl 0.001 0.0005 
Pyridoxine • HCl - 0.0005 
Riboflavin 0.0001 0.0002 
Thiamine • HCl 0.001 0.0002 
Vitamin B12 0.00136 0.002 
Other 
  D-Glucose - 3 
Glucose 1 - 
Glutathione (reduced) - 0.0005 
Peptone - 0.6 
Phenol Red • Na 0.011 0.011 
Pyruvic Acid 0.11 - 
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Appendix II. Solutions for Histology 
 
4% Paraformaldehyde (PFA) solution 
Paraformaldehyde (4g) was dissolved in phosphate buffer solution (100ml) in a glass bottle 
inside a flow hood, whilst wearing a mask.  The solution was heated to 60ºC with agitation to 
ensure full dissolution.  After allowing the solution to cool to room temperature it was 
transferred to 10ml glass eppendorfs (SLS). 
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Appendix III. Solutions for Molecular Analysis 
Lysis buffer mix 
Reagent Volume (μl) 
DynalR Lysis Buffer (Invitrogen) 910 
RNA later (Invitrogen) 50 
20% Sodium dodecyl sulphate  20 
Igepal 20 
The lysis buffer mix was prepared as detailed in the above table.  Note that the DynalR Lysis 
Buffer was stored at 4ºC and needed time to warm up to room temperature before use to 
prevent precipitation of the RNA later.  The solution was vortexed then stored at -20ºC. 
 
1x Tris Borate EDTA buffer (1xTBE) 
Tris (108g), Boric Acid (55g) and EDTA (7.4g) were added to 10 litres of distilled water and 
mixed on a magnetic stirrer, then stored at room temperature. 
 
1% agarose gel 
Agarose (1g; Bioline Ltd) was added to 100ml 1xTBE and heated in the microwave for 
~2minutes, or until the agarose had completely dissolved.  The solution was cooled by rinsing 
under a cold tap prior to the addition of 2μl ethidium bromide (10mgml-1).  The mixture was 
gently swirled to mix before being poured into a gel tray clamp (Bio-rad Laboratories Ltd, 
Hertfordshire, UK) which contained a comb to form wells.  The gel was left for ~20minutes to 
set, prior to addition of the samples.   
 
Gel loading buffer 
Gel loading buffer was prepared by adding Bromophenol Blue (0.125g), Xylene Cyanol FF 
(0.125g) to Glycerol (15ml) and HPLC grade water (35ml). 
 
1000bp ladder 
The 1000bp ladder was prepared by mixing 100bp marker (12μl; Invitrogen Ltd), loading buffer 
(20μl), 5M NaCl (0.4μl) and HPLC grade water (67.6μl). 
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Primer sequences of excluded genes.  Primers successfully and specifically amplified cDNA 
however, when used for RT PCR analysis of the melting curve along with high levels of 
expression in negative samples lead to these genes being excluded from the study, in Chapter 
5. 
Gene Primer sequence Size (base 
pairs) 
Reference/ Species 
GREMLIN F: 5’ GAAGCGAGACTGGTGCAAAAC 3’ 93 AY942576 (ovine) 
R: 5’ CCGTAGCAGAAGCGGTTGA 3’ 
AREG F: 5’ AAAAGGGAGGCAAAAATGGA 3’ 170  
R: 5’ CTTTTCCCCACATCGTTCAC 3’ 
EREG F: 5’ AGTCCACAGCTGGCTAGGAA 3’ 140 XM2688367 
(bovine) 
R: 5’ CGGGTTTTGTGGAAGACAAT 3’ 
LHR F: 5'CACGGTACCAGGAAATGCTT3' 145 L36329 (ovine) 
R: 5'CAGGTGTGCATTCTCCTTCA3' 
FIGLA F: 5'GCTCCTGGACGACGTGCT3' 114 XM_002691232.1 
(bovine) 
R: 5'CTCCAGCACCAACTGCAC3' 
 
360 
 
 
 
Appendix IV. Solutions for Ovary Perfusion 
Ringer’s Solution 
Ringer’s solution was prepared as detailed in the table below.  The pH was adjusted to 7.2-7.4 
using either 1M HCl or 1M NaOH, as required.  The solution was filter sterilised and stored at 4 
ºC for up to 2 weeks, prior to use.  Immediately prior to use 600μl of heparin (25,000 iuml-1) 
was added per 150ml Ringer’s solution, to give a final concentration of 100iuml-1.  
Reagent Quantity Extra Details 
NaCl 8.3g 
 KCl 0.3g 
 NaHCO3 0.17g 
 MgCl2 5g 
 
CaCl2 (2M) 1ml 
Prepared by adding 2.22g to 10ml distilled 
water 
Distilled 
water 800ml   
 
Cryoprotective Agent (CPA) solution 
A solution of CPA solution was made using the components listed in the table below, then 
adding Leibovitz solution to give a final volume of 100ml.  The pH was adjusted to 7.2-7.4 using 
either 1M HCl or 1M NaOH, as required.  The solution was filter sterilised and stored at 4 ºC for 
up to 1 weeks, prior to use. 
Reagent Quantity Final Concentration 
Dimethylsulphoxide (DMSO; Fisher) 11.72g 1.5M 
Sucrose 3.42g 0.1M 
Fetal calf serum (FCS) 10ml 10% (v/v) 
 
Phenol red-free basal culture medium 
To make a final volume of 50ml 0.5ml PenilcillinG/ streptomycin solution was added to 49.5ml 
phenol red-free α-MEM (Invitrogen), to give a final concentration of 1%(v/v).  BSA Fraction V 
(0.05g), fatty acid free (A6003);cell culture tested was then added to give a final concentration 
of 1mgml-1.  The solution was filter sterilised and stored for up to 2 weeks.  Note that phenol 
red-free α-MEM that was close to its expiry was used as this was optimal for the LDH assay. 
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Composition of L-15 medium (L5520) 
Component gL-1 
Inorganic Salts 
Calcium Chloride 0.1396 
Magnesium Chloride 0.0937 
Magnesium Sulfate (anhydrous) 0.09767 
Potassium Chloride 0.4 
Potassium Phosphate Monobasic (anhydrous) 0.06 
Sodium Chloride 8 
Sodium Phosphate Dibasic (anhydrous) 0.19 
Amino Acids 
L-Alanine 0.225 
L-Arginine (free base) 0.5 
L-Asparagine (anhydrous) 0.25 
L-Cysteine (free base) 0.12 
Glycine 0.2 
L-Histidine 0.25 
L-Isoleucine 0.125 
L-Leucine 0.125 
L-Lysine 0.0937 
L-Methionine 0.075 
L-Phenylalanine 0.125 
L-Serine 0.2 
L-Threonine 0.3 
L-Tryptophan 0.02 
L-Tyrosine (free base) 0.3 
L-Valine 0.1 
Vitamins   
Choline Chloride 0.001 
Flavin Mononucleotide • Na 0.0001 
Folic Acid 0.001 
myo-Inositol 0.002 
Niacinamide 0.001 
DL-Pantothenic Acid (hemicalcium) 0.001 
Pyridoxine • HCl 0.001 
Thiamine Monophosphate • HCl 0.001 
Other   
D-Galactose 0.9 
Phenol Red • Na 0.011 
Pyruvic Acid • Na 0.55 
Additives   
L-Glutamine 0.3 
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Concentration of certain components of ovine oviduct plasma.  Values presented are means 
according to that presented by . 
Component Units Oestrus Metestrus Diestrus 
Sodium mEqL-1 136-138 123-128 136-146 
Chloride mEqL-1 119-126 112-139 127-133 
Potassium mEqL-1 8.24-9.90 7.49-8.38 7.84-8.99 
Bicarbonate mEqL-1 21.8-22.6 15.6-17.0 17.6-21.8 
Calcium mEqL-1 2.72-3.09 2.74-3.81 3.04-3.32 
Magnesium mEqL-1 0.58-0.71 0.67-0.74 0.88-1.04 
Phosphate mEqL-1 0.98-1.02 0.75-1.38 1.38-1.59 
Total phosphorus mg100ml-1 2.28-4.05 1.50-21.3 3.04-4.63 
Acid-insoluble phosphorus mg100ml-1 0.77-0.87 0.46-0.80 0.84-2.07 
Total carbohydrate mg100ml-1 61.2-69.4 43.7-55.0 67.0-69.1 
Protein g100ml-1 0.93-1.45 0.48-2.80 1.59-3.20 
Non-protein nitrogen mg100ml-1 109.1 - - 
Lactate μmolesml-1 2.15-3.91 1.54-3.68 3.44-5.17 
Glucose mg100ml-1 28.5 - - 
Citrate mg100ml-1 0.8 - - 
Lipid choline mg100ml-1 1 - - 
Lipid aldehyde μg100ml-1 1.1 - - 
 
LDH assay – quality controls and standard preparations 
Quality controls (QCs) and Standards (S) were prepared as detailed in the table below, using 
LDH from the Cytotoxicity Detection Kit (Roche). 
Solution Reagent Volume of 
reagent (µl) 
Volume of phenol 
red-free α-MEM (µl) 
Final LDH 
concentration (Uml
-1
) 
Solution 0 LDH (5500Uml
-1
) 20 110 1000 
Solution 1 Solution 0 10 90 100 
Solution 2 Solution 1 10 990 1 
QC4 Solution 2 10 2490 0.004 
QC3 QC4 1000 1000 0.002 
QC2 QC3 1000 1000 0.001 
QC1 QC2 1000 1000 0.0005 
S7 Solution 2 20 1980 0.01 
S6 S7 1000 1000 0.005 
S5 S6 1000 1000 0.0025 
S4 S5 1000 1000 0.00125 
S3 S4 1000 1000 0.000625 
S2 S3 1000 1000 0.000313 
S1 S2 1000 1000 0.000156 
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Appendix V. Supplier Addresses 
Applied Biosystems, 3 Fountain Drive, Inchinnan Business Park, Paisley, UK, PA4 9RF 
Alpha Laboratories Ltd 40 Parham Dr, Eastleigh, Hampshire SO50 4NU, UK 
Baird and Tatlock, P.O. Box 1, Romford, RM1 1 HA. 
Chemlab, Astra House, Christy Close, Southfields Business Park, Laindon, Essex, SS15 6TQ, UK  
Cook Ireland Ltd., O'Halloran Road, National Technological Park, Limerick, Ireland 
Dynex Technologies Headquarters, 14340 Sullyfield Circle, Chantilly, VA 20151-1621, USA 
GE Healthcare, Pollards Wood, Global Headquarters, Diagnostic Imaging Services,  
Greiner,  Maybachstraße 2, 72636 Frickenhausen, Germany 
Invitrogen, LifeTechnologies Ltd, 3 FountainDrive, Inchinnan BusinessPark, Paisley PA4 9RF, UK 
J Penny and Sons,40 Leeds Road Rawdon, Leeds, LS19 6NU, UK 
Life Science, Bio-Rad Laboratories Ltd., Bio-Rad House, Maxted Road, Hemel Hempstead, 
Hertfordshire HP2 7DX 
Linkam Scientific Instruments Ltd., Unit 8 Epsom Downs Metro Centre, Tadworth, Surrey KT20 
5LR, UK 
New England Bio Lab Ltd. 75-77 Knowl Piece, Hitchin SG4 0TY, UK 
Nikon Inc., 1300 Walt Whitman Road, Melville, NY 11747-3064, USA 
Nightingales Lane, Chalfont St Giles, Buckinghamshire, HP8 4SP, UK  
Nunclon Kamstrupvej 90, Post Box 280 Roskilde, Roskilde-DK4 000, Denmark 
National Diagnostics, Unit 4 Fleet Business Park, Itlings Lane, Hessle, East Riding of Yorkshire, 
HU139LX 
Olympus Industrial Stock Road, Southend-on-Sea, Essex SS2 5QH United Kingdom 
Richardson Healthcare, Borehamwood, WD6 1QQ, UK 
Roche Diagnostics Roche Diagnostics Limited, Applied Science, Charles Avenue, Burgess Hill, 
West Sussex, RH15 9RY, United Kingdom 
Sakura Finetek Europe B.V., Flemingweg 10A, 2408 AV Alphen aan den Rijn, P.O. Box 362, 2400 
AJ Alphen aan den Rijn, The Netherlands 
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Sartorius Stedim UK Ltd. Longmead Business Centre Blenheim Road, Epsom KT19 9QQ Surrey, 
United Kingdom 
Scientific laboratory supplies (SLS, Head Office, Orchard House, The Square, Hessel, East Riding 
of Yorkshire, HU13 0AE, UK 
Sigma-Aldrich Company Limited, The Old Brickyard, New Rd, Gillingham, Dorset, SP8 4XT (UK) 
Simport, 2588 Bernard-Pilon, Beloeil, QC J3G 4S5, Canada   
Situatedat: Freshwater Road, Chadwell Heath, Essex, UK 
STARLAB(UK), Ltd, Unit 4 Tanners Drive, Blakelands, Milton Keynes, MK14 5NA, UK 
Sterilin Ltd, Parkway, Pen-y-Fan Industrial Estate, Newport, United Kingdom, NP11 3EF 
Swann-Morton Limited, Owlerton Green, Sheffield, S6 2BJ  
Terumo Europe N.V. 3001 Leuven, Belgium 
Thermo Fisher Scientific, Stafford House, 1 Boundary Park, Boundary Way, Hemel Hempstead, 
Hertfordshire, HP2 7GE, United Kingdom 
VWR International,Unit 15, The Birches, Willard Way, Imberhorne Industrial Estate, East 
Grinstead,  
Vygon, The Pierre Simonet Building, V Park, Gateway North, Latham Rd , Wiltshire, SN25 4DL, 
UK 
West Sussex, RH19 1XZ, UK 
Wilco Beheer B.V. Wg-Plein 275, 1054 SE Amsterdam, Netherlands 
Wilmad, 1172 North West Boulevard, Vineland, NJ 08360 
